This
value
set
has
>1000
codes
in
it.
In
order
to
keep
the
publication
size
manageable,
only
a
selection
(1000
codes)
of
the
whole
set
of
codes
is
shown
|
Code
|
Display
|
|
1-8
|
Acyclovir
[Susceptibility]
|
|
10-9
|
Amdinocillin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
100-8
|
Cefoperazone
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1000-9
|
DBG
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10000-8
|
R
wave
duration
in
lead
AVR
|
|
10001-6
|
R
wave
duration
in
lead
I
|
|
10002-4
|
R
wave
duration
in
lead
II
|
|
10003-2
|
R
wave
duration
in
lead
III
|
|
10004-0
|
R
wave
duration
in
lead
V1
|
|
10005-7
|
R
wave
duration
in
lead
V2
|
|
10006-5
|
R
wave
duration
in
lead
V3
|
|
10007-3
|
R
wave
duration
in
lead
V4
|
|
10008-1
|
R
wave
duration
in
lead
V5
|
|
10009-9
|
R
wave
duration
in
lead
V6
|
|
1001-7
|
DBG
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10010-7
|
R'
wave
amplitude
in
lead
AVF
|
|
10011-5
|
R'
wave
amplitude
in
lead
AVL
|
|
10012-3
|
R'
wave
amplitude
in
lead
AVR
|
|
10013-1
|
R'
wave
amplitude
in
lead
I
|
|
10014-9
|
R'
wave
amplitude
in
lead
II
|
|
10015-6
|
R'
wave
amplitude
in
lead
III
|
|
10016-4
|
R'
wave
amplitude
in
lead
V1
|
|
10017-2
|
R'
wave
amplitude
in
lead
V2
|
|
10018-0
|
R'
wave
amplitude
in
lead
V3
|
|
10019-8
|
R'
wave
amplitude
in
lead
V4
|
|
1002-5
|
DBG
Ab
[Presence]
in
Serum
or
Plasma
|
|
10020-6
|
R'
wave
amplitude
in
lead
V5
|
|
10021-4
|
R'
wave
amplitude
in
lead
V6
|
|
10022-2
|
R'
wave
duration
in
lead
AVF
|
|
10023-0
|
R'
wave
duration
in
lead
AVL
|
|
10024-8
|
R'
wave
duration
in
lead
AVR
|
|
10025-5
|
R'
wave
duration
in
lead
I
|
|
10026-3
|
R'
wave
duration
in
lead
II
|
|
10027-1
|
R'
wave
duration
in
lead
III
|
|
10028-9
|
R'
wave
duration
in
lead
V1
|
|
10029-7
|
R'
wave
duration
in
lead
V2
|
|
1003-3
|
Indirect
antiglobulin
test.complement
specific
reagent
[Presence]
in
Serum
or
Plasma
|
|
10030-5
|
R'
wave
duration
in
lead
V3
|
|
10031-3
|
R'
wave
duration
in
lead
V4
|
|
10032-1
|
R'
wave
duration
in
lead
V5
|
|
10033-9
|
R'
wave
duration
in
lead
V6
|
|
10034-7
|
S
wave
amplitude
in
lead
AVF
|
|
10035-4
|
S
wave
amplitude
in
lead
AVL
|
|
10036-2
|
S
wave
amplitude
in
lead
AVR
|
|
10037-0
|
S
wave
amplitude
in
lead
I
|
|
10038-8
|
S
wave
amplitude
in
lead
II
|
|
10039-6
|
S
wave
amplitude
in
lead
III
|
|
1004-1
|
Direct
antiglobulin
test.complement
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
10040-4
|
S
wave
amplitude
in
lead
V1
|
|
10041-2
|
S
wave
amplitude
in
lead
V2
|
|
10042-0
|
S
wave
amplitude
in
lead
V3
|
|
10043-8
|
S
wave
amplitude
in
lead
V4
|
|
10044-6
|
S
wave
amplitude
in
lead
V5
|
|
10045-3
|
S
wave
amplitude
in
lead
V6
|
|
10046-1
|
S
wave
duration
in
lead
AVF
|
|
10047-9
|
S
wave
duration
in
lead
AVL
|
|
10048-7
|
S
wave
duration
in
lead
AVR
|
|
10049-5
|
S
wave
duration
in
lead
I
|
|
1005-8
|
Indirect
antiglobulin
test.IgG
specific
reagent
[Presence]
in
Serum
or
Plasma
|
|
10050-3
|
S
wave
duration
in
lead
II
|
|
10051-1
|
S
wave
duration
in
lead
III
|
|
10052-9
|
S
wave
duration
in
lead
V1
|
|
10053-7
|
S
wave
duration
in
lead
V2
|
|
10054-5
|
S
wave
duration
in
lead
V3
|
|
10055-2
|
S
wave
duration
in
lead
V4
|
|
10056-0
|
S
wave
duration
in
lead
V5
|
|
10057-8
|
S
wave
duration
in
lead
V6
|
|
10058-6
|
S'
wave
amplitude
in
lead
AVF
|
|
10059-4
|
S'
wave
amplitude
in
lead
AVL
|
|
1006-6
|
Direct
antiglobulin
test.IgG
specific
reagent
[Interpretation]
on
Red
Blood
Cells
|
|
10060-2
|
S'
wave
amplitude
in
lead
AVR
|
|
10061-0
|
S'
wave
amplitude
in
lead
I
|
|
10062-8
|
S'
wave
amplitude
in
lead
II
|
|
10063-6
|
S'
wave
amplitude
in
lead
III
|
|
10064-4
|
S'
wave
amplitude
in
lead
V1
|
|
10065-1
|
S'
wave
amplitude
in
lead
V2
|
|
10066-9
|
S'
wave
amplitude
in
lead
V3
|
|
10067-7
|
S'
wave
amplitude
in
lead
V4
|
|
10068-5
|
S'
wave
amplitude
in
lead
V5
|
|
10069-3
|
S'
wave
amplitude
in
lead
V6
|
|
1007-4
|
Direct
antiglobulin
test.poly
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
10070-1
|
S'
wave
duration
in
lead
AVF
|
|
10071-9
|
S'
wave
duration
in
lead
AVL
|
|
10072-7
|
S'
wave
duration
in
lead
AVR
|
|
10073-5
|
S'
wave
duration
in
lead
I
|
|
10074-3
|
S'
wave
duration
in
lead
II
|
|
10075-0
|
S'
wave
duration
in
lead
III
|
|
10076-8
|
S'
wave
duration
in
lead
V1
|
|
10077-6
|
S'
wave
duration
in
lead
V2
|
|
10078-4
|
S'
wave
duration
in
lead
V3
|
|
10079-2
|
S'
wave
duration
in
lead
V4
|
|
1008-2
|
Indirect
antiglobulin
test.poly
specific
reagent
[Presence]
in
Serum
or
Plasma
|
|
10080-0
|
S'
wave
duration
in
lead
V5
|
|
10081-8
|
S'
wave
duration
in
lead
V6
|
|
10082-6
|
ST
initial
amplitude
6
ms
in
lead
AVF
|
|
10083-4
|
ST
initial
amplitude
6
ms
in
lead
AVL
|
|
10084-2
|
ST
initial
amplitude
6
ms
in
lead
AVR
|
|
10085-9
|
ST
initial
amplitude
6
ms
in
lead
I
|
|
10086-7
|
ST
initial
amplitude
6
ms
in
lead
II
|
|
10087-5
|
ST
initial
amplitude
6
ms
in
lead
III
|
|
10088-3
|
ST
initial
amplitude
6
ms
in
lead
V1
|
|
10089-1
|
ST
initial
amplitude
6
ms
in
lead
V2
|
|
1009-0
|
Deprecated
Direct
antiglobulin
test.poly
specific
reagent
[Presence]
on
Red
Blood
Cells
|
|
10090-9
|
ST
initial
amplitude
6
ms
in
lead
V3
|
|
10091-7
|
ST
initial
amplitude
6
ms
in
lead
V4
|
|
10092-5
|
ST
initial
amplitude
6
ms
in
lead
V5
|
|
10093-3
|
ST
initial
amplitude
6
ms
in
lead
V6
|
|
10094-1
|
ST
slope
in
lead
AVF
|
|
10095-8
|
ST
slope
in
lead
AVL
|
|
10096-6
|
ST
slope
in
lead
AVR
|
|
10097-4
|
ST
slope
in
lead
I
|
|
10098-2
|
ST
slope
in
lead
II
|
|
10099-0
|
ST
slope
in
lead
III
|
|
101-6
|
Cefoperazone
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1010-8
|
Ew
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10100-6
|
ST
slope
in
lead
V1
|
|
10101-4
|
ST
slope
in
lead
V2
|
|
10102-2
|
ST
slope
in
lead
V3
|
|
10103-0
|
ST
slope
in
lead
V4
|
|
10104-8
|
ST
slope
in
lead
V5
|
|
10105-5
|
ST
slope
in
lead
V6
|
|
10106-3
|
ST
wave
end
displacement
in
lead
AVF
|
|
10107-1
|
ST
wave
end
displacement
in
lead
AVL
|
|
10108-9
|
ST
wave
end
displacement
in
lead
AVR
|
|
10109-7
|
ST
wave
end
displacement
in
lead
I
|
|
1011-6
|
Ew
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10110-5
|
ST
wave
end
displacement
in
lead
II
|
|
10111-3
|
ST
wave
end
displacement
in
lead
III
|
|
10112-1
|
ST
wave
end
displacement
in
lead
V1
|
|
10113-9
|
ST
wave
end
displacement
in
lead
V2
|
|
10114-7
|
ST
wave
end
displacement
in
lead
V3
|
|
10115-4
|
ST
wave
end
displacement
in
lead
V4
|
|
10116-2
|
ST
wave
end
displacement
in
lead
V5
|
|
10117-0
|
ST
wave
end
displacement
in
lead
V6
|
|
10118-8
|
ST
wave
mid
displacement
in
lead
AVF
|
|
10119-6
|
ST
wave
mid
displacement
in
lead
AVL
|
|
1012-4
|
Ew
Ab
[Presence]
in
Serum
or
Plasma
|
|
10120-4
|
ST
wave
mid
displacement
in
lead
AVR
|
|
10121-2
|
ST
wave
mid
displacement
in
lead
I
|
|
10122-0
|
ST
wave
mid
displacement
in
lead
II
|
|
10123-8
|
ST
wave
mid
displacement
in
lead
III
|
|
10124-6
|
ST
wave
mid
displacement
in
lead
V1
|
|
10125-3
|
ST
wave
mid
displacement
in
lead
V2
|
|
10126-1
|
ST
wave
mid
displacement
in
lead
V3
|
|
10127-9
|
ST
wave
mid
displacement
in
lead
V4
|
|
10128-7
|
ST
wave
mid
displacement
in
lead
V5
|
|
10129-5
|
ST
wave
mid
displacement
in
lead
V6
|
|
1013-2
|
Ew
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10130-3
|
T'
wave
amplitude
in
lead
AVF
|
|
10131-1
|
T'
wave
amplitude
in
lead
AVL
|
|
10132-9
|
T'
wave
amplitude
in
lead
AVR
|
|
10133-7
|
T'
wave
amplitude
in
lead
I
|
|
10134-5
|
T'
wave
amplitude
in
lead
II
|
|
10135-2
|
T'
wave
amplitude
in
lead
III
|
|
10136-0
|
T'
wave
amplitude
in
lead
V1
|
|
10137-8
|
T'
wave
amplitude
in
lead
V2
|
|
10138-6
|
T'
wave
amplitude
in
lead
V3
|
|
10139-4
|
T'
wave
amplitude
in
lead
V4
|
|
1014-0
|
Ew
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10140-2
|
T'
wave
amplitude
in
lead
V5
|
|
10141-0
|
T'
wave
amplitude
in
lead
V6
|
|
10142-8
|
T
wave
amplitude
in
lead
AVF
|
|
10143-6
|
T
wave
amplitude
in
lead
AVL
|
|
10144-4
|
T
wave
amplitude
in
lead
AVR
|
|
10145-1
|
T
wave
amplitude
in
lead
I
|
|
10146-9
|
T
wave
amplitude
in
lead
II
|
|
10147-7
|
T
wave
amplitude
in
lead
III
|
|
10148-5
|
T
wave
amplitude
in
lead
V1
|
|
10149-3
|
T
wave
amplitude
in
lead
V2
|
|
1015-7
|
Ew
Ag
[Presence]
on
Red
Blood
Cells
|
|
10150-1
|
T
wave
amplitude
in
lead
V3
|
|
10151-9
|
T
wave
amplitude
in
lead
V4
|
|
10152-7
|
T
wave
amplitude
in
lead
V5
|
|
10153-5
|
T
wave
amplitude
in
lead
V6
|
|
10154-3
|
Chief
complaint
Narrative
-
Reported
|
|
10155-0
|
History
of
allergies,
reported
|
|
10156-8
|
History
of
Childhood
diseases
Narrative
|
|
10157-6
|
History
of
family
member
diseases
Narrative
|
|
10158-4
|
History
of
Functional
status
Narrative
|
|
10159-2
|
History
of
Industrial
exposure
Narrative
|
|
1016-5
|
E
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10160-0
|
History
of
Medication
use
Narrative
|
|
10161-8
|
History
of
Occupational
exposure
Narrative
|
|
10162-6
|
History
of
pregnancies
Narrative
|
|
10163-4
|
History
of
pregnancies
|
|
10164-2
|
History
of
Present
illness
Narrative
|
|
10165-9
|
Deprecated
History
of
psychiatric
symptoms
and
diseases
Narrative
|
|
10166-7
|
History
of
Social
function
Narrative
|
|
10167-5
|
History
of
Surgical
procedures
Narrative
|
|
10168-3
|
History
of
Cardiovascular
system
disorders
Narrative
|
|
10169-1
|
History
of
Ear
disorders
Narrative
|
|
1017-3
|
E
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10170-9
|
History
of
Endocrine
system
disorders
Narrative
|
|
10171-7
|
History
of
Eyes
disorders
Narrative
|
|
10172-5
|
History
of
Hematologic
system
disorders
Narrative
|
|
10173-3
|
History
of
Musculoskeletal
system
disorders
Narrative
|
|
10174-1
|
History
of
Nose
disorders
Narrative
|
|
10175-8
|
History
of
Oral
cavity
disorders
Narrative
|
|
10176-6
|
History
of
Reproductive
system
disorders
Narrative
|
|
10177-4
|
History
of
Respiratory
system
disorders
Narrative
|
|
10178-2
|
History
of
Skin
disorders
Narrative
|
|
10179-0
|
History
of
Throat
and
Neck
disorders
Narrative
|
|
1018-1
|
E
Ab
[Presence]
in
Serum
or
Plasma
|
|
10180-8
|
History
of
Throat
and
Neck
disorders
|
|
10181-6
|
History
of
Urinary
tract
disorders
Narrative
|
|
10182-4
|
History
of
Travel
Narrative
|
|
10183-2
|
Hospital
discharge
medications
Narrative
|
|
10184-0
|
Hospital
discharge
physical
findings
Narrative
|
|
10185-7
|
Hospital
discharge
procedures
Narrative
|
|
10186-5
|
Identifying
information
Narrative
Observed
|
|
10187-3
|
Review
of
systems
Narrative
-
Reported
|
|
10188-1
|
Review
of
systems
overview
Narrative
-
Reported
|
|
10189-9
|
Review
of
systems
overview
-
Reported
|
|
1019-9
|
E
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10190-7
|
Mental
status
Narrative
|
|
10191-5
|
Physical
findings
of
Abdomen
Narrative
|
|
10192-3
|
Physical
findings
of
Back
Narrative
|
|
10193-1
|
Physical
findings
of
Breasts
Narrative
|
|
10194-9
|
Physical
findings
of
Neurologic
deep
tendon
reflexes
Narrative
|
|
10195-6
|
Physical
findings
of
Ear
Narrative
|
|
10196-4
|
Physical
findings
of
Extremities
Narrative
|
|
10197-2
|
Physical
findings
of
Eye
Narrative
|
|
10198-0
|
Physical
findings
of
Genitourinary
tract
Narrative
|
|
10199-8
|
Physical
findings
of
Head
Narrative
|
|
102-4
|
Cefoperazone
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1020-7
|
E
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10200-4
|
Physical
findings
of
Heart
Narrative
|
|
10201-2
|
Physical
findings
of
Mouth
and
Throat
and
Teeth
Narrative
|
|
10202-0
|
Physical
findings
of
Nervous
system
Narrative
|
|
10203-8
|
Physical
findings
of
Nose
Narrative
|
|
10204-6
|
Physical
findings
of
Pelvis
Narrative
|
|
10205-3
|
Physical
findings
of
Rectum
Narrative
|
|
10206-1
|
Physical
findings
of
Skin
Narrative
|
|
10207-9
|
Physical
findings
of
Thorax
and
Lungs
Narrative
|
|
10208-7
|
Physical
findings
of
Vessels
Narrative
|
|
10209-5
|
Physical
findings
of
Neurologic
balance
and
Coordination
Narrative
|
|
1021-5
|
E
Ag
[Presence]
on
Red
Blood
Cells
|
|
10210-3
|
Physical
findings
of
General
status
Narrative
|
|
10211-1
|
Physical
findings
of
Sense
of
touch
Narrative
|
|
10212-9
|
Physical
findings
of
Strength
Narrative
|
|
10213-7
|
Surgical
operation
note
anesthesia
Narrative
|
|
10214-5
|
Surgical
operation
note
anesthesia
duration
|
|
10215-2
|
Surgical
operation
note
findings
Narrative
|
|
10216-0
|
Surgical
operation
note
fluids
Narrative
|
|
10217-8
|
Surgical
operation
note
indications
[Interpretation]
Narrative
|
|
10218-6
|
Surgical
operation
note
postoperative
diagnosis
Narrative
|
|
10219-4
|
Surgical
operation
note
preoperative
diagnosis
Narrative
|
|
1022-3
|
Fy
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10220-2
|
Surgical
operation
note
prep
time
duration
|
|
10221-0
|
Surgical
operation
note
specimens
taken
Narrative
|
|
10222-8
|
Surgical
operation
note
surgical
complications
[Interpretation]
Narrative
|
|
10223-6
|
Surgical
operation
note
surgical
procedure
Narrative
|
|
10224-4
|
Hemodynamic
method
special
circumstances
|
|
10225-1
|
Cardiac
measurement
device
Institution
inventory
number
|
|
10226-9
|
Oxygen
content
in
Intravascular
space
|
|
10227-7
|
Cardiac
measurement
device
Vendor
model
number
|
|
10228-5
|
Cardiac
measurement
device
Vendor
serial
number
|
|
10229-3
|
Hemodynamic
method
Type
of
|
|
1023-1
|
Fy
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10230-1
|
Left
ventricular
Ejection
fraction
|
|
10231-9
|
Right
ventricular
Ejection
fraction
|
|
10232-7
|
Oxygen
content
in
Aorta
root
|
|
10233-5
|
Oxygen
content
in
Left
atrium
|
|
10234-3
|
Oxygen
content
in
Right
atrium
|
|
10235-0
|
Oxygen
content
in
High
right
atrium
|
|
10236-8
|
Oxygen
content
in
Low
right
atrium
|
|
10237-6
|
Oxygen
content
in
Mid
right
atrium
|
|
10238-4
|
Oxygen
content
in
Left
ventricle
|
|
10239-2
|
Oxygen
content
in
Right
ventricular
outflow
tract
|
|
1024-9
|
Fy
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10240-0
|
Oxygen
content
in
Right
ventricle
|
|
10241-8
|
Oxygen
content
in
Coronary
sinus
|
|
10242-6
|
Oxygen
content
in
Ductus
arteriosus
|
|
10243-4
|
Oxygen
content
in
Inferior
vena
cava
|
|
10244-2
|
Oxygen
content
in
Left
pulmonary
artery
|
|
10245-9
|
Oxygen
content
in
Main
pulmonary
artery
|
|
10246-7
|
Oxygen
content
in
Right
pulmonary
artery
|
|
10247-5
|
Oxygen
content
in
Pulmonary
wedge
|
|
10248-3
|
Oxygen
content
in
Superior
vena
cava
|
|
10249-1
|
Heart
rate
device
Institution
inventory
number
|
|
1025-6
|
Fy
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10250-9
|
Heart
rate
device
Vendor
model
number
|
|
10251-7
|
Heart
rate
device
Vendor
serial
number
|
|
10252-5
|
Biliary
drain
site
|
|
10253-3
|
Type
of
Biliary
drain
|
|
10254-1
|
Type
of
Peritoneal
drain
|
|
10255-8
|
Type
of
Subarachnoid
drain
|
|
10256-6
|
Biliary
drain
Institution
inventory
number
|
|
10257-4
|
Chest
tube
Institution
inventory
number
|
|
10258-2
|
Enteral
tube
Institution
inventory
number
|
|
10259-0
|
Gastrostomy
tube
Institution
inventory
number
|
|
1026-4
|
Fy
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10260-8
|
GI
tube
Institution
inventory
number
|
|
10261-6
|
Intravascular
tube
Institution
inventory
number
|
|
10262-4
|
IO
tube
Institution
inventory
number
|
|
10263-2
|
Nasogastric
tube
Institution
inventory
number
|
|
10264-0
|
Oral
tube
Institution
inventory
number
|
|
10265-7
|
Peritoneal
drain
Institution
inventory
number
|
|
10266-5
|
Peritoneal
tube
Institution
inventory
number
|
|
10267-3
|
Rate
control
device
Institution
inventory
number
|
|
10268-1
|
Stool
collection
device
Institution
inventory
number
|
|
10269-9
|
Subarachnoid
drain
Institution
inventory
number
|
|
1027-2
|
Fy
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10270-7
|
Synovial
drain
Institution
inventory
number
|
|
10271-5
|
Tube
or
drain
Institution
inventory
number
|
|
10272-3
|
Upper
GI
tube
Institution
inventory
number
|
|
10273-1
|
Bladder
irrigation
tube
Institution
inventory
number
|
|
10274-9
|
Urine
tube
Institution
inventory
number
|
|
10275-6
|
Wound
drain
device
Institution
inventory
number
|
|
10276-4
|
Peritoneal
drain
site
|
|
10277-2
|
Stool
collection
site
|
|
10278-0
|
Subarachnoid
drain
site
|
|
10279-8
|
Biliary
drain
Vendor
model
number
|
|
1028-0
|
Fy
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10280-6
|
Chest
tube
Vendor
model
number
|
|
10281-4
|
Enteral
tube
Vendor
model
number
|
|
10282-2
|
Gastrostomy
tube
Vendor
model
number
|
|
10283-0
|
GI
tube
Vendor
model
number
|
|
10284-8
|
Intravascular
tube
Vendor
model
number
|
|
10285-5
|
IO
tube
Vendor
model
number
|
|
10286-3
|
Nasogastric
tube
Vendor
model
number
|
|
10287-1
|
Oral
tube
Vendor
model
number
|
|
10288-9
|
Peritoneal
drain
Vendor
model
number
|
|
10289-7
|
Peritoneal
tube
Vendor
model
number
|
|
1029-8
|
Fy
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10290-5
|
Rate
control
device
Vendor
model
number
|
|
10291-3
|
Stool
collection
device
Vendor
model
number
|
|
10292-1
|
Subarachnoid
drain
Vendor
model
number
|
|
10293-9
|
Synovial
drain
Vendor
model
number
|
|
10294-7
|
Tube
or
drain
Vendor
model
number
|
|
10295-4
|
Upper
GI
tube
Vendor
model
number
|
|
10296-2
|
Bladder
irrigation
tube
Vendor
model
number
|
|
10297-0
|
Urine
tube
Vendor
model
number
|
|
10298-8
|
Wound
drain
device
Vendor
model
number
|
|
10299-6
|
Biliary
drain
Vendor
serial
number
|
|
103-2
|
Ceforanide
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1030-6
|
Fy
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10300-2
|
Chest
tube
Vendor
serial
number
|
|
10301-0
|
Enteral
tube
Vendor
serial
number
|
|
10302-8
|
Gastrostomy
tube
Vendor
serial
number
|
|
10303-6
|
GI
tube
Vendor
serial
number
|
|
10304-4
|
Intravascular
tube
Vendor
serial
number
|
|
10305-1
|
IO
tube
Vendor
serial
number
|
|
10306-9
|
Nasogastric
tube
Vendor
serial
number
|
|
10307-7
|
Oral
tube
Vendor
serial
number
|
|
10308-5
|
Peritoneal
drain
Vendor
serial
number
|
|
10309-3
|
Peritoneal
tube
Vendor
serial
number
|
|
1031-4
|
Fy
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10310-1
|
Rate
control
device
Vendor
serial
number
|
|
10311-9
|
Stool
collection
device
Vendor
serial
number
|
|
10312-7
|
Subarachnoid
drain
Vendor
serial
number
|
|
10313-5
|
Synovial
drain
Vendor
serial
number
|
|
10314-3
|
Tube
or
drain
Vendor
serial
number
|
|
10315-0
|
Upper
GI
tube
Vendor
serial
number
|
|
10316-8
|
Bladder
irrigation
tube
Vendor
serial
number
|
|
10317-6
|
Urine
tube
Vendor
serial
number
|
|
10318-4
|
Wound
drain
device
Vendor
serial
number
|
|
10319-2
|
Enema
device
Institution
inventory
number
|
|
1032-2
|
Fy
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10320-0
|
Enema
device
Vendor
model
number
|
|
10321-8
|
Enema
device
Vendor
serial
number
|
|
10322-6
|
Potassium
intake
24
hour
|
|
10323-4
|
Wound
drain
fluid
[Appearance]
Lower
GI
tract
|
|
10324-2
|
Breath
rate
device
Institution
inventory
number
|
|
10325-9
|
Breath
rate
device
Vendor
model
number
|
|
10326-7
|
Breath
rate
device
Vendor
serial
number
|
|
10327-5
|
Eosinophils/100
leukocytes
in
Sputum
by
Manual
count
|
|
10328-3
|
Lymphocytes/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
10329-1
|
Monocytes/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
1033-0
|
Fy
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10330-9
|
Monocytes/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
10331-7
|
Rh
[Type]
in
Blood
|
|
10332-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
250
ug
corticotropin
IM
|
|
10333-3
|
Appearance
of
Cerebral
spinal
fluid
|
|
10334-1
|
Cancer
Ag
125
[Units/volume]
in
Serum
or
Plasma
|
|
10335-8
|
Color
of
Cerebral
spinal
fluid
|
|
10336-6
|
Gonadotropin
peptide
[Mass/volume]
in
Urine
|
|
10337-4
|
Procollagen
type
I
[Mass/volume]
in
Serum
|
|
10338-2
|
Barbiturates
[Mass/volume]
in
Serum
or
Plasma
|
|
10339-0
|
Fluoxetine+Norfluoxetine
[Mass/volume]
in
Serum
or
Plasma
|
|
1034-8
|
Fetal
cell
screen
[Interpretation]
in
Blood
|
|
10340-8
|
Molindone
[Mass/volume]
in
Serum
or
Plasma
|
|
10341-6
|
Norpropoxyphene
[Mass/volume]
in
Serum
or
Plasma
|
|
10342-4
|
Sulfamethoxazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10343-2
|
Temazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
10344-0
|
Tranylcypromine
[Mass/volume]
in
Serum
or
Plasma
|
|
10345-7
|
Trihexyphenidyl
[Mass/volume]
in
Urine
|
|
10346-5
|
Hemoglobin
A
[Units/volume]
in
Blood
by
Electrophoresis
|
|
10347-3
|
Babesia
microti
identified
in
Blood
by
Light
microscopy
|
|
10348-1
|
Bordetella
parapertussis
Ab
[Presence]
in
Serum
|
|
10349-9
|
Brucella
sp
Ab
[Units/volume]
in
Serum
|
|
1035-5
|
Fresh
frozen
plasma
given
[Volume]
|
|
10350-7
|
Herpes
simplex
virus
IgM
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
10351-5
|
HIV
1
RNA
[Units/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
with
amplification
|
|
10352-3
|
Bacteria
identified
in
Genital
specimen
by
Aerobe
culture
|
|
10353-1
|
Bacteria
identified
in
Nose
by
Aerobe
culture
|
|
10354-9
|
Bacteria
identified
in
Urethra
by
Culture
|
|
10355-6
|
Microscopic
observation
[Identifier]
in
Bone
marrow
by
Wright
Giemsa
stain
|
|
10356-4
|
Deprecated
Microscopic
observation
[Identifier]
in
Stool
by
Trichrome
stain
|
|
10357-2
|
Microscopic
observation
[Identifier]
in
Wound
by
Gram
stain
|
|
10358-0
|
Teichoate
Ab
[Titer]
in
Serum
by
Immune
diffusion
(ID)
|
|
10359-8
|
Asialoganglioside
GM1
IgM
Ab
[Titer]
in
Serum
|
|
1036-3
|
G
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10360-6
|
DNA
single
strand
IgG
Ab
[Units/volume]
in
Serum
|
|
10361-4
|
DNA
single
strand
IgM
Ab
[Units/volume]
in
Serum
|
|
10362-2
|
Endomysium
IgA
Ab
[Presence]
in
Serum
|
|
10363-0
|
Barbiturates
[Presence]
in
Unspecified
specimen
|
|
10364-8
|
Cotinine
[Mass/mass]
in
Hair
|
|
10365-5
|
Cotinine
[Mass/volume]
in
Serum
or
Plasma
|
|
10366-3
|
Cotinine
[Mass/volume]
in
Urine
|
|
10367-1
|
Ethanol
[Mass/volume]
in
Gastric
fluid
|
|
10368-9
|
Lead
[Mass/volume]
in
Capillary
blood
|
|
10369-7
|
Opiates
[Mass/mass]
in
Hair
|
|
1037-1
|
G
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10370-5
|
Phencyclidine
[Mass/mass]
in
Hair
|
|
10371-3
|
Bite
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
10372-1
|
Blister
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
10373-9
|
Fragments
[Presence]
in
Blood
by
Light
microscopy
|
|
10374-7
|
Helmet
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
10375-4
|
Irregularly
contracted
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
10376-2
|
Oval
macrocytes
[Presence]
in
Blood
by
Light
microscopy
|
|
10377-0
|
Pencil
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
10378-8
|
Polychromasia
[Presence]
in
Blood
by
Light
microscopy
|
|
10379-6
|
Erythrocytes.dual
population
[Presence]
in
Blood
by
Light
microscopy
|
|
1038-9
|
G
Ab
[Presence]
in
Serum
or
Plasma
|
|
10380-4
|
Stomatocytes
[Presence]
in
Blood
by
Light
microscopy
|
|
10381-2
|
Target
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
10382-0
|
A,B
variant
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10383-8
|
A,B
variant
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10384-6
|
A,B
variant
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
10385-3
|
Albumin
concentration
given
|
|
10386-1
|
Albumin
given
[Volume]
|
|
10387-9
|
Autologous
erythrocytes
given
[Volume]
|
|
10388-7
|
Autologous
whole
blood
given
[Volume]
|
|
10389-5
|
Blood
product.other
[Type]
|
|
1039-7
|
G
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10390-3
|
Blood
product
special
preparation
[Type]
|
|
10391-1
|
Cytomegalovirus
immune
globulin
given
[Volume]
|
|
10392-9
|
Cryoprecipitate
given
[Volume]
|
|
10393-7
|
Factor
IX
given
[Type]
|
|
10394-5
|
Factor
IX
given
[Volume]
|
|
10395-2
|
Factor
VIII
given
[Type]
|
|
10396-0
|
Factor
VIII
given
[Volume]
|
|
10397-8
|
Hepatitis
B
immune
globulin
given
[Volume]
|
|
10398-6
|
I
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10399-4
|
I
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
104-0
|
Ceforanide
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1040-5
|
G
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10400-0
|
I
Ag
[Presence]
on
Red
Blood
Cells
|
|
10401-8
|
Immune
serum
globulin
given
[Type]
|
|
10402-6
|
Immune
serum
globulin
given
[Volume]
|
|
10403-4
|
Inject
immune
serum
globulin
[Volume]
|
|
10404-2
|
Inject
Rh
immune
globulin
[Volume]
|
|
10405-9
|
Inject
varicella
zoster
virus
immune
globulin
[Volume]
|
|
10406-7
|
little
i
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10407-5
|
little
i
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10408-3
|
little
i
Ag
[Presence]
on
Red
Blood
Cells
|
|
10409-1
|
Pentaspan
given
[Volume]
|
|
1041-3
|
G
Ag
[Presence]
on
Red
Blood
Cells
|
|
10410-9
|
Plasma
given
[Type]
|
|
10411-7
|
Plasma
given
[Volume]
|
|
10412-5
|
Platelets
given
[Type]
|
|
10413-3
|
Rh
immune
globulin
given
[Volume]
|
|
10414-1
|
Transfuse
albumin
[Volume]
|
|
10415-8
|
Transfuse
blood
exchange
transfusion
[Volume]
|
|
10416-6
|
Transfuse
blood
product
other
[Volume]
|
|
10417-4
|
Transfuse
cryoprecipitate
[Volume]
|
|
10418-2
|
Transfuse
factor
IX
[Volume]
|
|
10419-0
|
Transfuse
factor
VIII
[Volume]
|
|
1042-1
|
H
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10420-8
|
Transfuse
immune
serum
globulin
[Volume]
|
|
10421-6
|
Transfuse
Pentaspan
[Volume]
|
|
10422-4
|
Transfuse
plasma
[Volume]
|
|
10423-2
|
Transfuse
platelets
[Volume]
|
|
10424-0
|
Transfuse
erythrocytes
[Volume]
|
|
10425-7
|
Transfuse
Rh
immune
globulin
[Volume]
|
|
10426-5
|
Transfuse
whole
blood
[Volume]
|
|
10427-3
|
Transfuse
whole
blood
autologous
[Volume]
|
|
10428-1
|
Varicella
zoster
virus
immune
globulin
given
[Volume]
|
|
10429-9
|
AE
1
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1043-9
|
H
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10430-7
|
AE
3
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10431-5
|
B-cell
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10432-3
|
CD30
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10433-1
|
BR-2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10434-9
|
Complement
C3
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10435-6
|
C5B-9
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10436-4
|
CD15
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10437-2
|
CD16
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10438-0
|
CD20
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10439-8
|
CD3
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1044-7
|
H
Ab
[Presence]
in
Serum
|
|
10440-6
|
Deprecated
CD30
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10441-4
|
CD34
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10442-2
|
CD56
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10443-0
|
CD43
T-cell
monocyte+myeloid
cell
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10444-8
|
CD57
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10445-5
|
CD11c
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10446-3
|
Leukocyte
common
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10447-1
|
M-5
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10448-9
|
T-cell
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10449-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
meal
|
|
1045-4
|
H
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10450-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
hours
fasting
|
|
10451-3
|
Proinsulin
[Moles/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
10452-1
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
25
g
xylose
PO
|
|
10453-9
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
xylose
PO
|
|
10454-7
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
25
g
xylose
PO
|
|
10455-4
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
25
g
xylose
PO
|
|
10456-2
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--6
hours
fasting
|
|
10457-0
|
Actin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10458-8
|
Alkaline
phosphatase.placental
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10459-6
|
Alpha-1-Fetoprotein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1046-2
|
H
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10460-4
|
Lactalbumin
alpha
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10461-2
|
Alpha-1-Antichymotrypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10462-0
|
Alpha
1
antitrypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10463-8
|
Amyloid
A
component
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10464-6
|
Amyloid
P
component
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10465-3
|
Amyloid.prealbumin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10466-1
|
Anion
gap
3
in
Serum
or
Plasma
|
|
10467-9
|
Beta-2-Microglobulin
amyloid
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10468-7
|
Calcitonin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10469-5
|
Carcinoembryonic
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1047-0
|
H
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
10470-3
|
Choriogonadotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10471-1
|
Chromogranin
A
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10472-9
|
Chromogranin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10473-7
|
Chymotrypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10474-5
|
Collagen
type
4
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10475-2
|
Corticotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10476-0
|
Desmin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10477-8
|
Enolase.neuron
specific
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10478-6
|
Eosinophil
major
basic
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10479-4
|
CD227
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1048-8
|
H
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10480-2
|
Estrogen+Progesterone
receptor
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10481-0
|
Follitropin.alpha
subunit
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10482-8
|
Follitropin.beta
subunit
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10483-6
|
Gastrin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10484-4
|
Glial
fibrillary
acidic
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10485-1
|
Glucagon
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10486-9
|
Hemoglobin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10487-7
|
HMB-45
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10488-5
|
IgA
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10489-3
|
IgA.heavy
chain
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1049-6
|
H
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10490-1
|
IgE
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10491-9
|
IgG
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10492-7
|
IgG.heavy
chain
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10493-5
|
IgM
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10494-3
|
IgM.heavy
chain
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10495-0
|
Insulin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10496-8
|
Immunoglobulin
light
chains.kappa
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10497-6
|
Immunoglobulin
light
chains.kappa
amyloid
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10498-4
|
Keratin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10499-2
|
Immunoglobulin
light
chains.lambda
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
105-7
|
Ceforanide
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1050-4
|
H
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
10500-7
|
Immunoglobulin
light
chains.lambda
amyloid
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10501-5
|
Lutropin
[Units/volume]
in
Serum
or
Plasma
|
|
10502-3
|
Lutropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10503-1
|
Lysozyme
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10504-9
|
Myelin
basic
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10505-6
|
Myoglobin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10506-4
|
Peanut
agglutinin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10507-2
|
Prolactin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10508-0
|
Prostate
specific
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10509-8
|
Prostatic
acid
phosphatase
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1051-2
|
Hemolytic
disease
of
newborn
screen
[Interpretation]
in
Blood
|
|
10510-6
|
S-100
Ag
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10511-4
|
Serotonin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10512-2
|
Somatostatin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10513-0
|
Somatotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10514-8
|
Synaptophysin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10515-5
|
Thyroglobulin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10516-3
|
Thyrotropin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10517-1
|
Trypsin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10518-9
|
Ulex
europaeus
I
lectin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10519-7
|
Vimentin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1052-0
|
Deprecated
I
(intermediate)
subtype
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10520-5
|
Coagulation
factor
VI
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10521-3
|
Coagulation
factor
VIII
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10522-1
|
Coagulation
factor
XIII
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10523-9
|
Fibrinogen
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10524-7
|
Microscopic
observation
[Identifier]
in
Cervix
by
Cyto
stain
|
|
10525-4
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Cyto
stain
|
|
10526-2
|
Microscopic
observation
[Identifier]
in
Sputum
by
Cyto
stain
|
|
10527-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Cyto
stain
|
|
10528-8
|
Acetophenazine
[Mass/volume]
in
Serum
or
Plasma
|
|
10529-6
|
Amoxapine
metabolite
[Mass/volume]
in
Serum
or
Plasma
|
|
1053-8
|
Deprecated
I
(intermediate)
subtype
[Presence]
in
serum
or
plasma
from
donor
|
|
10530-4
|
Aprobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
10531-2
|
Bretylium
[Mass/volume]
in
Serum
or
Plasma
|
|
10532-0
|
Deprecated
Desethylamiodarone
[Mass/volume]
in
Serum
or
Plasma
|
|
10533-8
|
Propoxyphene+Acetaminophen
[Mass/volume]
in
Serum
or
Plasma
|
|
10534-6
|
Diazoxide
[Mass/volume]
in
Serum
or
Plasma
|
|
10535-3
|
Digoxin
[Mass/volume]
in
Serum
or
Plasma
|
|
10536-1
|
Dipyridamole
[Mass/volume]
in
Serum
or
Plasma
|
|
10537-9
|
Deprecated
Doxepin+Nordoxepin
[Mass/volume]
in
Serum
or
Plasma
|
|
10538-7
|
Deprecated
Fluoxetine+Norfluoxetine
[Mass/volume]
in
Serum
or
Plasma
|
|
10539-5
|
Glipizide
[Mass/volume]
in
Serum
or
Plasma
|
|
1054-6
|
Deprecated
I
(intermediate)
subtype
[Presence]
in
srum
|
|
10540-3
|
Glyburide
[Mass/volume]
in
Serum
or
Plasma
|
|
10541-1
|
Mepivacaine
[Mass/volume]
in
Serum
or
Plasma
|
|
10542-9
|
Metharbital
[Mass/volume]
in
Serum
or
Plasma
|
|
10543-7
|
Methsuximide+Normethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
10544-5
|
Normeperidine
[Presence]
in
Serum
or
Plasma
|
|
10545-2
|
Normephenytoin
[Mass/volume]
in
Serum
or
Plasma
|
|
10546-0
|
Normethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
10547-8
|
Primidone+Phenobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
10548-6
|
Phenytoin
Free/Phenytoin.total
in
Serum
or
Plasma
|
|
10549-4
|
Pirmenol
[Mass/volume]
in
Serum
or
Plasma
|
|
1055-3
|
Deprecated
I
(intermediate)
subtype
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10550-2
|
Deprecated
Temazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
10551-0
|
Triamterene
[Mass/volume]
in
Serum
or
Plasma
|
|
10552-8
|
Tricyclic
antidepressants
[Mass/volume]
in
Serum
or
Plasma
|
|
10553-6
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Genital
fluid
|
|
10554-4
|
Deprecated
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Seminal
plasma
|
|
10555-1
|
Acrosin
[Entitic
Catalytic
Activity]
in
Spermatozoa
|
|
10556-9
|
Deprecated
Adenosine
triphosphatase
[Enzymatic
activity/volume]
in
Seminal
plasma
|
|
10557-7
|
Adenosine
triphosphate
[Moles/volume]
in
Semen
|
|
10558-5
|
Albumin
[Moles/volume]
in
Semen
|
|
10559-3
|
Deprecated
Calcium
[Molecules/volume]
in
Semen
|
|
1056-1
|
Deprecated
I
(intermediate)
subtype
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10560-1
|
Carcinoembryonic
Ag
[Units/volume]
in
Semen
|
|
10561-9
|
Carnitine
[Moles/volume]
in
Semen
|
|
10562-7
|
Cells
[#/volume]
in
Cervical
mucus
|
|
10563-5
|
Cells
other
than
spermatozoa
[#/volume]
in
Semen
|
|
10564-3
|
Cervical
mucus
[Volume]
|
|
10565-0
|
Choriogonadotropin
[Units/volume]
in
Semen
|
|
10566-8
|
Deprecated
Choriogonadotropin
[Molecules/volume]
in
Semen
|
|
10567-6
|
Citrate
[Moles/volume]
in
Semen
|
|
10568-4
|
Clarity
of
Semen
|
|
10569-2
|
Color
of
Semen
|
|
1057-9
|
Deprecated
I
(intermediate)
subtype
[Presence]
on
Red
Blood
Cells
|
|
10570-0
|
Consistency
of
Cervical
mucus
|
|
10571-8
|
Deprecated
Consistency
of
Semen
|
|
10572-6
|
Deprecated
Duration^post
ejaculation
|
|
10573-4
|
Ferning
[Type]
in
Cervical
mucus
|
|
10574-2
|
Fructose
[Moles/volume]
in
Semen
|
|
10575-9
|
Deprecated
Gamma
glutamyl
transferase
[Enzymatic
activity/volume]
in
Semen
|
|
10576-7
|
Germ
cells.immature
[#/volume]
in
Semen
|
|
10577-5
|
Glucosidase
[Enzymatic
activity/volume]
in
Seminal
plasma
|
|
10578-3
|
Glycerophosphocholine
[Moles/volume]
in
Seminal
plasma
|
|
10579-1
|
Leukocytes
[#/volume]
in
Semen
|
|
1058-7
|
I
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10580-9
|
Liquefaction
[Time]
in
Semen
|
|
10581-7
|
Deprecated
Number
of
entities
[#]
in
Spermatozoa
|
|
10582-5
|
pH
of
Cervical
mucus
|
|
10583-3
|
Prostaglandin
F1
alpha
[Moles/volume]
in
Semen
|
|
10584-1
|
Deprecated
Protein
[Mass/volume]
in
Semen
|
|
10585-8
|
Round
cells
[#/volume]
in
Semen
|
|
10586-6
|
Deprecated
Volume
of
Semen
|
|
10587-4
|
Sexual
abstinence
duration
|
|
10588-2
|
Spermatogonia
[#/volume]
in
Semen
|
|
10589-0
|
Spermatids
[#/volume]
in
Semen
by
Streptoavidin-biotin
method
(SAB)
|
|
1059-5
|
I
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10590-8
|
Spermatids
[#/volume]
in
Semen
by
Sertoli
cell
barrier
method
(SCB)
|
|
10591-6
|
Primary
Spermatocytes
[#/volume]
in
Semen
|
|
10592-4
|
Secondary
Spermatocytes
[#/volume]
in
Semen
|
|
10593-2
|
Spermatozoa
Pyriform
Head/100
spermatozoa
in
Semen
|
|
10594-0
|
Spermatozoa
Tapering
Head/100
spermatozoa
in
Semen
|
|
10595-7
|
Deprecated
Spermatozoa
[#/volume]
in
Semen
|
|
10596-5
|
Deprecated
Spermatozoa
Ab
in
cervical
mucosa
|
|
10597-3
|
Deprecated
Spermatozoa
Ab
in
semen
|
|
10598-1
|
Deprecated
Spermatozoa
Ab
in
serum
|
|
10599-9
|
Spermatozoa
penetration
[Presence]
in
Seminal
fluid
and
Cervical
mucosa
by
Kremer
test
|
|
106-5
|
Ceforanide
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1060-3
|
I
Ab
[Presence]
in
Serum
or
Plasma
|
|
10600-5
|
Spermatozoa
penetration
[Presence]
in
Seminal
fluid
and
Cervical
mucosa
|
|
10601-3
|
Spermatozoa
penetration
[Presence]
in
Seminal
fluid
and
Cervical
mucosa
--post
coitus
|
|
10602-1
|
Spermatozoa
Abnormal
Head/100
spermatozoa
in
Semen
|
|
10603-9
|
Spermatozoa
Abnormal
Midpiece/100
spermatozoa
in
Semen
|
|
10604-7
|
Spermatozoa
Abnormal
Tail/100
spermatozoa
in
Semen
|
|
10605-4
|
Spermatozoa
Agglutinated/100
spermatozoa
in
Semen
|
|
10606-2
|
Spermatozoa
Amorphous
Head/100
spermatozoa
in
Semen
|
|
10607-0
|
Spermatozoa
Coiled
Tail/100
spermatozoa
in
Semen
|
|
10608-8
|
Spermatozoa
Cytoplasmic
Droplet/100
spermatozoa
in
Semen
|
|
10609-6
|
Spermatozoa
Duplicate
Head/100
spermatozoa
in
Semen
|
|
1061-1
|
I
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10610-4
|
Spermatozoa
Duplicate
Tail/100
spermatozoa
in
Semen
|
|
10611-2
|
Spermatozoa
Immotile/100
spermatozoa
in
Semen
|
|
10612-0
|
Spermatozoa
Large
Oval
Head/100
spermatozoa
in
Semen
|
|
10613-8
|
Spermatozoa
Viable/100
spermatozoa
in
Semen
|
|
10614-6
|
Spermatozoa
Motile
w
IgA/100
spermatozoa
in
Semen
by
Immunobead
|
|
10615-3
|
Spermatozoa
Motile
w
IgA/100
spermatozoa
in
Semen
by
Mixed
antiglobulin
reaction
|
|
10616-1
|
Spermatozoa
Motile
w
IgG/100
spermatozoa
in
Semen
by
Immunobead
|
|
10617-9
|
Spermatozoa
Motile
w
IgG/100
spermatozoa
in
Semen
by
Mixed
antiglobulin
reaction
|
|
10618-7
|
Spermatozoa
Motile
w
IgM/100
spermatozoa
in
Semen
by
Immunobead
|
|
10619-5
|
Spermatozoa
Motile
w
IgM/100
spermatozoa
in
Semen
by
Mixed
antiglobulin
reaction
|
|
1062-9
|
I
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10620-3
|
Spermatozoa
Nonprogressive/100
spermatozoa
in
Semen
|
|
10621-1
|
Spermatozoa
Normal
Head/100
spermatozoa
in
Semen
|
|
10622-9
|
Spermatozoa
Normal/100
spermatozoa
in
Semen
|
|
10623-7
|
Spermatozoa
Pin
Head/100
spermatozoa
in
Semen
|
|
10624-5
|
Spermatozoa
Rapid/100
spermatozoa
in
Semen
|
|
10625-2
|
Spermatozoa
Round
Head/100
spermatozoa
in
Semen
|
|
10626-0
|
Spermatozoa
Slow/100
spermatozoa
in
Semen
|
|
10627-8
|
Spermatozoa
Small
Oval
Head/100
spermatozoa
in
Semen
|
|
10628-6
|
Spermatozoa
Tail
Swelling/100
spermatozoa
in
Semen
|
|
10629-4
|
Spermatozoa
Vacuolated
Head/100
spermatozoa
in
Semen
|
|
1063-7
|
I
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
10630-2
|
Spinnbarkeit
[Length]
in
Cervical
mucus
|
|
10631-0
|
Testosterone
[Moles/volume]
in
Semen
|
|
10632-8
|
Time
until
next
menstrual
period
|
|
10633-6
|
Zinc
[Moles/volume]
in
Semen
|
|
10634-4
|
Complement
C1
esterase
inhibitor.functional/Complement
C1
esterase
inhibitor.total
in
Serum
or
Plasma
|
|
10635-1
|
Acanthamoeba
sp
identified
in
Eye
by
Organism
specific
culture
|
|
10636-9
|
Acanthamoeba
sp
identified
in
Eye
by
Wet
preparation
|
|
10637-7
|
Microscopic
observation
[Identifier]
in
Tissue
by
Night
blue
stain
|
|
10638-5
|
Thermophilic
Actinomycetes
colony
count
[#/volume]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10639-3
|
Thermophilic
Actinomycetes
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
1064-5
|
I
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10640-1
|
Deprecated
Adenovirus
40+41
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10641-9
|
Amoeba
identified
in
Aspirate
by
Immune
stain
|
|
10642-7
|
Amoeba
identified
in
Aspirate
by
Wet
preparation
|
|
10643-5
|
Amoeba
identified
in
Stool
by
Organism
specific
culture
|
|
10644-3
|
Arthropod
identified
in
Unspecified
specimen
|
|
10645-0
|
Aspergillus
fumigatus
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
10646-8
|
Astrovirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10647-6
|
Babesia
sp
identified
in
Blood
by
Thick
film
|
|
10648-4
|
Babesia
sp
identified
in
Blood
by
Thin
film
|
|
10649-2
|
Calicivirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
1065-2
|
I
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10650-0
|
Candida
sp
DNA
[Presence]
in
Blood
by
Probe
with
amplification
|
|
10651-8
|
Chlamydophila
pneumoniae
Ag
[Presence]
in
Sputum
or
Bronchial
|
|
10652-6
|
Chlamydophila
pneumoniae
DNA
[Presence]
in
Sputum
or
Bronchial
by
Probe
with
amplification
|
|
10653-4
|
Clotrimazole
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
10654-2
|
Clotrimazole
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
10655-9
|
Coccidia
identified
in
Duodenal
fluid
by
Acid
fast
stain
|
|
10656-7
|
Coccidia
identified
in
Stool
by
Acid
fast
stain
|
|
10657-5
|
Deprecated
Cryptococcus
neoformans
Ag
[Presence]
in
Tissue
by
Immunofluorescence
|
|
10658-3
|
Cyanobacterium
identified
in
Water
by
Light
microscopy
|
|
10659-1
|
Cyclospora
sp
identified
in
Stool
by
Acid
fast
stain
|
|
1066-0
|
I
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
10660-9
|
Cytomegalovirus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10661-7
|
Dinoflagellate
identified
in
Water
by
Light
microscopy
|
|
10662-5
|
Filaria
identified
in
Blood
by
Concentration
|
|
10663-3
|
Filaria
identified
in
Blood
by
Thick
film
|
|
10664-1
|
Filaria
identified
in
Blood
by
Thin
film
|
|
10665-8
|
Fungus
colony
count
[#/volume]
in
Unspecified
specimen
by
Environmental
culture
|
|
10666-6
|
Fungus
identified
in
Tissue
by
Fontana-Masson
stain
|
|
10667-4
|
Fungus
identified
in
Unspecified
specimen
by
Animal
inoculation
|
|
10668-2
|
Fungus
identified
in
Unspecified
specimen
by
Environmental
culture
|
|
10669-0
|
Fungus
identified
in
Unspecified
specimen
by
Sticky
tape
for
environmental
fungus
|
|
1067-8
|
Jk
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10670-8
|
Giardia
lamblia
[Presence]
in
Stool
by
Organism
specific
culture
|
|
10671-6
|
Helminth
identified
in
Unspecified
specimen
|
|
10672-4
|
Helminth+Arthropod
identified
in
Unspecified
specimen
|
|
10673-2
|
Hepatitis
B
virus
core
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10674-0
|
Hepatitis
B
virus
surface
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10675-7
|
Hepatitis
B
virus
surface
Ag
[Presence]
in
Tissue
by
Orcein
stain
|
|
10676-5
|
Hepatitis
C
virus
RNA
[Units/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
with
amplification
|
|
10677-3
|
Herpes
simplex
virus
1
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10678-1
|
Herpes
simplex
virus
1+2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10679-9
|
Herpes
simplex
virus
2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1068-6
|
Jk
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10680-7
|
Herpes
simplex
virus
identified
in
Cerebral
spinal
fluid
by
Electron
microscopy
|
|
10681-5
|
Herpes
simplex
virus
identified
in
Tissue
by
Electron
microscopy
|
|
10682-3
|
Deprecated
HIV
1
RNA
[Units/volume]
in
Serum
or
Plasma
by
Probe
with
amplification
|
|
10683-1
|
Hydatid
cyst
identified
in
Aspirate
by
Immune
stain
|
|
10684-9
|
Hydatid
cyst
identified
in
Liver
by
Wet
preparation
|
|
10685-6
|
Hydatid
cyst
identified
in
Lung
tissue
by
Wet
preparation
|
|
10686-4
|
Leishmania
sp
identified
in
Tissue
by
Giemsa
stain
|
|
10687-2
|
Leishmania
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
10688-0
|
Microscopic
observation
[Identifier]
in
Hair
by
KOH
preparation
|
|
10689-8
|
Microscopic
observation
[Identifier]
in
Nail
by
KOH
preparation
|
|
1069-4
|
Jk
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10690-6
|
Microsporidia
identified
in
Duodenal
fluid
by
Trichrome
stain
modified
|
|
10691-4
|
Mushroom.toxic
identified
by
Inspection
|
|
10692-2
|
Mushroom.toxic
identified
in
Food
by
Light
microscopy
|
|
10693-0
|
Mushroom.toxic
identified
in
Vomitus
by
Light
microscopy
|
|
10694-8
|
Naegleria
sp
identified
in
Tissue
by
Organism
specific
culture
|
|
10695-5
|
Naegleria
sp
identified
in
Tissue
by
Wet
preparation
|
|
10696-3
|
Norovirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10697-1
|
Nystatin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
10698-9
|
Nystatin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
10699-7
|
Onchocerca
sp
identified
in
Tissue
by
Wet
preparation
|
|
107-3
|
Cefotaxime
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1070-2
|
Jk
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10700-3
|
Orthopoxvirus
[Identifier]
in
Skin
by
Electron
microscopy
|
|
10701-1
|
Ova
and
parasites
identified
in
Stool
by
Concentration
|
|
10702-9
|
Ova
and
parasites
identified
in
Stool
by
Immune
stain
|
|
10703-7
|
Ova
and
parasites
identified
in
Stool
by
Kinyoun
iron
hematoxylin
stain
|
|
10704-5
|
Ova
and
parasites
identified
in
Stool
by
Light
microscopy
|
|
10705-2
|
Human
papilloma
virus
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
10706-0
|
Picornavirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10707-8
|
Toxic
Plant
identified
in
plant
specimen
by
Inspection
|
|
10708-6
|
Toxic
Plant
identified
in
Vomitus
by
Light
microscopy
|
|
10709-4
|
Plasmodium
falciparum
Ag
[Units/volume]
in
Blood
by
Immunofluorescence
|
|
1071-0
|
Jk
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10710-2
|
Plasmodium
sp
identified
in
Blood
by
Thin
film
|
|
10711-0
|
Plasmodium
vivax
Ag
[Units/volume]
in
Blood
by
Immunofluorescence
|
|
10712-8
|
Pneumocystis
sp
identified
in
Lung
tissue
|
|
10713-6
|
Prototheca
identified
in
Unspecified
specimen
by
Culture
|
|
10714-4
|
Deprecated
Rotavirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10715-1
|
Schistosoma
sp
identified
in
Urine
sediment
by
Light
microscopy
|
|
10716-9
|
Schistosoma
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10717-7
|
Streptococcus
pneumoniae
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
10718-5
|
Strongyloides
sp
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10719-3
|
Taenia
solium
adult
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
1072-8
|
Jk
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10720-1
|
Terbinafine
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
10721-9
|
Terbinafine
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
10722-7
|
Torovirus
[Identifier]
in
Stool
by
Electron
microscopy
|
|
10723-5
|
Toxoplasma
gondii
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10724-3
|
Toxoplasma
gondii
IgE
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10725-0
|
Toxoplasma
gondii
DNA
[Units/volume]
in
Body
fluid
by
Probe
with
amplification
|
|
10726-8
|
Toxoplasma
gondii
[Presence]
in
Tissue
by
Giemsa
stain
|
|
10727-6
|
Toxoplasma
gondii
identified
in
Tissue
|
|
10728-4
|
Trichomonas
sp
identified
in
Genital
specimen
by
Organism
specific
culture
|
|
10729-2
|
Trypanosoma
sp
identified
in
Blood
by
Light
microscopy
|
|
1073-6
|
Jk
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10730-0
|
Trypanosoma
sp
identified
in
Blood
by
Organism
specific
culture
|
|
10731-8
|
Trypanosoma
sp
identified
in
Blood
by
Thick
film
|
|
10732-6
|
Trypanosoma
sp
identified
in
Blood
by
Thin
film
|
|
10733-4
|
Trypanosoma
sp
identified
in
Blood
by
Wet
preparation
|
|
10734-2
|
Varicella
zoster
virus
identified
in
Skin
by
Electron
microscopy
|
|
10735-9
|
Viral
sequencing
[Identifier]
in
Serum
by
Sequencing
|
|
10736-7
|
Virus
identified
in
Cerebral
spinal
fluid
by
Electron
microscopy
|
|
10737-5
|
Virus
identified
in
Stool
by
Electron
microscopy
|
|
10738-3
|
Virus
identified
in
Tissue
by
Electron
microscopy
|
|
10739-1
|
Virus
identified
in
Unspecified
specimen
by
Electron
microscopy
|
|
1074-4
|
Jk
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10740-9
|
Aluminum.microscopic
observation
[Identifier]
in
Bone
by
Histomorphometry
stain
|
|
10741-7
|
Amyloid.microscopic
observation
[Identifier]
in
Brain
by
Thioflavine-S
stain
|
|
10742-5
|
Amyloid.microscopic
observation
[Identifier]
in
Tissue
by
Bennhold
stain.Putchler
modified
|
|
10743-3
|
Amyloid.microscopic
observation
[Identifier]
in
Tissue
by
Highman
stain
|
|
10744-1
|
Amyloid.microscopic
observation
[Identifier]
in
Tissue
by
Vassar-culling
stain
|
|
10745-8
|
Bile.microscopic
observation
[Identifier]
in
Tissue
by
Fouchet
stain
|
|
10746-6
|
Calcium.microscopic
observation
[Identifier]
in
Tissue
by
Von
Kossa
stain
|
|
10747-4
|
Collagen
fibers+Elastic
fibers.microscopic
observation
[Identifier]
in
Tissue
by
Lawson-Van
Gieson
stain
|
|
10748-2
|
Collagen
fibers+Elastic
fibers.microscopic
observation
[Identifier]
in
Tissue
by
Verhoeff-Van
Gieson
stain
|
|
10749-0
|
Collagen
fibers.microscopic
observation
[Identifier]
in
Tissue
by
Van
Gieson
stain
|
|
1075-1
|
Jk
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10750-8
|
Connective
tissue.microscopic
observation
[Identifier]
in
Tissue
by
Trichrome
stain.Masson
|
|
10751-6
|
Copper.microscopic
observation
[Identifier]
in
Tissue
by
Rhodamine
stain
|
|
10752-4
|
Fat.microscopic
observation
[Identifier]
in
Milk
by
Sudan
IV
stain
|
|
10753-2
|
Fat.microscopic
observation
[Identifier]
in
Stool
by
Sudan
IV
stain
|
|
10754-0
|
Fat.microscopic
observation
[Identifier]
in
Tissue
by
Sudan
IV
stain
|
|
10755-7
|
Fungus.microscopic
observation
[Identifier]
in
Tissue
by
Methenamine
silver
stain.Grocott
|
|
10756-5
|
Glial
fibers.microscopic
observation
[Identifier]
in
Tissue
by
Holzer
stain
|
|
10757-3
|
Hematologic+Nuclear
elements.microscopic
observation
[Identifier]
in
Tissue
by
Giemsa
stain.May-Grunwald
|
|
10758-1
|
Iron.microscopic
observation
[Identifier]
in
Bone
by
Histomorphometry
stain
|
|
10759-9
|
Iron.microscopic
observation
[Identifier]
in
Sputum
by
Gomori
stain
|
|
1076-9
|
Jk
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10760-7
|
Iron.microscopic
observation
[Identifier]
in
Tissue
by
Gomori
stain
|
|
10761-5
|
Iron.microscopic
observation
[Identifier]
in
Tissue
by
Other
stain
|
|
10762-3
|
Microscopic
observation
[Identifier]
in
Blood
by
Hemosiderin
stain
|
|
10763-1
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Sudan
black
stain
|
|
10764-9
|
Microscopic
observation
[Identifier]
in
Sputum
by
Silver
stain
|
|
10765-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Acetate
esterase
stain
|
|
10766-4
|
Microscopic
observation
[Identifier]
in
Tissue
by
Alcian
blue
stain
|
|
10767-2
|
Microscopic
observation
[Identifier]
in
Tissue
by
Alcian
blue
stain.sulfated
|
|
10768-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Alcian
blue
stain.with
periodic
acid-Schiff
|
|
10769-8
|
Microscopic
observation
[Identifier]
in
Tissue
by
Alizarin
red
S
stain
|
|
1077-7
|
Jk
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10770-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Argentaffin
stain
|
|
10771-4
|
Deprecated
Microscopic
observation
[Identifier]
in
Tissue
by
Rhodamine-auramine
fluorochrome
stain
|
|
10772-2
|
Microscopic
observation
[Identifier]
in
Tissue
by
Azure-eosin
stain
|
|
10773-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Basic
fuchsin
stain
|
|
10774-8
|
Microscopic
observation
[Identifier]
in
Tissue
by
Bielschowsky
stain
|
|
10775-5
|
Microscopic
observation
[Identifier]
in
Tissue
by
Bleach
stain
|
|
10776-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Bodian
stain
|
|
10777-1
|
Microscopic
observation
[Identifier]
in
Tissue
by
Brown
and
Brenn
stain
|
|
10778-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Butyrate
esterase
stain
|
|
10779-7
|
Microscopic
observation
[Identifier]
in
Tissue
by
Carmine
stain.Best
|
|
1078-5
|
Jk
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10780-5
|
Microscopic
observation
[Identifier]
in
Tissue
by
Chloracetate
esterase
stain
|
|
10781-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Churukian-Schenk
stain
|
|
10782-1
|
Microscopic
observation
[Identifier]
in
Tissue
by
Congo
red
stain
|
|
10783-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Crystal
violet
stain
|
|
10784-7
|
Microscopic
observation
[Identifier]
in
Tissue
by
Esterase
stain.non-specific
|
|
10785-4
|
Microscopic
observation
[Identifier]
in
Tissue
by
Fite-Faraco
stain
|
|
10786-2
|
Microscopic
observation
[Identifier]
in
Tissue
by
Giemsa
stain.3
micron
|
|
10787-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Gridley
stain
|
|
10788-8
|
Microscopic
observation
[Identifier]
in
Tissue
by
Hansel
stain
|
|
10789-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Hematoxylin-eosin-Harris
regressive
stain
|
|
1079-3
|
Js
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10790-4
|
Microscopic
observation
[Identifier]
in
Tissue
by
Hematoxylin-eosin-Mayers
progressive
stain
|
|
10791-2
|
Microscopic
observation
[Identifier]
in
Tissue
by
Mallory-Heidenhain
stain
|
|
10792-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Methenamine
silver
stain.Jones
|
|
10793-8
|
Microscopic
observation
[Identifier]
in
Tissue
by
Methyl
green
stain
|
|
10794-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Methyl
green-pyronine
Y
stain
|
|
10795-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Methyl
violet
stain
|
|
10796-1
|
Microscopic
observation
[Identifier]
in
Tissue
by
Mucicarmine
stain
|
|
10797-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Neutral
red
stain
|
|
10798-7
|
Microscopic
observation
[Identifier]
in
Tissue
by
Oil
red
O
stain
|
|
10799-5
|
Microscopic
observation
[Identifier]
in
Tissue
by
Pentachrome
stain.Movat
|
|
108-1
|
Cefotaxime
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1080-1
|
Js
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10800-1
|
Microscopic
observation
[Identifier]
in
Tissue
by
Periodic
acid-Schiff
stain
with
diatase
digestion
|
|
10801-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Phosphotungstic
acid
Hematoxylin
(PTAH)
Stain
|
|
10802-7
|
Microscopic
observation
[Identifier]
in
Tissue
by
Prussian
blue
stain
|
|
10803-5
|
Microscopic
observation
[Identifier]
in
Tissue
by
Quinacrine
fluorescent
stain
|
|
10804-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Reticulin
stain
|
|
10805-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Safranin
stain
|
|
10806-8
|
Microscopic
observation
[Identifier]
in
Tissue
by
Schmorl
stain
|
|
10807-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Sevier-Munger
stain
|
|
10808-4
|
Microscopic
observation
[Identifier]
in
Tissue
by
Silver
impregnation
stain.Dieterle
|
|
10809-2
|
Microscopic
observation
[Identifier]
in
Tissue
by
Silver
nitrate
stain
|
|
1081-9
|
Js
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10810-0
|
Microscopic
observation
[Identifier]
in
Tissue
by
Silver
stain.Fontana-Masson
|
|
10811-8
|
Microscopic
observation
[Identifier]
in
Tissue
by
Silver
stain.Grimelius
|
|
10812-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Steiner
stain
|
|
10813-4
|
Microscopic
observation
[Identifier]
in
Tissue
by
Sudan
black
stain
|
|
10814-2
|
Microscopic
observation
[Identifier]
in
Tissue
by
Supravital
stain
|
|
10815-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Tetrachrome
stain
|
|
10816-7
|
Deprecated
Microscopic
observation
[Identifier]
in
Tissue
by
Toluidine
blue
O
stain
|
|
10817-5
|
Microscopic
observation
[Identifier]
in
Tissue
by
Trichrome
stain.Gomori-Wheatley
|
|
10818-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Trichrome
stain.Masson
modified
|
|
10819-1
|
Microscopic
observation
[Identifier]
in
Tissue
by
Wade
stain
|
|
1082-7
|
Js
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10820-9
|
Deprecated
Microscopic
observation
[Identifier]
in
Tissue
by
Warthin-Starry
stain
|
|
10821-7
|
Deprecated
Microscopic
observation
[Identifier]
in
Tissue
by
Wright
Giemsa
stain
|
|
10822-5
|
Mucin.microscopic
observation
[Identifier]
in
Tissue
by
Mucicarmine
stain.Mayer
|
|
10823-3
|
Mucopolysaccharides.microscopic
observation
[Identifier]
in
Tissue
by
Colloidal
ferric
oxide
stain.Hale
|
|
10824-1
|
Myelin+Myelin
breakdown
products.microscopic
observation
[Identifier]
in
Tissue
by
Luxol
fast
blue/Periodic
acid-Schiff
stain
|
|
10825-8
|
Myelin+Nerve
cells.microscopic
observation
[Identifier]
in
Tissue
by
Luxol
fast
blue/Cresyl
violet
stain
|
|
10826-6
|
Nissel.microscopic
observation
[Identifier]
in
Tissue
by
Cresyl
echt
violet
stain
|
|
10827-4
|
Reticulum.microscopic
observation
[Identifier]
in
Tissue
by
Gomori
stain
|
|
10828-2
|
Urate
crystals.microscopic
observation
[type]
in
Tissue
by
De
Galantha
stain
|
|
10829-0
|
Silicon
[Mass/volume]
in
Serum
or
Plasma
|
|
1083-5
|
Js
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10830-8
|
Deprecated
Surgical
operation
note
complications
|
|
10831-6
|
Surgical
operation
note
complications
[Interpretation]
|
|
10832-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
50
g
lactose
PO
|
|
10833-2
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--7
hours
post
75
g
glucose
PO
|
|
10834-0
|
Globulin
[Mass/volume]
in
Serum
by
calculation
|
|
10835-7
|
Lipoprotein
a
[Mass/volume]
in
Serum
or
Plasma
|
|
10836-5
|
Niacin
[Mass/volume]
in
Blood
|
|
10837-3
|
Organic
acids
[Presence]
in
Serum
or
Plasma
|
|
10838-1
|
Phosphoserine
[Mass/volume]
in
Serum
or
Plasma
|
|
10839-9
|
Troponin
I.cardiac
[Mass/volume]
in
Serum
or
Plasma
|
|
1084-3
|
Js
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10840-7
|
Atropine
[Mass/volume]
in
Urine
|
|
10841-5
|
Methazolamide
[Mass/volume]
in
Serum
or
Plasma
|
|
10842-3
|
Deprecated
HLA-DQ1
[Presence]
|
|
10843-1
|
Deprecated
HLA-DQ2
[Presence]
|
|
10844-9
|
Deprecated
HLA-DQ3
[Presence]
|
|
10845-6
|
Deprecated
HLA-DQ4
[Presence]
|
|
10846-4
|
Borrelia
burgdorferi
DNA
[Presence]
in
Blood
by
Probe
with
amplification
|
|
10847-2
|
Borrelia
burgdorferi
DNA
[Presence]
in
Body
fluid
by
Probe
with
amplification
|
|
10848-0
|
Chlamydia
sp
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10849-8
|
Chlamydia
sp
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
1085-0
|
Js
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10850-6
|
Cyclospora
cayetanensis
[Presence]
in
Unspecified
specimen
|
|
10851-4
|
Escherichia
coli
O157:H7
[Presence]
in
Stool
by
Organism
specific
culture
|
|
10852-2
|
Deprecated
Fungus
identified
in
Blood
by
Culture
|
|
10853-0
|
Isospora
belli
[Presence]
in
Unspecified
specimen
by
Acid
fast
stain.Kinyoun
modified
|
|
10854-8
|
Deprecated
Midrofilaria
identified
in
Blood
by
Concentration
|
|
10855-5
|
Ova
and
parasites
identified
in
Duodenal
fluid
or
Gastric
fluid
by
Light
microscopy
|
|
10856-3
|
Microscopic
observation
[Identifier]
in
Genital
mucus
by
Gram
stain
|
|
10857-1
|
Microsporidia
identified
in
Unspecified
specimen
by
Light
microscopy
|
|
10858-9
|
Teichoate
Ab
[Presence]
in
Serum
|
|
10859-7
|
Trypanosoma
sp
[Identifier]
in
Blood
by
Acridine
Orange
+
Giemsa
Stain
|
|
1086-8
|
Js
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10860-5
|
Varicella
zoster
virus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
10861-3
|
Progesterone
receptor
[Mass/mass]
in
Tissue
|
|
10862-1
|
Basement
membrane
Ab
[Titer]
in
Serum
|
|
10863-9
|
Endomysium
IgA
Ab
[Titer]
in
Serum
|
|
10864-7
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Raji
cell
assay
|
|
10865-4
|
Intercellular
substance
Ab
[Presence]
in
Serum
|
|
10866-2
|
Sulfatide
IgG
Ab
[Titer]
in
Serum
|
|
10867-0
|
Sulfatide
IgM
Ab
[Titer]
in
Serum
|
|
10868-8
|
Bacitracin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
10869-6
|
Xylose
[Mass/volume]
in
Blood
--3
hours
post
25
g
xylose
PO
|
|
1087-6
|
Js
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10870-4
|
Xylose
[Mass/volume]
in
Blood
--4
hours
post
25
g
xylose
PO
|
|
10871-2
|
Xylose
[Mass/volume]
in
Blood
--5
hours
post
25
g
xylose
PO
|
|
10872-0
|
Xylose
[Mass/volume]
in
Blood
--baseline
|
|
10873-8
|
Beta-2-Microglobulin
[Mass/time]
in
24
hour
Urine
|
|
10874-6
|
Bombesin
[Mass/volume]
in
Plasma
|
|
10875-3
|
Carnitine
esters
[Mass/volume]
in
Urine
|
|
10876-1
|
Carnitine
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
10877-9
|
Carnitine
free
(C0)
[Mass/volume]
in
Urine
|
|
10878-7
|
Iodine.protein
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
10879-5
|
Isovalerylglycine
[Mass/volume]
in
Urine
|
|
1088-4
|
Js
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10880-3
|
Magnesium
[Mass/mass]
in
Stool
|
|
10881-1
|
Pentacarboxylporphyrins
[Mass/volume]
in
Red
Blood
Cells
|
|
10882-9
|
Pentacarboxylporphyrins
[Mass/volume]
in
Serum
or
Plasma
|
|
10883-7
|
Phenolphthalein
[Mass/mass]
in
Stool
|
|
10884-5
|
Phosphate
[Mass/mass]
in
Stool
|
|
10885-2
|
Porphyrins
[Mass/time]
in
24
hour
Urine
|
|
10886-0
|
Prostate
Specific
Ag
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
10887-8
|
Pyridinoline
[Mass/time]
in
24
hour
Urine
|
|
10888-6
|
Lipase
[Enzymatic
activity/volume]
in
Urine
|
|
10889-4
|
Bisacodyl
[Mass/mass]
in
Stool
|
|
1089-2
|
Js
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10890-2
|
Deprecated
Normethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
10891-0
|
Oxyphenisatin
[Mass/mass]
in
Stool
|
|
10892-8
|
Pentoxifylline
[Mass/volume]
in
Serum
or
Plasma
|
|
10893-6
|
Trenbolone
[Mass/volume]
in
Urine
|
|
10894-4
|
Aspergillus
niger
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
10895-1
|
Clostridium
difficile
toxin
B
[Presence]
in
Stool
|
|
10896-9
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10897-7
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
10898-5
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10899-3
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
109-9
|
Cefotaxime
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1090-0
|
Js
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
10900-9
|
Hepatitis
B
virus
surface
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
10901-7
|
HIV
2
gp125
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
10902-5
|
HIV
2
gp36
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
10903-3
|
Hyaluronidase
Ab
[Titer]
in
Serum
|
|
10904-1
|
La
Crosse
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10905-8
|
La
Crosse
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10906-6
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10907-4
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
10908-2
|
Streptococcus
pneumoniae
7
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
10909-0
|
Benzidine
[Mass/volume]
in
Urine
|
|
1091-8
|
K
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10910-8
|
Borate
[Mass/volume]
in
Urine
|
|
10911-6
|
Dichlorobenzidine
[Mass/volume]
in
Urine
|
|
10912-4
|
Lead
[Mass/volume]
in
Serum
or
Plasma
|
|
10913-2
|
4,4'-Methylene
bis(2-Chloroaniline)
[Mass/volume]
in
Urine
|
|
10914-0
|
Methylenediamine
[Mass/volume]
in
Urine
|
|
10915-7
|
Phencyclidine
[Mass/volume]
in
Unspecified
specimen
|
|
10916-5
|
Platinum
[Mass/volume]
in
Blood
|
|
10917-3
|
Zinc
[Mass/mass]
in
Stool
|
|
10918-1
|
Zinc
[Mass/volume]
in
Unspecified
specimen
|
|
10919-9
|
Anisakis
IgE
Ab
[Units/volume]
in
Serum
|
|
1092-6
|
K
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10920-7
|
Bamboo
shoot
IgE
Ab
[Units/volume]
in
Serum
|
|
10921-5
|
Blomia
tropicalis
IgE
Ab
[Units/volume]
in
Serum
|
|
10922-3
|
Bovine
serum
albumin
(BSA)
IgE
Ab
[Units/volume]
in
Serum
|
|
10923-1
|
Bromelin
IgE
Ab
[Units/volume]
in
Serum
|
|
10924-9
|
Starfruit
IgE
Ab
[Units/volume]
in
Serum
|
|
10925-6
|
Chub
Mackerel
IgE
Ab
[Units/volume]
in
Serum
|
|
10926-4
|
Deer
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
10927-2
|
Elk
or
Moose
Meat
IgE
Ab
[Units/volume]
in
Serum
|
|
10928-0
|
Fennel
Fresh
IgE
Ab
[Units/volume]
in
Serum
|
|
10929-8
|
Fennel
Seed
IgE
Ab
[Units/volume]
in
Serum
|
|
1093-4
|
K
Ab
[Presence]
in
Serum
or
Plasma
|
|
10930-6
|
Fish
Feed
IgE
Ab
[Units/volume]
in
Serum
|
|
10931-4
|
Daphnia
(fish
feed)
IgE
Ab
[Units/volume]
in
Serum
|
|
10932-2
|
Tetramin
IgE
Ab
[Units/volume]
in
Serum
|
|
10933-0
|
Guar
gum
IgE
Ab
[Units/volume]
in
Serum
|
|
10934-8
|
Guava
IgE
Ab
[Units/volume]
in
Serum
|
|
10935-5
|
Horse
serum
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10936-3
|
Mare
milk
IgE
Ab
[Units/volume]
in
Serum
|
|
10937-1
|
Marjoram
IgE
Ab
[Units/volume]
in
Serum
|
|
10938-9
|
Mediterranean
flour
moth
IgE
Ab
[Units/volume]
in
Serum
|
|
10939-7
|
Whiff
IgE
Ab
[Units/volume]
in
Serum
|
|
1094-2
|
K
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
10940-5
|
Cow
milk
boiled
IgE
Ab
[Units/volume]
in
Serum
|
|
10941-3
|
Milk
powder
IgE
Ab
[Units/volume]
in
Serum
|
|
10942-1
|
Cockspur
IgE
Ab
[Units/volume]
in
Serum
|
|
10943-9
|
Mink
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
10944-7
|
Octopus
IgE
Ab
[Units/volume]
in
Serum
|
|
10945-4
|
Papain
IgE
Ab
[Units/volume]
in
Serum
|
|
10946-2
|
Passion
fruit
IgE
Ab
[Units/volume]
in
Serum
|
|
10947-0
|
Persimmon
IgE
Ab
[Units/volume]
in
Serum
|
|
10948-8
|
Pigeon
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
10949-6
|
Malassezia
furfur
IgE
Ab
[Units/volume]
in
Serum
|
|
1095-9
|
K
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
10950-4
|
Reindeer
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
10951-2
|
Sericin
IgE
Ab
[Units/volume]
in
Serum
|
|
10952-0
|
Swine
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10953-8
|
Timothy
IgG
Ab
[Units/volume]
in
Serum
|
|
10954-6
|
Pine
Nut
IgE
Ab
[Units/volume]
in
Serum
|
|
10955-3
|
Long
Leaf
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10956-1
|
Short
Leaf
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10957-9
|
Slash
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10958-7
|
Virginia
Scrub
Pine
IgE
Ab
[Units/volume]
in
Serum
|
|
10959-5
|
Plaice
IgE
Ab
[Units/volume]
in
Serum
|
|
1096-7
|
K
Ag
[Presence]
on
Red
Blood
Cells
|
|
10960-3
|
Rabbit
serum
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10961-1
|
Rabbit
urine
proteins
IgE
Ab
[Units/volume]
in
Serum
|
|
10962-9
|
Deprecated
Sagebrush
tridenda
IgE
Ab
[Units/volume]
in
Serum
|
|
10963-7
|
Spondylocladium
citrovirens
IgE
Ab
[Units/volume]
in
Serum
|
|
10964-5
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
250
ug
corticotropin
IM
|
|
10965-2
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
IM
|
|
10966-0
|
Glucose
[Presence]
in
Urine
by
Test
strip
--2.5
hours
post
75
g
glucose
PO
|
|
10967-8
|
Glucose
[Presence]
in
Urine
by
Test
strip
--3.5
hours
post
75
g
glucose
PO
|
|
10968-6
|
Glucose
[Presence]
in
Urine
by
Test
strip
--4.5
hours
post
75
g
glucose
PO
|
|
10969-4
|
Cystine+Homocysteine
[Presence]
in
Urine
|
|
1097-5
|
Kp
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
10970-2
|
Galactose
1
phosphate
uridyl
transferase
[Enzymatic
activity/volume]
in
Blood
|
|
10971-0
|
Lysozyme
[Mass/volume]
in
Urine
|
|
10972-8
|
Organic
acids
[Mass/volume]
in
Urine
|
|
10973-6
|
3
methoxy
O
desmethylencainide
[Mass/volume]
in
Serum
or
Plasma
|
|
10974-4
|
5-Fluorocytosine
[Mass/volume]
in
Urine
|
|
10975-1
|
6-Monoacetylmorphine
(6-MAM)
[Mass/volume]
in
Urine
|
|
10976-9
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Urine
|
|
10977-7
|
Alprazolam
[Mass/volume]
in
Blood
|
|
10978-5
|
Amitriptyline+Nortriptyline
[Mass/volume]
in
Urine
|
|
10979-3
|
Carisoprodol
[Mass/volume]
in
Urine
|
|
1098-3
|
Kp
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
10980-1
|
Cephapirin
[Mass/volume]
in
Serum
or
Plasma
|
|
10981-9
|
Clonidine
[Mass/volume]
in
Urine
|
|
10982-7
|
Demeclocycline
[Mass/volume]
in
Serum
or
Plasma
|
|
10983-5
|
Norparamethadione
[Mass/volume]
in
Serum
or
Plasma
|
|
10984-3
|
Dicloxacillin
[Mass/volume]
in
Serum
or
Plasma
|
|
10985-0
|
Doxapram
[Mass/volume]
in
Serum
or
Plasma
|
|
10986-8
|
Doxycycline
[Mass/volume]
in
Serum
or
Plasma
|
|
10987-6
|
Fluconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10988-4
|
Fluvoxamine
[Mass/volume]
in
Serum
or
Plasma
|
|
10989-2
|
Itraconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
1099-1
|
Kp
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
10990-0
|
Ketoconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10991-8
|
Metronidazole
[Mass/volume]
in
Serum
or
Plasma
|
|
10992-6
|
Norclozapine
[Mass/volume]
in
Serum
or
Plasma
|
|
10993-4
|
Nafcillin
[Mass/volume]
in
Serum
or
Plasma
|
|
10994-2
|
Naltrexone
[Mass/volume]
in
Serum
or
Plasma
|
|
10995-9
|
Neomycin
[Mass/volume]
in
Serum
or
Plasma
|
|
10996-7
|
Normeperidine
[Mass/volume]
in
Serum
or
Plasma
|
|
10997-5
|
O-desmethylencainide
[Mass/volume]
in
Serum
or
Plasma
|
|
10998-3
|
Oxycodone
[Presence]
in
Urine
|
|
10999-1
|
Paramethadione
[Mass/volume]
in
Serum
or
Plasma
|
|
11-7
|
Amikacin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
110-7
|
Cefotaxime
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1100-7
|
Kp
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11000-7
|
Promethazine
[Presence]
in
Urine
|
|
11001-5
|
Pyrazinamide
[Mass/volume]
in
Serum
or
Plasma
|
|
11002-3
|
Scopolamine
[Presence]
in
Urine
|
|
11003-1
|
Ticlopidine
[Mass/volume]
in
Serum
or
Plasma
|
|
11004-9
|
Tricyclic
antidepressants
[Presence]
in
Urine
|
|
11005-6
|
Trimethoprim
[Mass/volume]
in
Serum
or
Plasma
|
|
11006-4
|
Borrelia
burgdorferi
Ab
[Presence]
in
Serum
|
|
11007-2
|
Borrelia
burgdorferi
Ag
[Units/volume]
in
Urine
|
|
11008-0
|
Cytomegalovirus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
11009-8
|
Epstein
Barr
virus
capsid
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1101-5
|
Kp
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11010-6
|
Epstein
Barr
virus
capsid
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
11011-4
|
Hepatitis
C
virus
RNA
[Units/volume]
(viral
load)
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
11012-2
|
Reovirus
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
11013-0
|
DNA
double
strand
Ab
[Titer]
in
Serum
|
|
11014-8
|
Somatotropin
Ab
[Titer]
in
Serum
or
Plasma
|
|
11015-5
|
Somatotropin
binding
protein
[Moles/volume]
in
Serum
or
Plasma
|
|
11016-3
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Esterase
stain.non-specific
|
|
11017-1
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Chloracetate
esterase
stain
|
|
11018-9
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Peroxidase
stain
|
|
11019-7
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Sudan
black
B
stain
|
|
1102-3
|
Kp
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11020-5
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Tartrate-resistant
acid
phosphatase
stain
|
|
11021-3
|
Microscopic
observation
[Identifier]
in
Blood
or
Marrow
by
Terminal
deoxynucleotidyl
transferase
stain
|
|
11022-1
|
Barbiturates
[Mass/volume]
in
Meconium
|
|
11023-9
|
Benzodiazepines
[Mass/volume]
in
Meconium
|
|
11024-7
|
Benzodiazepines
[Mass/volume]
in
Serum
or
Plasma
|
|
11025-4
|
Methadone
[Mass/volume]
in
Meconium
|
|
11026-2
|
Methaqualone
[Mass/volume]
in
Meconium
|
|
11027-0
|
Propoxyphene
[Mass/volume]
in
Meconium
|
|
11028-8
|
Zinc
[Mass/volume]
in
Body
fluid
|
|
11029-6
|
Consistency
of
Stool
|
|
1103-1
|
Kp
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11030-4
|
Aspergillus
fumigatus+Aspergillus
niger
IgE
Ab
[Units/volume]
in
Serum
|
|
11031-2
|
Lymphocytes/100
leukocytes
in
Body
fluid
|
|
11032-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
50
g
lactose
PO
|
|
11033-8
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
dose
TRH
IV
|
|
11034-6
|
Acetylcholine
receptor
binding
Ab
[Moles/volume]
in
Serum
|
|
11035-3
|
Adenylate
kinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11036-1
|
Deprecated
Aldolase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11037-9
|
Alpha-N-acetylgalactosaminidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
11038-7
|
Beta+gamma
tocopherol
[Mass/volume]
in
Serum
or
Plasma
|
|
11039-5
|
C
reactive
protein
[Presence]
in
Serum
or
Plasma
|
|
1104-9
|
Kp
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11040-3
|
Cortisol
Free
[Mass/volume]
in
Urine
|
|
11041-1
|
Creatinine
[Mass/volume]
in
Serum
or
Plasma
--post
dialysis
|
|
11042-9
|
Creatinine
[Mass/volume]
in
Serum
or
Plasma
--pre
dialysis
|
|
11043-7
|
Cryofibrinogen
[Presence]
in
Plasma
|
|
11044-5
|
Diphosphoglycerate
mutase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11045-2
|
Enolase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11046-0
|
Epinephrine
[Mass/volume]
in
Urine
|
|
11047-8
|
Glucose
phosphate
isomerase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11048-6
|
Glyceraldehyde
3
phosphate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11049-4
|
Deprecated
Hydroxyproline
[Mass/volume]
in
Urine
|
|
1105-6
|
Kp
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11050-2
|
Immunoglobulin
light
chains.kappa
[Mass/volume]
in
Serum
or
Plasma
|
|
11051-0
|
Immunoglobulin
light
chains.lambda
[Mass/volume]
in
Serum
or
Plasma
|
|
11052-8
|
Ketamine
[Mass/volume]
in
Urine
|
|
11053-6
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11054-4
|
Cholesterol
in
LDL/Cholesterol
in
HDL
[Mass
Ratio]
in
Serum
or
Plasma
|
|
11055-1
|
Melatonin
[Mass/volume]
in
Serum
or
Plasma
|
|
11056-9
|
Melatonin
[Flow]
in
24
hour
Urine
|
|
11057-7
|
Monophosphoglyceromutase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11058-5
|
Phosphofructokinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11059-3
|
Phosphoglycerate
kinase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
1106-4
|
Kp
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11060-1
|
Reducing
substances
[Presence]
in
Stool
|
|
11061-9
|
Thromboxane
beta
2
[Mass/time]
in
24
hour
Urine
|
|
11062-7
|
Thyroxine
(T4).albumin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
11063-5
|
Triosephosphate
isomerase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11064-3
|
Urea
nitrogen
[Mass/volume]
in
Serum
or
Plasma
--post
dialysis
|
|
11065-0
|
Urea
nitrogen
[Mass/volume]
in
Serum
or
Plasma
--pre
dialysis
|
|
11066-8
|
Uroporphyrinogen
III
synthase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
11067-6
|
Bleeding
time
|
|
11068-4
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Cyto
stain
|
|
11069-2
|
Microscopic
observation
[Identifier]
in
Gastric
fluid
by
Cyto
stain
|
|
1107-2
|
Kp
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11070-0
|
Microscopic
observation
[Identifier]
in
Urine
by
Cyto
stain
|
|
11071-8
|
Butalbital
[Mass/volume]
in
Urine
|
|
11072-6
|
Despropionylfentanyl
[Mass/volume]
in
Serum
or
Plasma
|
|
11073-4
|
Despropionylfentanyl
[Mass/volume]
in
Urine
|
|
11074-2
|
Norfentanyl
[Mass/volume]
in
Serum
or
Plasma
|
|
11075-9
|
Norfentanyl
[Mass/volume]
in
Urine
|
|
11076-7
|
Hepatitis
C
virus
5-1-1
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
11077-5
|
Hepatitis
C
virus
superoxide
dismutase
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
11078-3
|
HIV
2
gp80
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
11079-1
|
HIV
2
p26
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1108-0
|
Kp
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11080-9
|
HIV
2
p53
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
11081-7
|
HIV
2
p56
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
11082-5
|
HIV
2
p68
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
11083-3
|
Human
papilloma
virus
identified
in
Cervix
|
|
11084-1
|
Reagin
Ab
[Titer]
in
Serum
|
|
11085-8
|
Schistosoma
sp
identified
in
Stool
by
Concentration
|
|
11086-6
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Serum
|
|
11087-4
|
Insulin
Ab
[Titer]
in
Serum
|
|
11088-2
|
Neuronal
nuclear
Ab
[Presence]
in
Serum
|
|
11089-0
|
Neuronal
nuclear
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
1109-8
|
Deprecated
L
little
b
|
|
11090-8
|
Smith
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
11091-6
|
Alpha
chlordane
[Mass/volume]
in
Serum
or
Plasma
|
|
11092-4
|
Barbiturates
[Mass/mass]
in
Hair
|
|
11093-2
|
Dichlorodiphenyldichloroethylene
[Mass/volume]
in
Serum
or
Plasma
|
|
11094-0
|
Dichlorodiphenyltrichloroethane
[Mass/volume]
in
Serum
or
Plasma
|
|
11095-7
|
Dieldrin
[Mass/volume]
in
Serum
or
Plasma
|
|
11096-5
|
Gamma
chlordane
[Mass/volume]
in
Serum
or
Plasma
|
|
11097-3
|
Lindane
[Mass/volume]
in
Serum
or
Plasma
|
|
11098-1
|
Malaoxon
[Mass/volume]
in
Serum
or
Plasma
|
|
11099-9
|
Methoxychlor
[Mass/volume]
in
Serum
or
Plasma
|
|
111-5
|
Cefotetan
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1110-6
|
Le
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11100-5
|
Tetrachloroethylene
[Mass/volume]
in
Blood
|
|
11101-3
|
Bacteria
[#/area]
in
Synovial
fluid
by
Microscopy
high
power
field
|
|
11102-1
|
Charcot-leyden
crystals
[type]
in
Unspecified
specimen
by
Trichrome
stain
|
|
11103-9
|
Band
form
neutrophils/100
cells
in
Bone
marrow
by
Manual
count
|
|
11104-7
|
Normoblasts
Basophilic/100
cells
in
Bone
marrow
by
Manual
count
|
|
11105-4
|
Basophils/100
cells
in
Bone
marrow
by
Manual
count
|
|
11106-2
|
Eosinophils/100
cells
in
Bone
marrow
by
Manual
count
|
|
11107-0
|
Variant
lymphocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11108-8
|
Lymphocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11109-6
|
Mast
cells/100
cells
in
Bone
marrow
by
Manual
count
|
|
1111-4
|
Le
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11110-4
|
Megakaryocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11111-2
|
Metamyelocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11112-0
|
Monocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11113-8
|
Myeloblasts/100
cells
in
Bone
marrow
by
Manual
count
|
|
11114-6
|
Myelocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11115-3
|
Neutrophils/100
cells
in
Bone
marrow
by
Manual
count
|
|
11116-1
|
Normoblasts
Orthochromic/100
cells
in
Bone
marrow
by
Manual
count
|
|
11117-9
|
Plasma
cells
immature/100
cells
in
Bone
marrow
by
Manual
count
|
|
11118-7
|
Plasma
cells/100
cells
in
Bone
marrow
by
Manual
count
|
|
11119-5
|
Normoblasts
Polychromatophilic/100
cells
in
Bone
marrow
by
Manual
count
|
|
1112-2
|
Le
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11120-3
|
Promyelocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11121-1
|
Prolymphocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11122-9
|
Promonocytes/100
cells
in
Bone
marrow
by
Manual
count
|
|
11123-7
|
Deprecated
Promyelocytes/100
cells
in
Bone
marrow
by
Microscopy
|
|
11124-5
|
Pronormoblasts/100
cells
in
Bone
marrow
by
Manual
count
|
|
11125-2
|
Platelet
morphology
finding
[Identifier]
in
Blood
|
|
11126-0
|
Platelets
[Morphology]
in
Bone
marrow
|
|
11127-8
|
Erythrocytes
[Morphology]
in
Bone
marrow
|
|
11128-6
|
Segmented
neutrophils/100
cells
in
Bone
marrow
|
|
11129-4
|
Pronormoblasts
[#/volume]
in
Blood
|
|
1113-0
|
Le
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11130-2
|
B
lymphocytes
[#/volume]
in
Blood
|
|
11131-0
|
Deprecated
Normoblasts
Basophilic/100
cells
in
Bone
marrow
by
Microscopy
|
|
11132-8
|
Deprecated
Bilirubin
[Mass/volume]
in
Body
fluid
|
|
11133-6
|
Catecholamines
Free
[Mass/volume]
in
Urine
|
|
11134-4
|
Appearance
of
Spun
Body
fluid
|
|
11135-1
|
Appearance
of
Spun
Cerebral
spinal
fluid
|
|
11136-9
|
Deprecated
Normoblasts
Orthochromic/100
cells
in
Bone
marrow
by
Microscopy
|
|
11137-7
|
Deprecated
Normoblasts
Polychromatophilic/100
cells
in
Bone
marrow
by
Microscopy
|
|
11138-5
|
Myeloid
cells/Erythroid
cells
[#
Ratio]
in
Bone
marrow
|
|
11139-3
|
Metanephrine
[Mass/volume]
in
Urine
|
|
1114-8
|
Le
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11140-1
|
Metanephrine
[Moles/time]
in
24
hour
Urine
|
|
11141-9
|
Phosphate/Creatinine
[Mass
Ratio]
in
Urine
|
|
11142-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
100
g
glucose
PO
|
|
11143-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
100
g
glucose
PO
|
|
11144-3
|
Homovanillate
[Mass/volume]
in
Urine
|
|
11145-0
|
5-Hydroxyindoleacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
11146-8
|
Homovanillate/Creatinine
[Mass
Ratio]
in
Urine
|
|
11147-6
|
Myoglobin/Creatinine
[Mass
Ratio]
in
Urine
|
|
11148-4
|
Potassium/Creatinine
[Mass
Ratio]
in
Urine
|
|
11149-2
|
Sodium/Creatinine
[Mass
Ratio]
in
Urine
|
|
1115-5
|
Le
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11150-0
|
Blasts/100
cells
in
Bone
marrow
|
|
11151-8
|
Hematocrit
[Volume
Fraction]
of
Cord
blood
|
|
11152-6
|
Eosinophils/100
cells
in
Bone
marrow
|
|
11153-4
|
Hematocrit
[Volume
Fraction]
of
Body
fluid
|
|
11154-2
|
Cholinesterase
[Enzymatic
activity/volume]
in
Blood
|
|
11155-9
|
Cortisol/Creatinine
[Mass
Ratio]
in
Urine
|
|
11156-7
|
Leukocyte
morphology
finding
[Identifier]
in
Blood
|
|
11157-5
|
Leukocytes
[Morphology]
in
Bone
marrow
|
|
11158-3
|
Appearance
of
Serum
|
|
11159-1
|
Alkalase
IgE
Ab
[Units/volume]
in
Serum
|
|
1116-3
|
Le
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11160-9
|
Beta
lactoglobulin
IgG
Ab
[Units/volume]
in
Serum
|
|
11161-7
|
Wheat
Bran
IgE
Ab
[Units/volume]
in
Serum
|
|
11162-5
|
Deprecated
Cocoa
IgE
Ab
[Units/volume]
in
Serum
|
|
11163-3
|
Carageenan
IgE
Ab
[Units/volume]
in
Serum
|
|
11164-1
|
Cream
Cheese
IgE
Ab
[Units/volume]
in
Serum
|
|
11165-8
|
Chinchilla
IgE
Ab
[Units/volume]
in
Serum
|
|
11166-6
|
Chortoglyphus
arcuatus
IgE
Ab
[Units/volume]
in
Serum
|
|
11167-4
|
Cockatiel
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
11168-2
|
Arizona
Cypress
IgE
Ab
[Units/volume]
in
Serum
|
|
11169-0
|
Deer
hair
IgE
Ab
[Units/volume]
in
Serum
|
|
1117-1
|
Le
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11170-8
|
Dematiaceae
IgE
Ab
[Units/volume]
in
Serum
|
|
11171-6
|
Erythromycin
IgE
Ab
[Units/volume]
in
Serum
|
|
11172-4
|
Ferret
epithelium
IgE
Ab
[Units/volume]
in
Serum
|
|
11173-2
|
Fig
IgE
Ab
[Units/volume]
in
Serum
|
|
11174-0
|
Grain
weevel
IgE
Ab
[Units/volume]
in
Serum
|
|
11175-7
|
Helminthosporium
sativum
IgE
Ab
[Units/volume]
in
Serum
|
|
11176-5
|
Lactalbumin
alpha
IgG
Ab
[Units/volume]
in
Serum
|
|
11177-3
|
Lactalbumin
beta
IgE
Ab
[Units/volume]
in
Serum
|
|
11178-1
|
Beta
galactosidase
IgE
Ab
[Units/volume]
in
Serum
|
|
11179-9
|
Linden
IgE
Ab
[Units/volume]
in
Serum
|
|
1118-9
|
Le
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11180-7
|
Lupin
IgE
Ab
[Units/volume]
in
Serum
|
|
11181-5
|
Lycopodium
spp
IgE
Ab
[Units/volume]
in
Serum
|
|
11182-3
|
Lysozyme
IgE
Ab
[Units/volume]
in
Serum
|
|
11183-1
|
Macadamia
IgE
Ab
[Units/volume]
in
Serum
|
|
11184-9
|
Scad
IgE
Ab
[Units/volume]
in
Serum
|
|
11185-6
|
Maxatase
IgE
Ab
[Units/volume]
in
Serum
|
|
11186-4
|
Foxtail
Millet
IgE
Ab
[Units/volume]
in
Serum
|
|
11187-2
|
Penicillium
frequentans
IgE
Ab
[Units/volume]
in
Serum
|
|
11188-0
|
Cayenne
IgE
Ab
[Units/volume]
in
Serum
|
|
11189-8
|
Jalepeno
Pepper
IgE
Ab
[Units/volume]
in
Serum
|
|
1119-7
|
Le
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11190-6
|
Mint
IgE
Ab
[Units/volume]
in
Serum
|
|
11191-4
|
Pollock
IgE
Ab
[Units/volume]
in
Serum
|
|
11192-2
|
Protamine
IgE
Ab
[Units/volume]
in
Serum
|
|
11193-0
|
Pumpkin
Seed
IgE
Ab
[Units/volume]
in
Serum
|
|
11194-8
|
Rape
Pollen
IgE
Ab
[Units/volume]
in
Serum
|
|
11195-5
|
Rapeseed
IgE
Ab
[Units/volume]
in
Serum
|
|
11196-3
|
Orange
roughy
IgE
Ab
[Units/volume]
in
Serum
|
|
11197-1
|
Sardine
(pilchard)
IgE
Ab
[Units/volume]
in
Serum
|
|
11198-9
|
Shark
IgE
Ab
[Units/volume]
in
Serum
|
|
11199-7
|
Silver
IgE
Ab
[Units/volume]
in
Serum
|
|
112-3
|
Cefotetan
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1120-5
|
Le
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11200-3
|
Escargot
IgE
Ab
[Units/volume]
in
Serum
|
|
11201-1
|
Succinylcholine
IgE
Ab
[Units/volume]
in
Serum
|
|
11202-9
|
Tarragon
IgE
Ab
[Units/volume]
in
Serum
|
|
11203-7
|
Trichosporon
pullulans
IgE
Ab
[Units/volume]
in
Serum
|
|
11204-5
|
Ulocladium
chartarum
IgE
Ab
[Units/volume]
in
Serum
|
|
11205-2
|
Deprecated
Paper
Wasp
IgE
Ab
[Units/volume]
in
Serum
|
|
11206-0
|
18-Hydroxydeoxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
11207-8
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Body
fluid
|
|
11208-6
|
Atrial
natriuretic
factor
[Mass/volume]
in
Plasma
|
|
11209-4
|
Beta
glucuronidase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
1121-3
|
Le
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11210-2
|
Cancer
Ag
125
[Units/volume]
in
Body
fluid
|
|
11211-0
|
Carbon
dioxide,
total
[Moles/volume]
in
Body
fluid
|
|
11212-8
|
Coproporphyrin
[Mass/volume]
in
Urine
|
|
11213-6
|
Corticotropin
releasing
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
11214-4
|
Deprecated
Creatinine
|
|
11215-1
|
Delta
aminolevulinate
[Mass/volume]
in
Urine
|
|
11216-9
|
Deoxypyridinoline
[Mass/volume]
in
Urine
|
|
11217-7
|
Deprecated
Hexaporphyrin
[Mass/time]
in
24
hour
Urine
|
|
11218-5
|
Microalbumin
[Mass/volume]
in
Urine
by
Test
strip
|
|
11219-3
|
Immunoglobulin
light
chains
[Presence]
in
Serum
|
|
1122-1
|
Le
sup(x)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11220-1
|
Iodine
Free
[Mass/time]
in
24
hour
Urine
|
|
11221-9
|
Pentacarboxylporphyrins
[Mass/volume]
in
Urine
|
|
11222-7
|
Pentacarboxylporphyrins
[Presence]
in
Urine
|
|
11223-5
|
Deprecated
Phenolphthalein
|
|
11224-3
|
Phosphoethanolamine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
11225-0
|
Porphyrins
[Mass/volume]
in
Urine
|
|
11226-8
|
Prorenin
[Units/volume]
in
Plasma
|
|
11227-6
|
Pyruvate
kinase
[Presence]
in
Blood
|
|
11228-4
|
Uroporphyrin
[Mass/volume]
in
Urine
|
|
11229-2
|
3-O-Methyldopa
[Mass/volume]
in
Serum
or
Plasma
|
|
1123-9
|
Le
sup(x)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11230-0
|
Amobarbital
[Mass/volume]
in
Urine
|
|
11231-8
|
Astemizole
[Mass/volume]
in
Serum
or
Plasma
|
|
11232-6
|
Bromocriptine
[Mass/volume]
in
Serum
or
Plasma
|
|
11233-4
|
Brompheniramine
[Mass/volume]
in
Serum
or
Plasma
|
|
11234-2
|
Propoxyphene
[Mass/mass]
in
Hair
|
|
11235-9
|
Fentanyl
[Presence]
in
Urine
|
|
11236-7
|
Gemfibrozil
[Mass/volume]
in
Serum
or
Plasma
|
|
11237-5
|
Hydralazine
[Mass/volume]
in
Serum
or
Plasma
|
|
11238-3
|
Hydroxyalprazolam
[Mass/volume]
in
Urine
|
|
11239-1
|
Deprecated
Hydroxyzine
|
|
1124-7
|
Le
sup(x)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11240-9
|
Hydroxyzine
[Mass/volume]
in
Urine
|
|
11241-7
|
Hyoscyamine
[Mass/volume]
in
Serum
or
Plasma
|
|
11242-5
|
Mercaptopurine
[Mass/volume]
in
Serum
or
Plasma
|
|
11243-3
|
Methadone
[Mass/mass]
in
Hair
|
|
11244-1
|
Morphine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
11245-8
|
Deprecated
Orphenadrine
|
|
11246-6
|
Oxycodone
[Mass/volume]
in
Urine
|
|
11247-4
|
Oxymorphone
[Presence]
in
Urine
|
|
11248-2
|
Pergolide
[Mass/volume]
in
Serum
or
Plasma
|
|
11249-0
|
Phenacemide
[Mass/volume]
in
Serum
or
Plasma
|
|
1125-4
|
Le
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11250-8
|
Phenylethylmalonate
[Mass/volume]
in
Serum
or
Plasma
|
|
11251-6
|
Piroxicam
[Mass/volume]
in
Serum
or
Plasma
|
|
11252-4
|
Scopolamine
[Mass/volume]
in
Serum
or
Plasma
|
|
11253-2
|
Tacrolimus
[Mass/volume]
in
Blood
|
|
11254-0
|
Chlamydophila
pneumoniae
Ab
[Titer]
in
Serum
|
|
11255-7
|
Haemophilus
ducreyi
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
11256-5
|
Haemophilus
influenzae
B
IgG
Ab
[Mass/volume]
in
Serum
|
|
11257-3
|
Haemophilus
influenzae
B
IgG
Ab
[Mass/volume]
in
Serum
by
Immunoassay
|
|
11258-1
|
Hepatitis
B
virus
DNA
[Units/volume]
in
Serum
|
|
11259-9
|
Hepatitis
C
virus
RNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
1126-2
|
Le
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11260-7
|
HTLV
I
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
11261-5
|
Bacteria
identified
in
Vaginal
fluid
by
Aerobe
culture
|
|
11262-3
|
Parainfluenza
virus
3
IgG
Ab
[Titer]
in
Serum
|
|
11263-1
|
Parainfluenza
virus
3
IgM
Ab
[Titer]
in
Serum
|
|
11264-9
|
Salmonella
paratyphi
A
Ab
[Presence]
in
Serum
by
Agglutination
|
|
11265-6
|
Salmonella
paratyphi
B
Ab
[Presence]
in
Serum
by
Agglutination
|
|
11266-4
|
Streptococcus
agalactiae
Ag
[Presence]
in
Unspecified
specimen
|
|
11267-2
|
Streptococcus.beta-hemolytic
[Presence]
in
Genital
specimen
by
Organism
specific
culture
|
|
11268-0
|
Streptococcus
pyogenes
[Presence]
in
Throat
by
Organism
specific
culture
|
|
11269-8
|
Streptococcus
pyogenes
Ag
[Presence]
in
Serum
by
Agglutination
|
|
1127-0
|
Le
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11270-6
|
Viral
inclusion
bodies
[Identifier]
in
Unspecified
specimen
by
Cyto
stain
|
|
11271-4
|
Hematocrit
[Volume
Fraction]
of
Cord
blood
by
Automated
count
|
|
11272-2
|
Erythrocyte
mean
corpuscular
volume
[Entitic
volume]
in
Cord
blood
by
Automated
count
|
|
11273-0
|
Erythrocytes
[Morphology]
in
Blood
by
Automated
count
|
|
11274-8
|
Elliptocytes
[Presence]
in
Blood
by
Light
microscopy
|
|
11275-5
|
Large
granular
lymphocytes/100
leukocytes
in
Blood
by
Manual
count
|
|
11276-3
|
Tubular
cells
[Presence]
in
Urine
sediment
by
Light
microscopy
|
|
11277-1
|
Epithelial
cells.squamous
[#/area]
in
Urine
sediment
by
Microscopy
high
power
field
|
|
11278-9
|
Bladder
cells
[#/area]
in
Urine
sediment
by
Microscopy
high
power
field
|
|
11279-7
|
Urine
sediment
comments
by
Light
microscopy
Narrative
|
|
1128-8
|
Le
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11280-5
|
Cabot
rings
[Presence]
in
Blood
by
Light
microscopy
|
|
11281-3
|
Auer
rods
[Presence]
in
Blood
by
Light
microscopy
|
|
11282-1
|
Cells
Counted
Total
[#]
in
Blood
|
|
11283-9
|
Acuity
assessment
[Function]
at
First
encounter
|
|
11284-7
|
Acuity
assessment
practitioner
identification
|
|
11285-4
|
Acuity
assessment
practitioner
profession
|
|
11286-2
|
Alcohol
binge
episodes
per
month
-
Reported
|
|
11287-0
|
Alcoholic
drinks
per
drinking
day
-
Reported
|
|
11288-8
|
Arrival
time
documented
|
|
11289-6
|
Body
temperature
at
First
encounter
|
|
1129-6
|
Le
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
11290-4
|
Body
temperature
measurement
site
at
First
encounter
|
|
11291-2
|
Respiratory
rate
at
First
encounter
|
|
11292-0
|
Deprecated
Chief
complaint:
Prid:
Pt:
^Patient:
Nom:
Reported
|
|
11293-8
|
Type
of
Referral
source
|
|
11294-6
|
Current
employment
Narrative
-
Reported
|
|
11295-3
|
Current
employment
-
Reported
|
|
11296-1
|
ED
clinical
finding
practitioner
identifier
|
|
11297-9
|
ED
clinical
finding
practitioner
profession
|
|
11298-7
|
ED
consultant
practitioner
identifier
|
|
11299-5
|
ED
consultant
practitioner
profession
|
|
113-1
|
Cefotetan
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1130-4
|
Le
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11300-1
|
ED
diagnosis
|
|
11301-9
|
ED
diagnosis
type
|
|
11302-7
|
ED
discharge
disposition
|
|
11303-5
|
ED
disposition
consult/referral
|
|
11304-3
|
ED
disposition
diagnosis
practitioner
identification
|
|
11305-0
|
ED
disposition
diagnosis
practitioner
profession
|
|
11306-8
|
ED
medication
practitioner
identification
|
|
11307-6
|
ED
medication
practitioner
profession
|
|
11308-4
|
ED
outcome
observation
practitioner
identification
|
|
11309-2
|
ED
outcome
observation
practitioner
profession
|
|
1131-2
|
Le
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11310-0
|
ED
patient
satisfaction
report
type
|
|
11311-8
|
ED
procedure
practitioner
profession
|
|
11312-6
|
ED
procedure
practitioner
identifier
|
|
11313-4
|
ED
procedure
result
observation
[Interpretation]
|
|
11314-2
|
ED
procedure
result
type
|
|
11315-9
|
ED
service
level
|
|
11316-7
|
ED
service
level
practitioner
profession
|
|
11317-5
|
ED
service
level
practitioner
identification
|
|
11318-3
|
Ambulance
transport
agency
EMS
system
|
|
11319-1
|
Ambulance
transport
unit
[Identifier]
EMS
system
|
|
1132-0
|
Le
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
11320-9
|
Feeding
and
dietary
status
Narrative
-
Reported
|
|
11321-7
|
Feeding
and
dietary
status
-
Reported
|
|
11322-5
|
History
of
General
health
Narrative
|
|
11323-3
|
General
health
-
Reported
|
|
11324-1
|
Glasgow
coma
score
eye
opening
at
First
encounter
|
|
11325-8
|
Glasgow
coma
score
motor
at
First
encounter
|
|
11326-6
|
Glasgow
coma
score
verbal
at
First
encounter
|
|
11327-4
|
Heart
rate
method
at
First
encounter
|
|
11328-2
|
Heart
rate
at
First
encounter
|
|
11329-0
|
History
general
Narrative
-
Reported
|
|
1133-8
|
Lu
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11330-8
|
History
of
Alcohol
use
Narrative
|
|
11331-6
|
History
of
Alcohol
use
|
|
11332-4
|
History
of
Cognitive
function
Narrative
|
|
11333-2
|
History
of
Cognitive
function
|
|
11334-0
|
History
of
Growth+Development
Narrative
|
|
11335-7
|
History
of
Growth+Development
|
|
11336-5
|
History
of
Hospitalization
Narrative
|
|
11337-3
|
History
of
Hospitalization
|
|
11338-1
|
History
of
Major
illnesses
and
injuries
Narrative
|
|
11339-9
|
History
of
Major
illnesses
and
injuries
|
|
1134-6
|
Lu
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11340-7
|
History
of
Occupation
Narrative
|
|
11341-5
|
History
of
Occupation
|
|
11342-3
|
History
of
Other
nonmedical
drug
use
Narrative
|
|
11343-1
|
History
of
Other
nonmedical
drug
use
|
|
11344-9
|
History
of
Other
social
factors
Narrative
|
|
11345-6
|
History
of
Other
social
factors
|
|
11346-4
|
History
of
Outpatient
visits
Narrative
|
|
11347-2
|
History
of
Outpatient
visits
|
|
11348-0
|
History
of
Past
illness
Narrative
|
|
11349-8
|
History
of
Past
illness
|
|
1135-3
|
Lu
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11350-6
|
History
of
Sexual
behavior
Narrative
|
|
11351-4
|
History
of
Sexual
behavior
|
|
11352-2
|
History
of
Allergenic
and
Immunologic
disorders
Narrative
|
|
11353-0
|
History
of
Breasts
disorders
Narrative
|
|
11354-8
|
History
of
Ears
and
Nose
and
Sinuses
and
Mouth
and
Throat
disorders
Narrative
|
|
11355-5
|
History
of
Gastrointestinal
system
disorders
Narrative
|
|
11356-3
|
History
of
Genitourinary
systems
disorders
Narrative
|
|
11357-1
|
History
of
Integumentary
system
disorders
Narrative
|
|
11358-9
|
History
of
Psychiatric
disorders
Narrative
|
|
11359-7
|
History
of
Allergenic
and
Immunologic
disorders
|
|
1136-1
|
Lu
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11360-5
|
History
of
Breasts
disorders
|
|
11361-3
|
History
of
Ears
and
Nose
and
Sinuses
and
Mouth
and
Throat
disorders
|
|
11362-1
|
History
of
Gastrointestinal
system
disorders
|
|
11363-9
|
History
of
Genitourinary
systems
disorders
|
|
11364-7
|
History
of
Integumentary
system
disorders
|
|
11365-4
|
History
of
Psychiatric
disorders
|
|
11366-2
|
History
of
Tobacco
use
Narrative
|
|
11367-0
|
History
of
Tobacco
use
|
|
11368-8
|
Illness
or
injury
onset
date
and
time
|
|
11369-6
|
History
of
Immunization
Narrative
|
|
1137-9
|
Lu
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11370-4
|
Immunization
status
-
Reported
|
|
11371-2
|
Initial
visit
for
chief
complaint
|
|
11372-0
|
Injury
associated
activity
|
|
11373-8
|
Injury
cause
|
|
11374-6
|
Injury
incident
description
Narrative
|
|
11375-3
|
Injury
intent
|
|
11376-1
|
Injury
location
|
|
11377-9
|
Diastolic
blood
pressure
at
First
encounter
|
|
11378-7
|
Systolic
blood
pressure
at
First
encounter
|
|
11379-5
|
Highest
level
of
education
[Time]
-
Reported
|
|
1138-7
|
Lu
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11380-3
|
Marital
status
and
living
arrangements
Narrative
-
Reported
|
|
11381-1
|
Marital
status
and
living
arrangements
-
Reported
|
|
11382-9
|
Medication
allergy
-
Reported
|
|
11383-7
|
Patient
problem
outcome
Narrative
|
|
11384-5
|
Physical
examination
by
organ
systems
|
|
11385-2
|
Physical
findings
of
Ankle
Narrative
|
|
11386-0
|
Physical
findings
of
Upper
arm
Narrative
|
|
11387-8
|
Physical
findings
of
Axilla
Narrative
|
|
11388-6
|
Physical
findings
of
Buttocks
Narrative
|
|
11389-4
|
Physical
findings
of
Calf
Narrative
|
|
1139-5
|
Lu
sup(ab)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11390-2
|
Physical
findings
of
Cardiovascular
system
Narrative
|
|
11391-0
|
Physical
findings
of
Chest
Narrative
|
|
11392-8
|
Physical
findings
of
Chest
wall
Narrative
|
|
11393-6
|
Physical
findings
of
Ears
and
Nose
and
Mouth
and
Throat
Narrative
|
|
11394-4
|
Physical
findings
of
Elbow
Narrative
|
|
11395-1
|
Deprecated
Physical
findings:
Find:
Pt:
Extremities:
Nar:
Observed
|
|
11396-9
|
Deprecated
Physical
findings:
Find:
Pt:
Extremities:
Nar:
Observed.
|
|
11397-7
|
Physical
findings
of
Foot
Narrative
|
|
11398-5
|
Physical
findings
of
Forearm
Narrative
|
|
11399-3
|
Physical
findings
of
Gastrointestinal
system
Narrative
|
|
114-9
|
Cefotetan
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1140-3
|
Lu
sup(ab)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11400-9
|
Physical
findings
of
Genitalia
Narrative
|
|
11401-7
|
Physical
findings
of
Female
genitalia
Narrative
|
|
11402-5
|
Physical
findings
of
Male
genitalia
Narrative
|
|
11403-3
|
Physical
findings
of
Groin
Narrative
|
|
11404-1
|
Physical
findings
of
Hand
Narrative
|
|
11405-8
|
Deprecated
Physical
findings:
Find:
Pt:
Heart:
Nar:
Observed
|
|
11406-6
|
Physical
findings
of
Hip
Narrative
|
|
11407-4
|
Physical
findings
of
Knee
Narrative
|
|
11408-2
|
Deprecated
Physical
findings:
Find:
Pt:
Mouth
&
Throat
&
Teeth:
Nar:
Observed
|
|
11409-0
|
Deprecated
Physical
findings:
Find:
Pt:
Mouth
&
Throat
&
Teeth:
Nar:
Observed.
|
|
1141-1
|
Lu
sup(ab)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11410-8
|
Physical
findings
of
Musculoskeletal
system
Narrative
|
|
11411-6
|
Physical
findings
of
Neck
Narrative
|
|
11412-4
|
Physical
findings
of
Respiratory
system
Narrative
|
|
11413-2
|
Physical
findings
of
Shoulder
Narrative
|
|
11414-0
|
Physical
findings
of
Thigh
Narrative
|
|
11415-7
|
Physical
findings
of
Wrist
Narrative
|
|
11416-5
|
Physical
findings
of
Ankle
|
|
11417-3
|
Physical
findings
of
Upper
arm
|
|
11418-1
|
Physical
findings
of
Axilla
|
|
11419-9
|
Physical
findings
of
Buttocks
|
|
1142-9
|
Lu
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11420-7
|
Physical
findings
of
Calf
|
|
11421-5
|
Physical
findings
of
Cardiovascular
system
|
|
11422-3
|
Physical
findings
of
Chest
|
|
11423-1
|
Physical
findings
of
Chest
wall
|
|
11424-9
|
Physical
findings
of
Ears
and
Nose
and
Mouth
and
Throat
|
|
11425-6
|
Physical
findings
of
Elbow
|
|
11426-4
|
Deprecated
Physical
findings:
Find:
Pt:
Extremities:
Nom:
Observed
|
|
11427-2
|
Deprecated
Physical
findings:
Find:
Pt:
Extremities:
Nom:
Observed.
|
|
11428-0
|
Physical
findings
of
Foot
|
|
11429-8
|
Physical
findings
of
Forearm
|
|
1143-7
|
Lu
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11430-6
|
Physical
findings
of
Gastrointestinal
system
|
|
11431-4
|
Physical
findings
of
Genitalia
|
|
11432-2
|
Physical
findings
of
Female
genitalia
|
|
11433-0
|
Physical
findings
of
Male
genitalia
|
|
11434-8
|
Physical
findings
of
Groin
|
|
11435-5
|
Physical
findings
of
Hand
|
|
11436-3
|
Deprecated
Physical
findings:
Find:
Pt:
Heart:
Nom:
Observed
|
|
11437-1
|
Physical
findings
of
Hip
|
|
11438-9
|
Physical
findings
of
Knee
|
|
11439-7
|
Deprecated
Physical
findings:
Find:
Pt:
Mouth
&
Throat
&
Teeth:
Nom:
Observed.
|
|
1144-5
|
Lu
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
11440-5
|
Deprecated
Physical
findings:
Find:
Pt:
Mouth
&
Throat
&
Teeth:
Nom:
Observed
|
|
11441-3
|
Physical
findings
of
Musculoskeletal
system
|
|
11442-1
|
Physical
findings
of
Neck
|
|
11443-9
|
Physical
findings
of
Respiratory
system
|
|
11444-7
|
Physical
findings
of
Shoulder
|
|
11445-4
|
Physical
findings
of
Thigh
|
|
11446-2
|
Physical
findings
of
Wrist
|
|
11447-0
|
Physical
findings
of
Hematologic
and
Lymphatic
and
Immunologic
System
Narrative
|
|
11448-8
|
Physical
findings
of
Hematologic
and
Lymphatic
and
Immunologic
System
|
|
11449-6
|
Pregnancy
status
[Interpretation]
-
Reported
|
|
1145-2
|
Lu
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11450-4
|
Problem
list
-
Reported
|
|
11451-2
|
Psychiatric
findings
Narrative
|
|
11452-0
|
Psychiatric
findings
|
|
11453-8
|
Receiving
facility
EMS
system
|
|
11454-6
|
Responsiveness
assessment
at
First
encounter
|
|
11455-3
|
Deprecated
Review
of
symptoms
and
diseases:
Find:
Pt:
^Patient:
Nar:
Reported
|
|
11456-1
|
Deprecated
Review
of
symptoms
and
diseases:
Find:
Pt:
^Patient:
Nom:
Reported
|
|
11457-9
|
Safety
equipment
used
|
|
11458-7
|
Clostridium
tetani
immunization
status
|
|
11459-5
|
Transport
mode
EMS
system
|
|
1146-0
|
Lu
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11467-8
|
Bacillus
anthracis
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
11468-6
|
Bacillus
anthracis
Ab
[Units/volume]
in
Unspecified
specimen
by
Immunofluorescence
|
|
11469-4
|
Bacillus
anthracis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
1147-8
|
Lu
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
11470-2
|
Clostridium
botulinum
toxin
[Units/volume]
in
Stool
|
|
11471-0
|
Deprecated
Cryptococcus
neoformans
Ag
[Titer]
in
Unspecified
specimen
|
|
11472-8
|
Deprecated
Cryptococcus
neoformans
Ag
[Presence]
in
Unspecified
specimen
|
|
11473-6
|
Cryptococcus
sp
Ag
[Titer]
in
Unspecified
specimen
|
|
11474-4
|
Hydatid
cyst
identified
in
Unspecified
specimen
by
Wet
preparation
|
|
11475-1
|
Microorganism
identified
in
Unspecified
specimen
by
Culture
|
|
11476-9
|
Microscopic
observation
[Identifier]
in
Gastric
fluid
by
Acid
fast
stain
|
|
11477-7
|
Microscopic
observation
[Identifier]
in
Sputum
by
Acid
fast
stain
|
|
11478-5
|
Microscopic
observation
[Identifier]
in
Stool
by
Acid
fast
stain
|
|
11479-3
|
Microscopic
observation
[Identifier]
in
Tissue
by
Acid
fast
stain
|
|
1148-6
|
Lu
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11480-1
|
Microscopic
observation
[Identifier]
in
Urine
by
Acid
fast
stain
|
|
11481-9
|
Human
papilloma
virus
identified
in
Unspecified
specimen
|
|
11482-7
|
Rickettsia
rickettsii
RNA
[Presence]
in
Tissue
by
Probe
and
target
amplification
method
|
|
11483-5
|
Varicella
zoster
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
11484-3
|
Virus
identified
in
Amniotic
fluid
by
Culture
|
|
11485-0
|
Anesthesia
records
|
|
11486-8
|
Chemotherapy
records
|
|
11487-6
|
Consultation
request
(narrative)
|
|
11488-4
|
Consult
note
|
|
11489-2
|
Dictating
practitioner
identifier
|
|
1149-4
|
Lu
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11490-0
|
Physician
Discharge
summary
|
|
11491-6
|
Deprecated
Provider-unspecified
ED
visit
note
|
|
11492-6
|
Provider-unspecifed,
History
and
physical
note
|
|
11493-4
|
Hospital
discharge
studies
summary
Narrative
|
|
11494-2
|
Deprecated
Physician
Initial
assessment
note
at
First
encounter
|
|
11495-9
|
Deprecated
Physical
therapy
Initial
assessment
note
at
First
encounter
|
|
11496-7
|
Deprecated
Podiatry
Initial
assessment
note
at
First
encounter
|
|
11497-5
|
Deprecated
Psychology
Initial
assessment
note
at
First
encounter
|
|
11498-3
|
Deprecated
Social
work
Initial
assessment
note
at
First
encounter
|
|
11499-1
|
Deprecated
Speech
therapy
Initial
assessment
note
at
First
encounter
|
|
115-6
|
Cefoxitin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1150-2
|
Lu
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
11500-6
|
Deprecated
Occupational
therapy
Initial
assessment
note
at
First
encounter
|
|
11501-6
|
Deprecated
Labor
and
delivery
records
|
|
11502-2
|
Laboratory
report
|
|
11503-0
|
Medical
records
|
|
11504-8
|
Provider-unspecified
Operation
note
|
|
11505-5
|
Physician
Procedure
note
|
|
11506-3
|
Provider-unspecified
Progress
note
|
|
11507-1
|
Occupational
therapy
Progress
note
|
|
11508-9
|
Physical
therapy
Progress
note
|
|
11509-7
|
Podiatry
Progress
note
|
|
1151-0
|
Lu
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11510-5
|
Psychology
Progress
note
|
|
11511-3
|
Deprecated
Provider-unspecified
progress
note
|
|
11512-1
|
Speech-language
pathology
Progress
note
|
|
11513-9
|
Provider.signing
[Identifier]
Report
|
|
11514-7
|
Chiropractic
Records
total
Encounter
|
|
11515-4
|
Physical
therapy
Records
total
Encounter
|
|
11516-2
|
Physician
Records
total
Encounter
|
|
11517-0
|
Podiatry
Records
total
Encounter
|
|
11518-8
|
Psychology
Records
total
Encounter
|
|
11519-6
|
Social
service
Records
total
Encounter
|
|
1152-8
|
Lu
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11520-4
|
Speech
therapy
Records
total
Encounter
|
|
11521-2
|
Occupational
therapy
Records
total
Encounter
|
|
11522-0
|
Deprecated
Cardiac
echo
study
|
|
11523-8
|
EEG
study
|
|
11524-6
|
EKG
Study
|
|
11525-3
|
US
Pelvis
Fetus
for
pregnancy
|
|
11526-1
|
Pathology
study
|
|
11527-9
|
Psychiatry
study
|
|
11528-7
|
Deprecated
Radiology
Unspecified
site
and
modality
Study
|
|
11529-5
|
Surgical
pathology
study
|
|
1153-6
|
Lu
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
11530-3
|
Surgeon.assisting
[Identifier]
|
|
11531-1
|
Surgeon.resident
[Identifier]
|
|
11532-9
|
Surgeon.staff
[Identifier]
|
|
11533-7
|
Surgical
drains
|
|
11534-5
|
Temperature
charts
|
|
11535-2
|
Hospital
discharge
Dx
Narrative
|
|
11536-0
|
Nurse
Notes
|
|
11537-8
|
Surgical
drains
Narrative
|
|
11538-6
|
Deprecated
CT
Chest
study
|
|
11539-4
|
Deprecated
CT
Head
study
|
|
1154-4
|
little
c
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11540-2
|
Deprecated
CT
Abdomen
study
|
|
11541-0
|
Deprecated
MRI
Brain
study
|
|
11542-8
|
Deprecated
Provider-unspecified
visit
note
|
|
11543-6
|
Nursery
records
|
|
11544-4
|
Hospital
discharge
follow-up
Narrative
|
|
11545-1
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Acid
fast
stain
|
|
11546-9
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Other
stain
|
|
1155-1
|
little
c
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11550-1
|
Borrelia
burgdorferi
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
11551-9
|
Borrelia
burgdorferi
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
with
amplification
|
|
11552-7
|
Microscopic
exam
[Interpretation]
of
Tissue
fine
needle
aspirate
by
Cytology
|
|
11553-5
|
Microscopic
exam
[Interpretation]
of
Sputum
by
Cytology
|
|
11554-3
|
Deprecated
Magnesium
[Molecules/volume]
in
Serum
or
Plasma
|
|
11555-0
|
Base
excess
in
Blood
by
calculation
|
|
11556-8
|
Oxygen
[Partial
pressure]
in
Blood
|
|
11557-6
|
Carbon
dioxide
[Partial
pressure]
in
Blood
|
|
11558-4
|
pH
of
Blood
|
|
11559-2
|
Fractional
oxyhemoglobin
in
Blood
|
|
1156-9
|
little
c
Ab
[Presence]
in
Serum
or
Plasma
|
|
11560-0
|
Acetylcholine
receptor
binding
Ab
[Units/volume]
in
Serum
|
|
11561-8
|
Acetylcholine
receptor
blocking
Ab
[Units/volume]
in
Serum
|
|
11562-6
|
Acetylcholine
receptor
modulation
Ab
[Units/volume]
in
Serum
|
|
11563-4
|
Deprecated
DNA
double
strand
Ab
[Units/volume]
in
Serum
|
|
11564-2
|
Intrinsic
factor
Ab
[Units/volume]
in
Serum
|
|
11565-9
|
Jo-1
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
11566-7
|
Liver
kidney
microsomal
Ab
[Units/volume]
in
Serum
|
|
11567-5
|
Deprecated
Neutrophil
cytoplasmic
Ab
[Units/volume]
in
Serum
|
|
11568-3
|
Phosphatidylserine
IgG
Ab
[Presence]
in
Serum
|
|
11569-1
|
Phosphatidylserine
IgM
Ab
[Presence]
in
Serum
|
|
1157-7
|
little
c
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11570-9
|
Platelet
IgG
Ab
[Units/volume]
in
Serum
|
|
11571-7
|
Rheumatoid
arthritis
nuclear
Ab
[Units/volume]
in
Serum
|
|
11572-5
|
Rheumatoid
factor
[Units/volume]
in
Serum
or
Plasma
|
|
11573-3
|
Rheumatoid
factor
IgM
[Units/volume]
in
Serum
|
|
11574-1
|
Deprecated
Thyroperoxidase
Ab
[Units/volume]
in
Serum
|
|
11575-8
|
Cefmetazole
[Susceptibility]
by
Gradient
strip
|
|
11576-6
|
Erythromycin+Sulfisoxazole
[Susceptibility]
by
Gradient
strip
|
|
11577-4
|
Sulfamethoxazole
[Susceptibility]
by
Gradient
strip
|
|
11578-2
|
Sulfisoxazole
[Susceptibility]
by
Gradient
strip
|
|
11579-0
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
by
Detection
limit
<=
0.05
mIU/L
|
|
1158-5
|
little
c
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11580-8
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
by
Detection
limit
<=
0.005
mIU/L
|
|
11581-6
|
Ebola
virus
Ab
[Units/volume]
in
Serum
|
|
11582-4
|
Wuchereria
bancrofti
Ab
[Units/volume]
in
Serum
|
|
11583-2
|
Aspergillus
fumigatus
1
Ab
[Presence]
in
Serum
|
|
11584-0
|
Aureobasidium
pullulans
Ab
[Presence]
in
Serum
|
|
11585-7
|
Bordetella
pertussis
Ab
[Units/volume]
in
Serum
|
|
11586-5
|
Brucella
abortus
Ab
[Units/volume]
in
Serum
|
|
11587-3
|
Brucella
canis
Ab
[Units/volume]
in
Serum
|
|
11588-1
|
Brucella
melitensis
Ab
[Units/volume]
in
Serum
|
|
11589-9
|
Brucella
suis
Ab
[Units/volume]
in
Serum
|
|
1159-3
|
little
c
Ag
[Presence]
on
Red
Blood
Cells
|
|
11590-7
|
Coxsackievirus
A10
Ab
[Units/volume]
in
Serum
|
|
11591-5
|
Coxsackievirus
A2
Ab
[Units/volume]
in
Serum
|
|
11592-3
|
Aspergillus
fumigatus
6
Ab
[Presence]
in
Serum
|
|
11593-1
|
Coxsackievirus
A4
Ab
[Units/volume]
in
Serum
|
|
11594-9
|
Echovirus
16
Ab
[Units/volume]
in
Serum
|
|
11595-6
|
Echovirus
18
Ab
[Units/volume]
in
Serum
|
|
11596-4
|
Shigella
dysenteriae
Ab
[Units/volume]
in
Serum
|
|
11597-2
|
Treponema
pallidum
Ab
[Units/volume]
in
Serum
|
|
11598-0
|
Toxoplasma
gondii
Ab
[Units/volume]
in
Serum
|
|
11599-8
|
Coxsackievirus
A21
Ab
[Units/volume]
in
Serum
|
|
116-4
|
Cefoxitin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1160-1
|
little
e
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11600-4
|
Shigella
flexneri
Ab
[Units/volume]
in
Serum
|
|
11601-2
|
Echovirus
7
Ab
[Units/volume]
in
Serum
|
|
11602-0
|
Shigella
boydii
Ab
[Units/volume]
in
Serum
|
|
11603-8
|
Salmonella
sp
Ab
[Units/volume]
in
Serum
|
|
11604-6
|
Burkholderia
pseudomallei
Ab
[Units/volume]
in
Serum
|
|
11605-3
|
Lymphocytic
choriomeningitis
virus
Ab
[Units/volume]
in
Serum
|
|
11606-1
|
Leptospira
interrogans
Ab
[Units/volume]
in
Serum
|
|
11607-9
|
Junin
virus
Ab
[Units/volume]
in
Serum
|
|
11608-7
|
Japanese
encephalitis
virus
Ab
[Units/volume]
in
Serum
|
|
11609-5
|
HTLV
I
Ab
[Units/volume]
in
Serum
|
|
1161-9
|
little
e
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11610-3
|
Heterophile
Ab
[Units/volume]
in
Serum
|
|
11611-1
|
Shigella
sonnei
Ab
[Units/volume]
in
Serum
|
|
11612-9
|
[#]
Abortions
|
|
11613-7
|
[#]
Abortions.induced
|
|
11614-5
|
[#]
Abortions.spontaneous
|
|
11615-2
|
Fetal
Heart
Activity
US
|
|
11616-0
|
Fetal
Heart
Narrative
Activity
US
|
|
11617-8
|
Fetal
Limbs
Activity
US
|
|
11618-6
|
Fetal
Limbs
Narrative
Activity
US
|
|
11619-4
|
Fetal
Respiratory
Activity
US
|
|
1162-7
|
little
e
Ab
[Presence]
in
Serum
or
Plasma
|
|
11620-2
|
Fetal
Respiratory
Narrative
Activity
US
|
|
11621-0
|
Fetal
Trunk
Activity
US
|
|
11622-8
|
Fetal
Trunk
Narrative
Activity
US
|
|
11623-6
|
Fetal
Quadrant
four
Amniotic
fluid
index
derived
by
US
|
|
11624-4
|
Fetal
Quadrant
four
one
Amniotic
fluid
index
derived
by
US
|
|
11625-1
|
Fetal
Quadrant
three
Amniotic
fluid
index
derived
by
US
|
|
11626-9
|
Fetal
Quadrant
two
Amniotic
fluid
index
derived
by
US
|
|
11627-7
|
Fetal
Amniotic
fluid
index.sum
derived
by
US
|
|
11628-5
|
Fetal
Head
Binocular
distance
estimated
from
Biparietal
diameter
on
US
|
|
11629-3
|
Fetal
Head
Binocular
distance
US
|
|
1163-5
|
little
e
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11630-1
|
Fetal
Biophysical
profile.amniotic
fluid
volume
US
|
|
11631-9
|
Fetal
Biophysical
profile.body
movement
US
|
|
11632-7
|
Fetal
Biophysical
profile.breathing
movement
US
|
|
11633-5
|
Fetal
Biophysical
profile.heart
rate
reactivity
US
|
|
11634-3
|
Fetal
Biophysical
profile.sum
Derived
|
|
11635-0
|
Fetal
Biophysical
profile.tone
US
|
|
11636-8
|
[#]
Births.live
|
|
11637-6
|
[#]
Births.preterm
|
|
11638-4
|
[#]
Births.still
living
|
|
11639-2
|
[#]
Births.term
|
|
1164-3
|
little
e
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11640-0
|
[#]
Births
total
|
|
11641-8
|
Fetal
Mitral
valve
Peak
A
wave
US.doppler
|
|
11642-6
|
Deprecated
Mitral
valve
Blood
flow.diastolic.atrial
wave.max
by
US.doppler
|
|
11643-4
|
Fetal
Tricuspid
valve
Peak
A
wave
US.doppler
|
|
11644-2
|
Deprecated
Tricuspid
valve
Peak
A
velocity
US.doppler
|
|
11645-9
|
Fetal
Mitral
valve
Peak
E
wave
US.doppler
|
|
11646-7
|
Deprecated
Mitral
valve
Peak
E
velocity
US.doppler
|
|
11647-5
|
Fetal
Tricuspid
valve
Peak
E
wave
US.doppler
|
|
11648-3
|
Deprecated
Tricuspid
valve
Peak
E
velocity
US.doppler
|
|
11649-1
|
Fetal
Mitral
valve
E-wave/A-wave
US.doppler
|
|
1165-0
|
little
e
Ag
[Presence]
on
Red
Blood
Cells
|
|
11650-9
|
Deprecated
Mitral
valve
Blood
flow.diastolic.early
wave/Atrial
wave
Doppler.measured
|
|
11651-7
|
Fetal
Tricuspid
valve
E-wave/A-wave
US.doppler
|
|
11652-5
|
Deprecated
Tricuspid
valve
Blood
flow.diastolic.early
wave/Atrial
wave
Doppler.measured
|
|
11653-3
|
Circulatory
system
End
diastolic
blood
flow
US.doppler
|
|
11654-1
|
Fetal
Cerebral
artery
anterior
Minimal
flow
velocity
US.doppler
|
|
11655-8
|
Cerebral
artery
anterior
Minimal
flow
velocity
US.doppler
|
|
11656-6
|
Fetal
Cerebral
artery
middle
Minimal
flow
velocity
US.doppler
|
|
11657-4
|
Cerebral
artery
middle
Minimal
flow
velocity
US.doppler
|
|
11658-2
|
Ovarian
artery
-
left
Minimal
flow
velocity
US.doppler
|
|
11659-0
|
Ovarian
artery
-
right
Minimal
flow
velocity
US.doppler
|
|
1166-8
|
little
f
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11660-8
|
Fetal
Umbilical
artery
at
fetus
Minimal
flow
velocity
US.doppler
|
|
11661-6
|
Fetal
Umbilical
artery
at
placenta
Minimal
flow
velocity
US.doppler
|
|
11662-4
|
Fetal
Umbilical
artery
between
fetus
and
placenta
Minimal
flow
velocity
US.doppler
|
|
11663-2
|
Uterine
artery
-
left
Minimal
flow
velocity
US.doppler
|
|
11664-0
|
Uterine
artery
-
right
Minimal
flow
velocity
US.doppler
|
|
11665-7
|
Circulatory
system
Minimal
flow
velocity
US.doppler
|
|
11666-5
|
Fetal
Aorta
ascending
Mean
blood
flow
US.doppler
|
|
11667-3
|
Aorta
ascending
Mean
blood
flow
US.doppler
|
|
11668-1
|
Fetal
Aorta
descending
Mean
blood
flow
US.doppler
|
|
11669-9
|
Aorta
descending
Mean
blood
flow
US.doppler
|
|
1167-6
|
little
f
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11670-7
|
Fetal
Aortic
arch
Mean
blood
flow
US.doppler
|
|
11671-5
|
Aortic
arch
Mean
blood
flow
US.doppler
|
|
11672-3
|
Fetal
Cerebral
artery
anterior
Mean
blood
flow
US.doppler
|
|
11673-1
|
Cerebral
artery
anterior
Mean
blood
flow
US.doppler
|
|
11674-9
|
Cerebral
artery
middle
Mean
blood
flow
US.doppler
|
|
11675-6
|
Fetal
Ductus
arteriosus
Mean
blood
flow
US.doppler
|
|
11676-4
|
Ductus
arteriosus
Mean
blood
flow
US.doppler
|
|
11677-2
|
Fetal
Pulmonary
valve
Mean
blood
flow
US.doppler
|
|
11678-0
|
Pulmonary
valve
Mean
blood
flow
by
US.doppler
|
|
11679-8
|
Fetal
Left
ventricular
outflow
tract
Mean
blood
flow
US.doppler
|
|
1168-4
|
little
f
Ab
[Presence]
in
Serum
or
Plasma
|
|
11680-6
|
Deprecated
Left
ventricular
outflow
tract
Mean
blood
flow
Doppler.measured
|
|
11681-4
|
Fetal
Right
ventricular
outflow
tract
Mean
blood
flow
US.doppler
|
|
11682-2
|
Deprecated
Right
ventricular
outflow
tract
Mean
blood
flow
Doppler.measured
|
|
11683-0
|
Ovarian
artery
-
left
Mean
blood
flow
US.doppler
|
|
11684-8
|
Ovarian
artery
-
right
Mean
blood
flow
US.doppler
|
|
11685-5
|
Fetal
Main
pulmonary
artery
Mean
blood
flow
US.doppler
|
|
11686-3
|
Main
pulmonary
artery
Mean
blood
flow
US.doppler
|
|
11687-1
|
Fetal
Umbilical
artery
at
fetus
Mean
blood
flow
US.doppler
|
|
11688-9
|
Fetal
Umbilical
artery
at
placenta
Mean
blood
flow
US.doppler
|
|
11689-7
|
Fetal
Umbilical
artery
between
fetus
and
placenta
Mean
blood
flow
US.doppler
|
|
1169-2
|
little
f
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11690-5
|
Uterine
artery
-
left
Mean
blood
flow
US.doppler
|
|
11691-3
|
Uterine
artery
-
right
Mean
blood
flow
US.doppler
|
|
11692-1
|
Circulatory
system
Maximum
blood
flow
mean
US.doppler
|
|
11693-9
|
Fetal
Aorta
ascending
Peak
systolic
flow
US.doppler
|
|
11694-7
|
Aorta
ascending
Peak
systolic
flow
US.doppler
|
|
11695-4
|
Fetal
Aorta
descending
Peak
systolic
flow
US.doppler
|
|
11696-2
|
Aorta
descending
Peak
systolic
flow
US.doppler
|
|
11697-0
|
Fetal
Aortic
arch
Peak
systolic
flow
US.doppler
|
|
11698-8
|
Aortic
arch
Peak
systolic
flow
US.doppler
|
|
11699-6
|
Fetal
Cerebral
artery
anterior
Peak
systolic
flow
US.doppler
|
|
117-2
|
Cefoxitin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1170-0
|
little
f
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11700-2
|
Cerebral
artery
anterior
Peak
systolic
flow
US.doppler
|
|
11701-0
|
Fetal
Cerebral
artery
middle
Peak
systolic
flow
US.doppler
|
|
11702-8
|
Cerebral
artery
middle
Peak
systolic
flow
US.doppler
|
|
11703-6
|
Fetal
Ductus
arteriosus
Peak
systolic
flow
US.doppler
|
|
11704-4
|
Ductus
arteriosus
Peak
systolic
flow
US.doppler
|
|
11705-1
|
Fetal
Aortic
valve
Peak
systolic
flow
US.doppler
|
|
11706-9
|
Aortic
valve
Peak
systolic
flow
by
US.doppler
|
|
11707-7
|
Fetal
Mitral
valve
Peak
systolic
flow
US.doppler
|
|
11708-5
|
Mitral
valve
Peak
systolic
flow
by
US.doppler
|
|
11709-3
|
Fetal
Pulmonary
valve
Peak
systolic
flow
US.doppler
|
|
1171-8
|
little
f
Ag
[Presence]
on
Red
Blood
Cells
|
|
11710-1
|
Pulmonary
valve
Peak
systolic
flow
by
US.doppler
|
|
11711-9
|
Fetal
Tricuspid
valve
Peak
systolic
flow
US.doppler
|
|
11712-7
|
Tricuspid
valve
Peak
systolic
flow
by
US.doppler
|
|
11713-5
|
Fetal
Left
ventricular
outflow
tract
Peak
systolic
flow
US.doppler
|
|
11714-3
|
Deprecated
Left
ventricular
outflow
tract
Peak
systolic
flow
Doppler.measured
|
|
11715-0
|
Fetal
Right
ventricular
outflow
tract
Peak
systolic
flow
US.doppler
|
|
11716-8
|
Deprecated
Right
ventricular
outflow
tract
Peak
systolic
flow
Doppler.measured
|
|
11717-6
|
Ovarian
artery
-
left
Peak
systolic
flow
US.doppler
|
|
11718-4
|
Ovarian
artery
-
right
Peak
systolic
flow
US.doppler
|
|
11719-2
|
Fetal
Main
pulmonary
artery
Peak
systolic
flow
US.doppler
|
|
1172-6
|
Deprecated
little
i-1
subtype
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11720-0
|
Main
pulmonary
artery
Peak
systolic
flow
US.doppler
|
|
11721-8
|
Fetal
Umbilical
artery
at
fetus
Peak
systolic
flow
US.doppler
|
|
11722-6
|
Fetal
Umbilical
artery
at
placenta
Peak
systolic
flow
US.doppler
|
|
11723-4
|
Fetal
Umbilical
artery
between
fetus
and
placenta
Peak
systolic
flow
US.doppler
|
|
11724-2
|
Uterine
artery
-
left
Peak
systolic
flow
US.doppler
|
|
11725-9
|
Uterine
artery
-
right
Peak
systolic
flow
US.doppler
|
|
11726-7
|
Circulatory
system
Peak
systolic
flow
US.doppler
|
|
11727-5
|
Fetal
Body
weight
estimated
by
US
|
|
11728-3
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
on
US
|
|
11729-1
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
|
|
1173-4
|
Deprecated
little
i-1
subtype
[Presence]
in
serum
or
plasma
from
donor
|
|
11730-9
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
on
US
|
|
11731-7
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
and
Head
circumference
on
US
|
|
11732-5
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
and
Head
circumference
on
US
by
Hadlock
1985
method
|
|
11733-3
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
and
Head
circumference
on
US
by
Roberts
1985
method
|
|
11734-1
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
on
US
by
Hadlock
1984
method
|
|
11735-8
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
on
US
by
Hadlock
1985
method
|
|
11736-6
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
and
Femur
length
on
US
by
Woo
1985
method
|
|
11737-4
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
by
Eik-Nes
1982
method
|
|
11738-2
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
by
Hadlock
1984
method
|
|
11739-0
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
by
Shepard
1982
method
|
|
1174-2
|
Deprecated
little
i-1
subtype
[Presence]
in
serum
|
|
11740-8
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
by
Thurnau
1983
method
|
|
11741-6
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
by
Warsof
1977
method
|
|
11742-4
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Biparietal
diameter
on
US
by
Weinberger
1984
method
|
|
11743-2
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
on
US
|
|
11744-0
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
and
Head
circumference
on
US
|
|
11745-7
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
and
Head
circumference
on
US
by
Hadlock
1984
method
|
|
11746-5
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
and
Head
circumference
on
US
by
Hadlock
1985
method
|
|
11747-3
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
and
Head
circumference
on
US
by
Ott
1986
method
|
|
11748-1
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
and
Head
circumference
on
US
by
Vintzileos
1987
method
|
|
11749-9
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
and
Head
circumference
on
US
by
Weiner
1985
method
|
|
1175-9
|
Deprecated
little
i-1
subtype
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11750-7
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
on
US
by
Hadlock
1984
method
|
|
11751-5
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
on
US
by
Hadlock
1985
method
|
|
11752-3
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Femur
length
on
US
by
Woo
1985
method
|
|
11753-1
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Head
circumference
on
US
|
|
11754-9
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Head
circumference
on
US
by
Hadlock
1984
method
|
|
11755-6
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
and
Head
circumference
on
US
by
Jordaan
1983
method
|
|
11756-4
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
on
US
by
Campbell
1975
method
|
|
11757-2
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
on
US
by
Vintzileos
1987
method
|
|
11758-0
|
Fetal
Body
weight
estimated
from
Abdominal
circumference
on
US
by
Warsof
1977
method
|
|
11759-8
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Biparietal
diameter
on
US
|
|
1176-7
|
Deprecated
little
i-1
subtype
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11760-6
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Biparietal
diameter
and
Femur
length
on
US
|
|
11761-4
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Biparietal
diameter
and
Femur
length
on
US
by
Rose
1987
method
|
|
11762-2
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Biparietal
diameter
on
US
by
Rose
1987
method
|
|
11763-0
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Biparietal
diameter
on
US
by
Vintzileos
1987
method
|
|
11764-8
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Femur
length
on
US
|
|
11765-5
|
Fetal
Body
weight
estimated
from
Abdominal
diameter
and
Femur
length
on
US
by
Rose
1987
method
|
|
11766-3
|
Fetal
Body
weight
percentile
Comparison
of
estimated
fetal
weight
with
standard
population
distribution
at
same
estimated
gestational
age
|
|
11767-1
|
Body
weight
percentile
Comparison
of
estimated
fetal
weight
with
standard
population
distribution
at
same
estimated
gestational
age
|
|
11768-9
|
Fetal
Body
weight
percentile
range
Categorization
by
comparison
with
standards
|
|
11769-7
|
Body
weight
percentile
range
Categorization
by
comparison
with
standards
|
|
1177-5
|
Deprecated
little
i-1
subtype
[Presence]
on
Red
Blood
Cells
|
|
11770-5
|
[Percentile]
Body
weight.10th
Estimated.pop
birth
wgt
gestational
age
corr.ref
|
|
11771-3
|
[Percentile]
Body
weight.25th
Estimated.pop
birth
wgt
gestational
age
corr.ref
|
|
11772-1
|
[Percentile]
Body
weight.50th
Estimated.pop
birth
wgt
gestational
age
corr.ref
|
|
11773-9
|
[Percentile]
Body
weight.75th
Estimated.pop
birth
wgt
gestational
age
corr.ref
|
|
11774-7
|
[Percentile]
Body
weight.90th
Estimated.pop
birth
wgt
gestational
age
corr.ref
|
|
11775-4
|
Fetal
body
weight
estimation
formula
Narrative
[Bibliographic
Citation]
Citation
|
|
11776-2
|
Gestational
age
estimation
formula
Narrative
[Bibliographic
Citation]
Citation
|
|
11777-0
|
Fetal
Abdomen
[Area]
Cross
section
derived
by
US
|
|
11778-8
|
Delivery
date
Estimated
|
|
11779-6
|
Delivery
date
Estimated
from
last
menstrual
period
|
|
1178-3
|
Deprecated
little
i-2
subtype
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11780-4
|
Delivery
date
Estimated
from
ovulation
date
|
|
11781-2
|
Delivery
date
US
composite
estimate
|
|
11782-0
|
Fetal
Bowel
Diameter
US
|
|
11783-8
|
Bowel
Diameter
US
|
|
11784-6
|
Cervical
canal
external
os
Diameter
palpation
|
|
11785-3
|
Cervical
canal
external
os
Diameter
US
|
|
11786-1
|
Cervical
canal
internal
os
Diameter
palpation
|
|
11787-9
|
Cervical
canal
internal
os
Diameter
US
|
|
11788-7
|
Cervical
canal
Diameter
Probe
insertion.Hagar
|
|
11789-5
|
Cervical
canal
Diameter
Probe
insertion.Pratt
|
|
1179-1
|
Deprecated
little
i-2
subtype
[Presence]
in
serum
or
plasmafrom
donor
|
|
11790-3
|
Fetal
Colon
lumen
Diameter
US
|
|
11791-1
|
Colon
lumen
Diameter
US
|
|
11792-9
|
Fetal
Eye
Diameter
US
|
|
11793-7
|
Follicle
Diameter
US
|
|
11794-5
|
Fetal
Aortic
valve
Diameter
US
|
|
11795-2
|
Aortic
valve
Diameter
by
US
|
|
11796-0
|
Fetal
Mitral
valve
Diameter
US
|
|
11797-8
|
Deprecated
Mitral
valve
Diameter
by
US
|
|
11798-6
|
Fetal
Pulmonary
valve
Diameter
US
|
|
11799-4
|
Pulmonary
valve
Diameter
by
US
|
|
118-0
|
Cefoxitin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1180-9
|
Deprecated
little
i-2
subtype
[Presence]
in
serum
|
|
11800-0
|
Fetal
Tricuspid
valve
Diameter
US
|
|
11801-8
|
Tricuspid
valve
Diameter
by
US
|
|
11802-6
|
Fetal
Left
ventricular
outflow
tract
Diameter
US.doppler
|
|
11803-4
|
Left
ventricular
outflow
tract
Diameter
US.doppler
|
|
11804-2
|
Fetal
Right
ventricular
outflow
tract
Diameter
US
|
|
11805-9
|
Right
ventricular
outflow
tract
Diameter
US
|
|
11806-7
|
Fetal
Pulmonary
artery
Diameter
US
|
|
11807-5
|
Pulmonary
artery
Diameter
US
|
|
11808-3
|
Fetal
Renal
pelvis
-
left
Diameter
US
|
|
11809-1
|
Renal
pelvis
-
left
Diameter
US
|
|
1181-7
|
Deprecated
little
i-2
subtype
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11810-9
|
Fetal
Renal
pelvis
-
right
Diameter
US
|
|
11811-7
|
Renal
pelvis
-
right
Diameter
US
|
|
11812-5
|
Fetal
Small
bowel
Diameter
US
|
|
11813-3
|
Small
bowel
Diameter
US
|
|
11814-1
|
Fetal
Umbilical
vein
Diameter
US
|
|
11815-8
|
Fetal
Urinary
bladder
Diameter
US
|
|
11816-6
|
Fetal
Yolk
sac
Diameter
US
|
|
11817-4
|
Fetal
Amniotic
fluid
space
Diameter
largest
pocket
US
|
|
11818-2
|
Fetal
Abdomen
Diameter.anterior-posterior
US
|
|
11819-0
|
Fetal
Thorax
Diameter.anterior-posterior
US
|
|
1182-5
|
Deprecated
little
i-2
subtype
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11820-8
|
Fetal
Head
Diameter.biparietal
US
|
|
11821-6
|
Fetal
Head
Mean
biparietal
diameter
Estimated
from
gestational
age
|
|
11822-4
|
Fetal
Head
Mean
biparietal
diameter
estimated
from
Cerebellar
diameter
(US)
|
|
11823-2
|
Fetal
Head
Diameter.biparietal/Diameter.occipital
derived
by
US
|
|
11824-0
|
Fetal
Head
Diameter.BPD.area-corrected
derived
by
US
|
|
11825-7
|
Fetal
Kidney
-
left
Hilum-cortex
diameter
US
|
|
11826-5
|
Kidney
-
left
Hilum-cortex
diameter
US
|
|
11827-3
|
Fetal
Kidney
-
right
Hilum-cortex
diameter
US
|
|
11828-1
|
Kidney
-
right
Hilum-cortex
diameter
US
|
|
11829-9
|
Ovary
-
left
Hilum-cortex
diameter
US
|
|
1183-3
|
Deprecated
little
i-2
subtype
[Presence]
on
Red
Blood
Cells
|
|
11830-7
|
Ovary
-
right
Hilum-cortex
diameter
US
|
|
11831-5
|
Fetal
Kidney
Mean
width
Estimated
from
gestational
age
|
|
11832-3
|
Fetal
Amniotic
fluid
space
Maximum
diameter
largest
pocket
US
|
|
11833-1
|
Fetal
Amniotic
fluid
space
Mean
diameter
largest
pocket
US
|
|
11834-9
|
Fetal
Kidney
-
left
Longitudinal
diameter
US
|
|
11835-6
|
Kidney
-
left
Longitudinal
diameter
US
|
|
11836-4
|
Fetal
Kidney
-
right
Longitudinal
diameter
US
|
|
11837-2
|
Kidney
-
right
Longitudinal
diameter
US
|
|
11838-0
|
Fetal
Liver
Longitudinal
diameter
US
|
|
11839-8
|
Liver
Longitudinal
diameter
US
|
|
1184-1
|
little
i
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11840-6
|
Ovary
-
left
Longitudinal
diameter
US
|
|
11841-4
|
Ovary
-
right
Longitudinal
diameter
US
|
|
11842-2
|
Uterus
Longitudinal
diameter
US
|
|
11843-0
|
Fetal
Kidney
Mean
longitudinal
diameter
Estimated
from
gestational
age
|
|
11844-8
|
Fetal
Liver
Mean
longitudinal
diameter
Estimated
from
abdominal
circumference
|
|
11845-5
|
Fetal
Liver
Mean
longitudinal
diameter
Estimated
from
gestational
age
|
|
11846-3
|
Ovary
largest
follicle
Maximum
diameter
US
|
|
11847-1
|
Ovary
-
left
largest
follicle
Maximum
diameter
US
|
|
11848-9
|
Ovary
-
right
largest
follicle
Maximum
diameter
US
|
|
11849-7
|
Fetal
Abdomen
Mean
diameter
Estimated
from
gestational
age
|
|
1185-8
|
little
i
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11850-5
|
Gestational
sac
Mean
diameter
US
|
|
11851-3
|
Fetal
Head
Diameter.occipito-frontal
US
|
|
11852-1
|
Fetal
Head
Diameter.outer
to
outer
US
|
|
11853-9
|
Fetal
Kidney
-
left
Thickeness
US
|
|
11854-7
|
Kidney
-
left
Thickeness
US
|
|
11855-4
|
Fetal
Kidney
-
right
Thickeness
US
|
|
11856-2
|
Kidney
-
right
Thickeness
US
|
|
11857-0
|
Ovary
-
left
Thickeness
US
|
|
11858-8
|
Ovary
-
right
Thickeness
US
|
|
11859-6
|
Uterus
Thickeness
US
|
|
1186-6
|
little
i
Ab
[Presence]
in
Serum
or
Plasma
|
|
11860-4
|
Fetal
Cisterna
magna
Diameter.sagittal
US
|
|
11861-2
|
Fetal
Cisterna
magna
Mean
sagittal
diameter
Estimated
from
gestational
age
|
|
11862-0
|
Fetal
Abdomen
Diameter
transverse
US
|
|
11863-8
|
Fetal
Cerebellum
Diameter
transverse
US
|
|
11864-6
|
Fetal
Thorax
Diameter
transverse
US
|
|
11865-3
|
Uterus
Diameter
transverse
US
|
|
11866-1
|
Fetal
Cerebellum
Mean
transverse
diameter
Estimated
from
gestational
age
|
|
11867-9
|
Effacement
Cervix
|
|
11868-7
|
Fetal
body
weight
estimation
formula
Narrative
[Equation]
Equation
|
|
11869-5
|
Gestational
age
estimation
formula
Narrative
[Equation]
Equation
|
|
1187-4
|
little
i
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11870-3
|
Examination
level
ultrasound
|
|
11871-1
|
Fetal
Femur
length/Abdominal
circumference
derived
by
US
|
|
11872-9
|
Fetal
Femur
length/Biparietal
diameter
derived
by
US
|
|
11873-7
|
Fetal
Femur
length/Head
circumference
derived
by
US
|
|
11874-5
|
Fetal
position
palpation
|
|
11875-2
|
Fetal
position
US
|
|
11876-0
|
Fetal
presentation
palpation
|
|
11877-8
|
Fetal
presentation
US
|
|
11878-6
|
Number
of
fetuses
by
US
|
|
11879-4
|
Ovary
-
left
[#]
Follicles
US
|
|
1188-2
|
little
i
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11880-2
|
Ovary
-
right
[#]
Follicles
US
|
|
11881-0
|
Uterus
Fundal
height
Tape
measure
|
|
11882-8
|
Fetal
Sex
US
|
|
11883-6
|
Fetal
Narrative
Sex
US
|
|
11884-4
|
Gestational
age
Estimated
|
|
11885-1
|
Gestational
age
Estimated
from
last
menstrual
period
|
|
11886-9
|
Gestational
age
Estimated
from
ovulation
date
|
|
11887-7
|
Gestational
age
Estimated
from
selected
delivery
date
|
|
11888-5
|
Gestational
age
US
composite
estimate
|
|
11889-3
|
Gestational
age
estimated
from
Abdominal
circumference
on
US
|
|
1189-0
|
little
i
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
11890-1
|
Gestational
age
estimated
from
Abdominal
circumference
on
US
by
Campbell
1975
method
|
|
11891-9
|
Gestational
age
estimated
from
Abdominal
circumference
on
US
by
Hadlock
1982
method
|
|
11892-7
|
Gestational
age
estimated
from
Abdominal
circumference
on
US
by
Hadlock
1984
method
|
|
11893-5
|
Gestational
age
estimated
from
Abdominal
circumference
on
US
by
Jeanty
1984
method
|
|
11894-3
|
Gestational
age
estimated
from
area
corrected
Biparietal
circumference
(US)
|
|
11895-0
|
Gestational
age
estimated
from
Binocular
distance
on
US
|
|
11896-8
|
Gestational
age
estimated
from
Binocular
distance
on
US
by
Jeanty
1984
method
|
|
11897-6
|
Gestational
age
estimated
from
Biparietal
circumference
(US)
|
|
11898-4
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
|
|
11899-2
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Campbell
1975
method
|
|
119-8
|
Cefpodoxime
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1190-8
|
little
k
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11900-8
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Doubilet
1993
method
|
|
11901-6
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Hadlock
1982
method
|
|
11902-4
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Hadlock
1984
method
|
|
11903-2
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Hansmann
1985
method
|
|
11904-0
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Hobbins
1983
method
|
|
11905-7
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Jeanty
1984
method
|
|
11906-5
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Kurtz
1980
method
|
|
11907-3
|
Gestational
age
estimated
from
Biparietal
diameter
on
US
by
Sabbagha
1978
method
|
|
11908-1
|
Gestational
age
estimated
from
Cerebellar
diameter
by
method
of
Goldstein
1987
(US)
|
|
11909-9
|
Gestational
age
estimated
from
Crown
rump
length
on
US
|
|
1191-6
|
little
k
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11910-7
|
Gestational
age
estimated
from
Crown
rump
length
on
US
by
Hadlock
1992
method
|
|
11911-5
|
Gestational
age
estimated
from
Crown
rump
length
on
US
by
Hansmann
1985
method
|
|
11912-3
|
Gestational
age
estimated
from
Crown
rump
length
on
US
by
Jeanty
1984
method
|
|
11913-1
|
Gestational
age
estimated
from
Crown
rump
length
on
US
by
Nelson
1981
method
|
|
11914-9
|
Gestational
age
estimated
from
Crown
rump
length
on
US
by
Robinson
1975
method
|
|
11915-6
|
Gestational
age
estimated
from
Crown
rump
length
on
US
by
Yeh
1988
method
|
|
11916-4
|
Gestational
age
estimated
from
Fibula
length
(US)
|
|
11917-2
|
Gestational
age
estimated
from
Fibula
length
by
method
of
Jeanty
1984
(US)
|
|
11918-0
|
Gestational
age
estimated
from
Fibula
length
by
method
of
Merz
1987
(US)
|
|
11919-8
|
Gestational
age
estimated
from
Femur
length
on
US
|
|
1192-4
|
little
k
Ab
[Presence]
in
Serum
or
Plasma
|
|
11920-6
|
Gestational
age
estimated
from
Femur
length
on
US
by
Hadlock
1984
method
|
|
11921-4
|
Gestational
age
estimated
from
Femur
length
on
US
by
Hansmann
1985
method
|
|
11922-2
|
Gestational
age
estimated
from
Femur
length
on
US
by
Hohler
1982
method
|
|
11923-0
|
Gestational
age
estimated
from
Femur
length
on
US
by
Jeanty
1984
method
|
|
11924-8
|
Gestational
age
estimated
from
Femur
length
on
US
by
Merz
1987
method
|
|
11925-5
|
Gestational
age
estimated
from
Femur
length
on
US
by
Obrien
1982
method
|
|
11926-3
|
Gestational
age
estimated
from
Foot
length
on
US
by
Mercer
1987
method
|
|
11927-1
|
Gestational
age
estimated
from
Gestational
sac
diameter
on
US
|
|
11928-9
|
Gestational
age
estimated
from
Gestational
sac
diameter
on
US
by
Hellman
1969
method
|
|
11929-7
|
Gestational
age
estimated
from
Gestational
sac
diameter
on
US
by
Rempen
1991
method
|
|
1193-2
|
little
k
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
11930-5
|
Gestational
age
estimated
from
Head
circumference
on
US
|
|
11931-3
|
Gestational
age
estimated
from
Head
circumference
on
US
by
Hadlock
1982
method
|
|
11932-1
|
Gestational
age
estimated
from
Head
circumference
on
US
by
Hadlock
1984
method
|
|
11933-9
|
Gestational
age
estimated
from
Head
circumference
on
US
by
Hoffbauer
1979
method
|
|
11934-7
|
Gestational
age
estimated
from
Head
circumference
on
US
by
Jeanty
1984
method
|
|
11935-4
|
Gestational
age
estimated
from
Humerus
length
on
US
|
|
11936-2
|
Gestational
age
estimated
from
Humerus
length
on
US
by
Jeanty
1984
method
|
|
11937-0
|
Gestational
age
estimated
from
Humerus
length
on
US
by
Merz
1987
method
|
|
11938-8
|
Gestational
age
estimated
from
Radius
length
(US)
|
|
11939-6
|
Gestational
age
estimated
from
Radius
length
by
method
of
Merz
1987
(US)
|
|
1194-0
|
little
k
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
11940-4
|
Gestational
age
estimated
from
Tibia
length
on
US
|
|
11941-2
|
Gestational
age
estimated
from
Tibia
length
on
US
by
Jeanty
1984
method
|
|
11942-0
|
Gestational
age
estimated
from
Tibia
length
on
US
by
Merz
1987
method
|
|
11943-8
|
Gestational
age
estimated
from
Ulna
length
(US)
|
|
11944-6
|
Gestational
age
estimated
from
Ulna
length
by
method
of
Jeanty
1984
(US)
|
|
11945-3
|
Gestational
age
estimated
from
Ulna
length
by
method
of
Merz
1987
(US)
|
|
11946-1
|
Fetal
Placenta
Grade
US
|
|
11947-9
|
Head
circumference/Abdominal
circumference
derived
by
US
|
|
11948-7
|
Fetal
Heart
rate
US
|
|
11949-5
|
Fetal
Identification
criteria
US
|
|
1195-7
|
little
k
Ag
[Presence]
on
Red
Blood
Cells
|
|
11950-3
|
Fetal
Narrative
Identification
criteria
US
|
|
11951-1
|
Fetal
[Identifier]
Identifier
|
|
11952-9
|
Fetal
Umbilical
cord.placenta
Narrative
Insertion
site
US
|
|
11953-7
|
OB
ultrasound
imaging
device
Institution
inventory
number
|
|
11954-5
|
Fetal
Kidney
length/Abdominal
circumference
derived
by
US
|
|
11955-2
|
Deprecated
Last
menstrual
period
|
|
11956-0
|
Fetal
Head
Lateral
ventricular
body
width/Hemispheric
width
derived
by
US
|
|
11957-8
|
Fetal
Crown
Rump
length
US
|
|
11958-6
|
Cervical
canal
[Length]
palpation
|
|
11959-4
|
Cervical
canal
[Length]
US
|
|
1196-5
|
Little
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11960-2
|
Cervix
externally
palpable
surface
[Length]
palpation
|
|
11961-0
|
Cervix
[Length]
US
|
|
11962-8
|
Fetal
Clavicle
diaphysis
[Length]
US
|
|
11963-6
|
Fetal
Femur
diaphysis
[Length]
US
|
|
11964-4
|
Fetal
Fibula
diaphysis
[Length]
US
|
|
11965-1
|
Fetal
Foot
[Length]
US
|
|
11966-9
|
Fetal
Humerus
diaphysis
[Length]
US
|
|
11967-7
|
Fetal
Radius
diaphysis
[Length]
US
|
|
11968-5
|
Fetal
Tibia
diaphysis
[Length]
US
|
|
11969-3
|
Fetal
Ulna
diaphysis
[Length]
US
|
|
1197-3
|
Little
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
11970-1
|
Fetal
Femur
diaphysis
[Length]
mean
Estimated
from
gestational
age.Merz.
1987
|
|
11971-9
|
Fetal
Fibula
diaphysis
[Length]
mean
Estimated
from
gestational
age.Merz.
1987
|
|
11972-7
|
Fetal
Humerus
diaphysis
[Length]
mean
Estimated
from
gestational
age.Merz.
1987
|
|
11973-5
|
Fetal
Radius
diaphysis
[Length]
mean
Estimated
from
gestational
age.Merz.
1987
|
|
11974-3
|
Fetal
Tibia
diaphysis
[Length]
mean
Estimated
from
gestational
age.Merz.
1987
|
|
11975-0
|
Fetal
Ulna
diaphysis
[Length]
mean
Estimated
from
gestational
age.Merz.
1987
|
|
11976-8
|
Ovulation
date
|
|
11977-6
|
[#]
Parity
|
|
11978-4
|
Fetal
Abdomen
Circumference
derived
by
US
|
|
11979-2
|
Fetal
Abdomen
Circumference
US
|
|
1198-1
|
Little
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
11980-0
|
Fetal
Abdomen
Circumference
measured
by
ellipse
overlay
(US)
|
|
11981-8
|
Fetal
Abdomen
Circumference
US.traced
|
|
11982-6
|
Fetal
Head
Circumference
derived
from
occipital-frontal
diameter
and
outer-outer
transaxial
diameter
(US)
|
|
11983-4
|
Fetal
Head
Circumference
derived
from
occipital-frontal
diameter
and
outer-inner
biparietal
diameter
(US)
|
|
11984-2
|
Fetal
Head
Circumference
US
|
|
11985-9
|
Fetal
Head
Circumference
measured
by
ellipse
overlay
(US)
|
|
11986-7
|
Fetal
Head
Circumference
US.traced
|
|
11987-5
|
Fetal
Thorax
Circumference
derived
by
US
|
|
11988-3
|
Fetal
Thorax
Circumference
US
|
|
11989-1
|
Fetal
Thorax
Circumference
measured
by
ellipse
overlay
(US)
|
|
1199-9
|
pk
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
11990-9
|
Fetal
Thorax
Circumference
US.traced
|
|
11991-7
|
Fetal
Abdomen
Mean
perimeter
Estimated
from
gestational
age
|
|
11992-5
|
Fetal
Heart
position
US
|
|
11993-3
|
Fetal
Narrative
Heart
position
US
|
|
11994-1
|
Placenta
position
US
|
|
11995-8
|
Narrative
Placenta
position
US
|
|
11996-6
|
[#]
Pregnancies
|
|
11997-4
|
Fetal
Cerebral
artery
anterior
Pulsatility
index
US.doppler
|
|
11998-2
|
Cerebral
artery
anterior
Pulsatility
index
US.doppler
|
|
11999-0
|
Fetal
Cerebral
artery
middle
Pulsatility
index
US.doppler
|
|
12-5
|
Amikacin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
120-6
|
Cefpodoxime
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1200-5
|
pk
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12000-6
|
Cerebral
artery
middle
Pulsatility
index
US.doppler
|
|
12001-4
|
Ovarian
artery
-
left
Pulsatility
index
US.doppler
|
|
12002-2
|
Ovarian
artery
-
right
Pulsatility
index
US.doppler
|
|
12003-0
|
Fetal
Umbilical
artery
at
fetus
Pulsatility
index
US.doppler
|
|
12004-8
|
Fetal
Umbilical
artery
at
placenta
Pulsatility
index
US.doppler
|
|
12005-5
|
Fetal
Umbilical
artery
between
fetus
and
placenta
Pulsatility
index
US.doppler
|
|
12006-3
|
Uterine
artery
-
left
Pulsatility
index
US.doppler
|
|
12007-1
|
Uterine
artery
-
right
Pulsatility
index
US.doppler
|
|
12008-9
|
Pulsatility
index
US.doppler
|
|
12009-7
|
Fetal
Heart
R-R
duration
US
|
|
1201-3
|
pk
Ab
[Presence]
in
Serum
or
Plasma
|
|
12010-5
|
R-R
duration
US
|
|
12011-3
|
Replicate
summarization
|
|
12012-1
|
Fetal
Cerebral
artery
anterior
Resistivity
index
US.doppler
|
|
12013-9
|
Deprecated
Fetal
Cerebral
artery
anterior
Resistivity
index
Doppler.calculated
|
|
12014-7
|
Cerebral
artery
middle
Resistivity
index
US.doppler
|
|
12015-4
|
Deprecated
Resistivity
index
of
Cerebral
artery
middle
Doppler.calculated
|
|
12016-2
|
Ovarian
artery
-
left
Resistivity
index
US.doppler
|
|
12017-0
|
Ovarian
artery
-
right
Resistivity
index
US.doppler
|
|
12018-8
|
Fetal
Umbilical
artery
at
fetus
Resistivity
index
US.doppler
|
|
12019-6
|
Fetal
Umbilical
artery
at
placenta
Resistivity
index
US.doppler
|
|
1202-1
|
pk
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12020-4
|
Fetal
Umbilical
artery
between
fetus
and
placenta
Resistivity
index
US.doppler
|
|
12021-2
|
Uterine
artery
-
left
Resistivity
index
US.doppler
|
|
12022-0
|
Uterine
artery
-
right
Resistivity
index
US.doppler
|
|
12023-8
|
Resistivity
index
US.doppler
|
|
12024-6
|
Left
ventricle
[Length]
Short
axis
during
diastole
US.M-mode+Measured
|
|
12025-3
|
Left
ventricle
[Length]
Short
axis
during
diastole
Measured
by
real
time
two
dimension
US
|
|
12026-1
|
Left
ventricle
[Length]
Short
axis
during
systole
US.M-mode+Measured
|
|
12027-9
|
Left
ventricle
[Length]
Short
axis
during
systole
Measured
by
real
time
two
dimension
US
|
|
12028-7
|
Fetal
Abdomen
Study
observation
US
|
|
12029-5
|
Fetal
Abdomen
Narrative
Study
observation
US
|
|
1203-9
|
pk
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12030-3
|
Fetal
Abdominal
wall
Study
observation
US
|
|
12031-1
|
Fetal
Abdominal
wall
Narrative
Study
observation
US
|
|
12032-9
|
Fetal
Aorta
ascending
Study
observation
US
|
|
12033-7
|
Fetal
Aorta
ascending
Narrative
Study
observation
US
|
|
12034-5
|
Fetal
Aorta
descending
Study
observation
US
|
|
12035-2
|
Fetal
Aorta
descending
Narrative
Study
observation
US
|
|
12036-0
|
Fetal
Aorta
Study
observation
US
|
|
12037-8
|
Fetal
Aorta
Narrative
Study
observation
US
|
|
12038-6
|
Fetal
Aortic
arch
Study
observation
US
|
|
12039-4
|
Fetal
Aortic
arch
Narrative
Study
observation
US
|
|
1204-7
|
pk
Ag
[Presence]
on
Red
Blood
Cells
|
|
12040-2
|
Fetal
Cerebellum
Study
observation
US
|
|
12041-0
|
Fetal
Cerebellum
Narrative
Study
observation
US
|
|
12042-8
|
Fetal
Cerebrum
Study
observation
US
|
|
12043-6
|
Fetal
Cerebrum
Narrative
Study
observation
US
|
|
12044-4
|
Inspection
Cervix
Study
observation
|
|
12045-1
|
palpation
Cervix
Study
observation
|
|
12046-9
|
US
Cervix
Study
observation
|
|
12047-7
|
Fetal
Colon
Study
observation
US
|
|
12048-5
|
Fetal
Colon
Narrative
Study
observation
US
|
|
12049-3
|
Fetal
Cranium
Study
observation
US
|
|
1205-4
|
little
p
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12050-1
|
Fetal
Cranium
Narrative
Study
observation
US
|
|
12051-9
|
Fetal
Diaphragm
Study
observation
US
|
|
12052-7
|
Fetal
Diaphragm
Narrative
Study
observation
US
|
|
12053-5
|
Fetal
ductal
arch
Study
observation
US
|
|
12054-3
|
Fetal
ductal
arch
Narrative
Study
observation
US
|
|
12055-0
|
Fetal
Face
Study
observation
US
|
|
12056-8
|
Fetal
Face
Narrative
Study
observation
US
|
|
12057-6
|
Fetal
Choroid
plexus
Study
observation
US
|
|
12058-4
|
Fetal
Choroid
plexus
Narrative
Study
observation
US
|
|
12059-2
|
Fetal
Fourth
ventricle
Study
observation
US
|
|
1206-2
|
little
p
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12060-0
|
Fetal
Fourth
ventricle
Narrative
Study
observation
US
|
|
12061-8
|
Fetal
Intracranial
anatomy
Study
observation
US
|
|
12062-6
|
Fetal
Intracranial
anatomy
Narrative
Study
observation
US
|
|
12063-4
|
Fetal
Lateral
cerebral
ventricles
Study
observation
US
|
|
12064-2
|
Fetal
Lateral
cerebral
ventricles
Narrative
Study
observation
US
|
|
12065-9
|
Fetal
Posterior
fossa
Study
observation
US
|
|
12066-7
|
Fetal
Posterior
fossa
Narrative
Study
observation
US
|
|
12067-5
|
Fetal
Head
Third
Ventricle
Study
observation
US
|
|
12068-3
|
Fetal
Head
Third
Ventricle
Narrative
Study
observation
US
|
|
12069-1
|
Fetal
Head
Study
observation
US
|
|
1207-0
|
little
p
Ag
[Presence]
on
Red
Blood
Cells
|
|
12070-9
|
Fetal
Head
Narrative
Study
observation
US
|
|
12071-7
|
Fetal
Aortic
valve
Study
observation
US
|
|
12072-5
|
Fetal
Aortic
valve
Narrative
Study
observation
US
|
|
12073-3
|
Fetal
Atrium
Study
observation
US
|
|
12074-1
|
Fetal
Atrium
Narrative
Study
observation
US
|
|
12075-8
|
Fetal
Heart
chambers
Study
observation
US
|
|
12076-6
|
Fetal
Heart
chambers
Narrative
Study
observation
US
|
|
12077-4
|
Fetal
Heart
great
vessels
Study
observation
US
|
|
12078-2
|
Fetal
Heart
great
vessels
Narrative
Study
observation
US
|
|
12079-0
|
Fetal
Interventricular
septum
Study
observation
US
|
|
1208-8
|
little
s
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12080-8
|
Fetal
Interventricular
septum
Narrative
Study
observation
US
|
|
12081-6
|
Fetal
Mitral
valve
Study
observation
US
|
|
12082-4
|
Fetal
Mitral
valve
Narrative
Study
observation
US
|
|
12083-2
|
Fetal
Pulmonary
valve
Study
observation
US
|
|
12084-0
|
Fetal
Tricuspid
valve
Study
observation
US
|
|
12085-7
|
Fetal
Tricuspid
valve
Narrative
Study
observation
US
|
|
12086-5
|
Fetal
Heart
valves
Study
observation
US
|
|
12087-3
|
Fetal
Heart
valves
Narrative
Study
observation
US
|
|
12088-1
|
Fetal
Left
ventricular
outflow
tract
Study
observation
US
|
|
12089-9
|
Fetal
Left
ventricular
outflow
tract
Narrative
Study
observation
US
|
|
1209-6
|
little
s
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12090-7
|
Fetal
Right
ventricular
outflow
tract
Study
observation
US
|
|
12091-5
|
Fetal
Right
ventricular
outflow
tract
Narrative
Study
observation
US
|
|
12092-3
|
Fetal
Intestine
Study
observation
US
|
|
12093-1
|
Fetal
Intestine
Narrative
Study
observation
US
|
|
12094-9
|
Fetal
Kidney
-
left
Study
observation
US
|
|
12095-6
|
Fetal
Kidney
-
left
Narrative
Study
observation
US
|
|
12096-4
|
Fetal
Kidney
-
right
Study
observation
US
|
|
12097-2
|
Fetal
Kidney
-
right
Narrative
Study
observation
US
|
|
12098-0
|
Fetal
Kidney
Study
observation
US
|
|
12099-8
|
Fetal
Kidney
Narrative
Study
observation
US
|
|
121-4
|
Cefpodoxime
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1210-4
|
little
s
Ab
[Presence]
in
Serum
or
Plasma
|
|
12100-4
|
Fetal
Limbs
Study
observation
US
|
|
12101-2
|
Fetal
Limbs
Narrative
Study
observation
US
|
|
12102-0
|
Fetal
Nuchal
fold
Study
observation
US
|
|
12103-8
|
Fetal
Nuchal
fold
Narrative
Study
observation
US
|
|
12104-6
|
Fetal
Pulmonary
artery
Study
observation
US
|
|
12105-3
|
Fetal
Pulmonary
artery
Narrative
Study
observation
US
|
|
12106-1
|
Fetal
Pulmonary
vein
Study
observation
US
|
|
12107-9
|
Fetal
Pulmonary
vein
Narrative
Study
observation
US
|
|
12108-7
|
Fetal
Small
bowel
Study
observation
US
|
|
12109-5
|
Fetal
Small
bowel
Narrative
Study
observation
US
|
|
1211-2
|
little
s
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12110-3
|
Fetal
Spine
Study
observation
US
|
|
12111-1
|
Fetal
Spine
Narrative
Study
observation
US
|
|
12112-9
|
Fetal
Stomach
Study
observation
US
|
|
12113-7
|
Fetal
Stomach
Narrative
Study
observation
US
|
|
12114-5
|
Fetal
Thorax
Study
observation
US
|
|
12115-2
|
Fetal
Thorax
Narrative
Study
observation
US
|
|
12116-0
|
Fetal
Umbilical
cord
Study
observation
US
|
|
12117-8
|
Fetal
Umbilical
cord
Narrative
Study
observation
US
|
|
12118-6
|
Fetal
Urinary
bladder
Study
observation
US
|
|
12119-4
|
Fetal
Urinary
bladder
Narrative
Study
observation
US
|
|
1212-0
|
little
s
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12120-2
|
Fetal
Inferior
vena
cava
Study
observation
US
|
|
12121-0
|
Fetal
Inferior
vena
cava
Narrative
Study
observation
US
|
|
12122-8
|
Fetal
Superior
vena
cava
Study
observation
US
|
|
12123-6
|
Fetal
Superior
vena
cava
Narrative
Study
observation
US
|
|
12124-4
|
Fetal
Vena
cava
Study
observation
US
|
|
12125-1
|
Fetal
Vena
cava
Narrative
Study
observation
US
|
|
12126-9
|
US
Unspecified
body
region
Study
observation
Narrative
|
|
12127-7
|
Deprecated
Fetal
Yolk
sac
Quantitative
Study
observation
US
|
|
12128-5
|
Fetal
Yolk
sac
Narrative
Study
observation
US
|
|
12129-3
|
Fetal
[Interpretation]
Study
observation
general
US
|
|
1213-8
|
little
s
Ag
[Presence]
on
Red
Blood
Cells
|
|
12130-1
|
Fetal
Narrative
[Interpretation]
Study
observation
general
US
|
|
12131-9
|
US
Study
observation
general
[Interpretation]
|
|
12132-7
|
US
Study
observation
general
[Interpretation]
Narrative
|
|
12133-5
|
Fetal
Cerebral
artery
anterior
Systolic
flow/Diastolic
flow
US.doppler
|
|
12134-3
|
Cerebral
artery
anterior
Systolic
flow/Diastolic
flow
US.doppler
|
|
12135-0
|
Fetal
Cerebral
artery
middle
Systolic
flow/Diastolic
flow
US.doppler
|
|
12136-8
|
Cerebral
artery
middle
Systolic
flow/Diastolic
flow
US.doppler
|
|
12137-6
|
Ovarian
artery
-
left
Systolic
flow/Diastolic
flow
US.doppler
|
|
12138-4
|
Ovarian
artery
-
right
Systolic
flow/Diastolic
flow
US.doppler
|
|
12139-2
|
Fetal
Umbilical
artery
at
fetus
Systolic
flow/Diastolic
flow
US.doppler
|
|
1214-6
|
LW
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12140-0
|
Fetal
Umbilical
artery
at
placenta
Systolic
flow/Diastolic
flow
US.doppler
|
|
12141-8
|
Fetal
Umbilical
artery
between
fetus
and
placenta
Systolic
flow/Diastolic
flow
US.doppler
|
|
12142-6
|
Uterine
artery
-
left
Systolic
flow/Diastolic
flow
US.doppler
|
|
12143-4
|
Uterine
artery
-
right
Systolic
flow/Diastolic
flow
US.doppler
|
|
12144-2
|
Systolic
flow/Diastolic
flow
US.doppler
|
|
12145-9
|
Endometrium
Thickness
US
|
|
12146-7
|
Fetal
Nuchal
fold
Thickness
US
|
|
12147-5
|
Fetal
Placenta
Thickness
US
|
|
12148-3
|
Fetal
Interventricular
septum
Thickness
diastolic
US.M-mode+Measured
|
|
12149-1
|
Fetal
Interventricular
septum
Thickness
diastolic
Measured
by
real
time
two
dimension
US
|
|
1215-3
|
LW
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12150-9
|
Fetal
Left
ventricular
posterior
wall
Thickness
diastolic
US.M-mode+Measured
|
|
12151-7
|
Fetal
Left
ventricular
posterior
wall
Thickness
diastolic
Measured
by
real
time
two
dimension
US
|
|
12152-5
|
Fetal
Interventricular
septum
Thickness.systolic
US.M-mode+Measured
|
|
12153-3
|
Fetal
Interventricular
septum
Thickness.systolic
Measured
by
real
time
two
dimension
US
|
|
12154-1
|
Fetal
Left
ventricular
posterior
wall
Thickness.systolic
US.M-mode+Measured
|
|
12155-8
|
Fetal
Left
ventricular
posterior
wall
Thickness.systolic
Measured
by
real
time
two
dimension
US
|
|
12156-6
|
Transducer
site
|
|
12157-4
|
Ultrasonographer
gravidity
number
|
|
12158-2
|
OB
ultrasound
imaging
device
Class
|
|
12159-0
|
Ultrasound
scan
quality
|
|
1216-1
|
LW
Ab
[Presence]
in
Serum
or
Plasma
|
|
12160-8
|
OB
ultrasound
imaging
device
Vendor
model
number
|
|
12161-6
|
OB
ultrasound
imaging
device
Vendor
serial
number
|
|
12162-4
|
Fetal
Kidney
-
left
Volume
derived
by
US
|
|
12163-2
|
Fetal
Kidney
-
right
Volume
derived
by
US
|
|
12164-0
|
Ovary
-
left
Volume
derived
by
US
|
|
12165-7
|
Ovary
-
right
Volume
derived
by
US
|
|
12166-5
|
Fetal
Yolk
sac
Volume
US
|
|
12167-3
|
Fetal
Amniotic
fluid
space
[Interpretation]
Volume.amniotic
fluid
US
|
|
12168-1
|
Fetal
Urinary
bladder
Volume
post
void
US
|
|
12169-9
|
Fetal
Urinary
bladder
Volume.pre
void
US
|
|
1217-9
|
LW
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12170-7
|
Fetal
Head
Hemisphere
width
US
|
|
12171-5
|
Fetal
Lateral
cerebral
ventricles
Transverse
width
US
|
|
12172-3
|
5-Hydroxyindoleacetate
[Presence]
in
24
hour
Urine
|
|
12173-1
|
Non
prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12174-9
|
Albumin/Globulin
[Mass
Ratio]
in
Body
fluid
|
|
12175-6
|
Deprecated
Albumin/Globulin
[Mass
ratio]
in
Serum
|
|
12176-4
|
Amino
acids
[Moles/volume]
in
Serum
or
Plasma
|
|
12177-2
|
Amino
acids/Creatinine
[Ratio]
in
Urine
|
|
12178-0
|
Bacteria
[Presence]
in
Genital
specimen
by
Wet
preparation
|
|
12179-8
|
Basophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
1218-7
|
LW
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12180-6
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
by
Ion-selective
membrane
electrode
(ISE)
|
|
12181-4
|
Calcium
[Moles/volume]
in
Body
fluid
|
|
12182-2
|
Cells
[#/volume]
in
Body
fluid
by
Manual
count
|
|
12183-0
|
Cholesterol
[Mass/volume]
in
Body
fluid
|
|
12184-8
|
Choriogonadotropin
[Presence]
in
Body
fluid
|
|
12185-5
|
aPTT
in
control
Blood
by
Coagulation
assay
|
|
12186-3
|
Colloid
oncotic
pressure
[Partial
pressure]
in
Plasma
|
|
12187-1
|
Creatine
kinase.MB/Creatine
kinase.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
12188-9
|
Deprecated
Creatine
kinase.MB/Creatine
kinase.total
|
|
12189-7
|
Creatine
kinase.MB/Creatine
kinase.total
in
Serum
or
Plasma
by
calculation
|
|
1219-5
|
LW
Ag
[Presence]
on
Red
Blood
Cells
|
|
12190-5
|
Creatinine
[Mass/volume]
in
Body
fluid
|
|
12191-3
|
Creatinine
[Mass/volume]
in
Peritoneal
fluid
|
|
12192-1
|
Creatinine
[Mass/volume]
in
Peritoneal
fluid
--2
hours
post
peritoneal
dialysis
|
|
12193-9
|
Creatinine
[Mass/volume]
in
Peritoneal
fluid
--4
hours
post
peritoneal
dialysis
|
|
12194-7
|
Creatinine
[Mass/volume]
in
Peritoneal
fluid
--12
hours
post
peritoneal
dialysis
|
|
12195-4
|
Creatinine
renal
clearance/1.73
sq
M
in
24
hour
|
|
12196-2
|
Cryofibrinogen
[Presence]
in
Plasma
by
4
hour
cold
incubation
|
|
12197-0
|
Cryofibrinogen
[Presence]
in
Plasma
by
1
day
cold
incubation
|
|
12198-8
|
Cryofibrinogen
[Presence]
in
Plasma
by
2
day
cold
incubation
|
|
12199-6
|
Cryofibrinogen
[Presence]
in
Plasma
by
3
day
cold
incubation
|
|
122-2
|
Cefpodoxime
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1220-3
|
Mg
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12200-2
|
Cryoglobulin
[Presence]
in
Serum
by
4
hour
cold
incubation
|
|
12201-0
|
Cryoglobulin
[Presence]
in
Serum
by
1
day
cold
incubation
|
|
12202-8
|
Cryoglobulin
[Presence]
in
Serum
by
2
day
cold
incubation
|
|
12203-6
|
Cryoglobulin
[Presence]
in
Serum
by
3
day
cold
incubation
|
|
12204-4
|
Cryoglobulin
[Presence]
in
Serum
by
4
day
cold
incubation
|
|
12205-1
|
Cryoglobulin
[Presence]
in
Serum
by
5
day
cold
incubation
|
|
12206-9
|
Cryoglobulin
[Presence]
in
Serum
by
6
day
cold
incubation
|
|
12207-7
|
Cryoglobulin
[Presence]
in
Serum
by
1
week
cold
incubation
|
|
12208-5
|
Eosinophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
12209-3
|
Eosinophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
1221-1
|
Mg
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12210-1
|
Eosinophils/100
leukocytes
in
Urine
sediment
by
Manual
count
|
|
12211-9
|
Epithelial
cells
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
12212-7
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
12213-5
|
Deprecated
Estradiol
[Mass/volume]
in
Serum
or
Plasma
by
RIA
|
|
12214-3
|
Deprecated
Estradiol
[Mass/volume]
in
Serum
or
Plasma
by
MEIA
|
|
12215-0
|
Fatty
acids.very
long
chain
[Moles/volume]
in
Serum
or
Plasma
|
|
12216-8
|
Deprecated
Gastrin
[Mass/volume]
in
Serum
or
Plasma
|
|
12217-6
|
Globulin
[Mass/volume]
in
Body
fluid
|
|
12218-4
|
Glucose
[Mass/volume]
in
Peritoneal
fluid
--2
hours
post
peritoneal
dialysis
|
|
12219-2
|
Glucose
[Mass/volume]
in
Peritoneal
fluid
--4
hours
post
peritoneal
dialysis
|
|
1222-9
|
Mg
Ab
[Presence]
in
Serum
or
Plasma
|
|
12220-0
|
Glucose
[Mass/volume]
in
Peritoneal
fluid
--12
hours
post
peritoneal
dialysis
|
|
12221-8
|
Heterophile
Ab
[Presence]
in
Serum
by
Sheep
Cell
Agglutination
|
|
12222-6
|
Human
papilloma
virus
Ag
[Presence]
in
Genital
specimen
|
|
12223-4
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Genital
specimen
|
|
12224-2
|
Leukocytes
[#/area]
in
Nose
by
Microscopy
high
power
field
|
|
12225-9
|
Leukocytes
[#/area]
in
Sputum
by
Microscopy
high
power
field
|
|
12226-7
|
Leukocytes
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
12227-5
|
Leukocytes
[#/volume]
corrected
for
nucleated
erythrocytes
in
Blood
|
|
12228-3
|
Triglyceride
[Mass/volume]
in
Body
fluid
|
|
12229-1
|
Macrophages/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
1223-7
|
Mg
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12230-9
|
Macrophages/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
12231-7
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
12232-5
|
Measles
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
12233-3
|
Mesothelial
cells/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
12234-1
|
Mesothelial
cells/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
12235-8
|
Microscopic
observation
[Identifier]
in
Urine
sediment
by
Light
microscopy
|
|
12236-6
|
Mononuclear
cells/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
12237-4
|
Mumps
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
12238-2
|
Neutrophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
12239-0
|
Oligosaccharides
[Presence]
in
Urine
|
|
1224-5
|
Mg
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12240-8
|
Orotidine
[Moles/volume]
in
Urine
|
|
12241-6
|
Osmotic
fragility
of
Red
Blood
Cells
by
Diluted
RBC
|
|
12242-4
|
Phosphate
[Mass/volume]
in
Body
fluid
|
|
12243-2
|
Deprecated
Platelets
[Morphology]
in
Blood
|
|
12244-0
|
Polymorphonuclear
cells/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
12245-7
|
Porphobilinogen
[Presence]
in
24
hour
Urine
|
|
12246-5
|
Porphyrins
[Presence]
in
24
hour
Urine
|
|
12247-3
|
Pyruvate
[Mass/volume]
in
Serum
or
Plasma
|
|
12248-1
|
Epithelial
cells.renal
[Presence]
in
Urine
sediment
by
Light
microscopy
|
|
12249-9
|
Deprecated
Renin
[Enzymatic
activity/volume]
in
Plasma
|
|
1225-2
|
Mg
Ag
[Presence]
on
Red
Blood
Cells
|
|
12250-7
|
Reticulocytes/1000
erythrocytes
hematocrit
adjusted
in
Blood
|
|
12251-5
|
Rubella
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
12252-3
|
Deprecated
Insulin-Like
growth
factor-I
[Mass/volume]
in
Serum
or
Plasma
|
|
12253-1
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
12254-9
|
Volume
of
Body
fluid
|
|
12255-6
|
Volume
of
5
hour
Urine
|
|
12256-4
|
Spermatozoa
[#/area]
in
Semen
by
Microscopy
high
power
field
--post
vasectomy
|
|
12257-2
|
Spermatozoa
Motile/100
spermatozoa
in
Semen
by
Microscopy
high
power
field
--post
vasectomy
|
|
12258-0
|
Epithelial
cells.squamous
[Presence]
in
Urine
sediment
by
Light
microscopy
|
|
12259-8
|
Streptococcus
pyogenes
enzyme
Ab
[Presence]
in
Serum
by
Sheep
Cell
Agglutination
|
|
1226-0
|
M
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12260-6
|
Sucrose
hemolysis
[Presence]
of
Red
Blood
Cells
|
|
12261-4
|
Toxoplasma
gondii
IgG
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
12262-2
|
Toxoplasma
gondii
IgM
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
12263-0
|
Deprecated
EBV
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
12264-8
|
Deprecated
Epstein
Barr
virus
early
restricted
Ab
[Mass/volume]
in
Body
fluid
|
|
12265-5
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
|
|
12266-3
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
--2
hours
post
peritoneal
dialysis
|
|
12267-1
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
--4
hours
post
peritoneal
dialysis
|
|
12268-9
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
--12
hours
post
peritoneal
dialysis
|
|
12269-7
|
Urobilinogen
[Presence]
in
24
hour
Urine
|
|
1227-8
|
M
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12270-5
|
Uroporphyrin
[Presence]
in
24
hour
Urine
|
|
12271-3
|
Varicella
zoster
virus
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
12272-1
|
Virus
identified
in
Unspecified
specimen
by
Immunofluorescence
|
|
12273-9
|
Xanthochromia
[Presence]
of
Body
fluid
Qualitative
|
|
12274-7
|
Xylose
[Mass/time]
in
5
hour
Urine
|
|
12275-4
|
Yeast
[Presence]
in
Genital
specimen
by
Wet
preparation
|
|
12276-2
|
Deprecated
Escherichia
coli
O157:H7
identified
in
Stool
by
Organism
specific
culture
|
|
12277-0
|
DNA
double
strand
Ab
[Presence]
in
Serum
by
Farr
method
|
|
12278-8
|
Band
form
neutrophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
12279-6
|
Deprecated
Spermatozoa
Ab
[Units/volume]
in
Semen
|
|
1228-6
|
M
Ab
[Presence]
in
Serum
or
Plasma
|
|
12280-4
|
Alanine
[Mass/volume]
in
Amniotic
fluid
|
|
12281-2
|
Bacteria
identified
in
Cervix
by
Anaerobe
culture
|
|
12282-0
|
Warfarin
[Presence]
in
Urine
|
|
12283-8
|
Corticotropin
releasing
hormone
[Units/volume]
in
Serum
or
Plasma
|
|
12284-6
|
Growth
hormone-releasing
hormone
[Units/volume]
in
Serum
or
Plasma
|
|
12285-3
|
HLA-DP
[Type]
|
|
12286-1
|
Drugs
identified
in
Urine
by
Screen
method
|
|
12287-9
|
Drugs
identified
in
Gastric
fluid
by
Screen
method
|
|
12288-7
|
Diuretics
[Identifier]
in
Urine
|
|
12289-5
|
Drugs
identified
in
Vitreous
fluid
by
Screen
method
|
|
1229-4
|
M
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12290-3
|
Procyclidine
[Presence]
in
Urine
|
|
12291-1
|
Mephentermine
[Presence]
in
Urine
|
|
12292-9
|
Dimethyltryptamine
[Presence]
in
Urine
|
|
12293-7
|
Cotinine
[Presence]
in
Urine
|
|
12294-5
|
Nicotine
[Presence]
in
Urine
|
|
12295-2
|
Hallucinogens
[Identifier]
in
Urine
|
|
12296-0
|
Mescaline
[Presence]
in
Urine
|
|
12297-8
|
Chlorate
[Presence]
in
Blood
|
|
12298-6
|
Erythromycin
[Presence]
in
Urine
|
|
12299-4
|
Ethinamate
[Presence]
in
Urine
|
|
123-0
|
Cefprozil
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1230-2
|
M
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12300-0
|
Polythiazide
[Presence]
in
Urine
|
|
12301-8
|
Procaine
[Presence]
in
Urine
|
|
12302-6
|
Theobromine
[Presence]
in
Serum
or
Plasma
|
|
12303-4
|
Theobromine
[Presence]
in
Urine
|
|
12304-2
|
Benzyl
alcohol
[Presence]
in
Serum
or
Plasma
|
|
12305-9
|
Chlordecone
[Presence]
in
Blood
|
|
12306-7
|
Cyclohexane
[Mass/volume]
in
Blood
|
|
12307-5
|
Dichloroethane
[Mass/volume]
in
Blood
|
|
12308-3
|
Hydrocodone
[Presence]
in
Urine
|
|
12309-1
|
Naltrexone
[Presence]
in
Urine
|
|
1231-0
|
M
Ag
[Presence]
on
Red
Blood
Cells
|
|
12310-9
|
Phenytoin
[Presence]
in
Urine
|
|
12311-7
|
Prazepam
[Mass/volume]
in
Urine
|
|
12312-5
|
Cyclopropane
[Mass/volume]
in
Blood
|
|
12313-3
|
Aprobarbital
[Presence]
in
Urine
|
|
12314-1
|
Clorazepate
[Presence]
in
Urine
|
|
12315-8
|
Mephobarbital
[Presence]
in
Urine
|
|
12316-6
|
Deprecated
Methapyrilene
[Presence]
in
Urine
|
|
12317-4
|
Phenolphthalein
[Presence]
in
Urine
|
|
12318-2
|
Spironolactone
[Presence]
in
Urine
|
|
12319-0
|
Thioridazine
[Presence]
in
Urine
|
|
1232-8
|
Mi
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12320-8
|
Thiothixene
[Presence]
in
Urine
|
|
12321-6
|
Trifluoperazine
[Presence]
in
Urine
|
|
12322-4
|
Triflupromazine
[Presence]
in
Urine
|
|
12323-2
|
Trimeprazine
[Presence]
in
Urine
|
|
12324-0
|
Hydroxyzine
[Presence]
in
Urine
|
|
12325-7
|
Tetrahydrocortisone
[Presence]
in
Urine
|
|
12326-5
|
Diamorphine
[Presence]
in
Unknown
substance
|
|
12327-3
|
Ketamine
[Presence]
in
Urine
|
|
12328-1
|
Beta
blockers
[Identifier]
in
Urine
|
|
12329-9
|
Chlorpropamide
[Presence]
in
Urine
|
|
1233-6
|
Mi
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12330-7
|
Hypoglycemics.oral
[Identifier]
in
Urine
|
|
12331-5
|
Phenethylamine
[Presence]
in
Urine
|
|
12332-3
|
Antihistamines
[Identifier]
in
Urine
|
|
12333-1
|
Butorphanol
[Presence]
in
Urine
|
|
12334-9
|
Para
aminophenol
[Mass/volume]
in
Urine
|
|
12335-6
|
Halothane
[Presence]
in
Blood
|
|
12336-4
|
Hydralazine
[Presence]
in
Serum
or
Plasma
|
|
12337-2
|
Dimethylsulfoxide
[Presence]
in
Serum
or
Plasma
|
|
12338-0
|
Pentachlorophenol
[Presence]
in
Serum
or
Plasma
|
|
12339-8
|
Diquat
[Presence]
in
Urine
|
|
1234-4
|
Mi
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
12340-6
|
Ethylene
[Presence]
in
Blood
|
|
12341-4
|
Mazindol
[Presence]
in
Serum
or
Plasma
|
|
12342-2
|
Oxymorphone
[Presence]
in
Serum
or
Plasma
|
|
12343-0
|
Thiazides
[Identifier]
in
Urine
|
|
12344-8
|
Antipsychotics
[Identifier]
in
Serum
or
Plasma
|
|
12345-5
|
Cyclothiazide
[Presence]
in
Urine
|
|
12346-3
|
Methyclothiazide
[Presence]
in
Urine
|
|
12347-1
|
Metolazone
[Presence]
in
Urine
|
|
12348-9
|
Quinethazone
[Presence]
in
Urine
|
|
12349-7
|
Trichlormethiazide
[Presence]
in
Urine
|
|
1235-1
|
Mi
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12350-5
|
Amphetamines
[Presence]
in
Stool
|
|
12351-3
|
Tetrahydrocannabinol
[Presence]
in
Stool
|
|
12352-1
|
Benzoylecgonine
[Presence]
in
Stool
|
|
12353-9
|
Methaqualone
[Presence]
in
Stool
|
|
12354-7
|
Opiates
[Presence]
in
Stool
|
|
12355-4
|
Phencyclidine
[Presence]
in
Stool
|
|
12356-2
|
Methadone
[Presence]
in
Stool
|
|
12357-0
|
Propoxyphene
[Presence]
in
Stool
|
|
12358-8
|
Barbiturates
[Presence]
in
Stool
|
|
12359-6
|
Benzodiazepines
[Presence]
in
Stool
|
|
1236-9
|
Mi
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12360-4
|
Barbital
[Presence]
in
Urine
|
|
12361-2
|
Oxazepam
[Presence]
in
Urine
|
|
12362-0
|
Oxazepam
[Presence]
in
Serum
or
Plasma
|
|
12363-8
|
Carbamazepine
[Presence]
in
Urine
|
|
12364-6
|
Benzodiazepines
[Presence]
in
Gastric
fluid
|
|
12365-3
|
Dimenhydrinate
[Presence]
in
Urine
|
|
12366-1
|
Disopyramide
[Presence]
in
Urine
|
|
12367-9
|
Mesoridazine
[Presence]
in
Urine
|
|
12368-7
|
Phenacetin
[Presence]
in
Urine
|
|
12369-5
|
Sympathomimetics
[Identifier]
in
Urine
|
|
1237-7
|
Mi
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
12370-3
|
Thiopental
[Mass/volume]
in
Urine
|
|
12371-1
|
Isopropyl
ether
[Mass/volume]
in
Blood
|
|
12372-9
|
Dimethylacetamide
[Mass/volume]
in
Urine
|
|
12373-7
|
Deprecated
Norchlordiazepoxide
[Mass/volume]
in
Serum
or
Plasma
|
|
12374-5
|
Clobazam
[Mass/volume]
in
Urine
|
|
12375-2
|
Clozapine+Norclozapine
[Mass/volume]
in
Serum
or
Plasma
|
|
12376-0
|
Deprecated
Norclozapine
[Mass/volume]
in
Serum
or
Plasma
|
|
12377-8
|
Demoxepam
[Mass/volume]
in
Serum
or
Plasma
|
|
12378-6
|
Diazepam
[Presence]
in
Stool
|
|
12379-4
|
Halazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
1238-5
|
M
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12380-2
|
Lorazepam
[Presence]
in
Stool
|
|
12381-0
|
Oxazepam
[Presence]
in
Stool
|
|
12382-8
|
Temazepam
[Mass/volume]
in
Urine
|
|
12383-6
|
Hydroxytriazolam
[Presence]
in
Stool
|
|
12384-4
|
Triazolam
[Presence]
in
Stool
|
|
12385-1
|
Deprecated
Nordoxepin
[Mass/volume]
in
Serum
or
Plasma
|
|
12386-9
|
Nordoxepin
[Mass/volume]
in
Urine
|
|
12387-7
|
Primidone
[Mass/volume]
in
Urine
|
|
12388-5
|
Phenylethylmalonamide
[Mass/volume]
in
Serum
or
Plasma
|
|
12389-3
|
Olanzapine
[Mass/volume]
in
Serum
or
Plasma
|
|
1239-3
|
M
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12390-1
|
Sulfasalazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12391-9
|
Dimenhydrinate
[Mass/volume]
in
Serum
or
Plasma
|
|
12392-7
|
Deprecated
Itraconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
12393-5
|
Deprecated
Ketoconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
12394-3
|
Butorphanol
[Mass/volume]
in
Serum
or
Plasma
|
|
12395-0
|
Butorphanol
[Mass/volume]
in
Urine
|
|
12396-8
|
Chlorpropamide
[Mass/volume]
in
Urine
|
|
12397-6
|
Colchicine
[Mass/volume]
in
Serum
or
Plasma
|
|
12398-4
|
Diphenoxylate
[Mass/volume]
in
Serum
or
Plasma
|
|
12399-2
|
Emetine
[Mass/volume]
in
Serum
or
Plasma
|
|
124-8
|
Cefprozil
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1240-1
|
M
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
12400-8
|
Emetine
[Mass/volume]
in
Urine
|
|
12401-6
|
Ethinamate
[Mass/volume]
in
Serum
or
Plasma
|
|
12402-4
|
Griseofulvin
[Mass/volume]
in
Serum
or
Plasma
|
|
12403-2
|
Mephentermine
[Mass/volume]
in
Blood
|
|
12404-0
|
Nitroglycerin
[Mass/volume]
in
Serum
or
Plasma
|
|
12405-7
|
Nabumetone
[Mass/volume]
in
Serum
or
Plasma
|
|
12406-5
|
Nadolol
[Mass/volume]
in
Serum
or
Plasma
|
|
12407-3
|
6-Beta
naltrexone
[Mass/volume]
in
Serum
or
Plasma
|
|
12408-1
|
Oxybutynin
[Mass/volume]
in
Serum
or
Plasma
|
|
12409-9
|
Deprecated
Pentoxyfylline
[Mass/volume]
in
Serum
or
Plasma
|
|
1241-9
|
M
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12410-7
|
Pimozide
[Mass/volume]
in
Serum
or
Plasma
|
|
12411-5
|
Promazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12412-3
|
Pyridine
[Mass/volume]
in
Serum
or
Plasma
|
|
12413-1
|
Resperine
[Mass/volume]
in
Serum
or
Plasma
|
|
12414-9
|
Resperine
[Mass/volume]
in
Urine
|
|
12415-6
|
Selegiline
[Mass/volume]
in
Serum
or
Plasma
|
|
12416-4
|
Sotalol
[Mass/volume]
in
Serum
or
Plasma
|
|
12417-2
|
Sulindac
[Mass/volume]
in
Serum
or
Plasma
|
|
12418-0
|
Terfenadine
[Mass/volume]
in
Serum
or
Plasma
|
|
12419-8
|
Terfenadine
[Mass/volume]
in
Urine
|
|
1242-7
|
M
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12420-6
|
Thiosulfate
[Mass/volume]
in
Urine
|
|
12421-4
|
Thiosulfate/Creatinine
[Mass
Ratio]
in
Urine
|
|
12422-2
|
Triflupromazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12423-0
|
Trimeprazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12424-8
|
Triprolidine
[Mass/volume]
in
Serum
or
Plasma
|
|
12425-5
|
Chlorzoxazone
[Mass/volume]
in
Serum
or
Plasma
|
|
12426-3
|
Brodifacoum
[Mass/volume]
in
Serum
or
Plasma
|
|
12427-1
|
Chlormezanone
[Mass/volume]
in
Serum
or
Plasma
|
|
12428-9
|
Flurbiprofen
[Mass/volume]
in
Serum
or
Plasma
|
|
12429-7
|
Succinylcholine
[Mass/volume]
in
Urine
|
|
1243-5
|
M
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
12430-5
|
Cumene
[Mass/volume]
in
Serum
or
Plasma
|
|
12431-3
|
Norfenfluramine
[Mass/volume]
in
Serum
or
Plasma
|
|
12432-1
|
Hydroxytriazolam
[Mass/volume]
in
Urine
|
|
12433-9
|
Bufotenine
[Mass/volume]
in
Serum
or
Plasma
|
|
12434-7
|
Prednisone
[Mass/volume]
in
Serum
or
Plasma
|
|
12435-4
|
Naphthalene
[Mass/volume]
in
Serum
or
Plasma
|
|
12436-2
|
Naphthol
[Mass/volume]
in
Serum
or
Plasma
|
|
12437-0
|
Tramadol
[Mass/volume]
in
Serum
or
Plasma
|
|
12438-8
|
Nortramadol
[Mass/volume]
in
Serum
or
Plasma
|
|
12439-6
|
Fluoxetine
[Mass/volume]
in
Urine
|
|
1244-3
|
M1
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12440-4
|
Midazolam
[Presence]
in
Stool
|
|
12441-2
|
Tolmetin
[Mass/volume]
in
Serum
or
Plasma
|
|
12442-0
|
Acetaminophen
[Mass/volume]
in
Unspecified
specimen
|
|
12443-8
|
Trimipramine
[Mass/volume]
in
Urine
|
|
12444-6
|
Nortrimipramine
[Mass/volume]
in
Urine
|
|
12445-3
|
Norfluoxetine
[Mass/volume]
in
Urine
|
|
12446-1
|
Halogenated
organic
molecules
[Identifier]
in
Urine
|
|
12447-9
|
Deprecated
Phenylethylmalonamide
|
|
12448-7
|
Ketones
[Mass/volume]
in
Urine
by
Test
strip
--fasting
|
|
12449-5
|
Ketones
[Mass/volume]
in
Urine
by
Test
strip
--1
hour
post
XXX
challenge
|
|
1245-0
|
M1
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12450-3
|
Ketones
[Mass/volume]
in
Urine
by
Test
strip
--2
hours
post
XXX
challenge
|
|
12451-1
|
Ketones
[Mass/volume]
in
Urine
by
Test
strip
--3
hours
post
XXX
challenge
|
|
12452-9
|
Epithelial
cells
[Presence]
in
Semen
by
Light
microscopy
|
|
12453-7
|
Phosphate
crystals
amorphous
[Presence]
in
Urine
sediment
by
Light
microscopy
|
|
12454-5
|
Urate
crystals
amorphous
[Presence]
in
Urine
sediment
by
Light
microscopy
|
|
12455-2
|
Histoplasma
capsulatum
yeast
phase
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
12456-0
|
Histoplasma
capsulatum
mycelial
phase
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
12457-8
|
Volume
of
Dialysis
fluid
|
|
12458-6
|
Corticotropin
[Mass/volume]
in
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12459-4
|
Corticotropin
[Mass/volume]
in
Plasma
--3rd
specimen
post
XXX
challenge
|
|
1246-8
|
M1
Ab
[Presence]
in
Serum
or
Plasma
|
|
12460-2
|
Corticotropin
[Mass/volume]
in
Plasma
--4th
specimen
post
XXX
challenge
|
|
12461-0
|
Corticotropin
[Mass/volume]
in
Plasma
--5th
specimen
post
XXX
challenge
|
|
12462-8
|
Corticotropin
[Mass/volume]
in
Plasma
--6th
specimen
post
XXX
challenge
|
|
12463-6
|
Corticotropin
[Mass/volume]
in
Plasma
--7th
specimen
post
XXX
challenge
|
|
12464-4
|
Corticotropin
[Mass/volume]
in
Plasma
--8th
specimen
post
XXX
challenge
|
|
12465-1
|
Ethanol
[Mass/volume]
in
Vitreous
fluid
|
|
12466-9
|
Alpha
1
antitrypsin
[Mass/volume]
in
Amniotic
fluid
by
Nephelometry
|
|
12467-7
|
Amino
acids
[Identifier]
in
Urine
|
|
12468-5
|
Amino
acids
[Identifier]
in
Serum
or
Plasma
|
|
12469-3
|
Cystine
crystals
[type]
in
Stone
by
Light
microscopy
|
|
1247-6
|
M1
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12470-1
|
Homocysteine
[Mass/volume]
in
Urine
|
|
12471-9
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Urine
|
|
12472-7
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
24
hour
Urine
|
|
12473-5
|
Phosphoethanolamine
[Mass/time]
in
Urine
|
|
12474-3
|
Carnosine
[Mass/volume]
in
24
hour
Urine
|
|
12475-0
|
Delta
aminolevulinate
[Mass/time]
in
Urine
|
|
12476-8
|
Bilirubin.total
[Mass/volume]
in
Amniotic
fluid
by
Spectrophotometry
direct
|
|
12477-6
|
Dextromethamphetamine
[Mass/volume]
in
Urine
|
|
12478-4
|
Levomethamphetamine
[Mass/volume]
in
Urine
|
|
12479-2
|
Androsterone
[Mass/time]
in
Urine
|
|
1248-4
|
M1
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12480-0
|
Angiotensin
converting
enzyme
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
12481-8
|
Arsenic.inorganic
[Mass/volume]
in
Urine
|
|
12482-6
|
Ascorbate
[Mass/volume]
in
Leukocytes
|
|
12483-4
|
Tungsten
[Presence]
in
Serum
or
Plasma
|
|
12484-2
|
Phenobarbital
[Presence]
in
Gastric
fluid
|
|
12485-9
|
Amobarbital
[Presence]
in
Gastric
fluid
|
|
12486-7
|
Butabarbital
[Presence]
in
Gastric
fluid
|
|
12487-5
|
Butalbital
[Presence]
in
Gastric
fluid
|
|
12488-3
|
Pentobarbital
[Presence]
in
Gastric
fluid
|
|
12489-1
|
Secobarbital
[Presence]
in
Gastric
fluid
|
|
1249-2
|
M1
Ag
[Presence]
on
Red
Blood
Cells
|
|
12490-9
|
Allyl-sec-butyl-barbiturate
[Mass/volume]
in
Serum
or
Plasma
|
|
12491-7
|
Methohexital
[Presence]
in
Serum
or
Plasma
|
|
12492-5
|
Thiamylal
[Presence]
in
Serum
or
Plasma
|
|
12493-3
|
Hexobarbital
[Mass/volume]
in
Serum
or
Plasma
|
|
12494-1
|
Amobarbital
[Presence]
in
Stool
|
|
12495-8
|
Barbital
[Presence]
in
Stool
|
|
12496-6
|
Butabarbital
[Presence]
in
Stool
|
|
12497-4
|
Butalbital
[Presence]
in
Stool
|
|
12498-2
|
Metharbital
[Presence]
in
Stool
|
|
12499-0
|
Pentobarbital
[Presence]
in
Stool
|
|
125-5
|
Cefprozil
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1250-0
|
Major
crossmatch
[Interpretation]
|
|
12500-5
|
Secobarbital
[Presence]
in
Stool
|
|
12501-3
|
Phenobarbital
[Presence]
in
Stool
|
|
12502-1
|
Allobarbital
[Presence]
in
Stool
|
|
12503-9
|
Hemoglobin.gastrointestinal
[Presence]
in
Stool
--4th
specimen
|
|
12504-7
|
Hemoglobin.gastrointestinal
[Presence]
in
Stool
--5th
specimen
|
|
12505-4
|
Cadmium
[Mass/volume]
in
Red
Blood
Cells
|
|
12506-2
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12507-0
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12508-8
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12509-6
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
1251-8
|
Major
crossmatch
[Interpretation]
by
Immediate
spin
|
|
12510-4
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12511-2
|
Calcium
[Mass/volume]
in
4
hour
Urine
|
|
12512-0
|
Calcium
hydrogen
phosphate
dihydrate
crystals
[Presence]
in
Urine
sediment
by
Light
microscopy
|
|
12513-8
|
Bicarbonate
[Moles/volume]
in
Water
|
|
12514-6
|
Bicarbonate
[Moles/volume]
in
Dialysis
fluid
|
|
12515-3
|
Carcinoembryonic
Ag
[Mass/volume]
in
Body
fluid
|
|
12516-1
|
Catecholamines
[Mass/volume]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
12517-9
|
Catecholamines
[Mass/volume]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
12518-7
|
Catecholamines
[Mass/volume]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
12519-5
|
Catecholamines
[Mass/volume]
in
Urine
--5th
specimen
post
XXX
challenge
|
|
1252-6
|
Major
crossmatch
[Interpretation]
--post
immediate
spin
|
|
12520-3
|
Catecholamines
[Mass/volume]
in
Urine
--6th
specimen
post
XXX
challenge
|
|
12521-1
|
Catecholamines
[Mass/volume]
in
Urine
--7th
specimen
post
XXX
challenge
|
|
12522-9
|
Catecholamines
[Mass/volume]
in
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12523-7
|
Catecholamines
[Mass/volume]
in
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12524-5
|
Catecholamines
[Mass/volume]
in
Plasma
--4th
specimen
post
XXX
challenge
|
|
12525-2
|
Norepinephrine
[Mass/volume]
in
Plasma
--1
hour
post
XXX
challenge
|
|
12526-0
|
Norepinephrine
[Mass/volume]
in
Plasma
--2
hours
post
XXX
challenge
|
|
12527-8
|
Norepinephrine
[Mass/volume]
in
Plasma
--3
hours
post
XXX
challenge
|
|
12528-6
|
Norepinephrine
[Mass/volume]
in
Plasma
--4
hours
post
XXX
challenge
|
|
12529-4
|
Epinephrine
[Mass/volume]
in
Plasma
--2
hours
post
XXX
challenge
|
|
1253-4
|
Major
crossmatch
[Interpretation]
by
Prewarmed
|
|
12530-2
|
Chloride
[Moles/volume]
in
Water
|
|
12531-0
|
Deprecated
Cholesterol
[Mass/volume]
in
Body
fluid
|
|
12532-8
|
Meclizine
[Presence]
in
Serum
or
Plasma
|
|
12533-6
|
Thiazolidine-2-Thione-4-Carboxylic
acid
[Mass/volume]
in
Urine
|
|
12534-4
|
Thiazolidine-2-Thione-4-Carboxylic
acid/Creatinine
[Mass
Ratio]
in
Urine
|
|
12535-1
|
Amyl
nitrite
[Presence]
in
Blood
|
|
12536-9
|
Butyl
nitrate
[Presence]
in
Blood
|
|
12537-7
|
Phenylglyoxylate
[Mass/volume]
in
Urine
|
|
12538-5
|
Nitrate
[Mass/volume]
in
Blood
|
|
12539-3
|
2-Methylcitrate
[Mass/volume]
in
Urine
|
|
1254-2
|
Major
crossmatch.re-crossmatch
[Interpretation]
|
|
12540-1
|
2-Methylcitrate
[Mass/volume]
in
Serum
or
Plasma
|
|
12541-9
|
Meta
methylhippurate+Para
methylhippurate
[Mass/volume]
in
Urine
|
|
12542-7
|
N-methylacetamide
[Mass/volume]
in
Urine
|
|
12543-5
|
Methyl
formamide
[Mass/volume]
in
Urine
|
|
12544-3
|
Nefazodone
[Mass/volume]
in
Serum
or
Plasma
|
|
12545-0
|
Zomepirac
[Mass/volume]
in
Serum
or
Plasma
|
|
12546-8
|
Quinethazone
[Presence]
in
Serum
or
Plasma
|
|
12547-6
|
Phorate
[Mass/volume]
in
Serum
or
Plasma
|
|
12548-4
|
Tybamate
[Mass/volume]
in
Serum
or
Plasma
|
|
12549-2
|
Turpentine
[Mass/volume]
in
Serum
or
Plasma
|
|
1255-9
|
Minor
crossmatch
[Interpretation]
|
|
12550-0
|
Papaverine
[Mass/volume]
in
Serum
or
Plasma
|
|
12551-8
|
Isocarboxazid
[Mass/volume]
in
Serum
or
Plasma
|
|
12552-6
|
Propylene
glycol
[Mass/volume]
in
Serum
or
Plasma
|
|
12553-4
|
Stimulants
[Identifier]
in
Urine
|
|
12554-2
|
Narcotics
and
opioids
[Identifier]
in
Urine
|
|
12555-9
|
Turpentine
[Mass/volume]
in
Urine
|
|
12556-7
|
Copper
[Mass/volume]
in
Blood
|
|
12557-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12558-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12559-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
1256-7
|
N
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12560-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12561-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12562-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12563-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
12564-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12565-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--10th
specimen
post
XXX
challenge
|
|
12566-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
12567-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12568-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
12569-0
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--2.5
hours
post
XXX
challenge
|
|
1257-5
|
N
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12570-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
12571-6
|
Deprecated
Creatinine
[Mass/volume]
in
Body
fluid
|
|
12572-4
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--2
hour
dwell
specimen
|
|
12573-2
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4
hour
dwell
specimen
|
|
12574-0
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--24
hour
specimen
|
|
12575-7
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--baseline
|
|
12576-5
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--1st
specimen
|
|
12577-3
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--2nd
specimen
|
|
12578-1
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--3rd
specimen
|
|
12579-9
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4th
specimen
|
|
1258-3
|
N
Ab
[Presence]
in
Serum
or
Plasma
|
|
12580-7
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--5th
specimen
|
|
12581-5
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--6th
specimen
|
|
12582-3
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--7th
specimen
|
|
12583-1
|
Creatinine
[Mass/volume]
in
Peritoneal
dialysis
fluid
--8th
specimen
|
|
12584-9
|
Creatinine
[Mass/volume]
in
Vitreous
fluid
|
|
12585-6
|
Creatinine
[Mass/time]
in
2
hour
Urine
|
|
12586-4
|
Creatinine
[Mass/time]
in
4
hour
Urine
|
|
12587-2
|
Creatinine
[Mass/time]
in
6
hour
Urine
|
|
12588-0
|
Creatinine
[Mass/time]
in
8
hour
Urine
|
|
12589-8
|
Creatinine
[Mass/time]
in
12
hour
Urine
|
|
1259-1
|
N
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12590-6
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12591-4
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12592-2
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12593-0
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12594-8
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12595-5
|
Estradiol
(E2)
[Mass/volume]
in
Urine
|
|
12596-3
|
Estradiol
(E2)
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
12597-1
|
Estrogen
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12598-9
|
Fat.neutral
[Presence]
in
Stool
|
|
12599-7
|
Pristanate
(C15:0(CH3)4)
[Mass/volume]
in
Serum
or
Plasma
|
|
126-3
|
Cefprozil
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1260-9
|
N
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12600-3
|
Pristanate
(C15:0(CH3)4)/Phytanate
(C16:0(CH3)4)
[Mass
Ratio]
in
Serum
or
Plasma
|
|
12601-1
|
Fluoride
[Mass/volume]
in
Dialysis
fluid
|
|
12602-9
|
Hydroxyethylflurazepam
[Mass/volume]
in
Urine
|
|
12603-7
|
N-desalkylflurazepam
[Presence]
in
Stool
|
|
12604-5
|
Hydroxyethylflurazepam
[Presence]
in
Stool
|
|
12605-2
|
Flurazepam
[Presence]
in
Stool
|
|
12606-0
|
Dolichol
[Mass/volume]
in
Serum
or
Plasma
|
|
12607-8
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--pre
dialysis
|
|
12608-6
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--2
hour
dwell
specimen
|
|
12609-4
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4
hour
dwell
specimen
|
|
1261-7
|
N
Ag
[Presence]
on
Red
Blood
Cells
|
|
12610-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
12611-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4
hour
specimen
|
|
12612-8
|
Glucose
[Mass/volume]
in
Dialysis
fluid
--2
hour
specimen
|
|
12613-6
|
Glucose
[Mass/volume]
in
Dialysis
fluid
--4
hour
specimen
|
|
12614-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--7
hours
post
meal
|
|
12615-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1st
specimen
post
XXX
challenge
|
|
12616-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12617-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12618-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12619-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
1262-5
|
N
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12620-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12621-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12622-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10th
specimen
post
XXX
challenge
|
|
12623-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--11th
specimen
post
XXX
challenge
|
|
12624-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12th
specimen
post
XXX
challenge
|
|
12625-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--13th
specimen
post
XXX
challenge
|
|
12626-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--14th
specimen
post
XXX
challenge
|
|
12627-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--15th
specimen
post
XXX
challenge
|
|
12628-4
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
|
|
12629-2
|
Glucose
[Mass/volume]
in
24
hour
Peritoneal
dialysis
fluid
|
|
1263-3
|
N
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12630-0
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--1st
specimen
|
|
12631-8
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--2nd
specimen
|
|
12632-6
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--3rd
specimen
|
|
12633-4
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4th
specimen
|
|
12634-2
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--5th
specimen
|
|
12635-9
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--6th
specimen
|
|
12636-7
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--7th
specimen
|
|
12637-5
|
Glucose
[Mass/volume]
in
Peritoneal
dialysis
fluid
--8th
specimen
post
XXX
challenge
|
|
12638-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
lactose
PO
|
|
12639-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
1264-1
|
N
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
12640-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--6.5
hours
post
XXX
challenge
|
|
12641-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--7
hours
post
XXX
challenge
|
|
12642-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--7.5
hours
post
XXX
challenge
|
|
12643-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
XXX
challenge
|
|
12644-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--9
hours
post
XXX
challenge
|
|
12645-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
hours
post
XXX
challenge
|
|
12646-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12647-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12
hours
post
XXX
challenge
|
|
12648-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
dose
lactose
PO
|
|
12649-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
dose
lactose
|
|
1265-8
|
N
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12650-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3.5
hours
post
dose
lactose
PO
|
|
12651-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
pre
XXX
challenge
|
|
12652-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
minutes
post
XXX
challenge
|
|
12653-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--8
minutes
post
XXX
challenge
|
|
12654-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
12655-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
12656-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4
minutes
post
XXX
challenge
|
|
12657-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
12658-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--50
minutes
post
XXX
challenge
|
|
12659-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--70
minutes
post
XXX
challenge
|
|
1266-6
|
N
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12660-7
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
12661-5
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
12662-3
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
12663-1
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
12664-9
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12665-6
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12666-4
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12667-2
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12668-0
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12669-8
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
1267-4
|
N
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
12670-6
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
12671-4
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12672-2
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
12673-0
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
12674-8
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--15
minutes
pre
XXX
challenge
|
|
12675-5
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
12676-3
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
12677-1
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12678-9
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12679-7
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
1268-2
|
Not
otherwise
specified
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12680-5
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12681-3
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12682-1
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12683-9
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
12684-7
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12685-4
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12686-2
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12687-0
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12688-8
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12689-6
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
1269-0
|
Not
otherwise
specified
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12690-4
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12691-2
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
12692-0
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12693-8
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--10th
specimen
post
XXX
challenge
|
|
12694-6
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
12695-3
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--15
minutes
pre
XXX
challenge
|
|
12696-1
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--pre
XXX
challenge
|
|
12697-9
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
12698-7
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
12699-5
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
127-1
|
Cefsulodin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1270-8
|
Unidentified
Ab
[Presence]
in
Serum
or
Plasma
|
|
12700-1
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
12701-9
|
Somatotropin
[Moles/volume]
in
Serum
or
Plasma
--2.5
hours
post
XXX
challenge
|
|
12702-7
|
Antimony
[Presence]
in
Serum
or
Plasma
|
|
12703-5
|
Gallium
[Mass/volume]
in
Serum
or
Plasma
|
|
12704-3
|
Length
of
Hair
|
|
12705-0
|
Strontium
[Mass/volume]
in
Urine
|
|
12706-8
|
Tellurium
[Mass/volume]
in
Serum
or
Plasma
|
|
12707-6
|
Thorium
[Mass/volume]
in
Serum
or
Plasma
|
|
12708-4
|
Tin
[Mass/volume]
in
Urine
|
|
12709-2
|
Norastemizole
[Mass/volume]
in
Serum
or
Plasma
|
|
1271-6
|
Deprecated
O
group
[Presence]
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12710-0
|
Hemoglobin
pattern
[Interpretation]
in
Blood
|
|
12711-8
|
Hemoglobin
A
region
[Presence]
in
Blood
by
Electrophoresis
alkaline
(pH
8.9)
|
|
12712-6
|
Hemoglobin
S+D+G
region
[Presence]
in
Blood
by
Electrophoresis
alkaline
(pH
8.9)
|
|
12713-4
|
Hemoglobin
C+E+O+A2
region
[Presence]
in
Blood
by
Electrophoresis
alkaline
(pH
8.9)
|
|
12714-2
|
N-methylhistamine
[Mass/volume]
in
Urine
|
|
12715-9
|
Homovanillate
[Mass/time]
in
Urine
|
|
12716-7
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12717-5
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12718-3
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12719-1
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
1272-4
|
Deprecated
O
group
[Presence]
in
serum
or
plasma
from
donor
|
|
12720-9
|
Hydroxyproline
[Mass/volume]
in
2
hour
Urine
|
|
12721-7
|
Melatonin
[Units/volume]
in
Serum
or
Plasma
|
|
12722-5
|
Insulin-like
growth
factor
binding
protein
1
[Mass/volume]
in
Serum
or
Plasma
|
|
12723-3
|
Insulin-like
growth
factor
binding
protein
2
[Mass/volume]
in
Serum
or
Plasma
|
|
12724-1
|
Voltage-gated
calcium
channel
IgG
Ab
[Units/volume]
in
Serum
|
|
12725-8
|
IgA.secretory
[Units/volume]
in
Serum
or
Plasma
|
|
12726-6
|
Leucine-enkephalin
[Units/volume]
in
Serum
or
Plasma
|
|
12727-4
|
Prednisolone
[Mass/volume]
in
Serum
or
Plasma
|
|
12728-2
|
Alpha
subunit
[Units/volume]
in
Serum
or
Plasma
|
|
12729-0
|
Interferon
gamma
[Units/volume]
in
Serum
or
Plasma
|
|
1273-2
|
Deprecated
O
group
[Presence]
in
serum
|
|
12730-8
|
Interferon
beta
[Units/volume]
in
Serum
or
Plasma
|
|
12731-6
|
Interferon
alpha
[Units/volume]
in
Serum
or
Plasma
|
|
12732-4
|
Interleukin
12
[Units/volume]
in
Serum
or
Plasma
|
|
12733-2
|
Tryptase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12734-0
|
Cytokeratin
Ab
[Units/volume]
in
Serum
|
|
12735-7
|
Collagen
Ab
[Units/volume]
in
Urine
|
|
12736-5
|
Hyaluronate
[Mass/volume]
in
Serum
or
Plasma
|
|
12737-3
|
Endothelin
[Units/volume]
in
Serum
or
Plasma
|
|
12738-1
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--pre
XXX
challenge
|
|
12739-9
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
1274-0
|
Deprecated
O
group
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12740-7
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12741-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12742-3
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12743-1
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12744-9
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12745-6
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
12746-4
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12747-2
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--3.5
hours
post
XXX
challenge
|
|
12748-0
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--4.5
hours
post
XXX
challenge
|
|
12749-8
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--5.5
hours
post
XXX
challenge
|
|
1275-7
|
Deprecated
O
group
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12750-6
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--7
hours
post
XXX
challenge
|
|
12751-4
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--7.5
hours
post
XXX
challenge
|
|
12752-2
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
XXX
challenge
|
|
12753-0
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--9
hours
post
XXX
challenge
|
|
12754-8
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--10
hours
post
XXX
challenge
|
|
12755-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--11
hour
post
XXX
challenge
|
|
12756-3
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--12
hours
post
XXX
challenge
|
|
12757-1
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
pre
XXX
challenge
|
|
12758-9
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
pre
XXX
challenge
|
|
12759-7
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--2
minutes
post
XXX
challenge
|
|
1276-5
|
Deprecated
O
group
[Presence]
on
Red
Blood
Cells
|
|
12760-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--4
minutes
post
XXX
challenge
|
|
12761-3
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--8
minutes
post
XXX
challenge
|
|
12762-1
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
12763-9
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--19
minutes
post
XXX
challenge
|
|
12764-7
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--22
minutes
post
XXX
challenge
|
|
12765-4
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
12766-2
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
12767-0
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--50
minutes
post
XXX
challenge
|
|
12768-8
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--70
minutes
post
XXX
challenge
|
|
12769-6
|
17-Ketosteroids.total
neutral
[Mass/time]
in
24
hour
Urine
|
|
1277-3
|
P
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12770-4
|
Lead
[Mass/mass]
in
Tissue
|
|
12771-2
|
Cholesterol
in
HDL
[Presence]
in
Serum
or
Plasma
by
Electrophoresis
|
|
12772-0
|
Cholesterol
in
HDL
[Units/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
12773-8
|
Cholesterol
in
LDL
[Units/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
12774-6
|
Mercury
[Mass/volume]
in
Red
Blood
Cells
|
|
12775-3
|
Mercury
[Mass/volume]
in
Dentin
|
|
12776-1
|
Mucin-like
carcinoma
associated
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
12777-9
|
Immunoglobulin
light
chains.kappa.free
[Units/volume]
in
Urine
|
|
12778-7
|
Immunoglobulin
light
chains.lambda.free
[Units/volume]
in
Urine
|
|
12779-5
|
Nickel
[Mass/time]
in
Urine
|
|
1278-1
|
P
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12780-3
|
Nickel
[Mass/volume]
in
Red
Blood
Cells
|
|
12781-1
|
Borrelia
burgdorferi
Ab
band
pattern
[Interpretation]
in
Serum
by
Immunoblot
(IB)
|
|
12782-9
|
Oligoclonal
bands
[Interpretation]
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
12783-7
|
Oligoclonal
bands
[Interpretation]
in
Serum
or
Plasma
|
|
12784-5
|
Codeine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12785-2
|
Dihydrocodeine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12786-0
|
Hydrocodone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12787-8
|
Hydromorphone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
12788-6
|
6-Monoacetylmorphine
(6-MAM)
[Mass/volume]
in
Serum
or
Plasma
|
|
12789-4
|
Oxycodone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
1279-9
|
P
Ab
[Presence]
in
Serum
or
Plasma
|
|
12790-2
|
Oxalate
[Mass/volume]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
12791-0
|
Oxalate
[Mass/volume]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
12792-8
|
Oxalate
[Mass/volume]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
12793-6
|
Oxalate
[Mass/volume]
in
Urine
--5th
specimen
post
XXX
challenge
|
|
12794-4
|
Oxalate
[Mass/volume]
in
Urine
--6th
specimen
post
XXX
challenge
|
|
12795-1
|
Oxalate
[Mass/volume]
in
Urine
--7th
specimen
post
XXX
challenge
|
|
12796-9
|
Oxalate
[Mass/volume]
in
Urine
--8th
specimen
post
XXX
challenge
|
|
12797-7
|
Oxalate
[Mass/volume]
in
Urine
--9th
specimen
post
XXX
challenge
|
|
12798-5
|
Oxalate
[Mass/volume]
in
Urine
--10th
specimen
post
XXX
challenge
|
|
12799-3
|
Parathyrin
Ab
[Units/volume]
in
Serum
|
|
128-9
|
Cefsulodin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1280-7
|
P
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12800-9
|
Deprecated
Trimeprazine
|
|
12801-7
|
Methdilazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12802-5
|
Propiomazine
[Mass/volume]
in
Serum
or
Plasma
|
|
12803-3
|
Phenylalanine
[Presence]
in
Blood
by
Guthrie
test
|
|
12804-1
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
12805-8
|
Alkaline
phosphatase
isoenzyme
[Units/volume]
in
Serum
or
Plasma
|
|
12806-6
|
Alkaline
phosphatase.lung
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12807-4
|
Phosphoserine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
12808-2
|
Uroporphyrin
[Mass/time]
in
Urine
|
|
12809-0
|
Coproporphyrin
[Mass/time]
in
Urine
|
|
1281-5
|
P
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12810-8
|
Porphobilinogen
deaminase
[Enzymatic
activity/volume]
in
Blood
|
|
12811-6
|
Uroporphyrinogen
III
synthase
[Enzymatic
activity/volume]
in
Blood
|
|
12812-4
|
Potassium
[Moles/volume]
in
Serum
or
Plasma
--2nd
specimen
|
|
12813-2
|
Potassium
[Moles/volume]
in
Serum
or
Plasma
--3rd
specimen
|
|
12814-0
|
Potassium
[Moles/volume]
in
Vitreous
fluid
|
|
12815-7
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12816-5
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12817-3
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12818-1
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12819-9
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
1282-3
|
P
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
12820-7
|
Progesterone
[Mass/volume]
in
24
hour
Urine
|
|
12821-5
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
12822-3
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12823-1
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12824-9
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12825-6
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12826-4
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12827-2
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12828-0
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12829-8
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
1283-1
|
P
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12830-6
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12831-4
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--10th
specimen
post
XXX
challenge
|
|
12832-2
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
12833-0
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
12834-8
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
12835-5
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
12836-3
|
Prostaglandin
E2
[Mass/volume]
in
24
hour
Urine
|
|
12837-1
|
Prostaglandin
E1
[Mass/volume]
in
24
hour
Urine
|
|
12838-9
|
Prostaglandin
D2
[Mass/volume]
in
Urine
|
|
12839-7
|
Prostaglandin
D2
[Mass/volume]
in
Serum
or
Plasma
|
|
1284-9
|
P
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12840-5
|
Prostaglandin
F2
alpha
[Moles/volume]
in
Urine
|
|
12841-3
|
Prostate
Specific
Ag
Free/Prostate
specific
Ag.total
in
Serum
or
Plasma
|
|
12842-1
|
Protein
[Mass/volume]
in
12
hour
Urine
|
|
12843-9
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
|
|
12844-7
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--2nd
specimen
|
|
12845-4
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--3rd
specimen
|
|
12846-2
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4th
specimen
|
|
12847-0
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--5th
specimen
|
|
12848-8
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--6th
specimen
|
|
12849-6
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--7th
specimen
|
|
1285-6
|
P
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
12850-4
|
Protein
[Mass/volume]
in
Peritoneal
dialysis
fluid
--8th
specimen
|
|
12851-2
|
Protein
Fractions
[Interpretation]
in
Serum
or
Plasma
by
Electrophoresis
|
|
12852-0
|
Bovine
inner
ear
Ag
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
12853-8
|
Purkinje
cells
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12854-6
|
Neuronal
nuclear
type
1
Ab
[Units/volume]
in
Serum
|
|
12855-3
|
HIV
1
p23
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12856-1
|
HIV
1
p65
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12857-9
|
HIV
1
p28
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12858-7
|
HIV
1
p32
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12859-5
|
HIV
1
p18
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1286-4
|
P1
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12860-3
|
Borrelia
burgdorferi
39kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12861-1
|
Borrelia
burgdorferi
88kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12862-9
|
Borrelia
burgdorferi
66kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12863-7
|
Borrelia
burgdorferi
41kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12864-5
|
Borrelia
burgdorferi
25kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12865-2
|
Borrelia
burgdorferi
29kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12866-0
|
Borrelia
burgdorferi
18kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12867-8
|
Borrelia
burgdorferi
58kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12868-6
|
Borrelia
burgdorferi
47kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12869-4
|
Borrelia
burgdorferi
30kD
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
1287-2
|
P1
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
12870-2
|
HIV
1
gp34
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12871-0
|
HIV
1
p26
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12872-8
|
HIV
1
p15
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12873-6
|
Borrelia
burgdorferi
88kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12874-4
|
Borrelia
burgdorferi
93kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12875-1
|
HIV
1
p64
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12876-9
|
HIV
1
p53
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12877-7
|
Borrelia
burgdorferi
47kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12878-5
|
Borrelia
burgdorferi
29kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12879-3
|
Borrelia
burgdorferi
25kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1288-0
|
P1
Ab
[Presence]
in
Serum
or
Plasma
|
|
12880-1
|
Borrelia
burgdorferi
58kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12881-9
|
Borrelia
burgdorferi
47kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12882-7
|
Borrelia
burgdorferi
29kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12883-5
|
Borrelia
burgdorferi
18kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12884-3
|
Borrelia
burgdorferi
39kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12885-0
|
Borrelia
burgdorferi
88kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12886-8
|
Borrelia
burgdorferi
66kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12887-6
|
Borrelia
burgdorferi
41kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12888-4
|
Borrelia
burgdorferi
25kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
12889-2
|
Borrelia
burgdorferi
30kD
Ab
[Presence]
in
Body
fluid
by
Immunoblot
(IB)
|
|
1289-8
|
P1
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12890-0
|
Borrelia
burgdorferi
45kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12891-8
|
Borrelia
burgdorferi
41kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12892-6
|
Borrelia
burgdorferi
30kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12893-4
|
HIV
1
gp105
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12894-2
|
HIV
1
p68
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12895-9
|
HIV
1
p58
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12896-7
|
Borrelia
burgdorferi
58kD
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
12897-5
|
Myelin
associated
glycoprotein
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
12898-3
|
Chloride
[Moles/volume]
in
Vitreous
fluid
|
|
12899-1
|
Acetylene
[Mass/volume]
in
Serum
or
Plasma
|
|
129-7
|
Cefsulodin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1290-6
|
P1
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12900-7
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12901-5
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12902-3
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--4th
specimen
post
XXX
challenge
|
|
12903-1
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--5th
specimen
post
XXX
challenge
|
|
12904-9
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--6th
specimen
post
XXX
challenge
|
|
12905-6
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--7th
specimen
post
XXX
challenge
|
|
12906-4
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--8th
specimen
post
XXX
challenge
|
|
12907-2
|
Sodium
[Moles/volume]
in
Red
Blood
Cells
|
|
12908-0
|
Sodium
[Moles/volume]
in
Vitreous
fluid
|
|
12909-8
|
Insulin-like
growth
factor-I
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
1291-4
|
P1
Ag
[Presence]
on
Red
Blood
Cells
|
|
12910-6
|
Insulin-like
growth
factor-I
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12911-4
|
Insulin-like
growth
factor-I
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
12912-2
|
Lipids
[Mass/volume]
in
Body
fluid
|
|
12913-0
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
12914-8
|
Beta-N-acetylhexosaminidase.A/Beta-n-acetylhexosaminidase.total
in
Serum
|
|
12915-5
|
Beta
galactosidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
12916-3
|
Porphobilinogen
synthase
[Enzymatic
activity/volume]
in
Blood
|
|
12917-1
|
Porphobilinogen
synthase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
12918-9
|
Monoamine
oxidase
[Enzymatic
activity/volume]
in
Platelet
rich
plasma
|
|
12919-7
|
Monoamine
oxidase
[Enzymatic
activity/volume]
in
Blood
|
|
1292-2
|
Deprecated
P2
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
12920-5
|
Sulfate
[Mass/volume]
in
24
hour
Urine
|
|
12921-3
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
12922-1
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12923-9
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12924-7
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12925-4
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12926-2
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12927-0
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12928-8
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12929-6
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
1293-0
|
Deprecated
P2
Ab
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12930-4
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12931-2
|
Thyroxine
(T4)
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12932-0
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
12933-8
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
12934-6
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
12935-3
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
12936-1
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
12937-9
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
12938-7
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
12939-5
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
1294-8
|
Deprecated
P2
Ab
|
|
12940-3
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--30
minutes
pre
XXX
challenge
|
|
12941-1
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12942-9
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12943-7
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12944-5
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12945-2
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12946-0
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12947-8
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
12948-6
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
12949-4
|
Transferrin.carbohydrate
deficient
[Mass/volume]
in
Serum
or
Plasma
|
|
1295-5
|
P2
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
12950-2
|
Deprecated
Triglyceride
[Mass/volume]
in
Body
fluid
|
|
12951-0
|
Triglyceride
[Mass/volume]
in
Serum
or
Plasma
by
calculation
|
|
12952-8
|
Deprecated
Thyroxine
(T4)
uptake
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
12953-6
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12954-4
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
12955-1
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
12956-9
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
12957-7
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
12958-5
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
12959-3
|
Triiodothyronine
(T3)
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
1296-3
|
P2
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
12960-1
|
Alpha
1
antitrypsin
fecal
clearance
|
|
12961-9
|
Urea
nitrogen
[Mass/volume]
in
Arterial
blood
|
|
12962-7
|
Urea
nitrogen
[Mass/volume]
in
Venous
blood
|
|
12963-5
|
Urea
nitrogen
[Mass/volume]
in
Peripheral
blood
|
|
12964-3
|
Urea
nitrogen
[Mass/volume]
in
Blood
--baseline
|
|
12965-0
|
Urea
nitrogen
[Mass/volume]
in
Serum
or
Plasma
--70
minute
specimen
|
|
12966-8
|
Urea
nitrogen
[Mass/volume]
in
Serum
or
Plasma
--2
hour
specimen
|
|
12967-6
|
Urea
nitrogen
[Mass/volume]
in
24
hour
Urine
|
|
12968-4
|
Urea
nitrogen
[Mass/volume]
in
Dialysis
fluid
--4
hour
specimen
|
|
12969-2
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--baseline
|
|
1297-1
|
P2
Ag
[Presence]
on
Red
Blood
Cells
|
|
12970-0
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--2
hour
dwell
specimen
|
|
12971-8
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4
hour
dwell
specimen
|
|
12972-6
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--1st
specimen
|
|
12973-4
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--4th
specimen
|
|
12974-2
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--3rd
specimen
|
|
12975-9
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--5th
specimen
|
|
12976-7
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--6th
specimen
|
|
12977-5
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--8th
specimen
|
|
12978-3
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--7th
specimen
|
|
12979-1
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
--24
hour
specimen
|
|
1298-9
|
Packed
erythrocytes
given
[Volume]
|
|
12980-9
|
Deprecated
Urate
[Mass/volume]
in
Body
fluid
|
|
12981-7
|
Urea
nitrogen
[Mass
Ratio]
in
Peritoneal
dialysis
fluid
--post
dialysis/pre
dialysis
|
|
12982-5
|
Vasopressin
[Mass/volume]
in
Plasma
--2nd
specimen
post
XXX
challenge
|
|
12983-3
|
Volatiles
and
gases
[Identifier]
in
Urine
|
|
12984-1
|
2,4
toluenediamine
[Mass/volume]
in
Blood
|
|
12985-8
|
2,6
toluenediamine
[Mass/volume]
in
Blood
|
|
12986-6
|
2,5-Hexanedione
[Mass/volume]
in
Blood
|
|
12987-4
|
Acetonitrile
[Mass/volume]
in
Urine
|
|
12988-2
|
Acrylamide
[Mass/volume]
in
Blood
|
|
12989-0
|
Allyl
alcohol
[Mass/volume]
in
Serum
or
Plasma
|
|
1299-7
|
Platelets
given
[Volume]
|
|
12990-8
|
Polychlorinated
biphenyl.Aroclor
1260
[Mass/volume]
in
Serum
or
Plasma
|
|
12991-6
|
Polychlorinated
biphenyl.Aroclor
1254
[Mass/volume]
in
Serum
or
Plasma
|
|
12992-4
|
Isobutane
[Mass/volume]
in
Blood
|
|
12993-2
|
Hydrocarbons.chlorinated
[Identifier]
in
Blood
|
|
12994-0
|
Oxychlordane
[Mass/volume]
in
Blood
|
|
12995-7
|
Cyclohexanone
[Mass/volume]
in
Blood
|
|
12996-5
|
Dichlorodifluoroethane
[Mass/volume]
in
Blood
|
|
12997-3
|
1,4-Dioxane
[Mass/volume]
in
Serum
or
Plasma
|
|
12998-1
|
Methylene
chloride
[Mass/volume]
in
Blood
|
|
12999-9
|
Epichlorohydrin
[Mass/volume]
in
Serum
or
Plasma
|
|
13-3
|
Amikacin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
130-5
|
Cefsulodin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1300-3
|
Deprecated
PP1
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13000-5
|
Mandelate
[Mass/volume]
in
Urine
|
|
13001-3
|
Mandelate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13002-1
|
Mesityl
oxide
[Mass/volume]
in
Blood
|
|
13003-9
|
Halogenated
organic
molecules
[Identifier]
in
Blood
|
|
13004-7
|
Hydrocarbons.halogenated.volatile
[Identifier]
in
Blood
|
|
13005-4
|
2,4,5-Trichlorophenoxyacetate
[Type]
in
Serum
or
Plasma
|
|
13006-2
|
1,4-Dichlorobenzene
[Mass/volume]
in
Serum
or
Plasma
|
|
13007-0
|
Ethane
[Mass/volume]
in
Blood
|
|
13008-8
|
Methyl
propyl
ketone
[Mass/volume]
in
Blood
|
|
13009-6
|
Methyl
ethyl
ketone
[Mass/volume]
in
Urine
|
|
1301-1
|
Deprecated
PP1
Ab
[Presence]
serum
or
plasma
from
donor
|
|
13010-4
|
Methyl
amyl
ketone
[Mass/volume]
in
Blood
|
|
13011-2
|
Methyl
ethyl
ketone
[Mass/volume]
in
Blood
|
|
13012-0
|
Methyl
isoamyl
ketone
[Mass/volume]
in
Blood
|
|
13013-8
|
Methyl
isobutyl
ketone
[Mass/volume]
in
Blood
|
|
13014-6
|
Methyl
butyl
ketone
[Mass/volume]
in
Blood
|
|
13015-3
|
Diisobutylketone
[Mass/volume]
in
Blood
|
|
13016-1
|
Nitrophenol
[Units/volume]
in
Blood
|
|
13017-9
|
Deprecated
Tetrachloroethylene
[Mass/volume]
in
Blood
|
|
13018-7
|
Pesticides
[Identifier]
in
Urine
|
|
13019-5
|
Pesticides
[Identifier]
in
Serum
or
Plasma
|
|
1302-9
|
Deprecated
PP1
Ab
|
|
13020-3
|
Pesticides
[Identifier]
in
Blood
|
|
13021-1
|
Pesticides
[Identifier]
in
Gastric
fluid
|
|
13022-9
|
Propane
[Mass/volume]
in
Blood
|
|
13023-7
|
Trichlorofluoromethane
[Mass/volume]
in
Blood
|
|
13024-5
|
Trichlorofluoroethane
[Mass/volume]
in
Blood
|
|
13025-2
|
Trichlorotrifluoroethane
[Mass/volume]
in
Blood
|
|
13026-0
|
Orthocresol
[Mass/volume]
in
Urine
|
|
13027-8
|
Ethyl
acetate
[Mass/volume]
in
Serum
or
Plasma
|
|
13028-6
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
13029-4
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
1303-7
|
Reverse
ABO
group
[Type]
|
|
13030-2
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
XXX
challenge
|
|
13031-0
|
Xylose
[Mass/volume]
in
Serum
or
Plasma
--5
hours
post
XXX
challenge
|
|
13032-8
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
13033-6
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
13034-4
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
13035-1
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
13036-9
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
13037-7
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--fasting
|
|
13038-5
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
13039-3
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
1304-5
|
D
Ab
[Titer]
in
Serum
or
Plasma
|
|
13040-1
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
13041-9
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
13042-7
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--2.5
hours
post
XXX
challenge
|
|
13043-5
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
13044-3
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--5
hours
post
XXX
challenge
|
|
13045-0
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
XXX
challenge
|
|
13046-8
|
Variant
lymphocytes/100
leukocytes
in
Blood
|
|
13047-6
|
Plasma
cells/100
leukocytes
in
Blood
|
|
13048-4
|
Sezary
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
13049-2
|
Deprecated
von
Willebrand
factor
(vWf)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
1305-2
|
D
Ag
[Presence]
in
Blood
|
|
13050-0
|
Protein
C/Coagulation
factor
IX
[Mass
Ratio]
in
Platelet
poor
plasma
|
|
13051-8
|
Deprecated
Protein
S
[Units/volume]
in
Platelet
poor
plasma
|
|
13052-6
|
Protein
S/Coagulation
factor
IX
[Mass
Ratio]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
13053-4
|
Kaolin
activated
time
[Units/volume]
in
Platelet
poor
plasma
|
|
13054-2
|
Fibrin+Fibrinogen
fragments
[Units/volume]
in
Urine
|
|
13055-9
|
Heparin
[Units/volume]
in
Platelet
poor
plasma
|
|
13056-7
|
Platelets
[#/volume]
in
Plasma
by
Automated
count
|
|
13057-5
|
Platelets
[Units/volume]
in
Dialysis
fluid
|
|
13058-3
|
aPTT
in
Platelet
poor
plasma
by
Coagulation
assay
--2nd
specimen
|
|
13059-1
|
aPTT
in
Platelet
poor
plasma
by
Coagulation
assay
--3rd
specimen
|
|
1306-0
|
D
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
13060-9
|
aPTT
in
Platelet
poor
plasma
by
Coagulation
assay
--4th
specimen
|
|
13061-7
|
Platelet
IgM
Ab
[Units/volume]
in
Serum
|
|
13062-5
|
Platelet
IgA
Ab
[Units/volume]
in
Serum
|
|
13063-3
|
Drug
induced
platelet
Ab
[Units/volume]
in
Serum
|
|
13064-1
|
Platelet
associated
IgA
Ab
[Units/volume]
in
Blood
|
|
13065-8
|
Deprecated
Platelet
Ab
[Units/volume]
in
Serum
|
|
13066-6
|
Nuclear
Ab
[Units/volume]
in
Body
fluid
by
Immunofluorescence
|
|
13067-4
|
Nuclear
Ab
pattern
[Interpretation]
in
Body
fluid
by
Immunofluorescence
|
|
13068-2
|
Nuclear
Ab
pattern
[Interpretation]
in
Serum
by
Immunofluorescence
|
|
13069-0
|
Phosphatidylserine
IgA
Ab
[Units/volume]
in
Serum
|
|
1307-8
|
D
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13070-8
|
Phosphatidate
IgG
Ab
[Units/volume]
in
Serum
|
|
13071-6
|
Phosphatidate
IgM
Ab
[Units/volume]
in
Serum
|
|
13072-4
|
Phosphatidate
IgA
Ab
[Units/volume]
in
Serum
|
|
13073-2
|
Phosphatidylcholine
IgG
Ab
[Units/volume]
in
Serum
|
|
13074-0
|
Phosphatidylcholine
IgM
Ab
[Units/volume]
in
Serum
|
|
13075-7
|
Phosphatidylcholine
IgA
Ab
[Units/volume]
in
Serum
|
|
13076-5
|
Phosphatidylethanolamine
IgG
Ab
[Units/volume]
in
Serum
|
|
13077-3
|
Phosphatidylethanolamine
IgM
Ab
[Units/volume]
in
Serum
|
|
13078-1
|
Phosphatidylethanolamine
IgA
Ab
[Units/volume]
in
Serum
|
|
13079-9
|
Phosphatidylglycerol
IgG
Ab
[Units/volume]
in
Serum
|
|
1308-6
|
D
NOS
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13080-7
|
Phosphatidylglycerol
IgM
Ab
[Units/volume]
in
Serum
|
|
13081-5
|
Phosphatidylglycerol
IgA
Ab
[Units/volume]
in
Serum
|
|
13082-3
|
Phosphatidylinositol
IgG
Ab
[Units/volume]
in
Serum
|
|
13083-1
|
Phosphatidylinositol
IgM
Ab
[Units/volume]
in
Serum
|
|
13084-9
|
Phosphatidylinositol
IgA
Ab
[Units/volume]
in
Serum
|
|
13085-6
|
Complement
C4
Nephritic
[Mass/volume]
in
Serum
or
Plasma
|
|
13086-4
|
Complement
C3
Nephritic
[Mass/volume]
in
Serum
or
Plasma
|
|
13087-2
|
Complement
alternate
pathway
AH50
[Units/volume]
in
Serum
or
Plasma
|
|
13088-0
|
Complement
total
hemolytic
CH100
[Units/volume]
in
Serum
or
Plasma
|
|
13089-8
|
Deprecated
Asialoganglioside
GM1
Ab
|
|
1309-4
|
Deprecated
D
NOS
Ab
[Presence]
in
Serum
or
Plasma
|
|
13090-6
|
Deprecated
Asialoganglioside
GM1
Ab.IgG
|
|
13091-4
|
Deoxyribonucleoprotein
Ab
[Units/volume]
in
Serum
|
|
13092-2
|
Endomysium
Ab
[Units/volume]
in
Serum
|
|
13093-0
|
Deprecated
Monosialoganglioside
GM1
Ab.IgM
|
|
13094-8
|
Deprecated
Monosialoganglioside
GM1
Ab.IgA
in
serum
|
|
13095-5
|
Deprecated
Monosialoganglioside
GM1
Ab.IgA
in
serum
or
plasma
|
|
13096-3
|
Deprecated
Myelin
associated
glycoprotein
Ab.IgM
in
serum
|
|
13097-1
|
Deprecated
PM-SCL
extractable
nuclear
Ab
|
|
13098-9
|
Deprecated
Sulfatide
Ab.IgG
|
|
13099-7
|
Deprecated
Sulfatide
Ab.IgM
in
serum
|
|
131-3
|
Cefsulodin
[Mass/volume]
in
Serum
or
Plasma
|
|
1310-2
|
D
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13100-3
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab.IgM
in
serum
|
|
13101-1
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab.IgM
in
CSF
|
|
13102-9
|
Deprecated
Disialylganglioside
GD1b
Ab
in
serum
|
|
13103-7
|
Deprecated
Disialylganglioside
GD1b
Ab.IgG
|
|
13104-5
|
Deprecated
Disialylganglioside
GD1b
Ab.IgM
|
|
13105-2
|
Deprecated
Tetrasialylganglioside
GQ1b
Ab.IgG
|
|
13106-0
|
Deprecated
Tetrasialylganglioside
GQ1b
Ab
in
serum
|
|
13107-8
|
Deprecated
Disialylganglioside
GD1a
Ab
|
|
13108-6
|
Deprecated
Tetrasialylganglioside
GQ1b
Ab
in
serum
or
plasma
|
|
13109-4
|
Deprecated
Disialylganglioside
GD1b
Ab
in
serum
or
plasma
|
|
1311-0
|
D
NOS
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13110-2
|
Deprecated
Beta
tubulin
Ab.IgM
|
|
13111-0
|
Deprecated
Nuclear
Ab
by
Immunofluorescence
|
|
13112-8
|
Deprecated
Nuclear
Ab
Immunofluorescence
(rat
kidney
substrate)
|
|
13113-6
|
Deprecated
Myelin
associated
glycoprotein
Ab.IgM
in
serum
or
plasma
|
|
13114-4
|
Deprecated
Neuronal
nuclear
type
2
Ab
|
|
13115-1
|
Deprecated
Neuronal
nuclear
type
1
Ab
|
|
13116-9
|
Deprecated
Reticulin
Ab.IgG
|
|
13117-7
|
Complement
Sc5b-9
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13118-5
|
Deprecated
Myelin
associated
glycoprotein
Ab
|
|
13119-3
|
Myelin
associated
glycoprotein
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1312-8
|
D
NOS
Ag
[Presence]
on
Red
Blood
Cells
|
|
13120-1
|
Ovary
Ab
[Units/volume]
in
Serum
|
|
13121-9
|
Deprecated
Ribosomal
P
protein
Ab
|
|
13122-7
|
Deprecated
Sulfatide
Ab.IgM
in
serum
or
plasma
|
|
13123-5
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab
in
serum
|
|
13124-3
|
Deprecated
Sulfate-3-Glucuronyl
paragloboside
Ab
in
serum
or
plasma
|
|
13125-0
|
Deprecated
Hepatitis
C
virus
c33c
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
13126-8
|
Deprecated
Hepatitis
B
virus
DNA
[Presence]
in
Blood
by
Immunoblot
(IB)
|
|
13127-6
|
Cancer
Ag
DM/70K
[Units/volume]
in
Serum
or
Plasma
|
|
13128-4
|
Protein.immunoacidic
[Units/volume]
in
Serum
or
Plasma
|
|
13129-2
|
Pancreatic
oncofetal
Ag
[Units/volume]
in
Serum
or
Plasma
|
|
1313-6
|
Rh
immune
globulin
dosage.vials
recommended
[#]
|
|
13130-0
|
Motilin
[Units/volume]
in
Serum
or
Plasma
|
|
13131-8
|
Streptococcus
pneumoniae
1
Ab
[Units/volume]
in
Serum
|
|
13132-6
|
Streptococcus
pneumoniae
4
Ab
[Units/volume]
in
Serum
|
|
13133-4
|
Streptococcus
pneumoniae
26
Ab
[Units/volume]
in
Serum
|
|
13134-2
|
Streptococcus
pneumoniae
8
Ab
[Units/volume]
in
Serum
|
|
13135-9
|
Streptococcus
pneumoniae
12
Ab
[Units/volume]
in
Serum
|
|
13136-7
|
Streptococcus
pneumoniae
56
Ab
[Units/volume]
in
Serum
|
|
13137-5
|
Streptococcus
pneumoniae
19
Ab
[Units/volume]
in
Serum
|
|
13138-3
|
Streptococcus
pneumoniae
23
Ab
[Units/volume]
in
Serum
|
|
13139-1
|
Streptococcus
pneumoniae
1
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1314-4
|
Rh
immune
globulin
screen
[interpretation]
|
|
13140-9
|
Streptococcus
pneumoniae
1
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13141-7
|
Streptococcus
pneumoniae
3
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13142-5
|
Streptococcus
pneumoniae
3
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13143-3
|
Streptococcus
pneumoniae
4
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13144-1
|
Streptococcus
pneumoniae
4
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13145-8
|
Streptococcus
pneumoniae
26
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13146-6
|
Streptococcus
pneumoniae
26
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13147-4
|
Streptococcus
pneumoniae
51
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13148-2
|
Streptococcus
pneumoniae
51
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13149-0
|
Streptococcus
pneumoniae
8
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1315-1
|
S
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13150-8
|
Streptococcus
pneumoniae
8
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13151-6
|
Streptococcus
pneumoniae
9
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13152-4
|
Streptococcus
pneumoniae
9
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13153-2
|
Streptococcus
pneumoniae
12
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13154-0
|
Streptococcus
pneumoniae
12
Ab
[Ratio]
in
Serum
--2nd
specimen/1st
specimen
|
|
13155-7
|
Streptococcus
pneumoniae
14
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13156-5
|
Streptococcus
pneumoniae
14
Ab
[Ratio]
in
Serum
--2nd
specimen/1st
specimen
|
|
13157-3
|
Streptococcus
pneumoniae
56
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13158-1
|
Streptococcus
pneumoniae
56
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13159-9
|
Streptococcus
pneumoniae
19
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1316-9
|
S
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13160-7
|
Streptococcus
pneumoniae
19
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13161-5
|
Streptococcus
pneumoniae
23
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13162-3
|
Streptococcus
pneumoniae
23
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13163-1
|
Deprecated
Streptococcus
pneumoniae
12
Ab
[Units/volume]
in
Serum
|
|
13164-9
|
Human
antimouse
Ab
[Units/volume]
in
Serum
|
|
13165-6
|
Deprecated
Streptococcus
pneumoniae
19
Ab
[Units/volume]
in
Serum
|
|
13166-4
|
Deprecated
Streptococcus
pneumoniae
23
Ab
[Units/volume]
in
Serum
|
|
13167-2
|
Streptococcus
pneumoniae
51
Ab
[Units/volume]
in
Serum
|
|
13168-0
|
Streptococcus
pneumoniae
6+26
Ab
[Units/volume]
in
Serum
|
|
13169-8
|
Immunoelectrophoresis
for
Serum
or
Plasma
|
|
1317-7
|
S
Ab
[Presence]
in
Serum
or
Plasma
|
|
13170-6
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Conglutinin
assay
|
|
13171-4
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Polyethylene
glycol
(PEG)
assay
|
|
13172-2
|
Complement
C1q
Ag
[Units/volume]
in
Serum
or
Plasma
by
Raji
cell
assay
|
|
13173-0
|
Fibronectin
aggregate
IgA
Ab
[Units/volume]
in
Serum
|
|
13174-8
|
Immunofixation
for
Cerebral
spinal
fluid
|
|
13175-5
|
Liver
cytosol
Ab
[Presence]
in
Serum
|
|
13176-3
|
Wasp
venom
IgE
Ab
[Units/volume]
in
Serum
|
|
13177-1
|
Russian
olive
IgE
Ab
[Units/volume]
in
Serum
|
|
13178-9
|
Wasp
venom
IgG
Ab
[Units/volume]
in
Serum
|
|
13179-7
|
English
Walnut
IgG
Ab
[Units/volume]
in
Serum
|
|
1318-5
|
S
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13180-5
|
Formaldehyde
IgG
Ab
[Units/volume]
in
Serum
|
|
13181-3
|
Bahia
grass
IgG
Ab
[Units/volume]
in
Serum
|
|
13182-1
|
Mesquite
IgG
Ab
[Units/volume]
in
Serum
|
|
13183-9
|
White
Elm
IgG
Ab
[Units/volume]
in
Serum
|
|
13184-7
|
Cottonwood
IgG
Ab
[Units/volume]
in
Serum
|
|
13185-4
|
Nettle
IgG
Ab
[Units/volume]
in
Serum
|
|
13186-2
|
Yellow
Dock
IgG
Ab
[Units/volume]
in
Serum
|
|
13187-0
|
False
ragweed
IgG
Ab
[Units/volume]
in
Serum
|
|
13188-8
|
Mugwort
IgG
Ab
[Units/volume]
in
Serum
|
|
13189-6
|
English
plantain
IgG
Ab
[Units/volume]
in
Serum
|
|
1319-3
|
S
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13190-4
|
Formaldehyde
IgM
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13191-2
|
Deprecated
Rheumatoid
factor
[Units/volume]
in
Serum
|
|
13192-0
|
Adenovirus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13193-8
|
Aspergillus
flavus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13194-6
|
Aspergillus
glaucus
Ab
[Units/volume]
in
Serum
|
|
13195-3
|
Ehrlichia
chaffeensis
Ab
[Units/volume]
in
Serum
|
|
13196-1
|
Ehrlichia
sp
IgG
Ab
[Presence]
in
Serum
|
|
13197-9
|
Ehrlichia
sp
IgM
Ab
[Presence]
in
Serum
|
|
13198-7
|
Thermoactinomyces
Ab
[Units/volume]
in
Serum
|
|
13199-5
|
Rickettsia
conorii
IgG
Ab
[Units/volume]
in
Serum
|
|
132-1
|
Ceftazidime
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1320-1
|
S
Ag
[Presence]
on
Red
Blood
Cells
|
|
13200-1
|
Rickettsia
conorii
IgM
Ab
[Units/volume]
in
Serum
|
|
13201-9
|
Blastomyces
dermatitidis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13202-7
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
13203-5
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
13204-3
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
13205-0
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
13206-8
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Synovial
fluid
by
Immunoblot
(IB)
|
|
13207-6
|
Borrelia
burgdorferi
IgM
Ab
[Presence]
in
Synovial
fluid
by
Immunoblot
(IB)
|
|
13208-4
|
Borrelia
hermsii
IgG
Ab
[Units/volume]
in
Serum
|
|
13209-2
|
Borrelia
hermsii
IgM
Ab
[Units/volume]
in
Serum
|
|
1321-9
|
Transfusion
duration
|
|
13210-0
|
Brucella
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
13211-8
|
Brucella
sp
IgA
Ab
[Units/volume]
in
Serum
|
|
13212-6
|
Brucella
abortus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13213-4
|
Brucella
abortus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13214-2
|
Brucella
canis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13215-9
|
Brucella
canis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13216-7
|
Candida
albicans
immune
complex
[Units/volume]
in
Serum
or
Plasma
|
|
13217-5
|
Chlamydia
trachomatis
B
Ab
[Units/volume]
in
Serum
|
|
13218-3
|
Chlamydia
trachomatis
C
Ab
[Units/volume]
in
Serum
|
|
13219-1
|
Chlamydia
trachomatis
G+F+K
Ab
[Units/volume]
in
Serum
|
|
1322-7
|
Transfusion
volume
|
|
13220-9
|
Chlamydia
trachomatis
C
IgM
Ab
[Units/volume]
in
Serum
|
|
13221-7
|
Chlamydia
trachomatis
G+F+K
IgM
Ab
[Units/volume]
in
Serum
|
|
13222-5
|
Deprecated
Chlamydia
trachomatis
C
Ab
[Units/volume]
in
Serum
|
|
13223-3
|
Deprecated
Chlamydia
trachomatis
B
Ab
[Units/volume]
in
Serum
|
|
13224-1
|
Deprecated
Chlamydia
trachomatis
G+F+K
Ab
[Units/volume]
in
Serum
|
|
13225-8
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13226-6
|
Cytomegalovirus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13227-4
|
Corynebacterium
diphtheriae
IgG
Ab
[Units/volume]
in
Serum
|
|
13228-2
|
Eastern
equine
encephalitis
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13229-0
|
Eastern
equine
encephalitis
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1323-5
|
U
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13230-8
|
Saint
Louis
encephalitis
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13231-6
|
Saint
Louis
encephalitis
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13232-4
|
Coxsackievirus
A
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13233-2
|
Coxsackievirus
A2
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13234-0
|
Coxsackievirus
A4
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13235-7
|
Coxsackievirus
A16
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13236-5
|
Epstein
Barr
virus
early
diffuse
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
13237-3
|
Epstein
Barr
virus
early
restricted
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
13238-1
|
Epstein
Barr
virus
Ab
[Units/volume]
in
Serum
|
|
13239-9
|
Deprecated
Epstein
Barr
virus
nuclear
IgG
Ab
[Presence]
in
Serum
|
|
1324-3
|
U
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13240-7
|
Phoma
herbarum
IgE
Ab
[Units/volume]
in
Serum
|
|
13241-5
|
Sporothrix
schenckii
IgG
Ab
[Units/volume]
in
Serum
|
|
13242-3
|
Sporothrix
schenckii
IgM
Ab
[Units/volume]
in
Serum
|
|
13243-1
|
Sporothrix
schenckii
IgA
Ab
[Units/volume]
in
Serum
|
|
13244-9
|
Filaria
IgG
Ab
[Units/volume]
in
Serum
|
|
13245-6
|
Filaria
IgM
Ab
[Units/volume]
in
Serum
|
|
13246-4
|
Haemophilus
influenzae
B
Ab
[Units/volume]
in
Serum
|
|
13247-2
|
HTLV
I+II
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13248-0
|
Hepatitis
D
virus
Ab
[Presence]
in
Serum
|
|
13249-8
|
Herpes
simplex
virus
1+2
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1325-0
|
U
Ab
[Presence]
in
Serum
or
Plasma
|
|
13250-6
|
Herpes
virus
6
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
13251-4
|
Herpes
simplex
virus
1
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13252-2
|
Herpes
simplex
virus
2
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13253-0
|
Legionella
non-pneumophila
Ab
[Presence]
in
Serum
|
|
13254-8
|
Legionella
pneumophila
atypical
Ab
[Presence]
in
Serum
|
|
13255-5
|
Legionella
longbeachae
1+2
Ab
[Presence]
in
Serum
|
|
13256-3
|
Leishmania
donovani
IgG
Ab
[Units/volume]
in
Serum
|
|
13257-1
|
Leishmania
donovani
IgM
Ab
[Units/volume]
in
Serum
|
|
13258-9
|
Leishmania
brasilensis
IgG
Ab
[Units/volume]
in
Serum
|
|
13259-7
|
Leishmania
brasilensis
IgM
Ab
[Units/volume]
in
Serum
|
|
1326-8
|
U
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13260-5
|
Leishmania
mexicana
IgG
Ab
[Units/volume]
in
Serum
|
|
13261-3
|
Leishmania
mexicana
IgM
Ab
[Units/volume]
in
Serum
|
|
13262-1
|
Leishmania
tropica
IgG
Ab
[Units/volume]
in
Serum
|
|
13263-9
|
Leishmania
tropica
IgM
Ab
[Units/volume]
in
Serum
|
|
13264-7
|
Leptospira
sp
IgG
Ab
[Titer]
in
Serum
|
|
13265-4
|
Leptospira
sp
IgM
Ab
[Titer]
in
Serum
|
|
13266-2
|
Mumps
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13267-0
|
Mumps
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13268-8
|
Mycoplasma
pneumoniae
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
13269-6
|
Mycoplasma
pneumoniae
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
1327-6
|
U
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13270-4
|
Mycoplasma
pneumoniae
IgA
Ab
[Units/volume]
in
Serum
|
|
13271-2
|
Neisseria
meningitidis
A
Ab
[Units/volume]
in
Serum
|
|
13272-0
|
Neisseria
meningitidis
C
Ab
[Units/volume]
in
Serum
|
|
13273-8
|
Sporothrix
schenckii
Ab
[Presence]
in
Serum
|
|
13274-6
|
Toxocara
canis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13275-3
|
Toxocara
canis
IgM
Ab
[Units/volume]
in
Serum
|
|
13276-1
|
Toxocara
canis
IgA
Ab
[Units/volume]
in
Serum
|
|
13277-9
|
Schistosoma
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
13278-7
|
Schistosoma
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
13279-5
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1328-4
|
U
Ag
[Presence]
on
Red
Blood
Cells
|
|
13280-3
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13281-1
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13282-9
|
Rubella
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13283-7
|
Measles
virus
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13284-5
|
Salmonella
typhi
H
D
Ab
[Presence]
in
Serum
|
|
13285-2
|
Salmonella
typhi
O
D
Ab
[Presence]
in
Serum
|
|
13286-0
|
Toxoplasma
gondii
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
13287-8
|
Toxoplasma
gondii
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13288-6
|
Treponema
pallidum
Ab
[Units/volume]
in
Blood
by
Immunofluorescence
|
|
13289-4
|
Hantavirus
hantaan
Ab
[Units/volume]
in
Serum
|
|
1329-2
|
V
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13290-2
|
Trypanosoma
cruzi
IgM
Ab
[Units/volume]
in
Serum
|
|
13291-0
|
Trypanosoma
cruzi
IgG
Ab
[Units/volume]
in
Serum
|
|
13292-8
|
Colorado
tick
fever
virus
IgG
Ab
[Units/volume]
in
Serum
|
|
13293-6
|
Colorado
tick
fever
virus
IgM
Ab
[Units/volume]
in
Serum
|
|
13294-4
|
Hepatitis
E
virus
Ab
[Presence]
in
Serum
|
|
13295-1
|
Coxsackievirus
A10
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
13296-9
|
Deprecated
Coxsackievirus
A10
Ab
[Units/volume]
in
Serum
|
|
13297-7
|
Coxsackievirus
A1
Ab
[Units/volume]
in
Serum
|
|
13298-5
|
HLA-A
[Type]
|
|
13299-3
|
HLA-B
[Type]
|
|
133-9
|
Ceftazidime
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1330-0
|
V
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13300-9
|
HLA-A+B
[Type]
|
|
13301-7
|
HLA-A+B+Bw
[Type]
|
|
13302-5
|
HLA-C
[Type]
|
|
13303-3
|
HLA-A+B+C
(class
I)
[Type]
|
|
13304-1
|
HLA-DR
[Type]
|
|
13305-8
|
HLA-DQ
[Type]
|
|
13306-6
|
HLA-DR
beta
[Type]
|
|
13307-4
|
HLA-DQ
alpha
[Type]
|
|
13308-2
|
Deprecated
DNA
|
|
13309-0
|
Duffy
group
Ag
[Type]
on
Red
Blood
Cells
|
|
1331-8
|
V
Ab
[Presence]
in
Serum
or
Plasma
|
|
13310-8
|
Kell
group
Ag
[Type]
on
Red
Blood
Cells
|
|
13311-6
|
MNS
group
Ag
[Type]
on
Red
Blood
Cells
|
|
13312-4
|
IgA
IgG
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13313-2
|
IgM
IgM
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
13314-0
|
Bacteria
identified
in
Semen
|
|
13315-7
|
Bacteria
identified
in
24
hour
Urine
by
Culture
|
|
13316-5
|
Vancomycin
resistant
enterococcus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
13317-3
|
Methicillin
resistant
Staphylococcus
aureus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
13318-1
|
Escherichia
coli
enteroinvasive
identified
in
Stool
by
Organism
specific
culture
|
|
13319-9
|
Ova
and
parasites
identified
in
Stool
by
Light
microscopy--2nd
specimen
|
|
1332-6
|
V
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13320-7
|
Ova
and
parasites
identified
in
Stool
by
Light
microscopy--3rd
specimen
|
|
13321-5
|
Human
papilloma
virus
IgG
Ab
[Presence]
in
Serum
|
|
13322-3
|
Human
papilloma
virus
IgM
Ab
[Presence]
in
Serum
|
|
13323-1
|
Herpes
simplex
virus
2
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
13324-9
|
Herpes
simplex
virus
1
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
13325-6
|
Bartonella
sp
identified
in
Blood
by
Light
microscopy
|
|
13326-4
|
Pneumocystis
sp
identified
in
Unspecified
specimen
by
Light
microscopy
|
|
13327-2
|
Parainfluenza
virus
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
13328-0
|
Measles
virus
Ag
[Presence]
in
Serum
or
Plasma
by
Immunofluorescence
|
|
13329-8
|
Escherichia
coli
labile
toxin
[Presence]
in
Unspecified
specimen
|
|
1333-4
|
V
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13330-6
|
Barr
bodies
[Presence]
in
Cervix
by
Light
microscopy
|
|
13331-4
|
CD2+CD26+
cells/100
cells
in
Blood
|
|
13332-2
|
CD4+CD25+
cells/100
cells
in
Blood
|
|
13333-0
|
CD3+CD25+
cells/100
cells
in
Blood
|
|
13334-8
|
CD8+CD25+
cells/100
cells
in
Blood
|
|
13335-5
|
CD4+CD29+
cells/100
cells
in
Blood
|
|
13336-3
|
CD4+CD45RA+
cells/100
cells
in
Blood
|
|
13337-1
|
CD8+HLA-DR+
cells/100
cells
in
Blood
|
|
13338-9
|
CD8+CD57+
cells/100
cells
in
Blood
|
|
13339-7
|
CD8+CD56+
cells/100
cells
in
Blood
|
|
1334-2
|
V
Ag
[Presence]
on
Red
Blood
Cells
|
|
13340-5
|
CD3+CD38+
cells/100
cells
in
Blood
|
|
13341-3
|
CD3+CD25+
cells/100
cells
in
Tissue
|
|
13342-1
|
CD3+CD26+
cells/100
cells
in
Blood
|
|
13343-9
|
CD4+HLA-DR+
cells/100
cells
in
Blood
|
|
13344-7
|
CD8+CD38+
cells/100
cells
in
Blood
|
|
13345-4
|
CD8+CD11b+
cells/100
cells
in
Blood
|
|
13346-2
|
CD35
cells/100
cells
in
Blood
|
|
13347-0
|
RNA
polymerase
I+II+III
Ab
[Presence]
in
Serum
|
|
13348-8
|
Monoclonal
band
observed
[Identifier]
in
Serum
or
Plasma
|
|
13349-6
|
Leukocytes
[#/volume]
in
Stool
by
Manual
count
|
|
1335-9
|
Whole
blood
given
[Volume]
|
|
13350-4
|
Deprecated
Eosinophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13351-2
|
Leukocytes
other
[#/volume]
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13352-0
|
Deprecated
Neutrophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13353-8
|
Deprecated
Eosinophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13354-6
|
Band
form
neutrophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13355-3
|
Unspecified
cells/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13356-1
|
Fat
[Presence]
in
Body
fluid
|
|
13357-9
|
Synovial
cells
[Units/volume]
in
Body
fluid
|
|
13358-7
|
Collection
time
of
Semen
|
|
13359-5
|
Character
of
Semen
|
|
1336-7
|
Xg
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13360-3
|
Deprecated
Color
of
Semen
-
impression
|
|
13361-1
|
Semen
analysis
panel
|
|
13362-9
|
Collection
duration
of
Urine
|
|
13363-7
|
Collection
duration
of
Stool
|
|
13364-5
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Plasma
|
|
13365-2
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13366-0
|
Alpha
aminoadipate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13367-8
|
Beta
aminoisobutyrate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13368-6
|
Beta
alanine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13369-4
|
Carnosine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
1337-5
|
Xg
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13370-2
|
Cystathionine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13371-0
|
Cystine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13372-8
|
Homocystine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13373-6
|
Hydroxylysine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13374-4
|
Hydroxyproline
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13375-1
|
Lysine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13376-9
|
Methionine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13377-7
|
1-Methylhistidine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13378-5
|
3-Methylhistidine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13379-3
|
Ornithine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
1338-3
|
Xg
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
13380-1
|
Sarcosine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13381-9
|
Tyrosine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13382-7
|
Amino
beta
guanidinopropionate
[Mass/volume]
in
Amniotic
fluid
|
|
13383-5
|
Alpha
aminobutyrate
[Mass/volume]
in
Amniotic
fluid
|
|
13384-3
|
Alpha
aminoadipate
[Mass/volume]
in
Amniotic
fluid
|
|
13385-0
|
Beta
aminoisobutyrate
[Mass/volume]
in
Amniotic
fluid
|
|
13386-8
|
Anserine
[Mass/volume]
in
Amniotic
fluid
|
|
13387-6
|
Arginine
[Mass/volume]
in
Amniotic
fluid
|
|
13388-4
|
Asparagine
[Mass/volume]
in
Amniotic
fluid
|
|
13389-2
|
Aspartate
[Mass/volume]
in
Amniotic
fluid
|
|
1339-1
|
Xg
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13390-0
|
Beta
alanine
[Mass/volume]
in
Amniotic
fluid
|
|
13391-8
|
Carnosine
[Mass/volume]
in
Amniotic
fluid
|
|
13392-6
|
Citrulline
[Mass/volume]
in
Amniotic
fluid
|
|
13393-4
|
Cystathionine
[Mass/volume]
in
Amniotic
fluid
|
|
13394-2
|
Cystine
[Mass/volume]
in
Amniotic
fluid
|
|
13395-9
|
Glutamate
[Mass/volume]
in
Amniotic
fluid
|
|
13396-7
|
Glutamine
[Mass/volume]
in
Amniotic
fluid
|
|
13397-5
|
Glycine
[Mass/volume]
in
Amniotic
fluid
|
|
13398-3
|
Histidine
[Mass/volume]
in
Amniotic
fluid
|
|
13399-1
|
Homocystine
[Mass/volume]
in
Amniotic
fluid
|
|
134-7
|
Ceftazidime
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1340-9
|
Xg
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13400-7
|
Hydroxylysine
[Mass/volume]
in
Amniotic
fluid
|
|
13401-5
|
Hydroxyproline
[Mass/volume]
in
Amniotic
fluid
|
|
13402-3
|
Isoleucine
[Mass/volume]
in
Amniotic
fluid
|
|
13403-1
|
Leucine
[Mass/volume]
in
Amniotic
fluid
|
|
13404-9
|
Lysine
[Mass/volume]
in
Amniotic
fluid
|
|
13405-6
|
Methionine
[Mass/volume]
in
Amniotic
fluid
|
|
13406-4
|
1-Methylhistidine
[Mass/volume]
in
Amniotic
fluid
|
|
13407-2
|
3-Methylhistidine
[Mass/volume]
in
Amniotic
fluid
|
|
13408-0
|
Ornithine
[Mass/volume]
in
Amniotic
fluid
|
|
13409-8
|
Phenylalanine
[Mass/volume]
in
Amniotic
fluid
|
|
1341-7
|
Xg
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
13410-6
|
Phosphoethanolamine
[Mass/volume]
in
Amniotic
fluid
|
|
13411-4
|
Phosphoserine
[Mass/volume]
in
Amniotic
fluid
|
|
13412-2
|
Proline
[Mass/volume]
in
Amniotic
fluid
|
|
13413-0
|
Sarcosine
[Mass/volume]
in
Amniotic
fluid
|
|
13414-8
|
Serine
[Mass/volume]
in
Amniotic
fluid
|
|
13415-5
|
Taurine
[Mass/volume]
in
Amniotic
fluid
|
|
13416-3
|
Threonine
[Mass/volume]
in
Amniotic
fluid
|
|
13417-1
|
Tyrosine
[Mass/volume]
in
Amniotic
fluid
|
|
13418-9
|
Tryptophan
[Mass/volume]
in
Amniotic
fluid
|
|
13419-7
|
Valine
[Mass/volume]
in
Amniotic
fluid
|
|
1342-5
|
Yt
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13420-5
|
Epinephrine
[Mass/volume]
in
Plasma
--2nd
specimen
post
XXX
challenge
|
|
13421-3
|
Epinephrine
[Mass/volume]
in
Plasma
--3rd
specimen
post
XXX
challenge
|
|
13422-1
|
Epinephrine
[Mass/volume]
in
Plasma
--4th
specimen
post
XXX
challenge
|
|
13423-9
|
Epinephrine
[Mass/volume]
in
Plasma
--5th
specimen
post
XXX
challenge
|
|
13424-7
|
Epinephrine
[Mass/volume]
in
Plasma
--6th
specimen
post
XXX
challenge
|
|
13425-4
|
Epinephrine
[Mass/volume]
in
Plasma
--7th
specimen
post
XXX
challenge
|
|
13426-2
|
Norepinephrine
[Mass/volume]
in
Plasma
--2nd
specimen
post
XXX
challenge
|
|
13427-0
|
Norepinephrine
[Mass/volume]
in
Plasma
--3rd
specimen
post
XXX
challenge
|
|
13428-8
|
Norepinephrine
[Mass/volume]
in
Plasma
--4th
specimen
post
XXX
challenge
|
|
13429-6
|
Norepinephrine
[Mass/volume]
in
Plasma
--5th
specimen
post
XXX
challenge
|
|
1343-3
|
Yt
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13430-4
|
Norepinephrine
[Mass/volume]
in
Plasma
--6th
specimen
post
XXX
challenge
|
|
13431-2
|
Norepinephrine
[Mass/volume]
in
Plasma
--7th
specimen
post
XXX
challenge
|
|
13432-0
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
13433-8
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
13434-6
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
13435-3
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
13436-1
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
13437-9
|
Dopamine
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
13438-7
|
Protein
Fractions
[Interpretation]
in
Urine
by
Electrophoresis
|
|
13439-5
|
Protein
Fractions
[Interpretation]
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
1344-1
|
Yt
sup(a)
Ab
[Presence]
in
Serum
or
Plasma
|
|
13440-3
|
Immunofixation
for
Urine
|
|
13441-1
|
Creatinine
renal
clearance
in
4
hour
|
|
13442-9
|
Creatinine
renal
clearance
in
6
hour
|
|
13443-7
|
Creatinine
renal
clearance
in
8
hour
|
|
13444-5
|
Calcium/Albumin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
13445-2
|
Deprecated
Creatinine
renal
clearance/1.73
sq
M
in
24
hour
|
|
13446-0
|
Creatinine
renal
clearance/1.73
sq
M
in
4
hour
|
|
13447-8
|
Creatinine
renal
clearance/1.73
sq
M
in
6
hour
|
|
13448-6
|
Calcium/Osmolality
[Mass
Ratio]
in
Serum
or
Plasma
|
|
13449-4
|
Creatinine
renal
clearance/1.73
sq
M
in
8
hour
|
|
1345-8
|
Yt
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13450-2
|
Creatinine
renal
clearance/1.73
sq
M
in
12
hour
|
|
13451-0
|
Creatinine
dialysis
fluid
clearance
|
|
13452-8
|
Iron/Transferrin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
13453-6
|
Deprecated
Glucose
mean
value
|
|
13454-4
|
Calcium-phosphorus
product
[(Moles/volume)*2]
in
Serum
or
Plasma
|
|
13455-1
|
Lithium.plasma/Lithium.RBC
[Mass
Ratio]
in
Blood
|
|
13456-9
|
IgG
synthesis
rate
[Units/volume]
in
Serum
and
CSF
|
|
13457-7
|
Cholesterol
in
LDL
[Mass/volume]
in
Serum
or
Plasma
by
calculation
|
|
13458-5
|
Cholesterol
in
VLDL
[Mass/volume]
in
Serum
or
Plasma
by
calculation
|
|
13459-3
|
Cholesterol
in
LDL/Cholesterol.total
[Mass
Ratio]
in
Serum
or
Plasma
|
|
1346-6
|
Yt
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13460-1
|
Deprecated
Cholesterol.in
LDL/Cholesterol.in
HDL
[Mass
ratio]
in
Serum
or
Plasma
|
|
13461-9
|
Monoacetyldapsone/Dapsone
[Mass
Ratio]
in
Serum
or
Plasma
|
|
13462-7
|
Apolipoprotein
A-I/Apolipoprotein
B
[Mass
Ratio]
in
Serum
or
Plasma
|
|
13463-5
|
Arsenic/Creatinine
[Mass
Ratio]
in
Urine
|
|
13464-3
|
Chromium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13465-0
|
Mercury/Creatinine
[Mass
Ratio]
in
Urine
|
|
13466-8
|
Lead/Creatinine
[Mass
Ratio]
in
Urine
|
|
13467-6
|
Selenium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13468-4
|
Cobalt/Creatinine
[Mass
Ratio]
in
Urine
|
|
13469-2
|
Thallium/Creatinine
[Mass
Ratio]
in
Urine
|
|
1347-4
|
Yt
sup(a)
Ag
[Presence]
on
Red
Blood
Cells
|
|
13470-0
|
Aluminum/Creatinine
[Mass
Ratio]
in
Urine
|
|
13471-8
|
Cadmium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13472-6
|
Nickel/Creatinine
[Mass
Ratio]
in
Urine
|
|
13473-4
|
Zinc/Creatinine
[Mass
Ratio]
in
Urine
|
|
13474-2
|
Magnesium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13475-9
|
Fluoride/Creatinine
[Mass
Ratio]
in
Urine
|
|
13476-7
|
Silver/Creatinine
[Mass
Ratio]
in
Urine
|
|
13477-5
|
Orthocresol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13478-3
|
Tetrahydrocannabinol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13479-1
|
Benzoylecgonine/Creatinine
[Mass
Ratio]
in
Urine
|
|
1348-2
|
Yt
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
13480-9
|
18-Hydroxydeoxycortisol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13481-7
|
Gonadotropin
peptide/Creatinine
[Mass
Ratio]
in
Urine
|
|
13482-5
|
Aldosterone/Creatinine
[Mass
Ratio]
in
Urine
|
|
13483-3
|
Oxalate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13484-1
|
Creatine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13485-8
|
Beta-2-Microglobulin/Creatinine
[Mass
Ratio]
in
Urine
|
|
13486-6
|
Testosterone/Creatinine
[Mass
Ratio]
in
Urine
|
|
13487-4
|
Phenol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13488-2
|
aPTT
in
control
Platelet
poor
plasma
by
Coagulation
assay
|
|
13489-0
|
Follitropin/Creatinine
[Mass
Ratio]
in
Urine
|
|
1349-0
|
Yt
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
13490-8
|
Lutropin/Creatinine
[Mass
Ratio]
in
Urine
|
|
13491-6
|
Deprecated
CD4+CD25+
cells/100
cells
in
Blood
|
|
13492-4
|
Deprecated
CD4+HLA-DR+
cells/100
cells
in
Blood
|
|
13493-2
|
Deprecated
CD8+CD25+
cells/100
cells
in
Blood
|
|
13494-0
|
Volume
of
4
hour
Dialysis
fluid
|
|
13495-7
|
Volume
of
24
hour
Dialysis
fluid
|
|
13496-5
|
Triple
phosphate
crystals
[type]
in
Stone
by
Light
microscopy
|
|
13497-3
|
Dextroamphetamine/Levoamphetamine
[Mass
Ratio]
in
Urine
|
|
13498-1
|
Dextromethamphetamine/Levomethamphetamine
[Mass
Ratio]
in
Urine
|
|
13499-9
|
HIV
1
Ab
band
pattern
[Interpretation]
in
Serum
by
Immunoblot
(IB)
|
|
135-4
|
Ceftazidime
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1350-8
|
Yt
sup(b)
Ab
[Presence]
in
Serum
or
Plasma
|
|
13500-4
|
Amino
acid
pattern
[Interpretation]
in
Serum
or
Plasma
|
|
13501-2
|
Herpes
simplex
virus
2
Ab
pattern
[Interpretation]
in
Serum
|
|
13502-0
|
Borrelia
burgdorferi
Ab.IgG
band
pattern
[Interpretation]
in
Serum
by
Immunoblot
(IB)
|
|
13503-8
|
Borrelia
burgdorferi
Ab.IgM
band
pattern
[Interpretation]
in
Serum
by
Immunoblot
(IB)
|
|
13504-6
|
Deprecated
Borrelia
burgdorferi
Ab
[interpretation]
in
Serum
|
|
13505-3
|
Herpes
simplex
virus
1+2
Ab
pattern
[Interpretation]
in
Serum
|
|
13506-1
|
Urea
nitrogen
renal
clearance
|
|
13507-9
|
Lupus
erythematosus
cells
[Presence]
in
Blood
|
|
13508-7
|
Hematocrit
[Volume
Fraction]
of
Cerebral
spinal
fluid
by
Centrifugation
|
|
13509-5
|
Microscopic
observation
[Identifier]
in
Blood
by
Crystal
violet
stain
|
|
1351-6
|
Yt
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
13510-3
|
Microscopic
observation
[Identifier]
in
Bone
marrow
by
Myeloperoxidase
stain
|
|
13511-1
|
Cyanide
ascorbate
screen
[Presence]
in
Blood
|
|
13512-9
|
Microscopic
observation
[Identifier]
in
Bone
marrow
by
Butyrate
esterase
stain
|
|
13513-7
|
Iron.microscopic
observation
[Identifier]
in
Bone
marrow
by
Potassium
ferrocyanide
stain
|
|
13514-5
|
Hemoglobin
pattern
[Interpretation]
in
Blood
by
Electrophoresis
Narrative
|
|
13515-2
|
Hemoglobin
pattern
[Interpretation]
in
Blood
by
Electrophesis
citrate
agar
Narrative
|
|
13516-0
|
Neutrophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13517-8
|
Variant
lymphocytes/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13518-6
|
Variant
lymphocytes/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13519-4
|
Basophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
1352-4
|
Yt
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
from
donor
|
|
13520-2
|
Deprecated
Basophils/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13521-0
|
Blasts/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13522-8
|
Blasts/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13523-6
|
Leukocytes
other/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13524-4
|
Leukocytes
other/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13525-1
|
Nonhematic
cells/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13526-9
|
Nonhematic
cells/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13527-7
|
Unidentified
cells/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
13528-5
|
Unidentified
cells/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13529-3
|
Nucleated
erythrocytes
[#/volume]
in
Cerebral
spinal
fluid
by
Manual
count
|
|
1353-2
|
Yt
sup(b)
Ag
[Presence]
on
Red
Blood
Cells
|
|
13530-1
|
Nucleated
erythrocytes
[#/volume]
in
Body
fluid
by
Manual
count
|
|
13531-9
|
Fat.microscopic
observation
[Presence]
in
Sputum
by
Sudan
III
stain
|
|
13532-7
|
Xanthochromia
[Presence]
of
Cerebral
spinal
fluid
Qualitative
|
|
13533-5
|
Acid
hemolysis
[Presence]
of
Blood
|
|
13534-3
|
Sucrose
hemolysis
[Presence]
of
Blood
|
|
13535-0
|
Sucrose
hemolysis
of
Red
Blood
Cells
|
|
13536-8
|
Globulin
[Mass/volume]
in
Plasma
|
|
13537-6
|
Deprecated
Protein
[Mass/volume]
in
Plasma.
|
|
13538-4
|
Carbon
dioxide,
total
[Moles/volume]
in
Urine
|
|
13539-2
|
Phosphate
[Moles/volume]
in
Urine
|
|
1354-0
|
11-Deoxycorticosteroids
[Mass/volume]
in
Plasma
--9
hours
post
3
g
metyrapone
PO
overnight
|
|
13540-0
|
Carbon
dioxide,
total
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
13541-8
|
Deprecated
Carbon
dioxide
[Molecules/volume]
in
Body
fluid
|
|
13542-6
|
Phosphate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13543-4
|
Deprecated
Phosphate
[Mass/volume]
in
Body
fluid
|
|
13544-2
|
4-Hydroxyglutethimide
[Presence]
in
Serum
or
Plasma
|
|
13545-9
|
Alprazolam
[Presence]
in
Serum
or
Plasma
|
|
13546-7
|
Amikacin
[Mass/volume]
in
Body
fluid
|
|
13547-5
|
Butriptyline
[Presence]
in
Serum
or
Plasma
|
|
13548-3
|
Chlorpromazine
[Presence]
in
Serum
or
Plasma
|
|
13549-1
|
Clomipramine
[Presence]
in
Serum
or
Plasma
|
|
1355-7
|
11-Deoxycorticosteroids
[Mass/volume]
in
Plasma
--pre
3
g
metyrapone
PO
overnight
|
|
13550-9
|
Clonazepam
[Presence]
in
Serum
or
Plasma
|
|
13551-7
|
Clorazepate
[Presence]
in
Serum
or
Plasma
|
|
13552-5
|
Clozapine
[Presence]
in
Serum
or
Plasma
|
|
13553-3
|
Cocaethylene
[Presence]
in
Serum
or
Plasma
|
|
13554-1
|
Cyclobenzaprine
[Presence]
in
Serum
or
Plasma
|
|
13555-8
|
D-pseudoephedrine
[Presence]
in
Serum
or
Plasma
|
|
13556-6
|
Demoxepam
[Presence]
in
Serum
or
Plasma
|
|
13557-4
|
Norsertraline
[Presence]
in
Serum
or
Plasma
|
|
13558-2
|
Disopyramide
[Presence]
in
Serum
or
Plasma
|
|
13559-0
|
Flecainide
[Presence]
in
Serum
or
Plasma
|
|
1356-5
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
30
mg/kg
metyrapone
PO
|
|
13560-8
|
Fluvoxamine
[Presence]
in
Serum
or
Plasma
|
|
13561-6
|
Gentamicin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13562-4
|
Gentamicin
[Mass/volume]
in
Body
fluid
|
|
13563-2
|
Glutethimide
[Presence]
in
Serum
or
Plasma
|
|
13564-0
|
Ibuprofen
[Presence]
in
Serum
or
Plasma
|
|
13565-7
|
Lorazepam
[Presence]
in
Serum
or
Plasma
|
|
13566-5
|
Mesoridazine
[Presence]
in
Serum
or
Plasma
|
|
13567-3
|
Mexiletine
[Presence]
in
Serum
or
Plasma
|
|
13568-1
|
N-desalkylflurazepam
[Presence]
in
Serum
or
Plasma
|
|
13569-9
|
Norchlordiazepoxide
[Presence]
in
Serum
or
Plasma
|
|
1357-3
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--post
750
mg
metyrapone
q4h
X
6
|
|
13570-7
|
Norclomipramine
[Presence]
in
Serum
or
Plasma
|
|
13571-5
|
Norclozapine
[Presence]
in
Serum
or
Plasma
|
|
13572-3
|
Nordiazepam
[Presence]
in
Serum
or
Plasma
|
|
13573-1
|
Nordoxepin
[Presence]
in
Serum
or
Plasma
|
|
13574-9
|
Norfluoxetine
[Presence]
in
Serum
or
Plasma
|
|
13575-6
|
Normaprotiline
[Presence]
in
Serum
or
Plasma
|
|
13576-4
|
Oxycodone
[Presence]
in
Serum
or
Plasma
|
|
13577-2
|
Paroxetine
[Presence]
in
Serum
or
Plasma
|
|
13578-0
|
Promazine
[Presence]
in
Serum
or
Plasma
|
|
13579-8
|
Sertraline
[Presence]
in
Serum
or
Plasma
|
|
1358-1
|
Corticotropin
[Mass/volume]
in
Plasma
--1.5
hours
post
dose
insulin
IV
|
|
13580-6
|
Temazepam
[Presence]
in
Serum
or
Plasma
|
|
13581-4
|
Theophylline
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13582-2
|
Theophylline
[Mass/volume]
in
Body
fluid
|
|
13583-0
|
Thioridazine
[Presence]
in
Serum
or
Plasma
|
|
13584-8
|
Tobramycin
[Mass/volume]
in
Body
fluid
|
|
13585-5
|
Trifluoperazine
[Presence]
in
Serum
or
Plasma
|
|
13586-3
|
Vancomycin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13587-1
|
Vancomycin
[Mass/volume]
in
Body
fluid
|
|
13588-9
|
Venlafaxine
[Presence]
in
Serum
or
Plasma
|
|
13589-7
|
Activated
protein
C
resistance
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
1359-9
|
Corticotropin
[Mass/volume]
in
Plasma
--1
hour
post
1
ug/kg
CRH
IV
|
|
13590-5
|
Activated
protein
C
resistance
[Time
Ratio]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
13591-3
|
Factor
inhibitor
XXX
[Units/volume]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
13592-1
|
Platelet
aggregation
XXX
induced
in
Platelet
rich
plasma
|
|
13593-9
|
Platelet
aggregation
prostaglandin
induced
in
Platelet
rich
plasma
|
|
13594-7
|
Prekallikrein
(Fletcher
Factor)
[Presence]
in
Platelet
poor
plasma
|
|
13595-4
|
Basophils/100
leukocytes
in
Nose
|
|
13596-2
|
Histiocytes
[Presence]
in
Nose
by
Light
microscopy
|
|
13597-0
|
Neutrophils/100
leukocytes
in
Nose
|
|
13598-8
|
Deprecated
Promyelocytes/100
leukocytes
in
Blood
by
Manual
count
|
|
13599-6
|
Promonocytes/100
leukocytes
in
Blood
by
Manual
count
|
|
136-2
|
Ceftizoxime
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1360-7
|
Corticotropin
[Mass/volume]
in
Plasma
--1
hour
post
dose
insulin
IV
|
|
13600-2
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
250
ug
corticotropin
|
|
13601-0
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
|
|
13602-8
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
|
|
13603-6
|
17-Hydroxypregnenolone
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
250
ug
corticotropin
|
|
13604-4
|
17-Hydroxypregnenolone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
|
|
13605-1
|
17-Hydroxypregnenolone
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
|
|
13606-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
50
g
lactose
PO
|
|
13607-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
50
g
lactose
PO
|
|
13608-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
75
g
glucose
PO
|
|
13609-3
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--2.5
hours
post
75
g
glucose
PO
|
|
1361-5
|
Corticotropin
[Mass/volume]
in
Plasma
--1
minute
post
1
ug/kg
CRH
IV
|
|
13610-1
|
3-Beta-Androstanediol
[Mass/volume]
in
Serum
or
Plasma
|
|
13611-9
|
6-Beta-Hydroxycortisol
[Mass/time]
in
24
hour
Urine
|
|
13612-7
|
Dehydroepiandrosterone
(DHEA)
[Mass/time]
in
24
hour
Urine
|
|
13613-5
|
Ethanolamine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13614-3
|
Etiocholanolone
[Mass/volume]
in
Serum
or
Plasma
|
|
13615-0
|
Gamma
aminobutyrate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13616-8
|
Nitrite
[Mass/volume]
in
Water
|
|
13617-6
|
Deprecated
Prostaglandin
D2
[Mass/volume]
in
Serum
or
Plasma
|
|
13618-4
|
Tetrahydroaldosterone
[Mass/time]
in
24
hour
Urine
|
|
13619-2
|
Volume
of
2
hour
Urine
|
|
1362-3
|
Corticotropin
[Mass/volume]
in
Plasma
--30
minutes
post
1
ug/kg
CRH
IV
|
|
13620-0
|
Volume
of
12
hour
Urine
|
|
13621-8
|
Deprecated
Thrombin
time
in
Platelet
poor
plasma
from
control
by
Coagulation
assay
|
|
13622-6
|
Acetaminophen
[Mass/volume]
in
Urine
|
|
13623-4
|
Dextromethorphan
[Mass/volume]
in
Serum
or
Plasma
|
|
13624-2
|
Doxorubicin
[Mass/volume]
in
Serum
or
Plasma
|
|
13625-9
|
Methoxsalen
[Mass/volume]
in
Serum
or
Plasma
|
|
13626-7
|
Mitotane
[Mass/volume]
in
Serum
or
Plasma
|
|
13627-5
|
Erythrocytes
[Presence]
in
Semen
by
Light
microscopy
|
|
13628-3
|
Deprecated
Spermatozoa
Motile/100
spermatozoa
in
Semen
|
|
13629-1
|
Interleukin
1
beta
[Mass/volume]
in
Serum
or
Plasma
|
|
1363-1
|
Corticotropin
[Mass/volume]
in
Plasma
--30
minutes
post
dose
insulin
IV
|
|
13630-9
|
Deprecated
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
Conglutinin
assay
|
|
13631-7
|
Immune
complex
[Mass/volume]
in
Serum
or
Plasma
by
Polyethylene
glycol
(PEG)
assay
|
|
13632-5
|
Insulin
receptor
Ab
[Titer]
in
Serum
|
|
13633-3
|
Insulin
receptor
Ab
[Presence]
in
Serum
|
|
13634-1
|
Rheumatoid
factor
[Units/volume]
in
Synovial
fluid
|
|
13635-8
|
Ribosomal
Ab
[Titer]
in
Serum
|
|
13636-6
|
Ribosomal
P
Ab
[Units/volume]
in
Serum
|
|
13637-4
|
Trichloroethane
[Mass/volume]
in
Serum
or
Plasma
|
|
13638-2
|
Chlordecone
[Mass/volume]
in
Blood
|
|
13639-0
|
Chlordecone
[Mass/volume]
in
Serum
or
Plasma
|
|
1364-9
|
Corticotropin
[Mass/volume]
in
Plasma
--45
minutes
post
1
ug/kg
CRH
IV
|
|
13640-8
|
Vinyl
chloride
[Mass/volume]
in
Urine
|
|
13641-6
|
Codeine
[Presence]
in
Urine
by
SAMHSA
confirm
method
|
|
13642-4
|
Deprecated
Ethylene
glycol
|
|
13643-2
|
Lindane
[Mass/volume]
in
Urine
|
|
13644-0
|
1,3-Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13645-7
|
Manganese
[Mass/volume]
in
Water
|
|
13646-5
|
Methaqualone
[Mass/mass]
in
Hair
|
|
13647-3
|
Deprecated
Methylene
chloride
[Mass/volume]
in
Blood
|
|
13648-1
|
Morphine
[Presence]
in
Urine
by
SAMHSA
confirm
method
|
|
13649-9
|
Nickel
[Mass/volume]
in
Water
|
|
1365-6
|
Corticotropin
[Mass/volume]
in
Plasma
--45
minutes
post
dose
insulin
IV
|
|
13650-7
|
1,2-Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13651-5
|
1,4-Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13652-3
|
Zinc
[Mass/mass]
in
Hair
|
|
13653-1
|
Epithelial
cells.renal
[#/volume]
in
Urine
sediment
|
|
13654-9
|
Epithelial
cells.squamous
[#/volume]
in
Urine
sediment
|
|
13655-6
|
Leukocytes
[Presence]
in
Stool
by
Light
microscopy
|
|
13656-4
|
Phosphate
crystals
amorphous
[#/volume]
in
Urine
sediment
|
|
13657-2
|
Urate
crystals
amorphous
[#/volume]
in
Urine
sediment
|
|
13658-0
|
Urobilinogen
[Presence]
in
Urine
|
|
13659-8
|
Epidermal
growth
factor
receptor
[Mass/mass]
in
Tissue
|
|
1366-4
|
Corticotropin
[Mass/volume]
in
Plasma
--5
minutes
post
1
ug/kg
CRH
IV
|
|
13660-6
|
Gonadotropin
releasing
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
13661-4
|
Ganglioside
GD1b
IgM
Ab
[Titer]
in
Serum
|
|
13662-2
|
Ganglioside
GD1b
IgG
Ab
[Titer]
in
Serum
|
|
13663-0
|
Asialoganglioside
GM1
IgG
Ab
[Titer]
in
Serum
|
|
13664-8
|
Myelin
associated
glycoprotein/Sulfated
glucuronic
paragloboside
IgM
Ab
[Titer]
in
Serum
|
|
13665-5
|
1-Methylhistidine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13666-3
|
Alpha
aminoadipate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13667-1
|
Alpha
aminobutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13668-9
|
2-Ethyl-3-Hydroxypropionate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13669-7
|
2-Hydroxy-3-Methylvalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1367-2
|
Corticotropin
[Mass/volume]
in
Plasma
--pre
1
ug/kg
CRH
IV
|
|
13670-5
|
2-Hydroxyadipate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13671-3
|
Alpha
hydroxybutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13672-1
|
2-Hydroxyglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13673-9
|
2-Hydroxyisocaproate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13674-7
|
2-Hydroxyisovalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13675-4
|
2-methyl-3-hydroxybutyrate
(C5-OH)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13676-2
|
2-Oxo,3-Methylvalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13677-0
|
2-Oxoadipate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13678-8
|
Alpha
ketoglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13679-6
|
2-Oxoisocaproate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1368-0
|
Corticotropin
[Mass/volume]
in
Plasma
--pre
dose
insulin
IV
|
|
13680-4
|
2-Oxoisovalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13681-2
|
Beta
aminoisobutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13682-0
|
3-Hydroxy,3-Methylglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13683-8
|
3-Hydroxyadipate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13684-6
|
Beta
hydroxybutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13685-3
|
3-Hydroxyglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13686-1
|
3-Hydroxyisobutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13687-9
|
3-Hydroxyisovalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13688-7
|
3-Hydroxypropionate
(3-OH-C3)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13689-5
|
3-Hydroxyvalerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1369-8
|
Ascorbate
[Mass/time]
in
24
hour
Urine
--post
dose
PO
|
|
13690-3
|
Deprecated
Vanillylmandelate/Creatinine
[Mass
ratio]
in
Urine
|
|
13691-1
|
3-Methylcrotonylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13692-9
|
3-Methylglutaconate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13693-7
|
3-Methylglutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13694-5
|
3-Methylhistidine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13695-2
|
Gamma
aminobutyrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13696-0
|
4-Hydroxyphenylacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13697-8
|
4-Hydroxyphenyllactate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13698-6
|
4-Hydroxyphenylpyruvate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13699-4
|
5-Hydroxyhexanoate/Creatinine
[Mass
Ratio]
in
Urine
|
|
137-0
|
Ceftizoxime
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1370-6
|
Carotene
[Mass/volume]
in
Serum
--post
15000
U
carotene
QDx3
for
3
day
poly
|
|
13700-0
|
5-Oxoproline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13701-8
|
Acetoacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13702-6
|
Aconitate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13703-4
|
Adipate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13704-2
|
Alanine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13705-9
|
Albumin/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13706-7
|
Amylase/Creatinine
[Mass
Ratio]
in
Urine
|
|
13707-5
|
Anserine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13708-3
|
Arginine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13709-1
|
Argininosuccinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1371-4
|
Bromsulphthalein
[Mass/volume]
in
Serum
or
Plasma
|
|
13710-9
|
Asparagine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13711-7
|
Aspartate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13712-5
|
Azelate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13713-3
|
Benzoate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13714-1
|
Beta
alanine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13715-8
|
C
peptide/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13716-6
|
C
peptide/Creatinine
[Mass
Ratio]
in
Urine
|
|
13717-4
|
Calcium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13718-2
|
Carnitine
free
(C0)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13719-0
|
Carnitine/Creatinine
[Mass
Ratio]
in
Urine
|
|
1372-2
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--90
seconds
post
0.5
ug/kg
pentagastrin
IV
|
|
13720-8
|
Carnosine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13721-6
|
Chloride/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13722-4
|
Citrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13723-2
|
Citrulline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13724-0
|
Cystathionine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13725-7
|
Cystine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13726-5
|
Decadienediate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13727-3
|
Decenedioate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13728-1
|
Delta
aminolevulinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13729-9
|
Deoxypyridinoline/Creatinine
[Mass
Ratio]
in
Urine
|
|
1373-0
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
2.4
mg/kg
calcium
short
IV
|
|
13730-7
|
Deoxypyridinoline/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13731-5
|
Deoxypyridinoline/Creatinine
[Mass
Ratio]
in
2
hour
Urine
|
|
13732-3
|
Dodecanedioate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13733-1
|
Dopamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13734-9
|
Epinephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13735-6
|
Epinephrine+Norepinephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13736-4
|
Estradiol
(E2)/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13737-2
|
Estriol
(E3)/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13738-0
|
Estrogen/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13739-8
|
Estrone
(E1)/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
1374-8
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
15
mg/kg
calcium
gluconate
IV
|
|
13740-6
|
Ethanolamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13741-4
|
Ethylmalonate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13742-2
|
Formate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13743-0
|
Fumarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13744-8
|
Galactose/Creatinine
[Mass
Ratio]
in
Urine
|
|
13745-5
|
Glutaconate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13746-3
|
Glutamate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13747-1
|
Glutamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13748-9
|
Glutarate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13749-7
|
Glycerate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1375-5
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
15
mg/kg
calcium
gluconate
IV
|
|
13750-5
|
Glycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13751-3
|
Glycolate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13752-1
|
Glyoxylate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13753-9
|
Hexanoylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13754-7
|
Hippurate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13755-4
|
Histamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13756-2
|
Histamine/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13757-0
|
Histidine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13758-8
|
Homocysteine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13759-6
|
Homocystine/Creatinine
[Mass
Ratio]
in
Urine
|
|
1376-3
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
0.5
ug/kg
pentagastrin
IV
|
|
13760-4
|
Homovanillate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13761-2
|
Hydroxydecanedioate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13762-0
|
Hydroxylysine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13763-8
|
Hydroxyproline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13764-6
|
Isocitrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13765-3
|
Isoleucine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13766-1
|
Isovalerylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13767-9
|
Lactate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13768-7
|
Leucine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13769-5
|
Lysine/Creatinine
[Mass
Ratio]
in
Urine
|
|
1377-1
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
2.4
mg/kg
calcium
short
IV
|
|
13770-3
|
Malate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13771-1
|
Metanephrines/Creatinine
[Mass
Ratio]
in
Urine
|
|
13772-9
|
Methionine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13773-7
|
2-Methylcitrate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13774-5
|
Methylhippurate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13775-2
|
Methylmalonate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13776-0
|
Methylmalonate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13777-8
|
Methylsuccinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13778-6
|
Mevalonate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13779-4
|
N-acetyl-L-aspartate/Creatinine
[Mass
Ratio]
in
Urine
|
|
1378-9
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--pre
0.5
ug/kg
pentagastrin
IV
|
|
13780-2
|
N-acetyltyrosine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13781-0
|
N-methylhistamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13782-8
|
Norepinephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13783-6
|
Normetanephrine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13784-4
|
Octanoate
(C8:0)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13785-1
|
Octenedioate
(C8:1)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13786-9
|
Ornithine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13787-7
|
Orotate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13788-5
|
Oxalate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13789-3
|
Phosphoethanolamine/Creatinine
[Mass
Ratio]
in
Urine
|
|
1379-7
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--pre
2.4
mg/kg
calcium
short
IV
|
|
13790-1
|
Para
nitrophenol/Creatinine
[Mass
Ratio]
in
Urine
|
|
13791-9
|
Phenylacetate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13792-7
|
Phenyllactate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13793-5
|
Phenylpropionylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13794-3
|
Phenylpyruvate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13795-0
|
Phosphate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13796-8
|
Phosphoserine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13797-6
|
Porphobilinogen/Creatinine
[Mass
Ratio]
in
Urine
|
|
13798-4
|
Potassium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13799-2
|
Proline/Creatinine
[Mass
Ratio]
in
Urine
|
|
138-8
|
Ceftizoxime
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1380-5
|
Calcium/Phosphate
parathyroid-challenge
test
[Mass
Ratio]
in
Serum
|
|
13800-8
|
Propionylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13801-6
|
Protein/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13802-4
|
Pyridinoline/Creatinine
[Mass
Ratio]
in
Urine
|
|
13803-2
|
Pyridinoline/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13804-0
|
Pyridinoline/Creatinine
[Mass
Ratio]
in
2
hour
Urine
|
|
13805-7
|
Pyruvate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13806-5
|
Sarcosine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13807-3
|
Sebacate
(C8)/Creatinine
[Mass
Ratio]
in
Urine
|
|
13808-1
|
Serine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13809-9
|
Sodium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
1381-3
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
--10
minutes
post
2.4
mg/kg
calcium
short
IV
|
|
13810-7
|
Suberate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13811-5
|
Suberylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13812-3
|
Succinate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13813-1
|
Succinylacetone/Creatinine
[Mass
Ratio]
in
Urine
|
|
13814-9
|
Taurine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13815-6
|
Threonine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13816-4
|
Tiglylglycine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13817-2
|
Tryptophan/Creatinine
[Mass
Ratio]
in
Urine
|
|
13818-0
|
Tyrosine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13819-8
|
Uracil/Creatinine
[Mass
Ratio]
in
Urine
|
|
1382-1
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
--5
minutes
post
2.4
mg/kg
calcium
short
IV
|
|
13820-6
|
Urate/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13821-4
|
Urea
nitrogen/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13822-2
|
Valine/Creatinine
[Mass
Ratio]
in
Urine
|
|
13823-0
|
Antimony/Creatinine
[Mass
Ratio]
in
Urine
|
|
13824-8
|
Arsenic/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13825-5
|
Arsenic.inorganic/Creatinine
[Mass
Ratio]
in
Urine
|
|
13826-3
|
Barium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13827-1
|
Beryllium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13828-9
|
Cadmium/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
13829-7
|
Copper/Creatinine
[Mass
Ratio]
in
Urine
|
|
1383-9
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
--pre
2.4
mg/kg
calcium
short
IV
|
|
13830-5
|
Phenylglyoxylate/Creatinine
[Mass
Ratio]
in
Urine
|
|
13831-3
|
Vanadium/Creatinine
[Mass
Ratio]
in
Urine
|
|
13832-1
|
Dimethylbenzene/Creatinine
[Mass
Ratio]
in
Urine
|
|
13833-9
|
Finch
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
13834-7
|
Total
IgE
[Units/volume]
in
Serum
by
Radioallergosorbent
test
(RAST)
|
|
13835-4
|
Monocytes/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
13836-2
|
Neutrophils/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
13837-0
|
CD10
blasts/100
blasts
in
Blood
|
|
13838-8
|
CD13
blasts/100
blasts
in
Blood
|
|
13839-6
|
CD14
blasts/100
blasts
in
Blood
|
|
1384-7
|
Calcium
[Moles/volume]
in
Blood
--post
calcium
infusion
|
|
13840-4
|
CD19
blasts/100
blasts
in
Blood
|
|
13841-2
|
CD2
blasts/100
blasts
in
Blood
|
|
13842-0
|
CD20
blasts/100
blasts
in
Blood
|
|
13843-8
|
CD33
blasts/100
blasts
in
Blood
|
|
13844-6
|
CD34
blasts/100
blasts
in
Blood
|
|
13845-3
|
CD5
blasts/100
blasts
in
Blood
|
|
13846-1
|
CD7
blasts/100
blasts
in
Blood
|
|
13847-9
|
Terminal
Deoxyribonucleotidyl
Transferase
blasts/100
blasts
in
Blood
by
Immunoperoxidase
stain
|
|
13848-7
|
CD3+CD26+
cells
[#/volume]
in
Blood
|
|
13849-5
|
Deprecated
CD3+CD26+
cells/100
cells
in
Blood
|
|
1385-4
|
Catecholamines
Free
fractionated
[Mass/volume]
in
Plasma
--1
hour
post
300
ug
clonidine
PO
|
|
13850-3
|
CD5+CD25+
cells
[#/volume]
in
Blood
|
|
13851-1
|
CD5+CD25+
cells/100
cells
in
Blood
|
|
13852-9
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
IM
|
|
13853-7
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
25
mg
captopril
PO
|
|
13854-5
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
25
mg
captopril
PO
|
|
13855-2
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
IM
|
|
13856-0
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
250
ug
corticotropin
IM
|
|
13857-8
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
IM
|
|
13858-6
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
IM
|
|
13859-4
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
1
mg
glucagon
IV
|
|
1386-2
|
Catecholamines
Free
fractionated
[Mass/volume]
in
Plasma
--2
hours
post
300
ug
clonidine
PO
|
|
13860-2
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
1
mg
glucagon
IV
|
|
13861-0
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
1
mg
glucagon
IV
|
|
13862-8
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
250
ug
corticotropin
|
|
13863-6
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
|
|
13864-4
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
|
|
13865-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2.5
hours
post
50
g
lactose
PO
|
|
13866-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5
hours
post
50
g
lactose
PO
|
|
13867-7
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--1
hour
post
25
mg
captopril
PO
|
|
13868-5
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--2
hours
post
25
mg
captopril
PO
|
|
13869-3
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
TRH
IV
|
|
1387-0
|
Catecholamines
Free
fractionated
[Mass/volume]
in
Plasma
--3
hours
post
300
ug
clonidine
PO
|
|
13870-1
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
dose
TRH
IV
|
|
13871-9
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
dose
TRH
IV
|
|
13872-7
|
11-Deoxycortisol
[Mass/time]
in
24
hour
Urine
|
|
13873-5
|
Albumin.glycated/Albumin.total
in
Serum
or
Plasma
|
|
13874-3
|
Alkaline
phosphatase.liver
1
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
13875-0
|
Alkaline
phosphatase.liver
2
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
13876-8
|
Beta-2
transferrin
[Presence]
in
Body
fluid
|
|
13877-6
|
Bilirubin.total
[Presence]
in
Amniotic
fluid
|
|
13878-4
|
Collagen
type
1
IgG
Ab
[Units/volume]
in
Serum
|
|
13879-2
|
Collagen
type
2
IgG
Ab
[Units/volume]
in
Serum
|
|
1388-8
|
Catecholamines
Free
fractionated
[Mass/volume]
in
Plasma
--pre
300
ug
clonidine
PO
|
|
13880-0
|
Collagen
type
4
IgG
Ab
[Units/volume]
in
Serum
|
|
13881-8
|
Deoxypyridinoline
Free/Creatinine
[Molar
ratio]
in
Urine
|
|
13882-6
|
Androstanolone
Free/Androstanolone.total
in
Serum
or
Plasma
|
|
13883-4
|
Estradiol
(E2).bioavailable/Estradiol
(E2).total
in
Serum
or
Plasma
|
|
13884-2
|
Estradiol
(E2).bioavailable
[Mass/volume]
in
Serum
or
Plasma
|
|
13885-9
|
Deprecated
Estrogen/Creatinine
[Mass
ratio]
in
24
hour
Urine
|
|
13886-7
|
Lactate
dehydrogenase
1/Lactate
dehydrogenase.total
in
Urine
by
Electrophoresis
|
|
13887-5
|
Lactate
dehydrogenase
2/Lactate
dehydrogenase.total
in
Urine
by
Electrophoresis
|
|
13888-3
|
Lactate
dehydrogenase
3/Lactate
dehydrogenase.total
in
Urine
by
Electrophoresis
|
|
13889-1
|
Lactate
dehydrogenase
4/Lactate
dehydrogenase.total
in
Urine
by
Electrophoresis
|
|
1389-6
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--24
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
13890-9
|
Lactate
dehydrogenase
5/Lactate
dehydrogenase.total
in
Urine
by
Electrophoresis
|
|
13891-7
|
Motilin
[Mass/volume]
in
Serum
or
Plasma
|
|
13892-5
|
Nitrosonaphthol
[Presence]
in
Urine
|
|
13893-3
|
Phenylalanine
[Presence]
in
Urine
|
|
13894-1
|
Pregnenolone
[Mass/time]
in
24
hour
Urine
|
|
13895-8
|
Sodium
[Moles/volume]
in
Milk
|
|
13896-6
|
Insulin-like
growth
factor-I
[Units/volume]
in
Blood
|
|
13897-4
|
Thyrotropin.beta
subunit
[Mass/volume]
in
Serum
or
Plasma
|
|
13898-2
|
Trichloroacetate
[Mass/volume]
in
Serum
or
Plasma
|
|
13899-0
|
Deprecated
Triglyceride
[Mass/volume]
in
fluid
|
|
139-6
|
Ceftizoxime
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1390-4
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--48
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
13900-6
|
Deprecated
Tumor
necrosis
factor.alpha
[Mass/volume]
in
Serum
or
Plasma
|
|
13901-4
|
Tyrosine
[Presence]
in
Urine
|
|
13902-2
|
Urate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
13903-0
|
Vasopressin
[Mass/volume]
in
Urine
|
|
13904-8
|
Meclizine
[Mass/volume]
in
Serum
or
Plasma
|
|
13905-5
|
Meclofenamate
[Mass/volume]
in
Serum
or
Plasma
|
|
13906-3
|
Deprecated
Mesoridazine
|
|
13907-1
|
Norethindrone
[Mass/volume]
in
Serum
or
Plasma
|
|
13908-9
|
Oxipurinol
[Mass/volume]
in
Serum
or
Plasma
|
|
13909-7
|
Tamoxifen
[Mass/volume]
in
Serum
or
Plasma
|
|
1391-2
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--48
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
13910-5
|
Deprecated
HLA-B22
[Presence]
|
|
13911-3
|
HLA-B27
related
Ag
[Presence]
|
|
13912-1
|
Deprecated
HLA-B42
[Presence]
|
|
13913-9
|
Adenovirus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
13914-7
|
Adenovirus
IgG
Ab
[Units/volume]
in
Serum
|
|
13915-4
|
Adenovirus
IgM
Ab
[Titer]
in
Serum
|
|
13916-2
|
Bordetella
parapertussis
Ag
[Presence]
in
Unspecified
specimen
by
Immunofluorescence
|
|
13917-0
|
Coccidioides
immitis
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
13918-8
|
Eastern
equine
encephalitis
virus
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
13919-6
|
Hepatitis
B
virus
core
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1392-0
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--48
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
13920-4
|
HIV
2
p41
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
13921-2
|
Mumps
virus
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
13922-0
|
Trichinella
spiralis
IgA
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13923-8
|
Trichinella
spiralis
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13924-6
|
Calcitonin
Ab
[Presence]
in
Serum
|
|
13925-3
|
Cytokeratin
Ab
[Presence]
in
Serum
|
|
13926-1
|
Glutamate
decarboxylase
65
Ab
[Units/volume]
in
Serum
|
|
13927-9
|
Pancreatic
islet
cell
Ab
[Titer]
in
Serum
|
|
13928-7
|
Parathyrin
Ab
[Presence]
in
Serum
|
|
13929-5
|
Rheumatoid
factor
[Titer]
in
Synovial
fluid
by
Sheep
Cell
Agglutination
|
|
1393-8
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--72
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
13930-3
|
Rheumatoid
factor
[Titer]
in
Synovial
fluid
by
Agglutination
|
|
13931-1
|
Striated
muscle
Ab
[Presence]
in
Serum
|
|
13932-9
|
Testes
IgG
Ab
[Titer]
in
Serum
|
|
13933-7
|
Benzodiazepines
[Mass/mass]
in
Hair
|
|
13934-5
|
Butanol
[Mass/volume]
in
Blood
|
|
13935-2
|
Dichlorodifluoromethane
[Mass/volume]
in
Blood
|
|
13936-0
|
Diethyl
ether
[Mass/volume]
in
Blood
|
|
13937-8
|
Ethyl
acetate
[Mass/volume]
in
Blood
|
|
13938-6
|
Trichloroethane
[Mass/volume]
in
Blood
|
|
13939-4
|
Deprecated
Trichlorotrifluoroethane
[Mass/volume]
in
Blood
|
|
1394-6
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--pre
50
ug
corticotropin
IM
3
day
|
|
13940-2
|
Dimethylbenzene
[Mass/volume]
in
Blood
|
|
13941-0
|
Lymphocytes/100
leukocytes
in
Body
fluid
by
Manual
count
|
|
13942-8
|
Spermatozoa
Motile
[Presence]
in
Semen
by
Light
microscopy
|
|
13943-6
|
Fructose
[Presence]
in
Semen
|
|
13944-4
|
Leukocyte
phosphatase
[Enzymatic
activity/volume]
in
control
Leukocytes
by
Light
microscopy
|
|
13945-1
|
Erythrocytes
[#/area]
in
Urine
sediment
by
Microscopy
high
power
field
|
|
13946-9
|
Complement+Immunoglobulin
[Presence]
in
Red
Blood
Cells
|
|
13947-7
|
Coccidioides
immitis
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13948-5
|
Coccidioides
immitis
IgM
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13949-3
|
Cytomegalovirus
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
1395-3
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--pre
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
13950-1
|
Hepatitis
A
virus
IgM
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13951-9
|
Hepatitis
A
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
13952-7
|
Hepatitis
B
virus
core
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13953-5
|
Hepatitis
B
virus
e
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13954-3
|
Hepatitis
B
virus
e
Ag
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13955-0
|
Hepatitis
C
virus
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
13956-8
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
13957-6
|
Clostridium
difficile
toxin
A
[Presence]
in
Stool
by
Immunoassay
|
|
13958-4
|
Arsenic
[Presence]
in
24
hour
Urine
|
|
13959-2
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
by
calculation
|
|
1396-1
|
Cortisol
Free
[Mass/volume]
in
24
hour
Urine
--pre
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
13960-0
|
Coproporphyrin
[Presence]
in
24
hour
Urine
|
|
13961-8
|
Mercury
[Presence]
in
24
hour
Urine
|
|
13962-6
|
Beta
glucuronidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
13963-4
|
Orotate
[Moles/volume]
in
Urine
|
|
13964-2
|
Methylmalonate
[Moles/volume]
in
Serum
or
Plasma
|
|
13965-9
|
Homocysteine
[Moles/volume]
in
Serum
or
Plasma
|
|
13966-7
|
Cystine
[Moles/time]
in
24
hour
Urine
|
|
13967-5
|
Sex
hormone
binding
globulin
[Moles/volume]
in
Serum
or
Plasma
|
|
13968-3
|
Penicillin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
13969-1
|
Creatine
kinase.MB
[Mass/volume]
in
Serum
or
Plasma
|
|
1397-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
0.05-0.15
U
insulin/kg
IV
12
hours
fasting
|
|
13970-9
|
Delta
tocopherol
[Mass/volume]
in
Serum
or
Plasma
|
|
13971-7
|
Histoplasma
capsulatum
Ag
[Units/volume]
in
Urine
by
Immunoassay
|
|
13972-5
|
Alpha
1
globulin/Protein.total
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
13973-3
|
Prealbumin/Protein.total
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
13974-1
|
Albumin/Protein.total
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
13975-8
|
Alpha
2
globulin/Protein.total
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
13976-6
|
Beta
globulin/Protein.total
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
13977-4
|
Gamma
globulin/Protein.total
in
Cerebral
spinal
fluid
by
Electrophoresis
|
|
13978-2
|
Alpha
1
globulin/Protein.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
13979-0
|
Prealbumin/Protein.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
1398-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
insulin
IV
|
|
13980-8
|
Albumin/Protein.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
13981-6
|
Alpha
2
globulin/Protein.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
13982-4
|
Beta
globulin/Protein.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
13983-2
|
Gamma
globulin/Protein.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
13984-0
|
Alpha
1
globulin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
13985-7
|
Prealbumin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
13986-5
|
Albumin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
13987-3
|
Alpha
2
globulin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
13988-1
|
Beta
globulin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
13989-9
|
Gamma
globulin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
1399-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
13990-7
|
Alpha
1
globulin/Protein.total
in
Urine
by
Electrophoresis
|
|
13991-5
|
Prealbumin/Protein.total
in
Urine
by
Electrophoresis
|
|
13992-3
|
Albumin/Protein.total
in
Urine
by
Electrophoresis
|
|
13993-1
|
Alpha
2
globulin/Protein.total
in
Urine
by
Electrophoresis
|
|
13994-9
|
Beta
globulin/Protein.total
in
Urine
by
Electrophoresis
|
|
13995-6
|
Gamma
globulin/Protein.total
in
Urine
by
Electrophoresis
|
|
13996-4
|
Hydroxyproline/Creatinine
[Molar
ratio]
in
24
hour
Urine
|
|
13997-2
|
Neuronal
nuclear
type
1
Ab
[Titer]
in
Serum
|
|
13998-0
|
Neuronal
nuclear
type
2
Ab
[Titer]
in
Serum
|
|
13999-8
|
Transferrin.carbohydrate
deficient
[Units/volume]
in
Serum
or
Plasma
|
|
14-1
|
Amikacin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
140-4
|
Ceftriaxone
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1400-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
1
ug/kg
CRH
IV
|
|
14000-4
|
Urea
nitrogen
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14001-2
|
IgE
[Units/volume]
in
Cord
blood
|
|
14002-0
|
IgM
[Units/volume]
in
Cord
blood
|
|
14003-8
|
Carbon
dioxide
[Partial
pressure]
in
Cord
blood
|
|
14004-6
|
Prostaglandin
A
[Mass/time]
in
24
hour
Urine
|
|
14005-3
|
Prostaglandin
E1
[Mass/time]
in
24
hour
Urine
|
|
14006-1
|
Prostaglandin
E2
[Mass/time]
in
24
hour
Urine
|
|
14007-9
|
Prostaglandin
F2
alpha
[Mass/time]
in
24
hour
Urine
|
|
14008-7
|
Phosphatidylcholine
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14009-5
|
Phosphatidylcholine
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1401-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
IM
rapid
|
|
14010-3
|
Phosphatidylcholine
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14011-1
|
Deprecated
Platelet
associated
IgA
Ab
[Units/volume]
in
Blood
|
|
14012-9
|
Platelet
associated
IgG
Ab
[Units/volume]
in
Blood
by
Flow
cytometry
(FC)
|
|
14013-7
|
Platelet
associated
IgM
Ab
[Units/volume]
in
Blood
by
Flow
cytometry
(FC)
|
|
14014-5
|
Thyroxine
(T4).prealbumin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
14015-2
|
Thyroxine
(T4).prealbumin
bound/Prealbumin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
14016-0
|
Thyroxine.thyroxine
binding
globulin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
14017-8
|
CD22
cells/100
cells
in
Blood
|
|
14018-6
|
CD23
cells/100
cells
in
Blood
|
|
14019-4
|
HTLV
I+II
gp46
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
1402-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
IV
rapid
|
|
14020-2
|
HTLV
I+II
p19
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
14021-0
|
HTLV
I+II
p24
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
14022-8
|
HTLV
I+II
p26
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14023-6
|
HTLV
I+II
p28
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14024-4
|
HTLV
I+II
p32
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14025-1
|
HTLV
I+II
p36
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14026-9
|
HTLV
I+II
p53
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14027-7
|
HTLV
I+II
rgp21
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoblot
(IB)
|
|
14028-5
|
Deprecated
HTLV
I+II
rgp46-I
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14029-3
|
Deprecated
HTLV
I+II
rgp46-II
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
1403-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
IM
|
|
14030-1
|
Smith
extractable
nuclear
Ab+Ribonucleoprotein
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14031-9
|
Ciprofloxacin
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
14032-7
|
Ciprofloxacin
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
14033-5
|
1,4-Dioxane
[Mass/volume]
in
Blood
by
Gas
chromatography
|
|
14034-3
|
Rheumatoid
factor
[Units/volume]
in
Cerebral
spinal
fluid
|
|
14035-0
|
Japanese
Cedar
IgE
Ab
[Units/volume]
in
Serum
|
|
14036-8
|
Dermatophagoides
microceras
IgE
Ab
[Units/volume]
in
Serum
|
|
14037-6
|
Fox
IgE
Ab
[Units/volume]
in
Serum
|
|
14038-4
|
Pacific
Squid
IgE
Ab
[Units/volume]
in
Serum
|
|
14039-2
|
Neutrophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Microscopy
|
|
1404-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
14040-0
|
Carbon
dioxide,
total
[Moles/volume]
in
Stool
|
|
14041-8
|
Choriogonadotropin.beta
subunit
[Units/volume]
in
Cerebral
spinal
fluid
|
|
14042-6
|
Corticosterone
[Mass/time]
in
24
hour
Urine
|
|
14043-4
|
Cortisol
Free
[Mass/time]
in
12
hour
Urine
|
|
14044-2
|
Cortisone
[Mass/time]
in
24
hour
Urine
|
|
14045-9
|
D-Lactate
[Moles/volume]
in
Serum
or
Plasma
|
|
14046-7
|
D-Lactate
[Moles/volume]
in
Urine
|
|
14047-5
|
Androstanolone
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
14048-3
|
Elastase.pancreatic
[Mass/volume]
in
Serum
|
|
14049-1
|
Epidermal
growth
factor
[Mass/volume]
in
Serum
or
Plasma
|
|
1405-0
|
Deprecated
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
14050-9
|
Epidermal
growth
factor
receptor
[Moles/mass]
in
Tissue
|
|
14051-7
|
Estrogen
binding
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
14052-5
|
Formate
[Mass/volume]
in
Urine
|
|
14053-3
|
Homocystine
[Presence]
in
Urine
|
|
14054-1
|
Prostaglandin
D2
[Mass/time]
in
24
hour
Urine
|
|
14055-8
|
Sodium
[Moles/mass]
in
Stool
|
|
14056-6
|
Carbamazepine
10,11-epoxide
free
[Mass/volume]
in
Serum
or
Plasma
|
|
14057-4
|
Carbamazepine
free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
14058-2
|
Deprecated
Ciprofloxacin
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
14059-0
|
Deprecated
Ciprofloxacin
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
1406-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
minute
post
1
ug/kg
CRH
IV
|
|
14060-8
|
Cyclobenzaprine
[Presence]
in
Urine
|
|
14061-6
|
Cyclobenzaprine
[Mass/volume]
in
Urine
|
|
14062-4
|
Dexamethasone
[Mass/volume]
in
Serum
or
Plasma
|
|
14063-2
|
Dezocine
[Presence]
in
Urine
|
|
14064-0
|
Diethylstilbestrol
[Mass/volume]
in
Serum
or
Plasma
|
|
14065-7
|
Diflunisal
[Mass/volume]
in
Serum
or
Plasma
|
|
14066-5
|
Dihydrocodeine
[Presence]
in
Urine
|
|
14067-3
|
Dihydrocodeine
[Mass/volume]
in
Blood
|
|
14068-1
|
Triamterene+Hydrochlorothiazide
[Mass/volume]
in
Serum
or
Plasma
|
|
14069-9
|
Estazolam
[Mass/volume]
in
Serum
or
Plasma
|
|
1407-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--24
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14070-7
|
Fluphenazine
[Presence]
in
Urine
|
|
14071-5
|
Ibuprofen
[Presence]
in
Urine
|
|
14072-3
|
Monoacetyldapsone
[Mass/volume]
in
Serum
or
Plasma
|
|
14073-1
|
Phenytoin
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
14074-9
|
Spironolactone
[Mass/volume]
in
Serum
or
Plasma
|
|
14075-6
|
Sulfapyridine
[Mass/volume]
in
Serum
or
Plasma
|
|
14076-4
|
Complement
total
hemolytic
CH100
[Presence]
in
Serum
or
Plasma
by
Immune
diffusion
(ID)
|
|
14077-2
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
14078-0
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
14079-8
|
Brucella
canis
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
1408-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--24
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14080-6
|
Brucella
canis
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14081-4
|
Coliform
bacteria
[Presence]
in
Water
|
|
14082-2
|
Echinococcus
sp
IgG
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
14083-0
|
Epstein
Barr
virus
early
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14084-8
|
Herpes
simplex
virus
1
[Presence]
in
Isolate
by
Immunofluorescence
|
|
14085-5
|
Herpes
simplex
virus
2
[Presence]
in
Isolate
by
Immunofluorescence
|
|
14086-3
|
Herpes
simplex
virus
1
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14087-1
|
Herpes
simplex
virus
1
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14088-9
|
Deprecated
Herpes
simplex
virus
1
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14089-7
|
Herpes
simplex
virus
2
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1409-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--24
hours
post
500
ug
corticotropin
IM
|
|
14090-5
|
Herpes
simplex
virus
2
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14091-3
|
Deprecated
Herpes
simplex
virus
2
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14092-1
|
HIV
1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
14093-9
|
Bacteria
identified
in
Water
by
Culture
|
|
14094-7
|
Trypanosoma
cruzi
IgG
Ab
[Titer]
in
Serum
|
|
14095-4
|
Fibronectin
aggregate
IgG
Ab
[Units/volume]
in
Serum
|
|
14096-2
|
Intercalated
disk
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14097-0
|
Antimony
[Mass/time]
in
24
hour
Urine
|
|
14098-8
|
Dimethylsulfoxide
[Mass/volume]
in
Serum
or
Plasma
|
|
14099-6
|
Nickel
[Mass/volume]
in
Urine
|
|
141-2
|
Ceftriaxone
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1410-0
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--24
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14100-2
|
Strontium
[Presence]
in
Urine
|
|
14101-0
|
Strychnine
[Mass/volume]
in
Gastric
fluid
|
|
14102-8
|
Strychnine
[Mass/volume]
in
Blood
|
|
14103-6
|
Epithelial
cells
[Presence]
in
Stool
by
Light
microscopy
|
|
14104-4
|
Barley
smut+Wheat
smut
IgE
Ab
[Units/volume]
in
Serum
|
|
14105-1
|
Leukocytes
[Presence]
in
Nose
by
Light
microscopy
|
|
14106-9
|
Lymphocytes
[#/volume]
in
Cerebral
spinal
fluid
by
Manual
count
|
|
14107-7
|
Segmented
neutrophils/100
leukocytes
in
Cerebral
spinal
fluid
by
Manual
count
|
|
14108-5
|
CD16C+CD56+
cells
[#/volume]
in
Blood
|
|
14109-3
|
CD16C+CD56+
cells/100
cells
in
Blood
|
|
1411-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--26
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14110-1
|
Deprecated
CD22
cells/100
cells
in
Blood
|
|
14111-9
|
Deprecated
CD23
cells/100
lymphocytes
in
Blood
|
|
14112-7
|
CD25+CD19+
cells/100
cells
in
Blood
|
|
14113-5
|
CD56
cells
[#/volume]
in
Blood
|
|
14114-3
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
250
ug
corticotropin
IM
|
|
14115-0
|
Collagen
crosslinked
N-telopeptide/Creatinine
[Molar
ratio]
in
Urine
|
|
14116-8
|
IgG
synthesis
rate
[Mass/time]
in
Serum
and
CSF
by
calculation
|
|
14117-6
|
IgG
clearance/Albumin
clearance
[Ratio]
in
Serum
and
CSF
|
|
14118-4
|
Lactate
[Mass/volume]
in
Serum
or
Plasma
|
|
14119-2
|
Lactate
dehydrogenase
1/Lactate
dehydrogenase
2
[Enzymatic
activity
ratio]
in
Serum
or
Plasma
|
|
1412-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--26
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14120-0
|
Deprecated
Prostate
Specific
Ag
Free/Prostate
specific
Ag.total
in
Serum
or
Plasma
|
|
14121-8
|
Pyruvate
[Moles/volume]
in
Blood
|
|
14122-6
|
Pyruvate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
14123-4
|
Thyroxine
(T4).albumin
bound/Albumin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
14124-2
|
Bacteria
[Presence]
in
Semen
by
Light
microscopy
|
|
14125-9
|
Entamoeba
histolytica
[Presence]
in
Stool
by
Trichrome
stain
|
|
14126-7
|
HIV
1
gp120+gp160
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
14127-5
|
Neisseria
gonorrhoeae
[Presence]
in
Anal
by
Organism
specific
culture
|
|
14128-3
|
Rabies
virus
Ab
[Titer]
in
Serum
|
|
14129-1
|
Respiratory
syncytial
virus
[Presence]
in
Nose
by
Organism
specific
culture
|
|
1413-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--2
days
post
500
ug
corticotropin
IM
|
|
14130-9
|
Estrogen
receptor
[Moles/mass]
in
Tissue
|
|
14131-7
|
PM-1
Ab
[Presence]
in
Serum
|
|
14132-5
|
Color
of
Gastric
fluid
|
|
14133-3
|
Silver
Maple
IgE
Ab
[Units/volume]
in
Serum
|
|
14134-1
|
Deprecated
Free
Hemoglobin
[Mass/volume]
in
Serum
|
|
14135-8
|
CD3+CD8+
(T8
suppressor
cells)
cells
[#/volume]
in
Blood
|
|
14136-6
|
CD34
cells
[#/volume]
in
Blood
|
|
14137-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5.5
hours
post
75
g
glucose
PO
|
|
14138-2
|
Ketones
[Presence]
in
Urine
--30
minutes
post
XXX
challenge
|
|
14139-0
|
Ketones
[Presence]
in
Urine
--4
hours
post
XXX
challenge
|
|
1414-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
14140-8
|
Ketones
[Presence]
in
Urine
--5
hours
post
XXX
challenge
|
|
14141-6
|
Ketones
[Presence]
in
Urine
--6
hours
post
XXX
challenge
|
|
14142-4
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
14143-2
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
14144-0
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
14145-7
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
14146-5
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
14147-3
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
14148-1
|
18-Hydroxycortisol
[Mass/time]
in
24
hour
Urine
|
|
14149-9
|
Corticotropin
Big
Fragment
[Mass/volume]
in
Serum
or
Plasma
|
|
1415-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
1
ug/kg
CRH
IV
|
|
14150-7
|
Deprecated
Beta
glucuronidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
14151-5
|
Bicarbonate
[Moles/volume]
in
Cord
blood
|
|
14152-3
|
Bilirubin.direct
[Mass/volume]
in
Body
fluid
|
|
14153-1
|
Carnitine
esters/Creatinine
[Mass
Ratio]
in
Urine
|
|
14154-9
|
Cholesterol
sulfate
[Mass/volume]
in
Serum
|
|
14155-6
|
Cholesterol
in
LDL
[Percentile]
|
|
14156-4
|
Coproporphyrin
[Mass/mass]
in
24
hour
Stool
|
|
14157-2
|
Coproporphyrin
[Mass/volume]
in
Serum
or
Plasma
|
|
14158-0
|
Cortisol
[Mass/time]
in
24
hour
Urine
|
|
14159-8
|
Cortisone
[Mass/volume]
in
Serum
or
Plasma
|
|
1416-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
IM
rapid
|
|
14160-6
|
Estrone
(E1).unconjugated/Estrone
(E1).total
in
Serum
or
Plasma
|
|
14161-4
|
Deprecated
Formaldehyde
in
Nonbiological
fluid
|
|
14162-2
|
Gamma
melanocyte
stimulating
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
14163-0
|
IgA.secretory
[Mass/volume]
in
Serum
or
Plasma
|
|
14164-8
|
Immunosuppressive
acidic
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
14165-5
|
Lactate
[Moles/volume]
in
Body
fluid
|
|
14166-3
|
Methane
[Mass/volume]
in
Blood
|
|
14167-1
|
N-methylimidazoleacetate
[Mass/time]
in
24
hour
Urine
|
|
14168-9
|
Palatinase
[Enzymatic
activity/mass]
in
Tissue
|
|
14169-7
|
Peptide
histidine
isoleucine
[Mass/volume]
in
Plasma
|
|
1417-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
IV
rapid
|
|
14170-5
|
Pituitary
glucoprotein
hormone.alpha
subunit
[Mass/volume]
in
Serum
|
|
14171-3
|
Porphyrins
[Mass/mass]
in
24
hour
Stool
|
|
14172-1
|
Potassium
[Moles/volume]
in
Synovial
fluid
|
|
14173-9
|
Progesterone
Free
[Mass/time]
in
24
hour
Urine
|
|
14174-7
|
Prostaglandin
F2
alpha
[Mass/volume]
in
Serum
or
Plasma
|
|
14175-4
|
Protoporphyrin
[Mass/mass]
in
24
hour
Stool
|
|
14176-2
|
Pyrroles
[Mass/volume]
in
Urine
|
|
14177-0
|
Growth
hormone-releasing
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
14178-8
|
Sucrase
[Enzymatic
activity/mass]
in
Tissue
|
|
14179-6
|
Tissue
polypeptide
Ag
[Mass/volume]
in
Serum
or
Plasma
|
|
1418-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
250
ug
corticotropin
IM
|
|
14180-4
|
Uroporphyrin
[Mass/volume]
in
Red
Blood
Cells
|
|
14181-2
|
Uroporphyrin
[Mass/mass]
in
24
hour
Stool
|
|
14182-0
|
Thrombin
antithrombin
complex
Ag
[Mass/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
14183-8
|
Aprobarbital
[Mass/volume]
in
Urine
|
|
14184-6
|
Atropine
[Presence]
in
Urine
|
|
14185-3
|
Methimazole
[Mass/volume]
in
Serum
or
Plasma
|
|
14186-1
|
Methylprednisolone
[Mass/volume]
in
Serum
or
Plasma
|
|
14187-9
|
OKT3
[Mass/volume]
in
Serum
or
Plasma
|
|
14188-7
|
Omeprazole
[Mass/volume]
in
Serum
or
Plasma
|
|
14189-5
|
Phenyltoloxamine
[Mass/volume]
in
Urine
|
|
1419-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
14190-3
|
Phenytoin
Free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
14191-1
|
Prazosin
[Mass/volume]
in
Serum
or
Plasma
|
|
14192-9
|
Triazolam
[Presence]
in
Urine
|
|
14193-7
|
Tripelennamine
[Presence]
in
Urine
|
|
14194-5
|
Spermatozoa
Progressive/100
spermatozoa
in
Semen
|
|
14195-2
|
Complement
C3b
Inactive
[Mass/volume]
in
Plasma
|
|
14196-0
|
Reticulocytes
[#/volume]
in
Blood
|
|
14197-8
|
Blastomyces
dermatitidis
exoantigen
[Identifier]
in
Isolate
|
|
14198-6
|
Chlamydophila
psittaci
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14199-4
|
Chlamydia
trachomatis
B
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
142-0
|
Ceftriaxone
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1420-9
|
Deprecated
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
14200-0
|
Chlamydia
trachomatis
B
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14201-8
|
Chlamydia
trachomatis
B
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14202-6
|
Chlamydia
trachomatis
C
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14203-4
|
Chlamydia
trachomatis
C
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14204-2
|
Chlamydia
trachomatis
C
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14205-9
|
Coccidioides
immitis
Ag
[Presence]
in
Isolate
by
Immune
diffusion
(ID)
|
|
14206-7
|
Coccidioides
immitis
exoantigen
[Identifier]
in
Isolate
|
|
14207-5
|
Streptococcal
DNAse
B
[Titer]
in
Serum
|
|
14208-3
|
Filaria
IgG4
Ab
[Units/volume]
in
Serum
|
|
14209-1
|
Francisella
tularensis
IgA
Ab
[Presence]
in
Serum
|
|
1421-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--32
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14210-9
|
Giardia
lamblia
Ag
[Presence]
in
Stool
by
Immunofluorescence
|
|
14211-7
|
Hepatitis
E
virus
IgG
Ab
[Presence]
in
Serum
|
|
14212-5
|
Hepatitis
E
virus
IgM
Ab
[Presence]
in
Serum
|
|
14213-3
|
Herpes
simplex
virus
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
14214-1
|
Histoplasma
capsulatum
exoantigen
[Identifier]
in
Isolate
|
|
14215-8
|
HTLV
I
g46
Ab
[Presence]
in
Serum
|
|
14216-6
|
HTLV
1
gp46
Ab
[Presence]
in
Serum
|
|
14217-4
|
HTLV
I
p19
Ab
[Presence]
in
Serum
|
|
14218-2
|
HTLV
I
p24
Ab
[Presence]
in
Serum
|
|
14219-0
|
HTLV
I
p26
Ab
[Presence]
in
Serum
|
|
1422-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--3
days
post
500
ug
corticotropin
IM
|
|
14220-8
|
HTLV
I
p28
Ab
[Presence]
in
Serum
|
|
14221-6
|
HTLV
I
p32
Ab
[Presence]
in
Serum
|
|
14222-4
|
HTLV
I
p36
Ab
[Presence]
in
Serum
|
|
14223-2
|
HTLV
I
p53
Ab
[Presence]
in
Serum
|
|
14224-0
|
HTLV
I
rgp21
Ab
[Presence]
in
Serum
|
|
14225-7
|
HTLV
II
g46
Ab
[Presence]
in
Serum
|
|
14226-5
|
Nocardia
sp
identified
in
Isolate
by
Organism
specific
culture
|
|
14227-3
|
Salmonella
typhi
H
D
Ab
[Titer]
in
Serum
|
|
14228-1
|
Estrogen
receptor/100
cells
in
Tissue
by
Immune
stain
|
|
14229-9
|
P53
protein
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
1423-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
1
ug/kg
CRH
IV
|
|
14230-7
|
Progesterone
receptor/100
cells
in
Tissue
by
Immune
stain
|
|
14231-5
|
H2a-H2b
DNA
IgG
Ab
[Units/volume]
in
Serum
|
|
14232-3
|
Adrenal
Ab
[Presence]
in
Serum
|
|
14233-1
|
Beta
tubulin
IgG
Ab
[Titer]
in
Serum
|
|
14234-9
|
Beta
tubulin
IgM
Ab
[Titer]
in
Serum
|
|
14235-6
|
Jo-1
extractable
nuclear
Ab
[Titer]
in
Serum
|
|
14236-4
|
Mitochondria
Ab
[Presence]
in
Serum
|
|
14237-2
|
Myelin
basic
protein
IgA
Ab
[Units/volume]
in
Serum
|
|
14238-0
|
Myelin
basic
protein
IgG
Ab
[Units/volume]
in
Serum
|
|
14239-8
|
Myelin
basic
protein
IgM
Ab
[Units/volume]
in
Serum
|
|
1424-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
dose
insulin
IV
|
|
14240-6
|
Neuronal
nuclear
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
14241-4
|
Parietal
cell
Ab
[Presence]
in
Serum
|
|
14242-2
|
Phosphatidylcholine
IgA
Ab
[Presence]
in
Serum
|
|
14243-0
|
Phosphatidylcholine
IgG
Ab
[Presence]
in
Serum
|
|
14244-8
|
Phosphatidylcholine
IgM
Ab
[Presence]
in
Serum
|
|
14245-5
|
Phosphatidylserine
IgG
Ab
[Units/volume]
in
Serum
|
|
14246-3
|
Phosphatidylserine
IgM
Ab
[Units/volume]
in
Serum
|
|
14247-1
|
Purkinje
cells
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14248-9
|
Purkinje
cells
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14249-7
|
Purkinje
cells
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
1425-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--48
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14250-5
|
Purkinje
cells
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
14251-3
|
Mitochondria
M2
IgG
Ab
[Units/volume]
in
Serum
|
|
14252-1
|
Smooth
muscle
Ab
[Presence]
in
Serum
|
|
14253-9
|
Somatotropin
Ab
[Presence]
in
Serum
or
Plasma
|
|
14254-7
|
Ganglioside
GQ1b
IgG
Ab
[Titer]
in
Serum
|
|
14255-4
|
Thyrotropin
blocking
Ab
[Units/volume]
in
Serum
|
|
14256-2
|
Tetrachlorodiphenylethane
[Mass/mass]
in
Tissue
|
|
14257-0
|
Tetrachlorodiphenylethane
[Mass/volume]
in
Serum
or
Plasma
|
|
14258-8
|
1,4-Dioxane
[Mass/volume]
in
Blood
|
|
14259-6
|
1-Pentanol
[Mass/volume]
in
Blood
|
|
1426-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--48
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14260-4
|
Bromoform
[Mass/volume]
in
Blood
|
|
14261-2
|
Codeine
[Presence]
in
Gastric
fluid
|
|
14262-0
|
Dichlorodiphenyldichloroethylene
[Mass/mass]
in
Tissue
|
|
14263-8
|
Dichlorodiphenyltrichloroethane
[Mass/mass]
in
Tissue
|
|
14264-6
|
Enflurane
[Mass/volume]
in
Blood
|
|
14265-3
|
Isobutyl
acetate
[Mass/volume]
in
Blood
|
|
14266-1
|
Methoxyflurane
[Mass/volume]
in
Blood
|
|
14267-9
|
Methylenedioxymethamphetamine
[Presence]
in
Urine
|
|
14268-7
|
Butyl
acetate
[Mass/volume]
in
Blood
|
|
14269-5
|
Sec-butyl
acetate
[Mass/volume]
in
Blood
|
|
1427-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--48
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14270-3
|
Tert-butyl
acetate
[Mass/volume]
in
Blood
|
|
14271-1
|
Character
of
Synovial
fluid
|
|
14272-9
|
Liver
kidney
microsomal
Ab
[Presence]
in
Serum
|
|
14273-7
|
Reticulin
IgA
Ab
[Presence]
in
Serum
|
|
14274-5
|
Uroporphyrin
[Mass/volume]
in
Serum
or
Plasma
|
|
14275-2
|
Immune
complex
[Units/volume]
in
Serum
or
Plasma
by
C3b
binding
assay
|
|
14276-0
|
Hemoglobin
F
distribution
[Interpretation]
in
Blood
by
Kleihauer-Betke
method
|
|
14277-8
|
Neutrophil
cytoplasmic
Ab.classic
[Titer]
in
Serum
by
Immunofluorescence
|
|
14278-6
|
Neutrophil
cytoplasmic
Ab.perinuclear
[Titer]
in
Serum
by
Immunofluorescence
|
|
1428-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--50
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14282-8
|
Acylcarnitine
[Moles/volume]
in
Serum
or
Plasma
|
|
14283-6
|
Acylcarnitine
[Moles/volume]
in
Urine
|
|
14284-4
|
Beta
glucuronidase
[Moles/volume]
in
Serum
or
Plasma
|
|
14285-1
|
Carnitine
free
(C0)
[Moles/volume]
in
Urine
|
|
14286-9
|
Carnitine
free
(C0)
[Moles/volume]
in
Serum
or
Plasma
|
|
14287-7
|
Carnitine
[Moles/volume]
in
Urine
|
|
14288-5
|
Carnitine
[Moles/volume]
in
Serum
or
Plasma
|
|
14289-3
|
Deprecated
Coproporphyrin
[Presence]
in
24
hour
Urine
|
|
1429-0
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--50
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14290-1
|
Deprecated
Erythrocytes
[Units/volume]
in
Urine
sediment
by
Manual
count
|
|
14291-9
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--baseline
|
|
14292-7
|
IgE
[Moles/volume]
in
Serum
|
|
14293-5
|
Insulin
[Moles/volume]
in
Serum
or
Plasma
--baseline
|
|
14294-3
|
Lysosomal
enzymes
screen
[Identifier]
in
Plasma
and
Urine
|
|
14295-0
|
Organic
acids/Creatinine
[Molar
ratio]
in
Urine
|
|
14296-8
|
Thyroperoxidase
Ab
[Moles/volume]
in
Serum
or
Plasma
|
|
14297-6
|
Thyrotropin
[Moles/volume]
in
Serum
or
Plasma
|
|
14298-4
|
Plasma
units
available
[#]
|
|
14299-2
|
Cryoprecipitate
units
available
[#]
|
|
143-8
|
Ceftriaxone
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1430-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--56
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14300-8
|
Plateletpheresis
units
available
[#]
|
|
14301-6
|
Platelet
concentrate
units
available
[#]
|
|
14302-4
|
Packed
erythrocytes
units
available
[#]
|
|
14303-2
|
Transfuse
plateletpheresis
[Volume]
|
|
14304-0
|
Measles
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
14305-7
|
Measles
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
14306-5
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
14307-3
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
14308-1
|
Amphetamines
[Presence]
in
Urine
by
Screen
method
>1000
ng/mL
|
|
14309-9
|
Amphetamines
[Presence]
in
Urine
by
Confirm
method
>200
ng/mL
|
|
1431-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
1
ug/kg
CRH
IV
|
|
14310-7
|
Phencyclidine
[Presence]
in
Urine
by
Screen
method
>25
ng/mL
|
|
14311-5
|
Phencyclidine
[Presence]
in
Urine
by
Confirm
method
>20
ng/mL
|
|
14312-3
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Screen
method
>50
ng/mL
|
|
14313-1
|
Tetrahydrocannabinol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
14314-9
|
Benzoylecgonine
[Presence]
in
Urine
by
Screen
method
|
|
14315-6
|
Benzoylecgonine
[Presence]
in
Urine
by
Confirmatory
method
|
|
14316-4
|
Benzodiazepines
[Presence]
in
Urine
by
Screen
method
|
|
14317-2
|
Microscopic
observation
[Identifier]
in
Genital
specimen
by
Wet
preparation
|
|
14318-0
|
Microscopic
observation
[Identifier]
in
Cervix
by
Wet
preparation
|
|
14319-8
|
Microscopic
observation
[Identifier]
in
Vaginal
fluid
by
Wet
preparation
|
|
1432-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--72
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14320-6
|
Deprecated
Bacteria
identified
in
Urine
by
Culture
@1:100
|
|
14321-4
|
Haemophilus
influenzae
B
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14322-2
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14323-0
|
Streptococcus
agalactiae
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14324-8
|
Escherichia
coli
K1
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
14325-5
|
Bacteria
identified
in
Unspecified
specimen
by
Environmental
culture
|
|
14326-3
|
Eosinophils/100
leukocytes
in
Stool
by
Manual
count
|
|
14327-1
|
Epithelial
cells.squamous
[Presence]
in
Sputum
by
Light
microscopy
|
|
14328-9
|
Leukocytes
[Presence]
in
Sputum
by
Light
microscopy
|
|
14329-7
|
Mucus
[Presence]
in
Sputum
by
Light
microscopy
|
|
1433-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--72
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14330-5
|
Polymorphonuclear
cells/100
leukocytes
in
Stool
by
Manual
count
|
|
14331-3
|
Erythrocytes
[Units/volume]
in
Stool
by
Manual
count
|
|
14332-1
|
Para
aminosalicylate
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
14333-9
|
Lead
[Presence]
in
24
hour
Urine
|
|
14334-7
|
Lithium
[Moles/volume]
in
Serum
or
Plasma
|
|
14335-4
|
Optical
density
of
Amniotic
fluid
by
Spectrophotometry
|
|
14336-2
|
Ethanol
[Mass/volume]
in
Serum
or
Plasma
by
Gas
chromatography
|
|
14337-0
|
Phenytoin.total/Phenytoin.free
[Mass
Ratio]
in
Serum
or
Plasma
|
|
14338-8
|
Prealbumin
[Mass/volume]
in
Serum
or
Plasma
|
|
14339-6
|
IgG/Protein.total
in
Cerebral
spinal
fluid
|
|
1434-0
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
1
mg
dexamethasone
PO
overnight
|
|
14340-4
|
Gammopathy
[Interpretation]
in
Serum
or
Plasma
by
Electrophoresis
|
|
14341-2
|
Globulin/Protein.total
in
24
hour
Urine
by
Electrophoresis
|
|
14342-0
|
Deprecated
Catecholamines/Creatinine
[Mass
ratio]
in
Urine
|
|
14343-8
|
Eosinophils/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
14344-6
|
Eosinophils/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
14345-3
|
Specific
gravity
of
Amniotic
fluid
by
Refractometry
|
|
14346-1
|
Specific
gravity
of
Cerebral
spinal
fluid
by
Refractometry
|
|
14347-9
|
Specific
gravity
of
Gastric
fluid
by
Refractometry
|
|
14348-7
|
Specific
gravity
of
Peritoneal
fluid
by
Refractometry
|
|
14349-5
|
Specific
gravity
of
Pleural
fluid
by
Refractometry
|
|
1435-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14350-3
|
Specific
gravity
of
Synovial
fluid
by
Refractometry
|
|
14351-1
|
Specific
gravity
of
Stool
by
Refractometry
|
|
14352-9
|
Specific
gravity
of
Water
by
Refractometry
|
|
14353-7
|
Microscopic
observation
[Identifier]
in
Pleural
fluid
by
Acid
fast
stain.Kinyoun
modified
|
|
14354-5
|
Microscopic
observation
[Identifier]
in
Wound
by
Acid
fast
stain.Kinyoun
modified
|
|
14355-2
|
Microscopic
observation
[Identifier]
in
Cervix
by
KOH
preparation
|
|
14356-0
|
Microscopic
observation
[Identifier]
in
Vaginal
fluid
by
KOH
preparation
|
|
14357-8
|
Microscopic
observation
[Identifier]
in
Cerebral
spinal
fluid
by
Gram
stain
|
|
14358-6
|
Microscopic
observation
[Identifier]
in
Aspirate
by
Gram
stain
|
|
14359-4
|
Microscopic
observation
[Identifier]
in
Peritoneal
fluid
by
Gram
stain
|
|
1436-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
30
mg/kg
metyrapone
PO
|
|
14360-2
|
Microscopic
observation
[Identifier]
in
Pleural
fluid
by
Gram
stain
|
|
14361-0
|
Microscopic
observation
[Identifier]
in
Vaginal
fluid
by
Gram
stain
|
|
14362-8
|
Microscopic
observation
[Identifier]
in
Throat
by
Gram
stain
|
|
14363-6
|
Microscopic
observation
[Identifier]
in
Synovial
fluid
by
Gram
stain
|
|
14364-4
|
Microscopic
observation
[Identifier]
in
Eye
by
Gram
stain
|
|
14365-1
|
Microscopic
observation
[Identifier]
in
Ear
by
Gram
stain
|
|
14366-9
|
Trichomonas
vaginalis
[Presence]
in
Cervix
by
Wet
preparation
|
|
14367-7
|
Trichomonas
vaginalis
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
14368-5
|
Trichomonas
vaginalis
[Presence]
in
Urethra
by
Wet
preparation
|
|
14369-3
|
Yeast
[Presence]
in
Cervix
by
Wet
preparation
|
|
1437-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14370-1
|
Yeast
[Presence]
in
Vaginal
fluid
by
Wet
preparation
|
|
14371-9
|
Yeast
[Presence]
in
Urethra
by
Wet
preparation
|
|
14372-7
|
Erythrocytes
[#/volume]
in
Gastric
fluid
by
Manual
count
|
|
14373-5
|
Leukocytes
[#/volume]
in
Gastric
fluid
by
Manual
count
|
|
14374-3
|
Polymorphonuclear
cells/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
14375-0
|
Polymorphonuclear
cells/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
14376-8
|
Polymorphonuclear
cells/100
leukocytes
in
Synovial
fluid
by
Manual
count
|
|
14377-6
|
Polymorphonuclear
cells/100
leukocytes
in
Semen
by
Manual
count
|
|
14378-4
|
Polymorphonuclear
cells/100
leukocytes
in
Urine
by
Manual
count
|
|
14379-2
|
Polymorphonuclear
cells/100
leukocytes
in
Gastric
fluid
by
Manual
count
|
|
1438-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--8
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14380-0
|
Mononuclear
cells/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
14381-8
|
Mononuclear
cells/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
14382-6
|
Mononuclear
cells/100
leukocytes
in
Synovial
fluid
by
Manual
count
|
|
14383-4
|
Mononuclear
cells/100
leukocytes
in
Semen
by
Manual
count
|
|
14384-2
|
Mononuclear
cells/100
leukocytes
in
Urine
sediment
by
Manual
count
|
|
14385-9
|
Mononuclear
cells/100
leukocytes
in
Gastric
fluid
by
Manual
count
|
|
14386-7
|
Glucose
[Mass/volume]
in
Gastric
fluid
|
|
14387-5
|
Protein
[Mass/volume]
in
Gastric
fluid
|
|
14388-3
|
Amylase
[Enzymatic
activity/volume]
in
Synovial
fluid
|
|
14389-1
|
Amylase
[Enzymatic
activity/volume]
in
Cerebral
spinal
fluid
|
|
1439-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--9.5
hours
post
8
mg
dexamethasone
PO
overnight
high
dose
|
|
14390-9
|
Amylase
[Enzymatic
activity/volume]
in
Dialysis
fluid
|
|
14391-7
|
Amylase
[Enzymatic
activity/volume]
in
Gastric
fluid
|
|
14392-5
|
Amylase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
14393-3
|
Urea
nitrogen
[Mass/volume]
in
Amniotic
fluid
|
|
14394-1
|
Urea
nitrogen
[Mass/volume]
in
Pleural
fluid
|
|
14395-8
|
Deprecated
Urea
nitrogen
[Mass/volume]
in
Peritoneal
fluid
|
|
14396-6
|
Urea
nitrogen
[Mass/volume]
in
Synovial
fluid
|
|
14397-4
|
Urea
nitrogen
[Mass/volume]
in
Gastric
fluid
|
|
14398-2
|
Creatinine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14399-0
|
Creatinine
[Mass/volume]
in
Pleural
fluid
|
|
144-6
|
Cefuroxime
Parenteral
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1440-7
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--9
hours
post
1
mg
dexamethasone
PO
overnight
|
|
14400-6
|
Deprecated
Creatinine
[Mass/volume]
in
Peritoneal
fluid
|
|
14401-4
|
Creatinine
[Mass/volume]
in
Synovial
fluid
|
|
14402-2
|
Creatinine
[Mass/volume]
in
Gastric
fluid
|
|
14403-0
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Gastric
fluid
|
|
14404-8
|
Phosphate
[Mass/volume]
in
Pleural
fluid
|
|
14405-5
|
Phosphate
[Mass/volume]
in
Peritoneal
fluid
|
|
14406-3
|
Phosphate
[Mass/volume]
in
Synovial
fluid
|
|
14407-1
|
Phosphate
[Mass/volume]
in
Gastric
fluid
|
|
14408-9
|
Phosphate
[Mass/volume]
in
Amniotic
fluid
|
|
14409-7
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Pleural
fluid
|
|
1441-5
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--9
hours
post
3
g
metyrapone
PO
overnight
|
|
14410-5
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Peritoneal
fluid
|
|
14411-3
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Synovial
fluid
|
|
14412-1
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Gastric
fluid
|
|
14413-9
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Urine
|
|
14414-7
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Dialysis
fluid
|
|
14415-4
|
Calcium
[Moles/volume]
in
Amniotic
fluid
|
|
14416-2
|
Calcium
[Moles/volume]
in
Pleural
fluid
|
|
14417-0
|
Calcium
[Moles/volume]
in
Peritoneal
fluid
|
|
14418-8
|
Calcium
[Moles/volume]
in
Synovial
fluid
|
|
14419-6
|
Calcium
[Moles/volume]
in
Gastric
fluid
|
|
1442-3
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--9
hours
post
8
mg
dexamethasone
PO
overnight
high
dose
|
|
14420-4
|
Bilirubin.total
[Mass/volume]
in
Dialysis
fluid
|
|
14421-2
|
Bilirubin.total
[Mass/volume]
in
Pleural
fluid
|
|
14422-0
|
Bilirubin.total
[Mass/volume]
in
Peritoneal
fluid
|
|
14423-8
|
Bilirubin.total
[Mass/volume]
in
Synovial
fluid
|
|
14424-6
|
Bilirubin.total
[Mass/volume]
in
Gastric
fluid
|
|
14425-3
|
Globulin
[Mass/volume]
in
Amniotic
fluid
|
|
14426-1
|
Globulin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14427-9
|
Globulin
[Mass/volume]
in
Pleural
fluid
|
|
14428-7
|
Globulin
[Mass/volume]
in
Peritoneal
fluid
|
|
14429-5
|
Globulin
[Mass/volume]
in
Semen
|
|
1443-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
1
ug/kg
CRH
IV
|
|
14430-3
|
Globulin
[Mass/volume]
in
Synovial
fluid
|
|
14431-1
|
Globulin
[Mass/volume]
in
Urine
|
|
14432-9
|
Albumin/Globulin
[Mass
Ratio]
in
Amniotic
fluid
|
|
14433-7
|
Albumin/Globulin
[Mass
Ratio]
in
Cerebral
spinal
fluid
|
|
14434-5
|
Albumin/Globulin
[Mass
Ratio]
in
Pleural
fluid
|
|
14435-2
|
Albumin/Globulin
[Mass
Ratio]
in
Peritoneal
fluid
|
|
14436-0
|
Albumin/Globulin
[Mass
Ratio]
in
Semen
|
|
14437-8
|
Albumin/Globulin
[Mass
Ratio]
in
Synovial
fluid
|
|
14438-6
|
Cholesterol
[Mass/volume]
in
Amniotic
fluid
|
|
14439-4
|
Cholesterol
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
1444-9
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
14440-2
|
Deprecated
Cholesterol
[Mass/volume]
in
Pleural
fluid
|
|
14441-0
|
Cholesterol
[Mass/volume]
in
Peritoneal
fluid
|
|
14442-8
|
Cholesterol
[Mass/volume]
in
Semen
|
|
14443-6
|
Cholesterol
[Mass/volume]
in
Synovial
fluid
|
|
14444-4
|
Cholesterol
[Mass/volume]
in
Urine
|
|
14445-1
|
Triglyceride
[Mass/volume]
in
Amniotic
fluid
|
|
14446-9
|
Triglyceride
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
14447-7
|
Triglyceride
[Mass/volume]
in
Peritoneal
fluid
|
|
14448-5
|
Triglyceride
[Mass/volume]
in
Semen
|
|
14449-3
|
Triglyceride
[Mass/volume]
in
Synovial
fluid
|
|
1445-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
1
mg
dexamethasone
PO
overnight
|
|
14450-1
|
Triglyceride
[Mass/volume]
in
Urine
|
|
14451-9
|
Virus
identified
in
Eye
by
Culture
|
|
14452-7
|
Virus
identified
in
Cervix
by
Culture
|
|
14453-5
|
Virus
identified
in
Vaginal
fluid
by
Culture
|
|
14454-3
|
Virus
identified
in
Nose
by
Culture
|
|
14455-0
|
Virus
identified
in
Pleural
fluid
by
Culture
|
|
14456-8
|
Virus
identified
in
Peritoneal
fluid
by
Culture
|
|
14457-6
|
Virus
identified
in
Urine
by
Culture
|
|
14458-4
|
Virus
identified
in
Sputum
by
Culture
|
|
14459-2
|
Virus
identified
in
Penis
by
Culture
|
|
1446-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
3
g
metyrapone
PO
overnight
|
|
14460-0
|
Virus
identified
in
Urethra
by
Culture
|
|
14461-8
|
Chlamydia
trachomatis
[Presence]
in
Blood
by
Organism
specific
culture
|
|
14462-6
|
Chlamydia
trachomatis
[Presence]
in
Cerebral
spinal
fluid
by
Organism
specific
culture
|
|
14463-4
|
Chlamydia
trachomatis
[Presence]
in
Cervix
by
Organism
specific
culture
|
|
14464-2
|
Chlamydia
trachomatis
[Presence]
in
Vaginal
fluid
by
Organism
specific
culture
|
|
14465-9
|
Chlamydia
trachomatis
[Presence]
in
Urethra
by
Organism
specific
culture
|
|
14466-7
|
Deprecated
Chlamydia
trachomatis
[Presence]
in
Penis
by
Organism
specific
culture
|
|
14467-5
|
Chlamydia
trachomatis
[Presence]
in
Urine
sediment
by
Organism
specific
culture
|
|
14468-3
|
Chlamydia
trachomatis
Ag
[Presence]
in
Blood
by
Immunoassay
|
|
14469-1
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
1447-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
40
ug
corticotropin
IM
3
day
|
|
14470-9
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cervix
by
Immunoassay
|
|
14471-7
|
Chlamydia
trachomatis
Ag
[Presence]
in
Vaginal
fluid
by
Immunoassay
|
|
14472-5
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urethra
by
Immunoassay
|
|
14473-3
|
Deprecated
Chlamydia
trachomatis
Ag
[Presence]
in
Penis
by
Immunoassay
|
|
14474-1
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urine
sediment
by
Immunoassay
|
|
14475-8
|
Bacteria
identified
in
Cervix
by
Aerobe
culture
|
|
14476-6
|
Deprecated
Bacteria
identified
in
Vaginal
fluid
by
Aerobe
culture
|
|
14477-4
|
Bacteria
identified
in
Urethra
by
Aerobe
culture
|
|
14478-2
|
Bacteria
identified
in
Penis
by
Aerobe
culture
|
|
14479-0
|
Diphtheria
identified
in
Throat
by
Organism
specific
culture
|
|
1448-0
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14480-8
|
Diphtheria
identified
in
Sputum
by
Organism
specific
culture
|
|
14481-6
|
Diphtheria
identified
in
Nose
by
Organism
specific
culture
|
|
14482-4
|
Diphtheria
identified
in
Skin
by
Organism
specific
culture
|
|
14483-2
|
Diphtheria
identified
in
Bronchial
specimen
by
Organism
specific
culture
|
|
14484-0
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Cervix
by
Organism
specific
culture
|
|
14485-7
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Vaginal
fluid
by
Organism
specific
culture
|
|
14486-5
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Penis
by
Organism
specific
culture
|
|
14487-3
|
Mycoplasma
sp
and
Ureaplasma
sp
[Identifier]
in
Urethra
by
Organism
specific
culture
|
|
14488-1
|
Virus
identified
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14489-9
|
Virus
identified
in
Blood
by
Immunofluorescence
|
|
1449-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
8
mg
dexamethasone
PO
overnight
high
dose
|
|
14490-7
|
Virus
identified
in
Semen
by
Immunofluorescence
|
|
14491-5
|
Virus
identified
in
Throat
by
Immunofluorescence
|
|
14492-3
|
Virus
identified
in
Eye
by
Immunofluorescence
|
|
14493-1
|
Virus
identified
in
Cervix
by
Immunofluorescence
|
|
14494-9
|
Virus
identified
in
Vaginal
fluid
by
Immunofluorescence
|
|
14495-6
|
Virus
identified
in
Urine
sediment
by
Immunofluorescence
|
|
14496-4
|
Virus
identified
in
Sputum
by
Immunofluorescence
|
|
14497-2
|
Virus
identified
in
Penis
by
Immunofluorescence
|
|
14498-0
|
Virus
identified
in
Urethra
by
Immunofluorescence
|
|
14499-8
|
Human
papilloma
virus
Ag
[Presence]
in
Cervix
|
|
145-3
|
Cefuroxime
Parenteral
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1450-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14500-3
|
Human
papilloma
virus
Ag
[Presence]
in
Vaginal
fluid
|
|
14501-1
|
Human
papilloma
virus
Ag
[Presence]
in
Penis
|
|
14502-9
|
Human
papilloma
virus
Ag
[Presence]
in
Urethra
|
|
14503-7
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Cervix
|
|
14504-5
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Vaginal
fluid
|
|
14505-2
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Penis
|
|
14506-0
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Urethra
|
|
14507-8
|
Chlamydia
trachomatis
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
14508-6
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14509-4
|
Chlamydia
trachomatis
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
1451-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
insulin
IV
|
|
14510-2
|
Chlamydia
trachomatis
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14511-0
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14512-8
|
Deprecated
Chlamydia
trachomatis
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14513-6
|
Chlamydia
trachomatis
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14514-4
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Blood
by
Immunofluorescence
|
|
14515-1
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14516-9
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Semen
by
Immunofluorescence
|
|
14517-7
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Stool
by
Immunofluorescence
|
|
14518-5
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14519-3
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
1452-2
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--24
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14520-1
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14521-9
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Urine
by
Immunofluorescence
|
|
14522-7
|
Pneumocystis
jiroveci
Ag
[Presence]
in
Bronchial
specimen
by
Immunofluorescence
|
|
14523-5
|
Rubella
virus
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14524-3
|
Rubella
virus
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14525-0
|
Rubella
virus
Ag
[Presence]
in
Skin
by
Immunofluorescence
|
|
14526-8
|
Rubella
virus
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14527-6
|
Rubella
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14528-4
|
Rubella
virus
Ag
[Presence]
in
Sputum
by
Immunofluorescence
|
|
14529-2
|
Rubella
virus
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
1453-0
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--48
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14530-0
|
Rubella
virus
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14531-8
|
Rubella
virus
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14532-6
|
Rubella
virus
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14533-4
|
Rubella
virus
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14534-2
|
Measles
virus
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14535-9
|
Measles
virus
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14536-7
|
Measles
virus
Ag
[Presence]
in
Skin
by
Immunofluorescence
|
|
14537-5
|
Measles
virus
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14538-3
|
Measles
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
14539-1
|
Measles
virus
Ag
[Presence]
in
Sputum
by
Immunofluorescence
|
|
1454-8
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--48
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14540-9
|
Measles
virus
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
14541-7
|
Measles
virus
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14542-5
|
Measles
virus
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14543-3
|
Measles
virus
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14544-1
|
Measles
virus
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14545-8
|
Mumps
virus
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
14546-6
|
Mumps
virus
Ag
[Presence]
in
Throat
by
Immunofluorescence
|
|
14547-4
|
Mumps
virus
Ag
[Presence]
in
Skin
by
Immunofluorescence
|
|
14548-2
|
Mumps
virus
Ag
[Presence]
in
Eye
by
Immunofluorescence
|
|
14549-0
|
Mumps
virus
Ag
[Presence]
in
Nose
by
Immunofluorescence
|
|
1455-5
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--48
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14550-8
|
Mumps
virus
Ag
[Presence]
in
Sputum
by
Immunofluorescence
|
|
14551-6
|
Mumps
virus
Ag
[Presence]
in
Cervix
by
Immunofluorescence
|
|
14552-4
|
Mumps
virus
Ag
[Presence]
in
Vaginal
fluid
by
Immunofluorescence
|
|
14553-2
|
Mumps
virus
Ag
[Presence]
in
Urine
sediment
by
Immunofluorescence
|
|
14554-0
|
Mumps
virus
Ag
[Presence]
in
Penis
by
Immunofluorescence
|
|
14555-7
|
Mumps
virus
Ag
[Presence]
in
Urethra
by
Immunofluorescence
|
|
14556-5
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Sputum
by
Probe
and
target
amplification
method
|
|
14557-3
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Bronchial
specimen
by
Probe
and
target
amplification
method
|
|
14558-1
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Gastric
fluid
by
Probe
and
target
amplification
method
|
|
14559-9
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Pleural
fluid
by
Probe
and
target
amplification
method
|
|
1456-3
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--72
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
14560-7
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Urine
by
Probe
and
target
amplification
method
|
|
14561-5
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
14562-3
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Semen
by
Probe
and
target
amplification
method
|
|
14563-1
|
Hemoglobin.gastrointestinal
[Presence]
in
Stool
--1st
specimen
|
|
14564-9
|
Hemoglobin.gastrointestinal
[Presence]
in
Stool
--2nd
specimen
|
|
14565-6
|
Hemoglobin.gastrointestinal
[Presence]
in
Stool
--3rd
specimen
|
|
14566-4
|
Calcitriol
[Moles/volume]
in
Serum
or
Plasma
|
|
14567-2
|
11-Deoxycortisol
[Moles/volume]
in
Serum
or
Plasma
|
|
14568-0
|
17-Hydroxycorticosteroids
[Moles/time]
in
24
hour
Urine
|
|
14569-8
|
17-Hydroxyprogesterone
[Moles/volume]
in
Serum
or
Plasma
|
|
1457-1
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--pre
40
ug
corticotropin
IM
3
day
|
|
14570-6
|
17-Hydroxyprogesterone
[Moles/volume]
in
Urine
|
|
14571-4
|
17-Hydroxyprogesterone
[Moles/time]
in
24
hour
Urine
|
|
14572-2
|
17-Ketosteroids
[Moles/time]
in
24
hour
Urine
|
|
14573-0
|
5-Hydroxyindoleacetate
[Moles/time]
in
24
hour
Urine
|
|
14574-8
|
8-Hydroxyamoxapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14575-5
|
Blood
group
antibody
investigation
[Interpretation]
in
Plasma
or
RBC
|
|
14576-3
|
Blood
group
antibody
investigation
[Interpretation]
in
Plasma
or
RBC
by
Senior
review
|
|
14577-1
|
ABO
and
Rh
group
[Type]
in
Blood
from
donor
|
|
14578-9
|
ABO
group
[Type]
in
Blood
from
Blood
product
unit
|
|
14579-7
|
ABO
group
[Type]
in
Blood
from
donor
|
|
1458-9
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--pre
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14580-5
|
ABO
group
[Type]
in
Blood
from
newborn
|
|
14581-3
|
Acetaminophen
[Moles/volume]
in
Serum
or
Plasma
|
|
14582-1
|
Acetone
[Moles/volume]
in
Serum
or
Plasma
|
|
14583-9
|
Acidity.titratable
[Mass/volume]
in
Gastric
fluid
|
|
14584-7
|
Adenosine
monophosphate.cyclic
[Moles/time]
in
24
hour
Urine
|
|
14585-4
|
Albumin/Creatinine
[Molar
ratio]
in
Urine
|
|
14586-2
|
Aldosterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14587-0
|
Aldosterone
[Moles/time]
in
24
hour
Urine
|
|
14588-8
|
Alkaline
phosphatase
isoenzymes
[Interpretation]
in
Serum
or
Plasma
|
|
14589-6
|
Amylase
isoenzymes
[Interpretation]
in
Serum
or
Plasma
|
|
1459-7
|
Creatinine
[Mass/volume]
in
24
hour
Urine
--pre
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
14590-4
|
Alpha
tocopherol
[Moles/volume]
in
Serum
or
Plasma
|
|
14591-2
|
Alprazolam
[Moles/volume]
in
Serum
or
Plasma
|
|
14592-0
|
Aluminum
[Moles/volume]
in
24
hour
Urine
|
|
14593-8
|
Aluminum
[Moles/volume]
in
Serum
or
Plasma
|
|
14594-6
|
Amitriptyline+Nortriptyline
[Presence]
in
Gastric
fluid
|
|
14595-3
|
Amitriptyline+Nortriptyline
[Presence]
in
Serum
or
Plasma
|
|
14596-1
|
Amitriptyline+Nortriptyline
[Presence]
in
Urine
|
|
14597-9
|
Amitriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14598-7
|
Amitriptyline+Nortriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14599-5
|
Ammonium
[Presence]
in
Stone
|
|
146-1
|
Cefuroxime
Parenteral
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1460-5
|
Cobalamin
(Vitamin
B12)
[Mass/time]
in
24
hour
Urine
--post
dose
cyanocobalamin
|
|
14600-1
|
Amoxapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14601-9
|
Amoxapine+8-Hydroxyamoxapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14602-7
|
Deprecated
Amoxapine+8-Hydroxyamoxapine
[Molecules/volume]
in
Serum
or
Plasma
|
|
14603-5
|
Androstenedione
[Moles/volume]
in
Serum
or
Plasma
|
|
14604-3
|
Blood
group
antibodies
identified
in
Serum
or
Plasma
from
Blood
product
unit
|
|
14605-0
|
Blood
group
antibodies
identified
in
Serum
or
Plasma
from
donor
|
|
14606-8
|
Blood
group
antibody
screen
[Presence]
in
Serum
or
Plasma
by
Prewarmed
|
|
14607-6
|
Nuclear
Ab
[Presence]
in
Body
fluid
|
|
14608-4
|
Nuclear
Ab
[Presence]
in
Pleural
fluid
|
|
14609-2
|
Nuclear
Ab
[Presence]
in
Peritoneal
fluid
|
|
1461-3
|
Epinephrine
[Mass/volume]
in
Plasma
--1
hour
post
300
ug
clonidine
PO
|
|
14610-0
|
Nuclear
Ab
[Presence]
in
Synovial
fluid
|
|
14611-8
|
Nuclear
Ab
pattern
[Interpretation]
in
Serum
|
|
14612-6
|
Nuclear
Ab
[Titer]
in
Pericardial
fluid
|
|
14613-4
|
Nuclear
Ab
[Titer]
in
Body
fluid
|
|
14614-2
|
Nuclear
Ab
[Titer]
in
Pleural
fluid
|
|
14615-9
|
Nuclear
Ab
[Titer]
in
Peritoneal
fluid
|
|
14616-7
|
Nuclear
Ab
[Titer]
in
Synovial
fluid
|
|
14617-5
|
Appearance
of
Pericardial
fluid
|
|
14618-3
|
Appearance
of
Stone
|
|
14619-1
|
Appearance
of
Plasma
|
|
1462-1
|
Epinephrine
[Mass/volume]
in
Plasma
--2
hours
post
300
ug
clonidine
PO
|
|
14620-9
|
Appearance
of
Pleural
fluid
|
|
14621-7
|
Appearance
of
Peritoneal
fluid
|
|
14622-5
|
Ascorbate
[Moles/volume]
in
Serum
or
Plasma
|
|
14623-3
|
Barbital
[Presence]
in
Serum
or
Plasma
|
|
14624-1
|
Barbiturates
[Presence]
in
Gastric
fluid
|
|
14625-8
|
Basophils/100
leukocytes
in
Bronchial
specimen
by
Manual
count
|
|
14626-6
|
Beta-2-Microglobulin
[Moles/volume]
in
Serum
|
|
14627-4
|
Bicarbonate
[Moles/volume]
in
Venous
blood
|
|
14628-2
|
Bile
acid
[Moles/volume]
in
Serum
|
|
14629-0
|
Bilirubin.direct
[Moles/volume]
in
Serum
or
Plasma
|
|
1463-9
|
Epinephrine
[Mass/volume]
in
Plasma
--3
hours
post
300
ug
clonidine
PO
|
|
14630-8
|
Bilirubin.indirect
[Moles/volume]
in
Serum
or
Plasma
|
|
14631-6
|
Bilirubin.total
[Moles/volume]
in
Serum
or
Plasma
|
|
14632-4
|
Deprecated
Buffy
coat
|
|
14633-2
|
C
peptide
[Moles/volume]
in
Serum
or
Plasma
|
|
14634-0
|
C
reactive
protein
[Titer]
in
Serum
or
Plasma
|
|
14635-7
|
Calcidiol
[Moles/volume]
in
Serum
or
Plasma
|
|
14636-5
|
Calcium
[Presence]
in
Stone
|
|
14637-3
|
Calcium
[Moles/time]
in
24
hour
Urine
|
|
14638-1
|
Calculus
analysis
[Interpretation]
in
Stone
|
|
14639-9
|
Carbamazepine
[Moles/volume]
in
Serum
or
Plasma
|
|
1464-7
|
Epinephrine
[Mass/volume]
in
Plasma
--pre
300
ug
clonidine
PO
|
|
14640-7
|
Carbon
dioxide,
total
[Moles/volume]
in
Dialysis
fluid
|
|
14641-5
|
Carbonate
[Presence]
in
Stone
|
|
14642-3
|
Carotene
[Moles/volume]
in
Serum
|
|
14643-1
|
Catecholamines
Free
[Moles/time]
in
24
hour
Urine
|
|
14644-9
|
Chlorpromazine
[Presence]
in
Gastric
fluid
|
|
14645-6
|
Chlorpromazine
[Moles/volume]
in
Serum
or
Plasma
|
|
14646-4
|
Cholesterol
in
HDL
[Moles/volume]
in
Serum
or
Plasma
|
|
14647-2
|
Cholesterol
[Moles/volume]
in
Serum
or
Plasma
|
|
14648-0
|
Chylomicrons
[Moles/volume]
in
Serum
or
Plasma
|
|
14649-8
|
Cimetidine
[Presence]
in
Gastric
fluid
|
|
1465-4
|
Epinephrine
[Mass/volume]
in
Plasma
--supine
|
|
14650-6
|
Citrate
[Moles/time]
in
24
hour
Urine
|
|
14651-4
|
Clobazam
[Moles/volume]
in
Serum
or
Plasma
|
|
14652-2
|
Clomipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14653-0
|
Clomipramine
[Moles/volume]
in
Urine
|
|
14654-8
|
Clomipramine+Norclomipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14655-5
|
Clonazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14656-3
|
Clozapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14657-1
|
Clozapine+Norclozapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14658-9
|
Cold
agglutinin
[Titer]
in
Serum
or
Plasma
|
|
14659-7
|
Deprecated
Collection
duration
of
Urine
|
|
1466-2
|
Deprecated
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
100
g
lutropin
IV
|
|
14660-5
|
Color
of
Peritoneal
fluid
|
|
14661-3
|
Color
of
Pericardial
fluid
|
|
14662-1
|
Color
of
Pleural
fluid
|
|
14663-9
|
Deprecated
Color
of
Semen
by
Visual
|
|
14664-7
|
Color
of
Synovial
fluid
|
|
14665-4
|
Copper
[Moles/volume]
in
Serum
or
Plasma
|
|
14666-2
|
Copper
[Moles/time]
in
24
hour
Urine
|
|
14667-0
|
Coproporphyrin
1
[Moles/volume]
in
Serum
or
Plasma
|
|
14668-8
|
Coproporphyrin
1
[Moles/volume]
in
Stool
|
|
14669-6
|
Coproporphyrin
1
[Moles/volume]
in
Urine
|
|
1467-0
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
gonadotropin
releasing
hormone
|
|
14670-4
|
Coproporphyrin
1/Porphyrins.total
in
Urine
|
|
14671-2
|
Coproporphyrin
3
[Moles/volume]
in
Serum
or
Plasma
|
|
14672-0
|
Coproporphyrin
3
[Moles/volume]
in
Stool
|
|
14673-8
|
Coproporphyrin
3
[Moles/volume]
in
Urine
|
|
14674-6
|
Corticotropin
[Moles/volume]
in
Plasma
|
|
14675-3
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
|
|
14676-1
|
Cortisol
Free
[Moles/time]
in
24
hour
Urine
|
|
14677-9
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
--24
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
14678-7
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
--PM
trough
specimen
|
|
14679-5
|
Cortisol
[Moles/volume]
in
Serum
or
Plasma
--AM
peak
specimen
|
|
1468-8
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--105
minutes
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14680-3
|
Creatine
kinase
isoenzymes
[Interpretation]
in
Serum
or
Plasma
by
Electrophoresis
|
|
14681-1
|
Creatinine
[Moles/volume]
in
Peritoneal
dialysis
fluid
|
|
14682-9
|
Creatinine
[Moles/volume]
in
Serum
or
Plasma
|
|
14683-7
|
Creatinine
[Moles/volume]
in
Urine
|
|
14684-5
|
Creatinine
[Moles/time]
in
24
hour
Urine
|
|
14685-2
|
Cobalamin
(Vitamin
B12)
[Moles/volume]
in
Serum
or
Plasma
|
|
14686-0
|
Cystine
[Presence]
in
Stone
|
|
14687-8
|
Transfusion
date
|
|
14688-6
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Moles/volume]
in
Serum
or
Plasma
|
|
14689-4
|
Delta
aminolevulinate
[Moles/time]
in
24
hour
Urine
|
|
1469-6
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14690-2
|
N-desalkylflurazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14691-0
|
Desipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14692-8
|
Desipramine
[Moles/volume]
in
Urine
|
|
14693-6
|
Norclobazam
[Moles/volume]
in
Serum
or
Plasma
|
|
14694-4
|
Norclomipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14695-1
|
Nordoxepin
[Moles/volume]
in
Serum
or
Plasma
|
|
14696-9
|
Deuteroporphyrin
[Moles/volume]
in
Stool
|
|
14697-7
|
Diazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14698-5
|
Digoxin
[Moles/volume]
in
Serum
or
Plasma
|
|
14699-3
|
Diphenhydramine+Dimenhydrinate
[Presence]
in
Gastric
fluid
|
|
147-9
|
Cefuroxime
Parenteral
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1470-4
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14700-9
|
Diphenhydramine+Dimenhydrinate
[Presence]
in
Serum
or
Plasma
|
|
14701-7
|
Diphenhydramine+Dimenhydrinate
[Presence]
in
Urine
|
|
14702-5
|
Disopyramide
[Moles/volume]
in
Serum
or
Plasma
|
|
14703-3
|
Dopamine
[Moles/volume]
in
Serum
or
Plasma
|
|
14704-1
|
Doxepin
[Presence]
in
Gastric
fluid
|
|
14705-8
|
Doxepin
[Moles/volume]
in
Serum
or
Plasma
|
|
14706-6
|
Doxepin
[Moles/volume]
in
Urine
|
|
14707-4
|
Doxepin+Nordoxepin
[Moles/volume]
in
Serum
or
Plasma
|
|
14708-2
|
Endomysium
Ab
[Titer]
in
Serum
|
|
14709-0
|
Eosinophils/100
leukocytes
in
Bronchial
specimen
by
Manual
count
|
|
1471-2
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
gonadotropin
releasing
hormone
|
|
14710-8
|
Ephedrine+Pseudoephedrine
[Presence]
in
Gastric
fluid
|
|
14711-6
|
Epinephrine
[Moles/volume]
in
Plasma
|
|
14712-4
|
Epinephrine
[Moles/time]
in
24
hour
Urine
|
|
14713-2
|
Erythrocytes
[#/volume]
in
Pericardial
fluid
by
Manual
count
|
|
14714-0
|
Erythropoietin
(EPO)
[Moles/volume]
in
Serum
or
Plasma
|
|
14715-7
|
Estradiol
(E2)
[Moles/volume]
in
Serum
or
Plasma
|
|
14716-5
|
Estriol
(E3)
[Moles/volume]
in
Serum
or
Plasma
|
|
14717-3
|
Estriol
(E3)
[Moles/volume]
in
Urine
|
|
14718-1
|
Estriol
(E3)
[Moles/time]
in
24
hour
Urine
|
|
14719-9
|
Ethanol
[Moles/volume]
in
Serum
or
Plasma
|
|
1472-0
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14720-7
|
Ethosuximide
[Moles/volume]
in
Serum
or
Plasma
|
|
14721-5
|
Ethylene
glycol
[Moles/volume]
in
Serum
or
Plasma
|
|
14722-3
|
Extractable
nuclear
Ab
[Presence]
in
Serum
|
|
14723-1
|
Ferritin
[Moles/volume]
in
Serum
or
Plasma
|
|
14724-9
|
Ferritin
[Interpretation]
in
Blood
|
|
14725-6
|
[Type]
of
Body
fluid
|
|
14726-4
|
Fluoride
[Moles/volume]
in
Serum
or
Plasma
|
|
14727-2
|
Fluoxetine
[Presence]
in
Gastric
fluid
|
|
14728-0
|
Fluoxetine
[Moles/volume]
in
Serum
or
Plasma
|
|
14729-8
|
Flurazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
1473-8
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14730-6
|
Flurazepam+N-desalkylflurazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14731-4
|
Folate
[Moles/volume]
in
Red
Blood
Cells
|
|
14732-2
|
Folate
[Moles/volume]
in
Serum
or
Plasma
|
|
14733-0
|
Folate+Cyanocobalamin
[Interpretation]
in
Serum
or
Blood
|
|
14734-8
|
Follitropin
[Moles/time]
in
24
hour
Urine
|
|
14735-5
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--10
minutes
post
0.2
U/kg
secretin
|
|
14736-3
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--15
minutes
post
0.2
U/kg
secretin
|
|
14737-1
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--20
minutes
post
0.2
U/kg
secretin
|
|
14738-9
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--25
minutes
post
0.2
U/kg
secretin
|
|
14739-7
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--2
minutes
post
0.2
U/kg
secretin
|
|
1474-6
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
gonadotropin
releasing
hormone
|
|
14740-5
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--30
minutes
post
0.2
U/kg
secretin
|
|
14741-3
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--5
minutes
post
0.2
U/kg
secretin
|
|
14742-1
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
--pre
0.2
U/kg
secretin
|
|
14743-9
|
Glucose
[Moles/volume]
in
Capillary
blood
by
Glucometer
|
|
14744-7
|
Glucose
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
14745-4
|
Glucose
[Moles/volume]
in
Body
fluid
|
|
14746-2
|
Glucose
[Moles/volume]
in
Peritoneal
dialysis
fluid
|
|
14747-0
|
Glucose
[Moles/volume]
in
Pleural
fluid
|
|
14748-8
|
Glucose
[Moles/volume]
in
Peritoneal
fluid
|
|
14749-6
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
|
|
1475-3
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14750-4
|
Glucose
[Moles/volume]
in
Synovial
fluid
|
|
14751-2
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1.5
hours
post
50
g
lactose
PO
|
|
14752-0
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
glucose
|
|
14753-8
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
100
g
glucose
PO
|
|
14754-6
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
glucose
PO
|
|
14755-3
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
lactose
PO
|
|
14756-1
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
dose
glucose
|
|
14757-9
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
100
g
glucose
PO
|
|
14758-7
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
50
g
lactose
PO
|
|
14759-5
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
dose
glucose
|
|
1476-1
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--75
minutes
post
100
ug
lutenizing
releasing
hormone
IV
|
|
14760-3
|
Glucose
[Moles/volume]
in
Capillary
blood
--2
hours
post
meal
|
|
14761-1
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
meal
|
|
14762-9
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--30
minutes
post
50
g
lactose
PO
|
|
14763-7
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
glucose
|
|
14764-5
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--3
hours
post
100
g
glucose
PO
|
|
14765-2
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--3
hours
post
dose
glucose
|
|
14766-0
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--4
hours
post
dose
glucose
|
|
14767-8
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--5
hours
post
dose
glucose
|
|
14768-6
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--baseline
|
|
14769-4
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
1477-9
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
14770-2
|
Fasting
glucose
[Moles/volume]
in
Capillary
blood
by
Glucometer
|
|
14771-0
|
Fasting
glucose
[Moles/volume]
in
Serum
or
Plasma
|
|
14772-8
|
Gold
[Moles/volume]
in
Serum
or
Plasma
|
|
14773-6
|
Granulocytes/100
leukocytes
in
Bronchial
specimen
by
Manual
count
|
|
14774-4
|
Haloperidol
[Moles/volume]
in
Serum
or
Plasma
|
|
14775-1
|
Hemoglobin
[Mass/volume]
in
Arterial
blood
by
Oximetry
|
|
14776-9
|
Heptacarboxylate
[Moles/volume]
in
Plasma
|
|
14777-7
|
Heptacarboxylate
[Moles/volume]
in
Stool
|
|
14778-5
|
Heptacarboxylate
[Moles/volume]
in
Urine
|
|
14779-3
|
Hexacarboxylate
[Moles/volume]
in
Plasma
|
|
1478-7
|
Follitropin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
gonadotropin
releasing
hormone
|
|
14780-1
|
Hexacarboxylate
[Moles/volume]
in
Stool
|
|
14781-9
|
Hexacarboxylate
[Moles/volume]
in
Urine
|
|
14782-7
|
Homovanillate
[Moles/volume]
in
Urine
|
|
14783-5
|
Homovanillate
[Moles/time]
in
24
hour
Urine
|
|
14784-3
|
Hydroxyproline
Free
[Moles/time]
in
24
hour
Urine
|
|
14785-0
|
Hydroxyproline
[Moles/time]
in
24
hour
Urine
|
|
14786-8
|
Deprecated
Arthropod
identified
in
Unspecified
specimen
|
|
14787-6
|
Arthropod
identified
in
Unspecified
specimen
by
Permanent
mount
|
|
14788-4
|
Helminth+Arthropod
identified
in
Unspecified
specimen
by
Rearing/Culture
|
|
14789-2
|
Helminth
identified
in
Unspecified
specimen
by
Macro/micro
identification
|
|
1479-5
|
Galactose
[Mass/volume]
in
Blood
--1.5
hours
post
40
g
galactose
PO
|
|
14790-0
|
Helminth
identified
in
Unspecified
specimen
by
Permanent
mount
|
|
14791-8
|
Imipramine+Desipramine
[Presence]
in
Gastric
fluid
|
|
14792-6
|
Imipramine+Desipramine
[Presence]
in
Serum
or
Plasma
|
|
14793-4
|
Imipramine+Desipramine
[Presence]
in
Urine
|
|
14794-2
|
Imipramine+Desipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14795-9
|
Immunoglobulin
light
chains
[Interpretation]
in
Urine
|
|
14796-7
|
Insulin
[Moles/volume]
in
Serum
or
Plasma
|
|
14797-5
|
Iron
[Interpretation]
in
Serum
or
Plasma
|
|
14798-3
|
Iron
[Moles/volume]
in
Serum
or
Plasma
|
|
14799-1
|
Iron
[Moles/time]
in
24
hour
Urine
|
|
148-7
|
Cephalexin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1480-3
|
Galactose
[Mass/volume]
in
Blood
--1
hour
post
40
g
galactose
PO
|
|
14800-7
|
Iron
binding
capacity
[Moles/volume]
in
Serum
or
Plasma
|
|
14801-5
|
Iron
saturation
[Molar
fraction]
in
Serum
or
Plasma
|
|
14802-3
|
Isopropanol
[Moles/volume]
in
Serum
or
Plasma
|
|
14803-1
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Body
fluid
by
Lactate
to
pyruvate
reaction
|
|
14804-9
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Lactate
to
pyruvate
reaction
|
|
14805-6
|
Lactate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Pyruvate
to
lactate
reaction
|
|
14806-4
|
Lactose.PO
[Mass]
of
Dose
|
|
14807-2
|
Lead
[Moles/volume]
in
Blood
|
|
14808-0
|
Lead
[Moles/volume]
in
Urine
|
|
14809-8
|
Lead
[Moles/time]
in
24
hour
Urine
|
|
1481-1
|
Galactose
[Mass/volume]
in
Blood
--2
hours
post
40
g
galactose
PO
|
|
14810-6
|
Leukocytes
[#/volume]
in
Bronchial
specimen
by
Manual
count
|
|
14811-4
|
Leukocytes
[#/volume]
in
Pericardial
fluid
by
Manual
count
|
|
14812-2
|
Lidocaine
[Moles/volume]
in
Serum
or
Plasma
|
|
14813-0
|
Lipoprotein.alpha
[Moles/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
14814-8
|
Lipoprotein.beta
[Moles/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
14815-5
|
Lipoprotein.beta
[Moles/volume]
in
Serum
or
Plasma
by
calculation
|
|
14816-3
|
Lipoprotein.pre-beta
[Moles/volume]
in
Serum
or
Plasma
by
Electrophoresis
|
|
14817-1
|
Lorazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
14818-9
|
Lymphocytes/100
leukocytes
in
Pericardial
fluid
by
Manual
count
|
|
14819-7
|
Lymphocytes/100
leukocytes
in
Bronchial
specimen
by
Manual
count
|
|
1482-9
|
Galactose
[Mass/volume]
in
Blood
--30
minutes
post
40
g
galactose
PO
|
|
14820-5
|
Lymphocytes/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
14821-3
|
Lymphocytes/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
14822-1
|
Lymphocytes/100
leukocytes
in
Synovial
fluid
by
Manual
count
|
|
14823-9
|
Macrophages/100
leukocytes
in
Bronchial
specimen
by
Manual
count
|
|
14824-7
|
Magnesium
[Presence]
in
Stone
|
|
14825-4
|
Maprotiline
[Moles/volume]
in
Serum
or
Plasma
|
|
14826-2
|
Meperidine
[Presence]
in
Gastric
fluid
|
|
14827-0
|
Mesoporphyrin
[Moles/volume]
in
Stool
|
|
14828-8
|
Mesothelial
cells/100
leukocytes
in
Pericardial
fluid
by
Manual
count
|
|
14829-6
|
Mesothelial
cells/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
1483-7
|
Galactose
[Mass/time]
in
5
hour
Urine
--post
40
g
dose
PO
|
|
14830-4
|
Mesothelial
cells/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
14831-2
|
Metanephrine/Creatinine
[Molar
ratio]
in
Urine
|
|
14832-0
|
Metanephrines
[Moles/volume]
in
Urine
|
|
14833-8
|
Metanephrines
[Moles/time]
in
24
hour
Urine
|
|
14834-6
|
Methamphetamine
[Presence]
in
Gastric
fluid
|
|
14835-3
|
Methanol
[Moles/volume]
in
Serum
or
Plasma
|
|
14836-1
|
Methotrexate
[Moles/volume]
in
Serum
or
Plasma
|
|
14837-9
|
Methsuximide
[Moles/volume]
in
Serum
or
Plasma
|
|
14838-7
|
Toxoplasma
gondii
[Presence]
in
Tissue
by
Organism
specific
culture
|
|
14839-5
|
Trypanosoma
sp
identified
in
Buffy
Coat
by
Light
microscopy
|
|
1484-5
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
0.2
U/kg
secretin
|
|
14840-3
|
Trypanosoma
sp
identified
in
Cerebral
spinal
fluid
by
Wet
preparation
|
|
14841-1
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Iron
hematoxylin
stain
|
|
14842-9
|
Microscopic
observation
[Identifier]
in
Unspecified
specimen
by
Kinyoun
iron
hematoxylin
stain
|
|
14843-7
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Gastric
fluid
|
|
14844-5
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Serum
or
Plasma
|
|
14845-2
|
Deprecated
Monoacetylmorphine
[Presence]
in
Urine
|
|
14846-0
|
N-acetylprocainamide
[Moles/volume]
in
Serum
or
Plasma
|
|
14847-8
|
Neutrophils/100
leukocytes
in
Pericardial
fluid
by
Manual
count
|
|
14848-6
|
Neutrophils/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
14849-4
|
Nitrazepam
[Moles/volume]
in
Serum
or
Plasma
|
|
1485-2
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
0.2
U/kg
secretin
|
|
14850-2
|
Nitrazepam
[Moles/volume]
in
Urine
|
|
14851-0
|
Norclozapine
[Moles/volume]
in
Serum
or
Plasma
|
|
14852-8
|
Norepinephrine
[Moles/volume]
in
Plasma
|
|
14853-6
|
Norepinephrine
[Moles/volume]
in
Urine
|
|
14854-4
|
Norepinephrine
[Moles/time]
in
24
hour
Urine
|
|
14855-1
|
Norfluoxetine
[Moles/volume]
in
Serum
or
Plasma
|
|
14856-9
|
Nortriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14857-7
|
Leukocytes
other/100
leukocytes
in
Pericardial
fluid
by
Manual
count
|
|
14858-5
|
Leukocytes
other/100
leukocytes
in
Pleural
fluid
by
Manual
count
|
|
14859-3
|
Leukocytes
other/100
leukocytes
in
Peritoneal
fluid
by
Manual
count
|
|
1486-0
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
0.2
U/kg
secretin
|
|
14860-1
|
Leukocytes
other/100
leukocytes
in
Synovial
fluid
by
Manual
count
|
|
14861-9
|
Oxalate
[Presence]
in
Stone
|
|
14862-7
|
Oxalate
[Moles/time]
in
24
hour
Urine
|
|
14863-5
|
Oxycodone
[Presence]
in
Gastric
fluid
|
|
14864-3
|
Oxygen
[Partial
pressure]
in
Cord
blood
|
|
14865-0
|
Parathyrin
[Interpretation]
in
Serum
or
Plasma
|
|
14866-8
|
Parathyrin.intact
[Moles/volume]
in
Serum
or
Plasma
|
|
14867-6
|
Paroxetine
[Moles/volume]
in
Serum
or
Plasma
|
|
14868-4
|
Pathologist
report
of
Plasma
or
RBC
tests
|
|
14869-2
|
Pathologist
review
of
Blood
tests
|
|
1487-8
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--25
minutes
post
0.2
U/kg
secretin
|
|
14870-0
|
Pentacarboxylate
[Moles/volume]
in
Plasma
|
|
14871-8
|
Pentacarboxylate
[Moles/volume]
in
Stool
|
|
14872-6
|
Pentacarboxylate
[Moles/volume]
in
Urine
|
|
14873-4
|
pH
of
Cord
blood
|
|
14874-2
|
Phenobarbital
[Moles/volume]
in
Serum
or
Plasma
|
|
14875-9
|
Phenylalanine
[Moles/volume]
in
Serum
or
Plasma
|
|
14876-7
|
Phenylpropanolamine
[Presence]
in
Gastric
fluid
|
|
14877-5
|
Phenytoin
[Moles/volume]
in
Serum
or
Plasma
|
|
14878-3
|
Phosphate
[Presence]
in
Stone
|
|
14879-1
|
Phosphate
[Moles/volume]
in
Serum
or
Plasma
|
|
1488-6
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.2
U/kg
secretin
|
|
14880-9
|
Deprecated
Phosphate
[Molecules/volume]
in
Urine
|
|
14881-7
|
Phosphate
[Moles/time]
in
24
hour
Urine
|
|
14882-5
|
Porphobilinogen
[Moles/time]
in
24
hour
Urine
|
|
14883-3
|
Porphyrins
[Interpretation]
in
Serum
or
Plasma
|
|
14884-1
|
Porphyrins
[Interpretation]
in
Stool
|
|
14885-8
|
Pregnanediol
[Moles/time]
in
24
hour
Urine
|
|
14886-6
|
Pregnanetriol
[Moles/time]
in
24
hour
Urine
|
|
14887-4
|
Primidone
[Moles/volume]
in
Serum
or
Plasma
|
|
14888-2
|
Procainamide
[Moles/volume]
in
Serum
or
Plasma
|
|
14889-0
|
Procainamide+N-acetylprocainamide
[Moles/volume]
in
Serum
or
Plasma
|
|
1489-4
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
0.2
U/kg
secretin
|
|
14890-8
|
Progesterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14891-6
|
Propranolol
[Moles/volume]
in
Serum
or
Plasma
|
|
14892-4
|
Propranolol
[Moles/volume]
in
Urine
|
|
14893-2
|
Propranolol
[Moles/time]
in
24
hour
Urine
|
|
14894-0
|
Propylene
glycol
[Presence]
in
Serum
or
Plasma
|
|
14895-7
|
Protein
Fractions
[Interpretation]
in
Serum
or
Plasma
by
Immunofixation
|
|
14896-5
|
Protein
Fractions
[Interpretation]
in
Urine
by
Immunofixation
|
|
14897-3
|
Deprecated
Protein
[Mass/volume]
in
Plasma
|
|
14898-1
|
Protriptyline
[Moles/volume]
in
Serum
or
Plasma
|
|
14899-9
|
Quinidine
[Moles/volume]
in
Serum
or
Plasma
|
|
149-5
|
Cephalexin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1490-2
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--pre
0.2
U/kg
secretin
|
|
14900-5
|
Ranitidine
[Presence]
in
Gastric
fluid
|
|
14901-3
|
Ranitidine
[Presence]
in
Serum
or
Plasma
|
|
14902-1
|
Ranitidine
[Presence]
in
Urine
|
|
14903-9
|
Folate
[Interpretation]
in
Blood
|
|
14904-7
|
Reagin
Ab
[Presence]
in
Unspecified
specimen
by
VDRL
|
|
14905-4
|
Retinol
[Moles/volume]
in
Serum
or
Plasma
|
|
14906-2
|
Rh
[Type]
in
Cord
blood
|
|
14907-0
|
Rh
[Type]
in
Blood
from
Blood
product
unit
|
|
14908-8
|
Rh
[Type]
in
Blood
from
newborn
|
|
14909-6
|
Salicylates
[Moles/volume]
in
Serum
or
Plasma
|
|
1491-0
|
Glucose
[Mass/volume]
in
Urine
--30
minutes
post
100
g
glucose
PO
|
|
14910-4
|
Serotonin
[Moles/volume]
in
Serum
|
|
14911-2
|
Sertraline
[Moles/volume]
in
Serum
or
Plasma
|
|
14912-0
|
Smudge
cells/100
leukocytes
in
Blood
by
Manual
count
|
|
14913-8
|
Testosterone
[Moles/volume]
in
Serum
or
Plasma
|
|
14914-6
|
Testosterone
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
14915-3
|
Theophylline
[Moles/volume]
in
Serum
or
Plasma
|
|
14916-1
|
Thiocyanate
[Moles/volume]
in
Serum
or
Plasma
|
|
14917-9
|
Thioridazine
[Moles/volume]
in
Serum
or
Plasma
|
|
14918-7
|
Thyroglobulin
[Moles/volume]
in
Serum
or
Plasma
|
|
14919-5
|
Thyrotropin
binding
inhibitory
immunoglobulins
[Presence]
in
Serum
|
|
1492-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
0.5
g/kg
glucose
IV
|
|
14920-3
|
Thyroxine
(T4)
free
[Moles/volume]
in
Serum
or
Plasma
|
|
14921-1
|
Thyroxine
(T4)
[Moles/volume]
in
Serum
or
Plasma
|
|
14922-9
|
Toxoplasma
gondii
IgA+IgE
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
14923-7
|
Toxoplasma
gondii
Ab
[Units/volume]
in
Unspecified
specimen
|
|
14924-5
|
Transfusion
reaction
[Interpretation]
in
Plasma
or
RBC
Narrative
|
|
14925-2
|
Trazodone
[Moles/volume]
in
Serum
or
Plasma
|
|
14926-0
|
Triazolam
[Moles/volume]
in
Serum
or
Plasma
|
|
14927-8
|
Triglyceride
[Moles/volume]
in
Serum
or
Plasma
|
|
14928-6
|
Triiodothyronine
(T3)
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
14929-4
|
Triiodothyronine
(T3).reverse
[Moles/volume]
in
Serum
or
Plasma
|
|
1493-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
0.05-0.15
U
insulin/kg
IV
12
hours
fasting
|
|
14930-2
|
Triiodothyronine
(T3)
[Moles/volume]
in
Serum
or
Plasma
|
|
14931-0
|
Trimipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
14932-8
|
Urate
[Presence]
in
Stone
|
|
14933-6
|
Urate
[Moles/volume]
in
Serum
or
Plasma
|
|
14934-4
|
Urate
[Moles/volume]
in
Urine
|
|
14935-1
|
Urate
[Moles/time]
in
24
hour
Urine
|
|
14936-9
|
Urea
nitrogen
[Moles/volume]
in
Peritoneal
dialysis
fluid
|
|
14937-7
|
Urea
nitrogen
[Moles/volume]
in
Serum
or
Plasma
|
|
14938-5
|
Urea
nitrogen
[Moles/volume]
in
Urine
|
|
14939-3
|
Urea
nitrogen
[Moles/time]
in
24
hour
Urine
|
|
1494-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
100
g
glucose
PO
|
|
14940-1
|
Uroporphyrin
1
isomer
[Moles/volume]
in
Serum
or
Plasma
|
|
14941-9
|
Uroporphyrin
1
isomer
[Moles/volume]
in
Stool
|
|
14942-7
|
Uroporphyrin
1
isomer
[Moles/volume]
in
Urine
|
|
14943-5
|
Uroporphyrin
3
isomer
[Moles/volume]
in
Serum
or
Plasma
|
|
14944-3
|
Uroporphyrin
3
isomer
[Moles/volume]
in
Stool
|
|
14945-0
|
Uroporphyrin
3
isomer
[Moles/volume]
in
Urine
|
|
14946-8
|
Valproate
[Moles/volume]
in
Serum
or
Plasma
|
|
14947-6
|
Vanillylmandelate
[Moles/time]
in
24
hour
Urine
|
|
14948-4
|
Vanillylmandelate/Creatinine
[Molar
ratio]
in
Urine
|
|
14949-2
|
Vasopressin
[Moles/volume]
in
Plasma
|
|
1495-1
|
Glucose
[Mass/volume]
in
Urine
--1.5
hours
post
100
g
glucose
PO
|
|
14950-0
|
Viscosity
of
Synovial
fluid
Qualitative
|
|
14951-8
|
Volatile
drugs
positive
[Identifier]
in
Serum
or
Plasma
by
Screen
method
|
|
14952-6
|
Xylose
[Moles/volume]
in
Blood
--1
hour
post
25
g
xylose
PO
|
|
14953-4
|
Xylose
[Moles/volume]
in
Blood
--2
hours
post
25
g
xylose
PO
|
|
14954-2
|
Xylose
[Moles/time]
in
5
hour
Urine
--post
dose
PO
|
|
14955-9
|
Zinc
[Moles/volume]
in
Serum
or
Plasma
|
|
14956-7
|
Microalbumin
[Mass/time]
in
24
hour
Urine
|
|
14957-5
|
Microalbumin
[Mass/volume]
in
Urine
|
|
14958-3
|
Microalbumin/Creatinine
[Mass
Ratio]
in
24
hour
Urine
|
|
14959-1
|
Microalbumin/Creatinine
[Mass
Ratio]
in
Urine
|
|
1496-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
75
g
glucose
PO
|
|
14960-9
|
Estradiol
(E2)
Free/Estradiol
(E2).total
in
Serum
or
Plasma
|
|
14961-7
|
CD10
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14962-5
|
CD13
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14963-3
|
CD14
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14964-1
|
CD19
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14965-8
|
CD2
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14966-6
|
CD20
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14967-4
|
CD33
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14968-2
|
CD5
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
14969-0
|
CD7
Abnormal
blood
cells/Abnormal
blood
cells.total
in
Blood
|
|
1497-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
insulin
IV
|
|
14970-8
|
Estrone
(E1).bioavailable
[Mass/volume]
in
Serum
or
Plasma
|
|
14971-6
|
Estrone
(E1).bioavailable/Estrone
(E1).total
in
Serum
or
Plasma
|
|
14972-4
|
Mycobacterium
sp
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
14973-2
|
Mycobacterium
sp
DNA
[Presence]
in
Sputum
by
Probe
and
target
amplification
method
|
|
14974-0
|
Mycobacterium
sp
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
14975-7
|
Human
antimouse
Ab
[Mass/volume]
in
Serum
|
|
14976-5
|
Lecithin/Sphingomyelin
[Ratio]
in
Amniotic
fluid
|
|
14977-3
|
Immunoglobulin
light
chains.free
[Type]
in
Urine
|
|
14978-1
|
Cyclosporine
[Mass/volume]
in
Blood
by
Immunoassay
|
|
14979-9
|
aPTT
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
1498-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
0.5
g/kg
glucose
IV
|
|
14980-7
|
A
variant
subtype
Ab
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
14981-5
|
A
variant
subtype
Ab
[Presence]
in
Serum
or
Plasma
from
donor
|
|
14982-3
|
A
variant
subtype
Ab
[Presence]
in
Serum
or
Plasma
|
|
14983-1
|
I
(intermediate)
subtype
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
14984-9
|
I
(intermediate)
subtype
[Presence]
on
Red
Blood
Cells
from
donor
|
|
14985-6
|
I
(intermediate)
subtype
[Presence]
on
Red
Blood
Cells
|
|
14986-4
|
little
i-1
subtype
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
14987-2
|
little
i-1
subtype
[Presence]
on
Red
Blood
Cells
from
donor
|
|
14988-0
|
little
i-1
subtype
[Presence]
on
Red
Blood
Cells
|
|
14989-8
|
little
i-2
subtype
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
1499-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
0.5
g/kg
glucose
IV
|
|
14990-6
|
little
i-2
subtype
[Presence]
on
Red
Blood
Cells
from
donor
|
|
14991-4
|
little
i-2
subtype
[Presence]
on
Red
Blood
Cells
|
|
14992-2
|
O
group
[Presence]
on
Red
Blood
Cells
from
Blood
product
unit
|
|
14993-0
|
O
group
[Presence]
on
Red
Blood
Cells
from
donor
|
|
14994-8
|
O
group
[Presence]
on
Red
Blood
Cells
|
|
14995-5
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
75
g
glucose
PO
|
|
14996-3
|
Glucose
[Moles/volume]
in
Serum
or
Plasma
--pre
75
g
glucose
PO
|
|
14997-1
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
TRH
IV
|
|
14998-9
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--1
hour
post
dose
TRH
IV
|
|
14999-7
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--baseline
|
|
15-8
|
Amoxicillin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
150-3
|
Cephalexin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1500-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
15000-3
|
Thyrotropin
[Units/volume]
in
Serum
or
Plasma
--pre
dose
TRH
IV
|
|
15001-1
|
Xylose
[Moles/volume]
in
Serum
or
Plasma
--1
hour
post
25
g
xylose
PO
|
|
15002-9
|
Xylose
[Moles/volume]
in
Serum
or
Plasma
--2
hours
post
25
g
xylose
PO
|
|
15003-7
|
11-Hydroxyandrosterone
[Moles/time]
in
24
hour
Urine
|
|
15004-5
|
11-Hydroxyetiocholanolone
[Moles/time]
in
24
hour
Urine
|
|
15005-2
|
11-Ketoandrosterone
[Moles/time]
in
24
hour
Urine
|
|
15006-0
|
11-Ketoetiocholanolone
[Moles/time]
in
24
hour
Urine
|
|
15007-8
|
2,3-Diphosphoglycerate
[Moles/volume]
in
Red
Blood
Cells
|
|
15008-6
|
3-Alpha-Androstanediol
glucuronide
[Moles/volume]
in
Serum
|
|
15009-4
|
5-Hydroxyindoleacetate
[Moles/volume]
in
Urine
|
|
1501-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
100
g
glucose
PO
|
|
15010-2
|
Aldosterone
[Moles/volume]
in
Urine
|
|
15011-0
|
Aldosterone
[Moles/volume]
in
Serum
or
Plasma
--supine
|
|
15012-8
|
Aldosterone
[Moles/volume]
in
Serum
or
Plasma
--upright
|
|
15013-6
|
Alkaline
phosphatase.bone/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15014-4
|
Alkaline
phosphatase.intestinal/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15015-1
|
Alkaline
phosphatase.liver/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15016-9
|
Alkaline
phosphatase.placental/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15017-7
|
Alkaline
phosphatase.regan/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15018-5
|
Alkaline
phosphatase.renal/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15019-3
|
Alpha-1-Fetoprotein
[Moles/volume]
in
Amniotic
fluid
|
|
1502-4
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
100
g
glucose
PO
|
|
15020-1
|
Amylase.P1/Amylase.total
in
Serum
or
Plasma
|
|
15021-9
|
Amylase.P2/Amylase.total
in
Serum
or
Plasma
|
|
15022-7
|
Amylase.P3/Amylase.total
in
Serum
or
Plasma
|
|
15023-5
|
Amylase
S1/Amylase.total
in
Serum
or
Plasma
|
|
15024-3
|
Amylase
S2/Amylase.total
in
Serum
or
Plasma
|
|
15025-0
|
Amylase
S3/Amylase.total
in
Serum
or
Plasma
|
|
15026-8
|
Androstanediol
[Moles/volume]
in
Serum
or
Plasma
|
|
15027-6
|
Androstenedione
[Moles/volume]
in
Urine
|
|
15028-4
|
Androstenedione
[Moles/time]
in
24
hour
Urine
|
|
15029-2
|
Androsterone
[Moles/volume]
in
Serum
or
Plasma
|
|
1503-2
|
Glucose
[Mass/volume]
in
Urine
--1
hour
post
100
g
glucose
PO
|
|
15030-0
|
Androsterone
[Moles/time]
in
24
hour
Urine
|
|
15031-8
|
Angiotensin
I
[Moles/volume]
in
Plasma
|
|
15032-6
|
Angiotensin
II
[Moles/volume]
in
Plasma
|
|
15033-4
|
Ascorbate
[Moles/time]
in
24
hour
Urine
|
|
15034-2
|
Bromide
[Moles/volume]
in
Serum
or
Plasma
|
|
15035-9
|
Calcitonin
[Moles/volume]
in
Serum
or
Plasma
|
|
15036-7
|
Catecholamines
[Moles/time]
in
24
hour
Urine
|
|
15037-5
|
Chymotrypsin
[Moles/mass]
in
Stool
|
|
15038-3
|
Citrate
[Moles/volume]
in
Serum
or
Plasma
|
|
15039-1
|
Deprecated
Cobalamin
[Molecules/volume]
in
Serum
|
|
1504-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
glucose
PO
|
|
15040-9
|
Coproporphyrin
[Moles/time]
in
24
hour
Stool
|
|
15041-7
|
Coproporphyrin
[Moles/time]
in
24
hour
Urine
|
|
15042-5
|
Corticotropin
[Units/volume]
in
Serum
|
|
15043-3
|
Cortisol
[Moles/volume]
in
Urine
|
|
15044-1
|
Cortisol
Free
[Moles/volume]
in
Serum
or
Plasma
|
|
15045-8
|
Creatine
[Moles/volume]
in
Serum
or
Plasma
|
|
15046-6
|
Creatine
[Moles/volume]
in
Urine
|
|
15047-4
|
Creatine
[Moles/time]
in
24
hour
Urine
|
|
15048-2
|
Creatine
kinase.BB/Creatine
kinase.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
15049-0
|
Creatine
kinase.MM/Creatine
kinase.total
in
Serum
or
Plasma
by
Electrophoresis
|
|
1505-7
|
Glucose
[Mass/volume]
in
Urine
--1
hour
post
50
g
glucose
PO
|
|
15050-8
|
Creatinine
[Moles/volume]
in
Amniotic
fluid
|
|
15051-6
|
Creatinine
[Moles/volume]
in
Dialysis
fluid
|
|
15052-4
|
Cobalamin
(Vitamin
B12).unsaturated
Binding
Capacity
[Moles/volume]
in
Serum
or
Plasma
|
|
15053-2
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Moles/time]
in
24
hour
Urine
|
|
15054-0
|
Dehydroepiandrosterone
(DHEA)
[Moles/volume]
in
Serum
or
Plasma
|
|
15055-7
|
Deoxypyridinoline
[Moles/time]
in
24
hour
Urine
|
|
15056-5
|
Deprecated
Deoxypyridinoline
[Molecules/time]
in
24
hour
Urine
|
|
15057-3
|
Androstanolone
[Moles/volume]
in
Serum
or
Plasma
|
|
15058-1
|
Dopamine
[Moles/volume]
in
Urine
|
|
15059-9
|
Dopamine
[Moles/time]
in
24
hour
Urine
|
|
1506-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
lactose
PO
|
|
15060-7
|
Enolase.neuron
specific
[Mass/volume]
in
Serum
or
Plasma
|
|
15061-5
|
Erythropoietin
(EPO)
[Units/volume]
in
Serum
or
Plasma
|
|
15062-3
|
Estradiol
(E2).unconjugated
[Moles/time]
in
24
hour
Urine
|
|
15063-1
|
Estriol
(E3).conjugated
[Moles/volume]
in
Serum
or
Plasma
|
|
15064-9
|
Estriol
(E3).unconjugated
[Moles/volume]
in
Serum
or
Plasma
|
|
15065-6
|
Etiocholanolone
[Moles/time]
in
24
hour
Urine
|
|
15066-4
|
Fatty
acids.nonesterified
[Moles/volume]
in
Serum
or
Plasma
|
|
15067-2
|
Follitropin
[Units/volume]
in
Serum
or
Plasma
|
|
15068-0
|
Follitropin
[Units]
in
24
hour
Urine
|
|
15069-8
|
Fructosamine
[Moles/volume]
in
Serum
or
Plasma
|
|
1507-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
75
g
glucose
PO
|
|
15070-6
|
Fructose
[Moles/time]
in
24
hour
Urine
|
|
15071-4
|
Galactose
[Moles/time]
in
24
hour
Urine
|
|
15072-2
|
Gastrin
[Moles/volume]
in
Serum
or
Plasma
|
|
15073-0
|
Glucagon
[Moles/volume]
in
Serum
or
Plasma
|
|
15074-8
|
Glucose
[Moles/volume]
in
Blood
|
|
15075-5
|
Glucose
[Moles/volume]
in
Dialysis
fluid
|
|
15076-3
|
Glucose
[Moles/volume]
in
Urine
|
|
15077-1
|
Glucose
[Moles/time]
in
24
hour
Urine
|
|
15078-9
|
Lactate
[Moles/time]
in
24
hour
Urine
|
|
15079-7
|
Lutropin
[Units/volume]
in
Urine
|
|
1508-1
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
75
g
glucose
PO
|
|
15080-5
|
Lutropin
[Units]
in
24
hour
Urine
|
|
15081-3
|
Prolactin
[Units/volume]
in
Serum
or
Plasma
|
|
15082-1
|
Methemoglobin
[Mass/volume]
in
Blood
|
|
15083-9
|
Normetanephrine
[Moles/time]
in
24
hour
Urine
|
|
15084-7
|
Osteocalcin
[Moles/volume]
in
Serum
or
Plasma
|
|
15085-4
|
Oxalate
[Moles/volume]
in
Serum
or
Plasma
|
|
15086-2
|
Oxalate
[Moles/volume]
in
Urine
|
|
15087-0
|
Parathyrin
related
protein
[Moles/volume]
in
Serum
or
Plasma
|
|
15088-8
|
Parathyrin.C-terminal
[Moles/volume]
in
Serum
or
Plasma
|
|
15089-6
|
Phospholipid
[Moles/volume]
in
Serum
or
Plasma
|
|
1509-9
|
Glucose
[Mass/volume]
in
Urine
--1
hour
post
75
g
glucose
PO
|
|
15090-4
|
Porphyrins
[Moles/time]
in
24
hour
Stool
|
|
15091-2
|
Pregnanediol
[Moles/volume]
in
Urine
|
|
15092-0
|
Pregnanetriol
[Moles/volume]
in
Urine
|
|
15093-8
|
Protoporphyrin
Free
[Moles/volume]
in
Blood
|
|
15094-6
|
Testosterone
[Moles/volume]
in
Urine
|
|
15095-3
|
Testosterone
[Moles/time]
in
24
hour
Urine
|
|
15096-1
|
Uroporphyrin
[Moles/time]
in
24
hour
Urine
|
|
15097-9
|
Vanillylmandelate
[Moles/volume]
in
Urine
|
|
15098-7
|
Amikacin
[Moles/volume]
in
Serum
or
Plasma
--random
|
|
15099-5
|
Amiodarone
[Moles/volume]
in
Serum
or
Plasma
|
|
151-1
|
Cephalexin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1510-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
15100-1
|
Barbiturates
[Moles/volume]
in
Serum
or
Plasma
|
|
15101-9
|
Chloramphenicol
[Moles/volume]
in
Serum
or
Plasma
|
|
15102-7
|
Codeine
[Moles/volume]
in
Serum
or
Plasma
|
|
15103-5
|
Cyclosporine
[Moles/volume]
in
Serum
|
|
15104-3
|
Digitoxin
[Moles/volume]
in
Serum
or
Plasma
|
|
15105-0
|
Flecainide
[Moles/volume]
in
Serum
or
Plasma
|
|
15106-8
|
Gentamicin
[Moles/volume]
in
Serum
or
Plasma
--random
|
|
15107-6
|
Imipramine
[Moles/volume]
in
Serum
or
Plasma
|
|
15108-4
|
Methadone
[Moles/volume]
in
Serum
or
Plasma
|
|
15109-2
|
Midazolam
[Moles/volume]
in
Serum
or
Plasma
|
|
1511-5
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
15110-0
|
Morphine
[Moles/volume]
in
Serum
or
Plasma
|
|
15111-8
|
Tricyclic
antidepressants
[Moles/volume]
in
Serum
or
Plasma
|
|
15112-6
|
Leukocyte
phosphatase
[Units/volume]
in
Leukocytes
|
|
15113-4
|
Aluminum
[Moles/volume]
in
Dialysis
fluid
|
|
15114-2
|
Arsenic
[Moles/volume]
in
Blood
|
|
15115-9
|
Arsenic
[Moles/volume]
in
Urine
|
|
15116-7
|
Deprecated
Arsenic
[Molecules/volume]
in
Urine
|
|
15117-5
|
Cadmium
[Moles/volume]
in
Blood
|
|
15118-3
|
Chromium
[Moles/volume]
in
Blood
|
|
15119-1
|
Cobalt
[Moles/volume]
in
Blood
|
|
1512-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--1
minute
post
0.5
g/kg
glucose
IV
|
|
15120-9
|
Ethanol
[Moles/volume]
in
Blood
|
|
15121-7
|
Lipoprotein.alpha/total
Lipoprotein
in
Serum
or
Plasma
|
|
15122-5
|
Lipoprotein.beta/total
Lipoprotein
in
Serum
or
Plasma
|
|
15123-3
|
Lipoprotein.pre-beta/total
Lipoprotein
in
Serum
or
Plasma
|
|
15124-1
|
Albumin/Protein.total
in
Synovial
fluid
by
Electrophoresis
|
|
15125-8
|
Alpha
1
globulin/Protein.total
in
Synovial
fluid
by
Electrophoresis
|
|
15126-6
|
Alpha
2
globulin/Protein.total
in
Synovial
fluid
by
Electrophoresis
|
|
15127-4
|
Beta
globulin/Protein.total
in
Synovial
fluid
by
Electrophoresis
|
|
15128-2
|
Gamma
globulin/Protein.total
in
Synovial
fluid
by
Electrophoresis
|
|
15129-0
|
Deprecated
Fibrin
D-dimer
EIA
|
|
1513-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
0.5
g/kg
glucose
IV
|
|
15130-8
|
Methionine+Tryptophan
[Presence]
in
Serum
or
Plasma
|
|
15131-6
|
Isoleucine+Leucine
[Presence]
in
Serum
or
Plasma
|
|
15132-4
|
Beta
aminoisobutyrate+Proline
[Presence]
in
Serum
or
Plasma
|
|
15133-2
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine
[Presence]
in
Serum
or
Plasma
|
|
15134-0
|
Glutamate+Glutamine+Threonine
[Presence]
in
Serum
or
Plasma
|
|
15135-7
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline
[Presence]
in
Serum
or
Plasma
|
|
15136-5
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine
[Presence]
in
Serum
or
Plasma
|
|
15137-3
|
Alanine+Ethanolamine
[Presence]
in
Serum
or
Plasma
|
|
15138-1
|
Isoleucine+Leucine
[Presence]
in
Urine
|
|
15139-9
|
Anserine+Carnosine+Cysteine+Histidine+Ornithine
[Presence]
in
Urine
|
|
1514-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
100
g
glucose
PO
|
|
15140-7
|
Arginine+Argininosuccinate+Lysine+Serine+Taurine
[Presence]
in
Urine
|
|
15141-5
|
Beta
aminoisobutyrate+Proline
[Presence]
in
Urine
|
|
15142-3
|
Alanine+Ethanolamine
[Presence]
in
Urine
|
|
15143-1
|
Aspartate+Citrulline+Glycine+Homocystine+Hydroxyproline
[Presence]
in
Urine
|
|
15144-9
|
Glutamate+Glutamine+Threonine
[Presence]
in
Urine
|
|
15145-6
|
Methionine+Tryptophan
[Presence]
in
Urine
|
|
15146-4
|
Acetone
[Units/volume]
in
Body
fluid
|
|
15147-2
|
Deprecated
Acetone
[Units]
in
24
hour
Urine
Qualitative
|
|
15148-0
|
Alkaline
phosphatase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
15149-8
|
Ammonia
[Moles/volume]
in
Body
fluid
|
|
1515-6
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
100
g
glucose
PO
|
|
15150-6
|
Anisocytosis
[Presence]
in
Blood
by
Automated
count
|
|
15151-4
|
Aspergillus
fumigatus
3
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15152-2
|
Bilirubin.conjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
15153-0
|
Deprecated
Indirect
bilirubin
[Mass/volume]
in
Serum
or
Plasma
|
|
15154-8
|
Blasts
[Presence]
in
Blood
by
Automated
count
|
|
15155-5
|
Calcium
[Mass/volume]
in
Body
fluid
|
|
15156-3
|
Cancer
Ag
125
[Units/volume]
in
Body
fluid
by
Dilution
|
|
15157-1
|
Cancer
Ag
125
[Units/volume]
in
Serum
or
Plasma
by
Dilution
|
|
15158-9
|
Chloride
[Moles/volume]
in
Stool
|
|
15159-7
|
Coagulation
factor
extrinsic
pathway
[Interpretation]
in
Platelet
poor
plasma
Narrative
|
|
1516-4
|
Glucose
[Mass/volume]
in
Urine
--2
hours
post
100
g
glucose
PO
|
|
15160-5
|
Coagulation
factor
Intrinsic
Factor
[Interpretation]
in
Platelet
poor
plasma
Narrative
|
|
15161-3
|
Complement
C1
esterase
inhibitor.functional
[Presence]
in
Serum
or
Plasma
|
|
15162-1
|
Complement
C1q
[Mass/volume]
in
Body
fluid
|
|
15163-9
|
Complement
C2
[Mass/volume]
in
Body
fluid
|
|
15164-7
|
Complement
C3
[Mass/volume]
in
Synovial
fluid
|
|
15165-4
|
Complement
C4
[Mass/volume]
in
Synovial
fluid
|
|
15166-2
|
Complement
C5
[Mass/volume]
in
Body
fluid
|
|
15167-0
|
Complement
C6
[Mass/volume]
in
Body
fluid
|
|
15168-8
|
Complement
total
hemolytic
C50
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
15169-6
|
Complement
total
hemolytic
C50
[Units/volume]
in
Serum
or
Plasma
by
Immunoassay
|
|
1517-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
50
g
lactose
PO
|
|
15170-4
|
Complement
total
hemolytic
C50
[Units/volume]
in
Synovial
fluid
by
Immunoassay
|
|
15171-2
|
Cryoglobulin.IgA
[Units/volume]
in
Serum
|
|
15172-0
|
Cryoglobulin.IgG
[Units/volume]
in
Serum
|
|
15173-8
|
Cryoglobulin.IgM
[Units/volume]
in
Serum
|
|
15174-6
|
Cryocrit
of
Serum
by
Spun
Westergren
|
|
15175-3
|
Cryoproteins
[Interpretation]
in
Serum
or
Plasma
by
Electrophoresis
agarose
gel
|
|
15176-1
|
Cryoproteins
identified
in
Serum
or
Plasma
|
|
15177-9
|
DNA
double
strand
Ab
[Units/volume]
in
Body
fluid
|
|
15178-7
|
Complement
factor
B
[Mass/volume]
in
Body
fluid
|
|
15179-5
|
Fibrin
D-dimer
[Presence]
in
Platelet
poor
plasma
|
|
1518-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
75
g
glucose
PO
|
|
15180-3
|
Hypochromia
[Presence]
in
Blood
by
Automated
count
|
|
15181-1
|
IgA
[Mass/volume]
in
Body
fluid
|
|
15182-9
|
IgA
[Presence]
in
Serum
by
Immunoelectrophoresis
|
|
15183-7
|
IgG
[Mass/volume]
in
Body
fluid
|
|
15184-5
|
IgG
[Presence]
in
Serum
by
Immunoelectrophoresis
|
|
15185-2
|
IgM
[Mass/volume]
in
Body
fluid
|
|
15186-0
|
IgM
[Presence]
in
Serum
by
Immunoelectrophoresis
|
|
15187-8
|
Immunoglobulin
light
chains.lambda
[Mass/volume]
in
24
hour
Urine
|
|
15188-6
|
Immunoglobulin
light
chains.kappa
[Mass/volume]
in
24
hour
Urine
|
|
15189-4
|
Immunoglobulin
light
chains.kappa/Immunoglobulin
light
chains.lambda
[Mass
Ratio]
in
Serum
|
|
1519-8
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
75
g
glucose
PO
|
|
15190-2
|
Leukocytes
other
[Identifier]
in
Blood
by
Automated
count
|
|
15191-0
|
Lupus
anticoagulant
neutralization
dilute
phospholipid
[Presence]
in
Platelet
poor
plasma
|
|
15192-8
|
Variant
lymphocytes
[Presence]
in
Blood
by
Automated
count
|
|
15193-6
|
CD3-CD16+
cells
[#/volume]
in
Blood
|
|
15194-4
|
CD3-CD16+
cells/100
cells
in
Blood
|
|
15195-1
|
CD3-CD19+
cells
[#/volume]
in
Blood
|
|
15196-9
|
CD3-CD19+
cells/100
cells
in
Blood
|
|
15197-7
|
Lymphocytes
clefted/100
leukocytes
in
Blood
by
Manual
count
|
|
15198-5
|
Macrocytes
[Presence]
in
Blood
by
Automated
count
|
|
15199-3
|
Microcytes
[Presence]
in
Blood
by
Automated
count
|
|
152-9
|
Cephaloglycin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1520-6
|
Glucose
[Mass/volume]
in
Urine
--2
hours
post
75
g
glucose
PO
|
|
15200-9
|
Osmolality
of
Body
fluid
|
|
15201-7
|
Platelets
Large
Fragments
[#/volume]
in
Blood
by
Manual
count
|
|
15202-5
|
Potassium
[Moles/volume]
in
Stool
|
|
15203-3
|
Rheumatoid
factor
[Units/volume]
in
Body
fluid
by
Nephelometry
|
|
15204-1
|
Rheumatoid
factor
[Titer]
in
Serum
by
Nephelometry
|
|
15205-8
|
Rheumatoid
factor
[Units/volume]
in
Serum
by
Nephelometry
|
|
15206-6
|
Rheumatoid
factor
[Units/volume]
in
Synovial
fluid
by
Nephelometry
|
|
15207-4
|
Sodium
[Moles/volume]
in
Stool
|
|
15208-2
|
Taurine
[Presence]
in
Nose
|
|
15209-0
|
Saccharomonospora
viridis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
1521-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
meal
|
|
15210-8
|
Thyroglobulin
Ab
[Presence]
in
Serum
|
|
15211-6
|
Biopsy
[Interpretation]
in
Thyroid
Narrative
|
|
15212-4
|
Lipase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
15213-2
|
Epidermal
Allergen
Mix
2
(Cat
dander+Dog
dander+Guinea
pig
epithelium+Mouse+Rat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15214-0
|
Epidermal
Allergen
Mix
70
(Guinea
pig
epithelium+Hamster
epithelium+Mouse+Rabbit
epithelium+Rat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15215-7
|
Epidermal
Allergen
Mix
71
(Chicken
feather+Duck
feather+Goose
feather+Turkey
feather)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15216-5
|
Epidermal
Allergen
Mix
72
(Budgerigar
feather+Canary
feather+Finch
feather+Parakeet
feather+Parrot
feather)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15217-3
|
Food
Allergen
Mix
1
(Peanut+Brazil
nut+Coconut+Hazelnut+Almond)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15218-1
|
Food
Allergen
Mix
2
(Cod+Blue
Mussel+Shrimp+Salmon+Tuna)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15219-9
|
Food
Allergen
Mix
3
(Oat+Buckwheat+Sesame
seed+Wheat+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1522-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.5
g/kg
glucose
IV
|
|
15220-7
|
Food
Allergen
Mix
A
(Peanut+Cow
milk+Egg
white+Soybean+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15221-5
|
Food
Allergen
Mix
F
(Buckwheat+Soybean+Rice+Sesame
seed+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15222-3
|
Food
Allergen
Mix
E
(Crab+Buckwheat+Shrimp+Sesame
seed+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15223-1
|
Food
Allergen
Mix
B
(Tarragon+Lovage+Marjoram)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15224-9
|
Food
Allergen
Mix
71
(Caraway+Cardamon+Mace+Clove)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15225-6
|
Food
Allergen
Mix
72
(Fennel
seed+Basil+Anise+Ginger)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15226-4
|
Food
Allergen
Mix
G
(Beef+Chicken
meat+Pork+Plaice)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15227-2
|
Food
Allergen
Mix
74
(Herring+Cod+Plaice+Mackerel)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15228-0
|
Grass
Allergen
Mix
4
(Sweet
vernal
grass+Velvet
grass+Perennial
rye
grass+Common
reed+Rye)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15229-8
|
Grass
Allergen
Mix
3
(Sweet
vernal
grass+Perennial
rye
grass+Timothy+Rye+Velvet
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1523-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.05-0.15
U
insulin/kg
IV
post
12H
CFst
|
|
15230-6
|
Grass
Allergen
Mix
C
(Brome+Bermuda
grass+Velvet
grass+Bahia
grass+Timothy+Johnson
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15231-4
|
Dust
Allergen
Mix
A
(Cockroach+American
house
dust
mite+European
house
dust
mite+House
dust
Greer)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15232-2
|
Regional
Allergen
Mix
A
(Common
ragweed+Mugwort+Japenese
cedar+Orchard
grass+Timothy)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15233-0
|
Mold
Allergen
Mix
A
(Alternaria
alternata+Aspergillus
fumigatus+Candida
albicans+Setomelanomma
rostrata+Penicillium
notatum)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15234-8
|
Mold
Allergen
Mix
2
(Alternaria
alternata+Aspergillus
fumigatus+Candida
albicans+Cladosporium
herbarum+Setomelanomma
rostrata+Penicillium
notatum)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15235-5
|
Occupational
Allergen
Mix
1
(Chicken
feather+Cow
dander+Goose
feather+Horse
dander)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15236-3
|
Occupational
Allergen
Mix
2
(Acarus
siro+Lepidoglyphus
destructor+Horse
bot
fly+Grain
weevel)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15237-1
|
Occupational
Allergen
Mix
3
(Alternaria
alternata+Aspergillus
fumigatus+rye
pollen+wheat
pollen)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15238-9
|
Occupational
Allergen
Mix
4
(Amylase+Soybean+Grain
weevel+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15239-7
|
Occupational
Allergen
Mix
5
(Isocyanate
HDI+MDI+TDI+Phthalic
anhydride)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1524-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
0.1
U/kg
insulin
|
|
15240-5
|
Occupational
Allergen
Mix
6
(Chloramin
T+Ethylene
oxide+Formaldehyde+Phthalic
anhydride)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15241-3
|
Food
Allergen
Mix
10
(Beef+Chicken
meat+Egg
yolk+Pork+Turkey
meat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15242-1
|
Food
Allergen
Mix
11
(Broccoli+Carrot+White
bean+Peas+Corn)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15243-9
|
Food
Allergen
Mix
12
(Mushroom+Pumpkin+Rice+Rye+Potato)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15244-7
|
Food
Allergen
Mix
13
(Carrot+White
bean+Peas+Potato)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15245-4
|
Food
Allergen
Mix
14
(Cabbage+Paprika+Tomato+Spinach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15246-2
|
Food
Allergen
Mix
15
(Orange+Apple+Banana+Peach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15247-0
|
Food
Allergen
Mix
H
(Pineapple+Lemon+Strawberry+Avocado)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15248-8
|
Food
Allergen
Mix
18
(Peanut+Soybean+Peas)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15249-6
|
Food
Allergen
Mix
19
(Cucumber+Carrot+Potato+Spinach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1525-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
100
g
glucose
PO
|
|
15250-4
|
Food
Allergen
Mix
20
(Barley+Rice+Rye+Wheat)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15251-2
|
Food
Allergen
Mix
21
(Kiwi+Pineapple+Melon+Banana+Peach)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15252-0
|
Food
Allergen
Mix
22
(Cashew+Pecan
or
Hickory
nut+Walnut+Pistachio)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15253-8
|
Food
Allergen
Mix
7
(Onion+Garlic+Celery+Tomato+Yeast)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15254-6
|
Food
Allergen
Mix
8
(Brazil
nut+Orange+Hazelnut+Apple+Cocoa)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15255-3
|
Food
Allergen
Mix
9
(Kiwi+Melon+Banana+Almond+Grape)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15256-1
|
Regional
Allergen
Mix
1
(Mugwort+Silver
birch+Pellitory+Timothy+English
plantain)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15257-9
|
Regional
Allergen
Mix
2
(Alternaria
alternata+Cat
dander+American
house
dust
mite+Dog
dander+Horse
dander)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15258-7
|
Regional
Allergen
Mix
B
(Common
ragweed+Goosefoot
or
Lambs
quarters+Bermuda
grass+Perennial
rye
grass+Bahia
grass)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15259-5
|
Regional
Allergen
Mix
4
(Bermuda
grass+Perennial
rye
grass+Brome+Common
ragweed+Mugwort+English
plantain)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1526-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
50
g
lactose
PO
|
|
15260-3
|
Tree
Allergen
Mix
10
(Grey
alder+Silver
birch+Hazelnut+White
ash)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15261-1
|
Weed
Allergen
Mix
209
(Common
ragweed+Western
ragweed+Giant
ragweed)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15262-9
|
Tree
Allergen
Mix
1
(Boxelder+Silver
birch+White
oak+White
elm+California
walnut)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15263-7
|
Tree
Allergen
Mix
D
(Cottonwood+Elm+Maple+Oak+Pecan
tree)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15264-5
|
Tree
Allergen
Mix
3
(Mountain
juniper+White
oak+White
elm+Cottonwood+Mesquite)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15265-2
|
Tree
Allergen
Mix
E
(American
sycamore+Cottonwood+White
oak+Willow+White
elm)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15266-0
|
Tree
Allergen
Mix
5
(Grey
alder+Hazelnut+White
elm+Willow+Cottonwood)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15267-8
|
Tree
Allergen
Mix
6
(Boxelder+Silver
birch+American
beech+White
oak+California
walnut)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15268-6
|
Tree
Allergen
Mix
7
(Olive+Willow+Eastern
white
pine+Eucalyptus
spp+Wattle+Cajeput)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15269-4
|
Tree
Allergen
Mix
9
(Grey
alder+Silver
birch+Hazelnut+White
oak+Willow)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
1527-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
75
g
glucose
PO
|
|
15270-2
|
Tree
Allergen
Mix
8
(Boxelder+Silver
birch+Hazelnut+White
oak+London
plane
or
Maple
leaf
sycamore)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15271-0
|
Weed
Allergen
Mix
1
(Common
ragweed+Mugwort+Goosefoot
or
Lambs
quarters+English
plantain+Saltwort)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15272-8
|
Weed
Allergen
Mix
2
(Western
ragweed+Mugwort+Lenscale+Goosefoot
or
Lambs
quarters+English
plantain)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15273-6
|
Weed
Allergen
Mix
3
(Mugwort+Goosefoot
or
Lambs
quarters+English
plantain+Goldenrod+Nettle)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15274-4
|
Weed
Allergen
Mix
5
(Common
ragweed+Mugwort+Ox-eye
daisy+Dandelion+Goldenrod)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15275-1
|
Weed
Allergen
Mix
6
(English
plantain+Goosefoot
or
Lambs
quarters+Saltwort+Sheep
sorrel)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15276-9
|
Weed
Allergen
Mix
7
(Ox-eye
daisy+Dandelion+English
plantain+Goosefoot
or
Lambs
quarters+Goldenrod)
IgE
Ab
[Presence]
in
Serum
by
Multidisk
|
|
15277-7
|
Deprecated
Turkey
feather
IgE
Ab
[Units/volume]
in
Serum
|
|
15278-5
|
Lovage
IgE
Ab
[Units/volume]
in
Serum
|
|
15279-3
|
Cardamon
IgE
Ab
[Units/volume]
in
Serum
|
|
1528-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
15280-1
|
Mace
IgE
Ab
[Units/volume]
in
Serum
|
|
15281-9
|
Horse
Bot
Fly
IgE
Ab
[Units/volume]
in
Serum
|
|
15282-7
|
Deprecated
Cultivated
Rye
IgE
Ab
[Units/volume]
in
Serum
|
|
15283-5
|
Silver
Birch
IgE
Ab
[Units/volume]
in
Serum
|
|
15284-3
|
Grey
Alder
IgE
Ab
[Units/volume]
in
Serum
|
|
15285-0
|
London
Plane
IgE
Ab
[Units/volume]
in
Serum
|
|
15286-8
|
Kidney
-
left
Height
by
US
|
|
15287-6
|
Kidney
-
left
Width
by
US
|
|
15288-4
|
Kidney
-
left
Length
by
US
|
|
15289-2
|
Kidney
-
right
Height
by
US
|
|
1529-7
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
15290-0
|
Kidney
-
right
Width
by
US
|
|
15291-8
|
Kidney
-
right
Length
by
US
|
|
15292-6
|
Testis
-
left
Height
by
US
|
|
15293-4
|
Testis
-
left
Width
by
US
|
|
15294-2
|
Testis
-
left
Length
by
US
|
|
15295-9
|
Testis
-
right
Height
by
US
|
|
15296-7
|
Testis
-
right
Width
by
US
|
|
15297-5
|
Testis
-
right
Length
by
US
|
|
15298-3
|
Urinary
bladder
Height
by
US
|
|
15299-1
|
Urinary
bladder
Width
by
US
|
|
153-7
|
Cephaloglycin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1530-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
100
g
glucose
PO
|
|
15300-7
|
Urinary
bladder
Length
by
US
|
|
15301-5
|
Prostate
Height
by
US
|
|
15302-3
|
Prostate
Width
by
US
|
|
15303-1
|
Prostate
Length
by
US
|
|
15304-9
|
Kidney
-
left
Volume
by
derived
from
height,
width
and
length
(US)
|
|
15305-6
|
Kidney
-
right
Volume
by
derived
from
height,
width
and
length
(US)
|
|
15306-4
|
Testis
-
left
Volume
by
derived
from
height,
width
and
length
(US)
|
|
15307-2
|
Testis
-
right
Volume
by
derived
from
height,
width
and
length
(US)
|
|
15308-0
|
Prostate
Volume
by
derived
from
height,
width
and
length
(US)
|
|
15309-8
|
Urinary
bladder
Volume
by
derived
from
height,
width
and
length
(US)
|
|
1531-3
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
100
g
glucose
PO
|
|
15310-6
|
Kidney
-
left
Volume
by
derived.from
ROT
(US)
|
|
15311-4
|
Kidney
-
right
Volume
by
derived.from
ROT
(US)
|
|
15312-2
|
Testis
-
left
Volume
by
derived.from
ROT
(US)
|
|
15313-0
|
Testis
-
right
Volume
by
derived.from
ROT
(US)
|
|
15314-8
|
Prostate
Volume
by
derived.from
ROT
(US)
|
|
15315-5
|
Prostate
Volume
by
derived
by
planimetry
(US)
|
|
15316-3
|
Volume
planimetry
Stepsize
by
-
Reported
|
|
15317-1
|
Kidney
-
left
Volume
by
derived
by
automated
ultrasound
testing
(US)
|
|
15318-9
|
Kidney
-
right
Volume
by
derived
by
automated
ultrasound
testing
(US)
|
|
15319-7
|
Testis
-
left
Volume
by
derived
by
automated
ultrasound
testing
(US)
|
|
1532-1
|
Glucose
[Mass/volume]
in
Urine
--3
hours
post
100
g
glucose
PO
|
|
15320-5
|
Testis
-
right
Volume
by
derived
by
automated
ultrasound
testing
(US)
|
|
15321-3
|
Urinary
bladder
Volume
by
derived
by
EMP
(US)
|
|
15323-9
|
Prostate
specific
Ag/Prostate
volume
calculated
from
height,
width
and
length
|
|
15324-7
|
Prostate
specific
Ag/Prostate
volume
calculated
from
planimetry
|
|
15325-4
|
Prostate
specific
Ag/Prostate
volume
calculated
|
|
15326-2
|
Prostate
Adenoma
Volume
by
derived
from
height,
width
and
length
(US)
|
|
15327-0
|
Prostate
Adenoma
Volume
by
derived
by
planimetry
(US)
|
|
15328-8
|
Penile
cavernosal
artery
Peak
systolic
flow-baseline-
by
US.doppler
|
|
15329-6
|
Penile
cavernosal
artery
Peak
systolic
flow-post
XXX
challenge-
by
US.doppler
|
|
1533-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
75
g
glucose
PO
|
|
15330-4
|
Penile
cavernosal
artery
End
diastolic
blood
flow-baseline-
by
US.doppler
|
|
15331-2
|
Penile
cavernosal
artery
End
diastolic
blood
flow-post
XXX
challenge-
by
US.doppler
|
|
15332-0
|
Penile
cavernosal
artery
Resistance
index-baseline-
by
US.calculated
|
|
15333-8
|
Penile
cavernosal
artery
Resistance
index-post
XXX
challenge-
by
US.calculated
|
|
15334-6
|
Challenge
|
|
15335-3
|
Penile
cavernosal
artery
Pulsativity
index
by
US.calculated
|
|
15336-1
|
Other
Antibiotic
[Susceptibility]
by
Serum
bactericidal
titer
|
|
15337-9
|
Other
Antibiotic
[Susceptibility]
by
Serum
bactericidal
titer
--peak
|
|
15338-7
|
Other
Antibiotic
[Susceptibility]
by
Serum
bactericidal
titer
--trough
|
|
15339-5
|
Berlin
Beetle
IgE
Ab
[Units/volume]
in
Serum
|
|
1534-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
minutes
post
0.5
g/kg
glucose
IV
|
|
15340-3
|
Italian
Cedar
IgE
Ab
[Units/volume]
in
Serum
|
|
15341-1
|
Black
Fly
IgE
Ab
[Units/volume]
in
Serum
|
|
15342-9
|
European
Hornet
IgE
Ab
[Units/volume]
in
Serum
|
|
15343-7
|
Blood
group
antibody
screen
[Titer]
in
Serum
or
Plasma
|
|
15344-5
|
little
i
Ab
[Titer]
in
Serum
or
Plasma
|
|
15345-2
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
15346-0
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
15347-8
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
15348-6
|
Alkaline
phosphatase.liver
1/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
15349-4
|
Alkaline
phosphatase.liver
2/Alkaline
phosphatase.total
in
Serum
or
Plasma
|
|
1535-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--40
minutes
post
0.5
g/kg
glucose
IV
|
|
15350-2
|
Amylase
[Enzymatic
activity/time]
in
2
hour
Urine
|
|
15351-0
|
Apolipoprotein
E2
[Presence]
in
Blood
|
|
15352-8
|
Apolipoprotein
E3
[Presence]
in
Blood
|
|
15353-6
|
Apolipoprotein
E4
[Presence]
in
Blood
|
|
15354-4
|
Bombesin
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
15355-1
|
Estrone
sulfate
[Mass/volume]
in
Serum
or
Plasma
|
|
15356-9
|
Globulin
[Mass/time]
in
24
hour
Urine
|
|
15357-7
|
Iron
[Mass/mass]
in
Tissue
|
|
15358-5
|
Macroamylase
[Presence]
in
Serum
or
Plasma
|
|
15359-3
|
dRVVT
actual/normal
(normalized
LA
screen)
|
|
1536-2
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
dose
insulin
IV
|
|
15360-1
|
dRVVT
actual/normal
[Presence]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
15361-9
|
aPTT.factor
substitution
in
Platelet
poor
plasma
by
Coagulation
assay
--immediately
after
1:4
addition
of
normal
plasma
|
|
15362-7
|
aPTT.inhibitor
sensitive
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
15363-5
|
Busulfan
[Mass/volume]
in
Serum
or
Plasma
|
|
15364-3
|
Codeine
[Mass/volume]
in
Meconium
|
|
15365-0
|
Deprecated
Codeine
|
|
15366-8
|
Dextroamphetamine
[Mass/volume]
in
Urine
|
|
15367-6
|
Ganciclovir
[Mass/volume]
in
Serum
or
Plasma
|
|
15368-4
|
Hypoglycemics.sulfonyluric
[Identifier]
in
Serum
or
Plasma
|
|
15369-2
|
Lithium.saliva/Lithium.serum
|
|
1537-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
100
g
glucose
PO
|
|
15370-0
|
Morphine
[Mass/volume]
in
Meconium
|
|
15371-8
|
Deprecated
Morphine
|
|
15372-6
|
Nordiazepam
[Mass/volume]
in
Urine
|
|
15373-4
|
Phenyltoloxamine
[Mass/volume]
in
Blood
|
|
15374-2
|
Sulfonylurea
[Presence]
in
Serum
or
Plasma
|
|
15375-9
|
Valproate
Free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
15376-7
|
Spermatozoa
Abnormal/100
spermatozoa
in
Semen
|
|
15377-5
|
Cytomegalovirus
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
15378-3
|
Fungus
identified
in
Isolate
by
Culture
|
|
15379-1
|
Haemophilus
influenzae
B
Ag
[Presence]
in
Urine
|
|
1538-8
|
Glucose
[Mass/volume]
in
Urine
--4
hours
post
100
g
glucose
PO
|
|
15380-9
|
Leishmania
brasilensis
IgG
Ab
[Titer]
in
Serum
|
|
15381-7
|
Leishmania
brasilensis
IgM
Ab
[Titer]
in
Serum
|
|
15382-5
|
Leishmania
donovani
IgG
Ab
[Titer]
in
Serum
|
|
15383-3
|
Leishmania
donovani
IgM
Ab
[Titer]
in
Serum
|
|
15384-1
|
Leishmania
mexicana
IgG
Ab
[Titer]
in
Serum
|
|
15385-8
|
Leishmania
mexicana
IgM
Ab
[Titer]
in
Serum
|
|
15386-6
|
Leishmania
tropica
IgG
Ab
[Titer]
in
Serum
|
|
15387-4
|
Leishmania
tropica
IgM
Ab
[Titer]
in
Serum
|
|
15388-2
|
Mycoplasma
hominis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
15389-0
|
Parainfluenza
virus
1
IgG
Ab
[Presence]
in
Serum
|
|
1539-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
75
g
glucose
PO
|
|
15390-8
|
Parainfluenza
virus
1
IgM
Ab
[Presence]
in
Serum
|
|
15391-6
|
Parainfluenza
virus
1
IgM
Ab
[Titer]
in
Serum
|
|
15392-4
|
Parainfluenza
virus
2
IgG
Ab
[Presence]
in
Serum
|
|
15393-2
|
Parainfluenza
virus
2
IgM
Ab
[Titer]
in
Serum
|
|
15394-0
|
Parainfluenza
virus
3
IgG
Ab
[Presence]
in
Serum
|
|
15395-7
|
Parainfluenza
virus
3
IgM
Ab
[Presence]
in
Serum
|
|
15396-5
|
Deprecated
Toxoplasma
gondii
IgG
Ab
[Units/volume]
in
Serum
|
|
15397-3
|
Trypanosoma
cruzi
IgM
Ab
[Titer]
in
Serum
|
|
15398-1
|
Neuronal
nuclear
Ab
[Titer]
in
Serum
|
|
15399-9
|
Neuronal
nuclear
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
154-5
|
Cephaloglycin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1540-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5
hours
post
100
g
glucose
PO
|
|
15400-5
|
Platelet
IgG
Ab
[Presence]
in
Serum
|
|
15401-3
|
Drugs
identified
in
Blood
by
Screen
method
|
|
15402-1
|
Ethanol
[Presence]
in
Meconium
|
|
15403-9
|
Isopropanol
[Presence]
in
Meconium
|
|
15404-7
|
Levomethamphetamine/Amphetamines.total
in
Urine
|
|
15405-4
|
Methamphetamine
[Mass/volume]
in
Meconium
|
|
15406-2
|
Deprecated
Methamphetamine
|
|
15407-0
|
Methanol
[Presence]
in
Meconium
|
|
15408-8
|
Thallium
[Mass/mass]
in
Hair
|
|
15409-6
|
Thallium
[Mass/mass]
in
Nail
|
|
1541-2
|
Glucose
[Mass/volume]
in
Urine
--5
hours
post
100
g
glucose
PO
|
|
15410-4
|
Varicella
zoster
virus
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15411-2
|
Ergosterol
[Mass/volume]
in
Serum
or
Plasma
|
|
15412-0
|
Service
comment
21
|
|
15413-8
|
Service
comment
22
|
|
15414-6
|
Service
comment
23
|
|
15415-3
|
Service
comment
24
|
|
15416-1
|
Service
comment
25
|
|
15417-9
|
Service
comment
26
|
|
15418-7
|
Service
comment
27
|
|
15419-5
|
Service
comment
28
|
|
1542-0
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5
hours
post
75
g
glucose
PO
|
|
15420-3
|
Service
comment
29
|
|
15421-1
|
Service
comment
30
|
|
15422-9
|
Service
comment
31
|
|
15423-7
|
Service
comment
32
|
|
15424-5
|
Service
comment
33
|
|
15425-2
|
Service
comment
34
|
|
15426-0
|
Service
comment
35
|
|
15427-8
|
Service
comment
36
|
|
15428-6
|
Service
comment
37
|
|
15429-4
|
Service
comment
38
|
|
1543-8
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
0.5
g/kg
glucose
IV
|
|
15430-2
|
Service
comment
39
|
|
15431-0
|
Service
comment
40
|
|
15432-8
|
Testosterone
Free/Testosterone.total
in
Serum
or
Plasma
|
|
15433-6
|
Anaplasma
marginale
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15434-4
|
Avian
adenovirus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15435-1
|
Avian
adenovirus
2
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15436-9
|
Avian
encephalomyelitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15437-7
|
Avian
encephalomyelitis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15438-5
|
Avian
hemorrhagic
enteritis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15439-3
|
Infectious
bronchitis
virus
Ark-99
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
1544-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
100
g
glucose
PO
|
|
15440-1
|
Infectious
bronchitis
virus
Mass-41
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15441-9
|
Infectious
bronchitis
virus
Conn-42
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15442-7
|
Avian
infectious
laryngotracheitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15443-5
|
Avian
infectious
laryngotracheitis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15444-3
|
Influenza
virus
A
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15445-0
|
Avian
leukosis
virus
Ag
[Titer]
in
Serum
by
Immunoassay
|
|
15446-8
|
Avian
leukosis
virus
Ag
[Titer]
in
Egg
yolk
by
Immunoassay
|
|
15447-6
|
Avian
paramyxovirus
1
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15448-4
|
Avian
paramyxovirus
1
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15449-2
|
Avian
paramyxovirus
2
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
1545-3
|
Deprecated
Glucose
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
100
g
glucose
PO
|
|
15450-0
|
Avian
paramyxovirus
3
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15451-8
|
Avian
pox
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15452-6
|
Avian
reovirus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15453-4
|
Avian
reovirus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15454-2
|
Reticuloendotheliosis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15455-9
|
Bluetongue
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15456-7
|
Bluetongue
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15457-5
|
Bordetella
avium
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15458-3
|
Bordetella
avium
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15459-1
|
Bovine
herpesvirus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
1546-1
|
Glucose
[Mass/volume]
in
Urine
--6
hours
post
100
g
glucose
PO
|
|
15460-9
|
Bovine
leukemia
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15461-7
|
Bovine
leukemia
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15462-5
|
Bovine
diarrhea
virus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15463-3
|
Bovine
diarrhea
virus
2
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15464-1
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15465-8
|
Caprine
arthritis
encephalitis
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15466-6
|
Epizootic
hemorrhagic
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15467-4
|
Equine
herpesvirus
1
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15468-2
|
Equine
infectious
anemia
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15469-0
|
Equine
influenza
virus
A1
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
1547-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
15470-8
|
Equine
influenza
virus
A2
Ab
[Presence]
in
Serum
|
|
15471-6
|
Equine
influenza
virus
A2
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15472-4
|
Equine
influenza
virus
Ag
[Presence]
in
Nose
by
Immunoassay
|
|
15473-2
|
Equine
arteritis
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
15474-0
|
Infectious
bursal
disease
virus
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15475-7
|
Infectious
bursal
disease
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15476-5
|
Leptospira
interrogans
sv
Bratislava
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15477-3
|
Leptospira
interrogans
sv
Canicola
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15478-1
|
Leptospira
interrogans
sv
Grippotyphosa
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15479-9
|
Leptospira
interrogans
sv
Hardjo
Ab
[Titer]
in
Serum
by
Agglutination
|
|
1548-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
0.5
g/kg
glucose
IV
|
|
15480-7
|
Leptospira
interrogans
sv
Icterohaemorrhagiae
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15481-5
|
Leptospira
interrogans
sv
Pomona
Ab
[Titer]
in
Serum
by
Agglutination
|
|
15482-3
|
Mycobacterium
avium
ss
paratuberculosis
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
15483-1
|
Mycobacterium
avium
ss
paratuberculosis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15484-9
|
Mycoplasma
gallisepticum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15485-6
|
Mycoplasma
gallisepticum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15486-4
|
Mycoplasma
gallisepticum
rRNA
[Presence]
in
Nose
or
Trachea
by
DNA
probe
|
|
15487-2
|
Mycoplasma
meleagridis
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15488-0
|
Mycoplasma
meleagridis
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15489-8
|
Mycoplasma
synoviae
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
1549-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
100
g
glucose
PO
|
|
15490-6
|
Mycoplasma
synoviae
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15491-4
|
Mycoplasma
synoviae
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
15492-2
|
Neospora
caninum
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15493-0
|
Parainfluenza
virus
3
Ab
[Titer]
in
Serum
by
Hemagglutination
inhibition
|
|
15494-8
|
Pasteurella
multocida
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15495-5
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15496-3
|
Porcine
reproductive
and
respiratory
syndrome
virus
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
15497-1
|
Pseudorabies
virus
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15498-9
|
Pseudorabies
virus
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
15499-7
|
Pseudorabies
virus
Ab
[Titer]
in
Serum
by
Neutralization
test
|
|
155-2
|
Cephaloglycin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1550-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
15500-2
|
Pseudorabies
virus
Clinease
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15501-0
|
Pseudorabies
virus
Herdcheck
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15502-8
|
Pseudorabies
virus
Omnimark
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15503-6
|
Pseudorabies
virus
Tolvid
gene
deletion
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
15504-4
|
Salmonella
arizonae
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15505-1
|
Salmonella
pullorum
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15506-9
|
Salmonella
typhimurium
Ab
[Presence]
in
Serum
by
Agglutination
|
|
15507-7
|
Provider-unspecified
ED
Progress
note
|
|
15508-5
|
Labor
and
delivery
records
|
|
15509-3
|
Ambulance
transport,
Rationale
for
scheduled
transport
|
|
1551-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
50
g
lactose
PO
|
|
15510-1
|
Ambulance
transport,
Distance
transported
Length
|
|
15511-9
|
Ambulance
transport,
Origination
site
information
Set
|
|
15512-7
|
Ambulance
transport,
Destination
site
information
Set
|
|
15513-5
|
Ambulance
transport,
Reason
for
scheduled
trip
Set
|
|
15514-3
|
Ambulance
transport,
Ordering
practitioner
identifier
type
|
|
15515-0
|
Ambulance
transport,
Medical
reason
for
transport
|
|
15516-8
|
Ambulance
transport,
Justification
for
extra
attendants
|
|
15517-6
|
Ambulance
transport,
Transport
direction
|
|
15518-4
|
Abalone
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15519-2
|
Wattle
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1552-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
75
g
glucose
PO
|
|
15520-0
|
Corticotropin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15521-8
|
White
Alder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15522-6
|
Deprecated
Alder
Ab.IgE.RAST
class
|
|
15523-4
|
Smooth
Alder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15524-2
|
Alfalfa
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15525-9
|
Alkalase
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15526-7
|
Allspice
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15527-5
|
Almond
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15528-3
|
Almond
Tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15529-1
|
Lactalbumin
alpha
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1553-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
insulin
IV
|
|
15530-9
|
Alternaria
alternata
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15531-7
|
Deprecated
Alternaria
alternata
IgE
Ab
RAST
class
in
Serum
|
|
15532-5
|
Amoxicillin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15533-3
|
Ampicillin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15534-1
|
Anchovy
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15535-8
|
Anisakis
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15536-6
|
Anise
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15537-4
|
Red
Imported
Fire
Ant
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15538-2
|
Deprecated
Red
Imported
Fire
Ant
IgE
Ab
RAST
class
in
Serum
|
|
15539-0
|
Apple
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1554-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
15540-8
|
Apple
Tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15541-6
|
Apricot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15542-4
|
Arrowroot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15543-2
|
Artichoke
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15544-0
|
Ascaris
sp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15545-7
|
Arizona
Ash
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15546-5
|
White
Ash
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15547-3
|
Asparagus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15548-1
|
Aspen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15549-9
|
Aspergillus
fumigatus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1555-2
|
Glucose
[Mass/volume]
in
Urine
--12
hours
fasting
|
|
15550-7
|
Aspergillus
niger
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15551-5
|
Avocado
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15552-3
|
Groundsel
Tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15553-1
|
Bamboo
shoot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15554-9
|
Banana
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15555-6
|
Barley
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15556-4
|
Barley
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15557-2
|
Basil
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15558-0
|
Bass,
Black
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15559-8
|
Fivehook
Bassia
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1556-0
|
Fasting
glucose
[Mass/volume]
in
Capillary
blood
|
|
15560-6
|
Bayberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15561-4
|
Bayleaf
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15562-2
|
Castor
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15563-0
|
Green
Coffee
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15564-8
|
Green
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15565-5
|
Red
Kidney
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15566-3
|
Lima
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15567-1
|
Pinto
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15568-9
|
Soybean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15569-7
|
White
Bean
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1557-8
|
Fasting
glucose
[Mass/volume]
in
Venous
blood
|
|
15570-5
|
Honey
bee
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15571-3
|
American
Beech
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15572-1
|
Beef
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15573-9
|
Beet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15574-7
|
Sugar
Beet
Seed
(Beta
vulgaris
seed)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15575-4
|
Berlin
Beetle
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15576-2
|
Lactalbumin
beta
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15577-0
|
Beta
lactoglobulin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15578-8
|
Deprecated
Birch
Ab.IgE.RAST
class
|
|
15579-6
|
Silver
Birch
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1558-6
|
Fasting
glucose
[Mass/volume]
in
Serum
or
Plasma
|
|
15580-4
|
Blackberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15581-2
|
Blomia
tropicalis
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15582-0
|
Bloodworm
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15583-8
|
Blueberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15584-6
|
Botrytis
cinerea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15585-3
|
Boxelder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15586-1
|
Brazil
Nut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15587-9
|
Broccoli
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15588-7
|
Bromelin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15589-5
|
Brussel
Sprouts
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1559-4
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
tolbutamide
IV
|
|
15590-3
|
Bovine
serum
albumin
(BSA)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15591-1
|
Buckwheat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15592-9
|
Budgerigar
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15593-7
|
Bumble
Bee
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15594-5
|
Burrobrush
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15595-2
|
Burweed
marshelder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15596-0
|
Cabbage
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15597-8
|
Cocoa
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15598-6
|
Canary
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15599-4
|
Candida
albicans
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
156-0
|
Cephaloridine
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1560-2
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
tolbutamide
IV
|
|
15600-0
|
Deprecated
Melon
IgE
Ab
RAST
class
in
Serum
|
|
15601-8
|
Starfruit
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15602-6
|
Caraway
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15603-4
|
Careless
Weed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15604-2
|
Carob
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15605-9
|
Carrot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15606-7
|
Casein
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15607-5
|
Cashew
Nut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15608-3
|
Deprecated
Cat
IgE
Ab
RAST
class
in
Serum
|
|
15609-1
|
Cat
dander
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1561-0
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
75
g
glucose
PO
|
|
15610-9
|
Deprecated
Cat
epithelium
IgE
Ab
RAST
class
in
Serum
|
|
15611-7
|
Catfish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15612-5
|
Cauliflower
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15613-3
|
Italian
Cedar
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15614-1
|
Japanese
Cedar
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15615-8
|
Mountain
Juniper
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15616-6
|
Red
Cedar
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15617-4
|
Saltcedar
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15618-2
|
Celery
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15619-0
|
Acremonium
sp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1562-8
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--2.5
hours
post
dose
tolbutamide
IV
|
|
15620-8
|
Chaetomium
globosum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15621-6
|
Chamomile
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15622-4
|
American
Cheese
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15623-2
|
Cheese
cheddar
type
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15624-0
|
Cottage
Cheese
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15625-7
|
Mozzarella
Cheese
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15626-5
|
Parmesan
Cheese
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15627-3
|
Swiss
Cheese
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15628-1
|
Cherry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15629-9
|
Chestnut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1563-6
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
dose
tolbutamide
IV
|
|
15630-7
|
Horse
Chestnut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15631-5
|
Deprecated
Chestnut
IgE
Ab
RAST
class
in
Serum
|
|
15632-3
|
Chestnut
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15633-1
|
Chicken
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15634-9
|
Chicken
meat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15635-6
|
Chicory
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15636-4
|
Chinchilla
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15637-2
|
Chloramin
T
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15638-0
|
Chortoglyphus
arcuatus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15639-8
|
Deprecated
Chymofast
IgE
Ab
RAST
class
in
Serum
|
|
1564-4
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
75
g
glucose
PO
|
|
15640-6
|
Chymopapain
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15641-4
|
Cinnamon
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15642-2
|
Cladosporium
herbarum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15643-0
|
Clam
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15644-8
|
Clove
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15645-5
|
Clover
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15646-3
|
Cocklebur
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15647-1
|
Cockroach
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15648-9
|
Deprecated
Cocoa
IgE
Ab
RAST
class
in
Serum
|
|
15649-7
|
Coconut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1565-1
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
tolbutamide
IV
|
|
15650-5
|
Codfish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15651-3
|
Coffee
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15652-1
|
Cola
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15653-9
|
Corn
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15654-7
|
Cultivated
Corn
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15655-4
|
Cultivated
Cotton
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15656-2
|
Cotton
fibers
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15657-0
|
Cotton
western
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15658-8
|
Cottonseed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15659-6
|
Cottonwood
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1566-9
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
dose
tolbutamide
IV
|
|
15660-4
|
Western
Cottonwood
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15661-2
|
Cow
dander
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15662-0
|
Cow
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15663-8
|
Crab
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15664-6
|
Cranberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15665-3
|
Crawfish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15666-1
|
Cryptococcus
terreus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15667-9
|
Cucumber
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15668-7
|
Curry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15669-5
|
Curvularia
lunata
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1567-7
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
75
g
glucose
PO
|
|
15670-3
|
Curvularia
specifera
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15671-1
|
Arizona
Cypress
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15672-9
|
Bald
Cypress
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15673-7
|
Italian
Cypress
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15674-5
|
Daisy
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15675-2
|
Ox-eye
daisy
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15676-0
|
Dandelion
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15677-8
|
Daphnia
(fish
feed)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15678-6
|
Date
Palm
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15679-4
|
Deer
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1568-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
75
g
glucose
PO
|
|
15680-2
|
American
house
dust
mite
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15681-0
|
Dermatophagoides
microceras
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15682-8
|
European
house
dust
mite
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15683-6
|
Dill
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15684-4
|
Yellow
Dock
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15685-1
|
Dog
dander
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15686-9
|
Dog
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15687-7
|
Duck
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15688-5
|
Echinococcus
sp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15689-3
|
Egg
white
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1569-3
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--5
hours
post
75
g
glucose
PO
|
|
15690-1
|
Whole
Egg
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15691-9
|
Egg
yolk
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15692-7
|
Eggplant
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15693-5
|
Marsh
Elder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15694-3
|
Elder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15695-0
|
Deprecated
Elderberry
IgE
Ab
RAST
class
in
Serum
|
|
15696-8
|
Elk
or
Moose
Meat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15697-6
|
White
Elm
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15698-4
|
Chinese
Elm
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15699-2
|
Endive
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
157-8
|
Cephaloridine
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1570-1
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
15700-8
|
Epicoccum
purpurascens
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15701-6
|
Epidermophyton
floccosum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15702-4
|
Ethylene
oxide
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15703-2
|
Gum-Tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15704-0
|
Euroglyphus
maynei
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15705-7
|
Dog
Fennel
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15706-5
|
Fennel
Fresh
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15707-3
|
Fennel
Seed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15708-1
|
Ferret
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15709-9
|
Meadow
Fescue
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1571-9
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
tolbutamide
IV
|
|
15710-7
|
Finch
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15711-5
|
Douglas
Fir
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15712-3
|
Firebush
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15713-1
|
Fiscus
sp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15714-9
|
Flea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15715-6
|
Flounder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15716-4
|
Black
Fly
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15717-2
|
Horse
Fly
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15718-0
|
Formaldehyde
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15719-8
|
Fox
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1572-7
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--pre
75
g
glucose
PO
|
|
15720-6
|
Meadow
Foxtail
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15721-4
|
Fusarium
culmorum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15722-2
|
Fusarium
moniliforme
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15723-0
|
Fusarium
solani
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15724-8
|
Garlic
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15725-5
|
Gelatin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15726-3
|
Geotrichum
candidum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15727-1
|
Gerbil
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15728-9
|
Ginger
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15729-7
|
Gluten
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1573-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
15730-5
|
Glycyphagus
domesticus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15731-3
|
Goat
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15732-1
|
Goat
milk
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15733-9
|
Goldenrod
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15734-7
|
Goose
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15735-4
|
Grape
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15736-2
|
Grapefruit
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15737-0
|
Bahia
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15738-8
|
Bermuda
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15739-6
|
Canadian
blue
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1574-3
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--24
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
15740-4
|
Brome
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15741-2
|
False
oat
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15742-0
|
Gramma
grass
(Bouteloua
gracilis)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15743-8
|
Johnson
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15744-6
|
Kentucky
blue
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15745-3
|
Koehlers
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15746-1
|
Cocksfoot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15747-9
|
Quack
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15748-7
|
Red
top
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15749-5
|
Perennial
rye
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1575-0
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--48
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
15750-3
|
Deprecated
Grass
rye
Italian
IgE
Ab
RAST
class
in
Serum
|
|
15751-1
|
Wild
rye
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15752-9
|
Salt
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15753-7
|
Sorghum
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15754-5
|
Sudan
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15755-2
|
Sweet
Vernal
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15756-0
|
Velvet
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15757-8
|
Guar
gum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15758-6
|
Guava
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15759-4
|
Guinea
pig
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1576-8
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--48
hours
post
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
15760-2
|
Gum
arabic
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15761-0
|
Sweet
gum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15762-8
|
Hackberry
tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15763-6
|
Haddock
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15764-4
|
Halibut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15765-1
|
Hamster
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15766-9
|
Hazelnut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15767-7
|
Hazelnut
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15768-5
|
Helminthosporium
sp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15769-3
|
Setomelanomma
rostrata
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1577-6
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--48
hours
post
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
15770-1
|
Eastern
Hemlock
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15771-9
|
Water
Hemp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15772-7
|
Herring
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15773-5
|
Pecan
or
Hickory
Nut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15774-3
|
Pecan
or
Hickory
Tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15775-0
|
Shellbark
Hickory
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15776-8
|
White
Hickory
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15777-6
|
Honey
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15778-4
|
Honeysuckle
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15779-2
|
Hop
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1578-4
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--72
hours
post
40
ug
corticotropin
IM
BID
3
day
|
|
15780-0
|
Horn
beam
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15781-8
|
Hornet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15782-6
|
Whitefaced
Hornet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15783-4
|
Yellow
Hornet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15784-2
|
Horse
dander
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15785-9
|
Horse
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15786-7
|
Horse
serum
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15787-5
|
Horseradish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15788-3
|
House
dust
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15789-1
|
House
dust
Greer
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1579-2
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--pre
50
ug
corticotropin
IM
3
day
|
|
15790-9
|
House
dust
Hausstaub
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15791-7
|
House
dust
Hollister
Stier
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15792-5
|
Insulin
bovine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15793-3
|
Insulin
human
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15794-1
|
Insulin
porcine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15795-8
|
Iodinebush
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15796-6
|
Isocyanate
HDI
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15797-4
|
Isocyanate
MDI
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15798-2
|
Isocyanate
TDI
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15799-0
|
Ispaghula
laxative
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
158-6
|
Cephaloridine
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1580-0
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--pre
500
ug
dexamethasone
PO
2.5
day
low
dose
q6h
|
|
15800-6
|
Juniper
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15801-4
|
Kapok
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15802-2
|
Kiwifruit
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15803-0
|
Lamb
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15804-8
|
Deprecated
Mutton
IgE
Ab
RAST
class
in
Serum
|
|
15805-5
|
Goosefoot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15806-3
|
Latex
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15807-1
|
Latex
glove
extract
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15808-9
|
Latex
glove
extract
ammoniated
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15809-7
|
Latex
glove
extract
buffered
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1581-8
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--pre
2
mg
dexamethasone
PO
2.5
day
high
dose
q6h
|
|
15810-5
|
Legume
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15811-3
|
Lemon
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15812-1
|
Lenscale
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15813-9
|
Lentils
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15814-7
|
Lepidoglyphus
destructor
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15815-4
|
Lettuce
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15816-2
|
Lilac
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15817-0
|
Easter
lily
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15818-8
|
Lime
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15819-6
|
Linden
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1582-6
|
Lactose
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
50
g
lactose
PO
|
|
15820-4
|
Liver
beef
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15821-2
|
Lobster
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15822-0
|
Spiny
lobster
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15823-8
|
Black
Locust
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15824-6
|
Lupin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15825-3
|
Lycopodium
spp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15826-1
|
Lysozyme
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15827-9
|
Mackerel
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15828-7
|
Chub
Mackerel
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15829-5
|
Scad
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1583-4
|
Lactose
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
50
g
lactose
PO
|
|
15830-3
|
Deprecated
Corn
IgE
Ab
RAST
class
in
Serum
|
|
15831-1
|
Malt
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15832-9
|
Mango
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15833-7
|
Coastal
Maple
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15834-5
|
Red
Maple
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15835-2
|
Silver
Maple
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15836-0
|
Maple
sugar
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15837-8
|
Mare
milk
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15838-6
|
Marjoram
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15839-4
|
Maxatase
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1584-2
|
Lactose
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
50
g
lactose
PO
|
|
15840-2
|
Whiff
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15841-0
|
Cajeput
tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15842-8
|
Deprecated
Melon
IgE
Ab
RAST
class
in
Serum.
|
|
15843-6
|
Mesquite
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15844-4
|
Mexican
tea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15845-1
|
Green
Nimitti
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15846-9
|
Milk
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15847-7
|
Cow
milk
boiled
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15848-5
|
Milk
powder
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15849-3
|
Common
Millet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1585-9
|
Lactose
[Mass/volume]
in
Serum
or
Plasma
--pre
12
hour
fast
|
|
15850-1
|
Foxtail
Millet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15851-9
|
Cockspur
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15852-7
|
Mink
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15853-5
|
Mint
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15854-3
|
Cheese
mold
type
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15855-0
|
Chrysonilia
sitophila
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15856-8
|
Aedes
mosquito
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15857-6
|
Moth
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15858-4
|
Mediterranean
flour
moth
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15859-2
|
Mouse
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1586-7
|
Lead
[Mass/volume]
in
Urine
--post
EDTA
therapy
|
|
15860-0
|
Mouse
serum
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15861-8
|
Mouse
urine
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15862-6
|
Mucor
racemosus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15863-4
|
Mugwort
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15864-2
|
White
mulberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15865-9
|
Deprecated
White
mulberry
IgE
Ab
RAST
class
in
Serum
|
|
15866-7
|
Mushroom
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15867-5
|
Deprecated
Melon
IgE
Ab
Ab
RAST
class
in
Serum
|
|
15868-3
|
Deprecated
Blue
mussel
IgE
Ab
RAST
class
in
Serum
|
|
15869-1
|
Blue
mussel
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1587-5
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
100
g
lutropin
IV
|
|
15870-9
|
Mustard
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15871-7
|
Nectarine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15872-5
|
Nettle
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15873-3
|
Nigrospora
sphaerica
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15874-1
|
Nutmeg
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15875-8
|
White
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15876-6
|
California
Black
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15877-4
|
Coastal
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15878-2
|
Gamble
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15879-0
|
Jerusalem
oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1588-3
|
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
gonadotropin
releasing
hormone
|
|
15880-8
|
Virginia
Live
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15881-6
|
Red
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15882-4
|
Valley
Oak
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15883-2
|
Deprecated
Virginia
Live
Oak
IgE
Ab
RAST
class
in
Serum
|
|
15884-0
|
Deprecated
White
Oak
IgE
Ab
RAST
class
in
Serum
|
|
15885-7
|
Oat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15886-5
|
Oat
pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15887-3
|
Deprecated
Oat
pollen
IgE
Ab
RAST
class
in
Serum
|
|
15888-1
|
Octopus
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15889-9
|
Oidiodendrum
spp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1589-1
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--105
minutes
post
100
g
lutropin
IV
|
|
15890-7
|
Okra
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15891-5
|
Deprecated
Olive
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15892-3
|
Olive
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15893-1
|
Onion
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15894-9
|
Orange
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15895-6
|
Oregano
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15896-4
|
Orris
root
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15897-2
|
Ovalbumin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15898-0
|
Ovomucoid
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15899-8
|
Oyster
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
159-4
|
Cephaloridine
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1590-9
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
100
g
lutropin
IV
|
|
15900-4
|
Queen
Palm
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15901-2
|
Papaya
(Carica
papaya)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15902-0
|
Paprika
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15903-8
|
Parakeet
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15904-6
|
Budgerigar
droppings
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15905-3
|
Deprecated
Budgerigar
feather
IgE
Ab
RAST
class
in
Serum
|
|
15906-1
|
Budgerigar
serum
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15907-9
|
Parrot
droppings
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15908-7
|
Parrot
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15909-5
|
Parrot
serum
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1591-7
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
100
g
lutropin
IV
|
|
15910-3
|
Parsley
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15911-1
|
Parsnip
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15912-9
|
Passion
fruit
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15913-7
|
Pea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15914-5
|
Black-eye
pea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15915-2
|
Chick
Pea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15916-0
|
Peach
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15917-8
|
Peanut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15918-6
|
Pear
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15919-4
|
Deprecated
Pecan
or
Hickory
Nut
IgE
Ab
RAST
class
in
Serum
|
|
1592-5
|
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
gonadotropin
releasing
hormone
|
|
15920-2
|
Deprecated
Pecan
or
Hickory
Tree
IgE
Ab
RAST
class
in
Serum
|
|
15921-0
|
Penicillin
G
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15922-8
|
Penicillin
V
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15923-6
|
Penicillium
frequentans
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15924-4
|
Penicillium
notatum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15925-1
|
Black
Pepper
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15926-9
|
Cayenne
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15927-7
|
Chili
Pepper
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15928-5
|
Green
Pepper
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15929-3
|
Pepper
tree
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1593-3
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
100
g
lutropin
IV
|
|
15930-1
|
Perch
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15931-9
|
Phoma
betae
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15932-7
|
Phospholipase
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15933-5
|
Phthalic
anhydride
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15934-3
|
Pigeon
droppings
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15935-0
|
Pigeon
feather
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15936-8
|
Common
Pigweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15937-6
|
Rough
Pigweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15938-4
|
Spiny
Pigweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15939-2
|
Austrian
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1594-1
|
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
dose
gonadotropin
releasing
hormone
|
|
15940-0
|
Loblolly
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15941-8
|
Long
Leaf
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15942-6
|
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15943-4
|
Pine
Nut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15944-2
|
Short
Leaf
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15945-9
|
Slash
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15946-7
|
Virginia
Scrub
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15947-5
|
Eastern
White
Pine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15948-3
|
Pineapple
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15949-1
|
Pistachio
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1595-8
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
100
g
lutropin
IV
|
|
15950-9
|
Malassezia
furfur
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15951-7
|
Plaice
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15952-5
|
English
plantain
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15953-3
|
Plum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15954-1
|
Black
Cottonwood
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15955-8
|
Poppy
Seed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15956-6
|
Pork
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15957-4
|
Potato
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15958-2
|
Sweet
potato
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15959-0
|
Povertyweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1596-6
|
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
gonadotropin
releasing
hormone
|
|
15960-8
|
Privet
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15961-6
|
Protamine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15962-4
|
Prune
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15963-2
|
Psyllium
seed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15964-0
|
Aureobasidium
pullulans
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15965-7
|
Deprecated
Pullularia
pullulans
IgE
Ab
RAST
class
in
Serum
|
|
15966-5
|
Pumpkin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15967-3
|
Pumpkin
Seed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15968-1
|
Pyrethrum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15969-9
|
Rabbit
meat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1597-4
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
100
g
lutropin
IV
|
|
15970-7
|
Rabbit
Bush
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15971-5
|
Rabbit
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15972-3
|
Rabbit
serum
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15973-1
|
Rabbit
urine
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15974-9
|
Radish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15975-6
|
Common
Ragweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15976-4
|
Desert
Ragweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15977-2
|
False
ragweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15978-0
|
Giant
Ragweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15979-8
|
Deprecated
Common
Ragweed
IgE
Ab
RAST
class
in
Serum
|
|
1598-2
|
Deprecated
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--75
minutes
post
100
g
lutropin
IV
|
|
15980-6
|
Southern
Ragweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15981-4
|
Western
Ragweed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15982-2
|
Rapeseed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15983-0
|
Raspberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15984-8
|
Rat
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15985-5
|
Rat
serum
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15986-3
|
Rat
urine
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15987-1
|
Redwood
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15988-9
|
Canary
grass
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15989-7
|
Common
Reed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1599-0
|
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
15990-5
|
Reindeer
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15991-3
|
Rhizopus
nigricans
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15992-1
|
Rhodotorula
spp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15993-9
|
Rhubarb
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15994-7
|
Rice
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15995-4
|
Wild
Rice
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15996-2
|
Rose
Hip
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15997-0
|
Cultivated
Rye
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15998-8
|
Rye
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
15999-6
|
Deprecated
Cultivated
Rye
IgE
Ab
RAST
class
in
Serum
|
|
16-6
|
Amoxicillin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
160-2
|
Cephalothin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1600-6
|
Lutropin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
gonadotropin
releasing
hormone
|
|
16000-2
|
Deprecated
rye
Perennial
IgE
Ab
RAST
class
in
Serum
|
|
16001-0
|
Safflower
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16002-8
|
Sage
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16003-6
|
Common
Sagebrush
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16004-4
|
Deprecated
Sagebrush
IgE
Ab
RAST
class
in
Serum
|
|
16005-1
|
Saline
fish
feed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16006-9
|
Salmon
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16007-7
|
Saltbush
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16008-5
|
Sardine
(pilchard)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16009-3
|
Savinase
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1601-4
|
Norepinephrine
[Mass/volume]
in
Plasma
--supine
|
|
16010-1
|
Deprecated
Lenscale
IgE
Ab
RAST
class
in
Serum
|
|
16011-9
|
Scallop
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16012-7
|
Scotch
broom
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16013-5
|
Sericin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16014-3
|
Sesame
Seed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16015-0
|
Sheep
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16016-8
|
Sheep
Sorrel
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16017-6
|
Sheep
wool
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16018-4
|
Shrimp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16019-2
|
Silk
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1602-2
|
Norepinephrine
[Mass/volume]
in
Plasma
--10
minutes
post
standing
|
|
16020-0
|
Silk
waste
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16021-8
|
Silver
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16022-6
|
Bermuda
grass
smut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16023-4
|
Johnson
grass
smut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16024-2
|
Escargot
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16025-9
|
Red
Snapper
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16026-7
|
Sole
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16027-5
|
Spinach
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16028-3
|
Spondylocladium
citrovirens
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16029-1
|
Spruce
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1603-0
|
Norepinephrine
[Mass/volume]
in
Plasma
--1
hour
post
300
ug
clonidine
PO
|
|
16030-9
|
Squash
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16031-7
|
Squid
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16032-5
|
Pacific
Squid
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16033-3
|
Stemphylium
botryosum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16034-1
|
Stemphylium
solani
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16035-8
|
Acarus
siro
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16037-4
|
Tyrophagus
putrescentiae
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16038-2
|
Strawberry
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16039-0
|
Succinylcholine
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1604-8
|
Norepinephrine
[Mass/volume]
in
Plasma
--2
hours
post
300
ug
clonidine
PO
|
|
16040-8
|
Sugar
Cane
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16041-6
|
Sunflower
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16042-4
|
Sunflower
Seed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16043-2
|
Swine
epithelium
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16044-0
|
Swine
urine
proteins
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16045-7
|
Swordfish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16046-5
|
American
Sycamore
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16047-3
|
Mandarin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16048-1
|
Tapioca
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16049-9
|
Tarragon
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1605-5
|
Norepinephrine
[Mass/volume]
in
Plasma
--3
hours
post
300
ug
clonidine
PO
|
|
16050-7
|
Tea
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16051-5
|
Tetramin
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16052-3
|
Saltwort
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16053-1
|
Thyme
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16054-9
|
Timothy
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16055-6
|
Deprecated
Tobacco
IgE
Ab
RAST
class
in
Serum
|
|
16056-4
|
Tobacco
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16057-2
|
Tomato
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16058-0
|
Tragacanth
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16059-8
|
Trichoderma
viride
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1606-3
|
Norepinephrine
[Mass/volume]
in
Plasma
--pre
300
ug
clonidine
PO
|
|
16060-6
|
Trichophyton
sp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16061-4
|
Trichophyton
rubrum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16062-2
|
Trichosporon
spp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16063-0
|
Trimellitic
anhydride
(TMA)
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16064-8
|
Trout
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16065-5
|
Tuna
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16066-3
|
Turkey
meat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16067-1
|
Turnip
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16069-7
|
Ulocladium
chartarum
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1607-1
|
Osmolality
of
Urine--12
hours
post
fluid
fast
|
|
16070-5
|
Barley
smut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16071-3
|
Vanilla
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16072-1
|
Veal
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16073-9
|
Wall
pellitory
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16074-7
|
Walnut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16075-4
|
Black
Walnut
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16076-2
|
Black
Walnut
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16077-0
|
English
Walnut
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16078-8
|
California
Walnut
Pollen
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16079-6
|
Deprecated
California
Walnut
Pollen
IgE
Ab
RAST
class
in
Serum
|
|
1608-9
|
Osmolality
of
Urine--8
hours
post
fluid
fast
|
|
16080-4
|
Paper
wasp
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16081-2
|
Deprecated
Paper
Wasp
IgE
Ab
RAST
class
in
Serum
|
|
16082-0
|
Yellow
Jacket
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16083-8
|
Watermelon
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16084-6
|
Grain
weevel
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16085-3
|
Wheat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16086-1
|
Cultivated
Wheat
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16087-9
|
Deprecated
Cultivated
Wheat
IgE
Ab
RAST
class
in
Serum
|
|
16088-7
|
Wheat
Stem
Rust
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16089-5
|
Cow
whey
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
1609-7
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
insulin
IV
|
|
16090-3
|
Whitefish
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16091-1
|
Willow
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16092-9
|
Black
Willow
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16093-7
|
Pussy
Willow
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16094-5
|
Wingscale
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16095-2
|
Wormwood
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16096-0
|
Baker's
yeast
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16097-8
|
Deprecated
Bakers
Yeast
IgE
Ab
RAST
class
in
Serum
|
|
16098-6
|
Brewer's
yeast
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
16099-4
|
Ethionamide
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
161-0
|
Cephalothin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1610-5
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
L-dopa
PO
|
|
16100-0
|
Rifabutin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16101-8
|
Cumin
IgE
Ab
[Units/volume]
in
Serum
|
|
16102-6
|
Bovine
Gelatin
IgE
Ab
[Units/volume]
in
Serum
|
|
16103-4
|
Porcine
Gelatin
IgE
Ab
[Units/volume]
in
Serum
|
|
16104-2
|
Paper
Mulberry
IgE
Ab
[Units/volume]
in
Serum
|
|
16105-9
|
Pheasant
IgE
Ab
[Units/volume]
in
Serum
|
|
16106-7
|
CD8+CD28+
cells
[#/volume]
in
Blood
|
|
16107-5
|
CD8+HLA-DR+
cells
[#/volume]
in
Blood
|
|
16108-3
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
250
ug
corticotropin
IM
|
|
16109-1
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
1611-3
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
TRH
IV
|
|
16110-9
|
11-Deoxycorticosterone
[Mass/time]
in
24
hour
Urine
|
|
16111-7
|
Epinephrine+Norepinephrine
[Mass/time]
in
24
hour
Urine
|
|
16112-5
|
Estrogen
receptor
[Interpretation]
in
Tissue
|
|
16113-3
|
Progesterone
receptor
[Interpretation]
in
Tissue
|
|
16114-1
|
Amitriptyline
[Mass/volume]
in
Urine
|
|
16115-8
|
Doxepin
[Mass/mass]
in
Tissue
|
|
16116-6
|
Tetrahydrocortisone
[Mass/time]
in
24
hour
Urine
|
|
16117-4
|
Babesia
microti
IgG
Ab
[Titer]
in
Serum
|
|
16118-2
|
Babesia
microti
IgM
Ab
[Titer]
in
Serum
|
|
16119-0
|
Brucella
abortus
IgG
Ab
[Titer]
in
Serum
|
|
1612-1
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
16120-8
|
Brucella
abortus
IgM
Ab
[Titer]
in
Serum
|
|
16121-6
|
Colorado
tick
fever
virus
IgG
Ab
[Titer]
in
Serum
|
|
16122-4
|
Colorado
tick
fever
virus
IgM
Ab
[Titer]
in
Serum
|
|
16123-2
|
Cryptococcus
sp
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16124-0
|
Cryptococcus
sp
Ab
[Titer]
in
Serum
|
|
16125-7
|
Helicobacter
pylori
IgA
Ab
[Presence]
in
Serum
|
|
16126-5
|
Helicobacter
pylori
IgG
Ab
[Presence]
in
Serum
|
|
16127-3
|
Helicobacter
pylori
IgM
Ab
[Presence]
in
Serum
|
|
16128-1
|
Hepatitis
C
virus
Ab
[Presence]
in
Serum
|
|
16129-9
|
Hepatitis
C
virus
IgG
Ab
[Presence]
in
Serum
|
|
1613-9
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
dose
L-dopa
PO
|
|
16130-7
|
Herpes
simplex
virus
1
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16131-5
|
Herpes
simplex
virus
2
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16132-3
|
HIV
1
p15+p18
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16133-1
|
Legionella
pneumophila
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
16134-9
|
Neisseria
meningitidis
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16135-6
|
Beta
2
glycoprotein
1
IgG
Ab
[Units/volume]
in
Serum
|
|
16136-4
|
Beta
2
glycoprotein
1
IgM
Ab
[Units/volume]
in
Serum
|
|
16137-2
|
Centromere
Ab
[Presence]
in
Serum
|
|
16138-0
|
Ganglioside
GM1
IgA
Ab
[Titer]
in
Serum
|
|
16139-8
|
Neuronal
nuclear
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1614-7
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
TRH
IV
|
|
16140-6
|
Tellurium
[Mass/volume]
in
Blood
|
|
16141-4
|
Nitrogen
[Mass/time]
in
24
hour
Stool
|
|
16142-2
|
Fat
[Mass/time]
in
24
hour
Stool
|
|
16143-0
|
Deprecated
Butane
[Mass/volume]
in
Blood
|
|
16144-8
|
Droperidol
[Presence]
in
Serum
or
Plasma
|
|
16145-5
|
Mescaline
[Mass/volume]
in
Serum
or
Plasma
|
|
16146-3
|
Psilocin
[Mass/volume]
in
Serum
or
Plasma
|
|
16147-1
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
16148-9
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
16149-7
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
1615-4
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
16150-5
|
Carboxy
tetrahydrocannabinol
[Mass/volume]
in
Serum
or
Plasma
|
|
16151-3
|
Dechlorane
[Presence]
in
Serum
or
Plasma
|
|
16152-1
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
16153-9
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
16154-7
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
16155-4
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
16156-2
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
16157-0
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16158-8
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
16159-6
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
1616-2
|
Deprecated
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
16160-4
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--10th
specimen
post
XXX
challenge
|
|
16161-2
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
16162-0
|
Parathyrin.intact
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
16163-8
|
Parathyrin.intact
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
16164-6
|
Parathyrin.intact
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
16165-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--10
AM
specimen
|
|
16166-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--11
AM
specimen
|
|
16167-9
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--2
PM
specimen
|
|
16168-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
PM
specimen
|
|
16169-5
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--4
PM
specimen
|
|
1617-0
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
dose
L-dopa
PO
|
|
16170-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--5
PM
specimen
|
|
16171-1
|
Cocaethylene
[Mass/mass]
in
Hair
|
|
16172-9
|
Magnesium
[Mass/mass]
in
Hair
|
|
16173-7
|
Amyl
ether
[Mass/volume]
in
Blood
|
|
16174-5
|
Bartonella
henselae
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16175-2
|
Bartonella
henselae
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16176-0
|
Bartonella
quintana
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16177-8
|
Bartonella
quintana
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16178-6
|
Beryllium
[Mass/mass]
in
Tissue
|
|
16179-4
|
Polychlorinated
biphenyl
(PCB)
[Mass/mass]
in
Tissue
|
|
1618-8
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
dose
insulin
IV
|
|
16180-2
|
Zinc
[Mass/mass]
in
Tissue
|
|
16181-0
|
Tricyclic
antidepressants
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16182-8
|
Alkaline
phosphatase
isoenzymes
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Heat
stability
|
|
16183-6
|
Phenolphthalein
[Mass/volume]
in
Stool
|
|
16184-4
|
Temazepam
[Mass/volume]
in
Stool
|
|
16185-1
|
Chlordiazepoxide
[Mass/volume]
in
Stool
|
|
16186-9
|
Hydroxyalprazolam
[Mass/volume]
in
Stool
|
|
16187-7
|
Alprazolam
[Mass/volume]
in
Stool
|
|
16188-5
|
Creatinine
[Mass/volume]
in
Serum
or
Plasma
--2
hour
specimen
|
|
16189-3
|
Creatinine
[Mass/volume]
in
Serum
or
Plasma
--4
hour
specimen
|
|
1619-6
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
L-dopa
PO
|
|
16190-1
|
Amobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16191-9
|
Butabarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16192-7
|
Phenobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16193-5
|
Pentobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16194-3
|
Secobarbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
16195-0
|
Benzodiazepines
[Presence]
in
Urine
by
Confirmatory
method
|
|
16196-8
|
Morphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16197-6
|
Codeine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16198-4
|
Diamorphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16199-2
|
Methadone
[Presence]
in
Urine
by
Confirmatory
method
|
|
162-8
|
Cephalothin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1620-4
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
TRH
IV
|
|
16200-8
|
Propoxyphene
[Presence]
in
Urine
by
Confirmatory
method
|
|
16201-6
|
Oxazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16202-4
|
Nordiazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16203-2
|
Alprazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16204-0
|
Clonazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16205-7
|
Lorazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16206-5
|
Temazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16207-3
|
Meperidine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16208-1
|
Buprenorphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16209-9
|
Chlorpheniramine
[Presence]
in
Urine
by
Confirmatory
method
|
|
1621-2
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
insulin
IV
|
|
16210-7
|
Diethylpropion
[Presence]
in
Urine
by
Confirmatory
method
|
|
16211-5
|
Dihydrocodeine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16212-3
|
Ethylamphetamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16213-1
|
Levorphanol
[Presence]
in
Urine
by
Confirmatory
method
|
|
16214-9
|
Lysergate
diethylamide
[Presence]
in
Urine
by
Confirmatory
method
|
|
16215-6
|
Mephobarbital
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16216-4
|
Methylephedrine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16217-2
|
Methyprylon
[Presence]
in
Urine
by
Confirmatory
method
|
|
16218-0
|
Nalbuphine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16219-8
|
Pentazocine
[Presence]
in
Urine
by
Confirmatory
method
|
|
1622-0
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--5
hours
post
600
ug
furosemide
PO
|
|
16220-6
|
Phenmetrazine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16221-4
|
Phenothiazines
[Presence]
in
Urine
by
Confirmatory
method
|
|
16222-2
|
Phentermine
[Presence]
in
Urine
by
Confirmatory
method
|
|
16223-0
|
Thiopental
[Presence]
in
Urine
by
Confirmatory
method
|
|
16224-8
|
Triazolam
[Presence]
in
Urine
by
Confirmatory
method
|
|
16225-5
|
Amitriptyline
[Presence]
in
Urine
by
Confirmatory
method
|
|
16226-3
|
Benzoylecgonine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16227-1
|
Diazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16228-9
|
Nordiazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16229-7
|
Clonazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1623-8
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--pre
600
ug
furosemide
PO
|
|
16230-5
|
N-desalkylflurazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16231-3
|
Flurazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16232-1
|
Triazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16233-9
|
Midazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16234-7
|
Amphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16235-4
|
Methamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16236-2
|
Butabarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16237-0
|
Butalbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16238-8
|
Secobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16239-6
|
Amobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1624-6
|
Retinol
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
5000
units
|
|
16240-4
|
Pentobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16241-2
|
Phenobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16242-0
|
Propoxyphene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16243-8
|
Cannabinoids
[Mass/volume]
in
Blood
by
Confirmatory
method
|
|
16244-6
|
Methaqualone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16245-3
|
Hydroxyethylflurazepam
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16246-1
|
Methadone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16247-9
|
Dextromethorphan
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16248-7
|
6-monoacetylmorphine
free
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16249-5
|
Oxycodone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1625-3
|
Retinol
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
5000
units
|
|
16250-3
|
Codeine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16251-1
|
Morphine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16252-9
|
Hydrocodone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16253-7
|
Meperidine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16254-5
|
Phencyclidine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16255-2
|
Troponin
I.cardiac
[Units/volume]
in
Serum
or
Plasma
|
|
16257-8
|
Sodium
urate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16258-6
|
Ammonium
urate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16259-4
|
Urate
dihydrate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
1626-1
|
Retinol
[Mass/volume]
in
Serum
or
Plasma
--pre
5000
units
|
|
16260-2
|
Triamterene
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16261-0
|
Calcium
bilirubinate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16262-8
|
Newberyite
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16263-6
|
Calcium
oxalate
dihydrate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16264-4
|
Calcium
oxalate
monohydrate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16265-1
|
Triple
phosphate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16266-9
|
Calcium
hydrogen
phosphate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16267-7
|
Calcium
carbonate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16268-5
|
Calcium
phosphate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16269-3
|
Urate
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
1627-9
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
dose
insulin
IV
|
|
16270-1
|
Calcium
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
16271-9
|
Calcium
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
16272-7
|
Calcium
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
16273-5
|
Calcium
[Mass/mass]
in
Red
Blood
Cells
|
|
16274-3
|
Deprecated
Cells.CD4/Cells.C4
|
|
16275-0
|
Bartonella
sp
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16276-8
|
Bartonella
henselae
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16277-6
|
Bartonella
quintana
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16278-4
|
Mycobacterium
tuberculosis
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16279-2
|
Toxoplasma
gondii
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
1628-7
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
1
g/kg
glucose
PO
|
|
16280-0
|
Human
papilloma
virus
DNA
[Presence]
in
Unspecified
specimen
by
Probe
with
amplification
|
|
16281-8
|
Trazodone
[Units/volume]
in
Urine
|
|
16282-6
|
Acetaminophen
[Units/volume]
in
Urine
|
|
16283-4
|
Escherichia
coli
verotoxin
[Presence]
in
Unspecified
specimen
|
|
16284-2
|
Polio
virus
Ab
[Units/volume]
in
Serum
|
|
16285-9
|
Creatinine/Protein
[Mass
Ratio]
in
Urine
|
|
16286-7
|
Deprecated
Testosterone
Free/Testosterone.total
in
Serum
or
Plasma
|
|
16287-5
|
Deprecated
Sulfatide
Ab
|
|
16288-3
|
Deprecated
Monosialoganglioside
GM1
Ab.IgG+IgM
|
|
16289-1
|
Deprecated
Monosialoganglioside
GM1
Ab
|
|
1629-5
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
insulin
IV
|
|
16290-9
|
Neutrophils
[Presence]
in
Stool
|
|
16291-7
|
Herpes
simplex
virus
1
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16292-5
|
1,4-Dioxane
[Mass/volume]
in
Urine
|
|
16293-3
|
11-Deoxycorticosteroids
[Mass/volume]
in
Plasma
|
|
16294-1
|
11-Deoxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
16295-8
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
16296-6
|
11-Hydroxyandrosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16297-4
|
17-Hydroxypregnenolone
[Mass/volume]
in
Urine
|
|
16298-2
|
17-Hydroxypregnenolone
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
16299-0
|
17-Hydroxypregnenolone
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
XXX
challenge
|
|
163-6
|
Cephalothin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1630-3
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
1
g/kg
glucose
PO
|
|
16300-6
|
17-Ketogenic
steroids
[Mass/time]
in
72
hour
Urine
|
|
16301-4
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
--baseline
|
|
16302-2
|
1-Methylhistidine
[Presence]
in
Urine
|
|
16303-0
|
2-Hexanol
[Mass/volume]
in
Urine
|
|
16304-8
|
2-Hexanol/Creatinine
[Mass
Ratio]
in
Urine
|
|
16305-5
|
2-Methoxyethanol
[Mass/volume]
in
Blood
|
|
16306-3
|
3-Methylhistidine
[Presence]
in
Urine
|
|
16307-1
|
Acetate
[Mass/volume]
in
Dialysis
fluid
|
|
16308-9
|
Acetazolamide
[Units/volume]
in
Serum
or
Plasma
|
|
16309-7
|
Acetazolamide
[Units/volume]
in
Urine
|
|
1631-1
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
insulin
IV
|
|
16310-5
|
Acetone
[Presence]
in
Body
fluid
|
|
16311-3
|
Acetone
[Mass/volume]
in
Body
fluid
|
|
16312-1
|
Acetonitrile
[Mass/volume]
in
Serum
or
Plasma
|
|
16313-9
|
Acetylene
[Mass/volume]
in
Blood
|
|
16314-7
|
Acetylsalicylate
[Presence]
in
Urine
|
|
16315-4
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Blood
by
Tartrate
inhibited
|
|
16316-2
|
Acid
phosphatase
tartrate
resistant
[Enzymatic
activity/volume]
in
Blood
|
|
16317-0
|
Prostatic
acid
phosphatase
[Presence]
in
Vaginal
fluid
|
|
16318-8
|
Acrylamide
[Mass/volume]
in
Urine
|
|
16319-6
|
Acrylamide
[Mass/volume]
in
Serum
or
Plasma
|
|
1632-9
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
1
g/kg
glucose
PO
|
|
16320-4
|
Acyclovir
[Susceptibility]
by
Serum
bactericidal
titer
|
|
16321-2
|
Deprecated
Acyl
carnitine
[Mass/volume]
in
Serum
or
Plasma
|
|
16322-0
|
Biperiden
[Mass/volume]
in
Serum
or
Plasma
|
|
16323-8
|
Alanine
[Presence]
in
Urine
|
|
16324-6
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16325-3
|
Alanine
aminotransferase/Aspartate
aminotransferase
[Enzymatic
activity
ratio]
in
Serum
or
Plasma
|
|
16327-9
|
Allyl
alcohol
[Mass/volume]
in
Blood
|
|
16328-7
|
Benzyl
alcohol
[Presence]
in
Blood
|
|
16329-5
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
1633-7
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
dose
insulin
IV
|
|
16330-3
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16331-1
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
16332-9
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
16333-7
|
Aldrin
[Mass/volume]
in
Blood
|
|
16334-5
|
Alfentanil
[Mass/volume]
in
Urine
|
|
16335-2
|
Hydrocarbons
Aliphatic
[Identifier]
in
Blood
|
|
16336-0
|
Deprecated
Alkaline
phosphatase.placental
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16337-8
|
Alkaline
phosphatase
[Enzymatic
activity/volume]
in
Urine
|
|
16338-6
|
Alpha
aminoadipate
[Presence]
in
Urine
|
|
16339-4
|
Alpha
aminoisobutyrate
[Presence]
in
Urine
|
|
1634-5
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--52
hours
post
250
ug
L-dopa
TID
2day
PO
|
|
16340-2
|
Alpha
aminoisobutyrate
[Mass/volume]
in
Urine
|
|
16341-0
|
Alpha
aminoisobutyrate
[Presence]
in
Plasma
|
|
16342-8
|
Alpha
aminoisobutyrate
[Mass/volume]
in
Plasma
|
|
16343-6
|
Alpha
aminoisobutyrate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16344-4
|
Alpha
aminoisobutyrate
[Mass/volume]
in
Amniotic
fluid
|
|
16345-1
|
Alpha
aminobutyrate
[Presence]
in
Urine
|
|
16346-9
|
Alpha
chlordane
[Mass/volume]
in
Urine
|
|
16347-7
|
Alpha
chlordane
[Mass/volume]
in
Blood
|
|
16348-5
|
Alpha
hydroxyalprazolam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16349-3
|
Aluminum
[Mass/volume]
in
Body
fluid
|
|
1635-2
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--pre
1
g/kg
glucose
PO
|
|
16350-1
|
Amantadine
[Susceptibility]
by
Serum
bactericidal
titer
|
|
16351-9
|
Amiloride
[Units/volume]
in
Serum
or
Plasma
|
|
16352-7
|
Amiloride
[Units/volume]
in
Urine
|
|
16353-5
|
Amino
beta
guanidinopropionate
[Presence]
in
Urine
|
|
16354-3
|
Deprecated
Amino
beta
guanidinopropionate
[Mass/volume]
in
Urine
|
|
16355-0
|
Amino
beta
guanidinopropionate
[Presence]
in
Plasma
|
|
16356-8
|
Deprecated
Amino
beta
guanidinopropionate
[Mass/volume]
in
Plasma
|
|
16357-6
|
Deprecated
Amino
beta
guanidinopropionate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16358-4
|
Deprecated
Amino
beta
guanidinopropionate
[Mass/volume]
in
Amniotic
fluid
|
|
16359-2
|
Deprecated
Amiodarone+Desethylamiodarone
[Mass/volume]
in
Serum
or
Plasma
|
|
1636-0
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--pre
250
ug
L-dopa
TID
2day
PO
|
|
16360-0
|
Amitriptyline
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
16361-8
|
Amitriptyline
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
16362-6
|
Ammonia
[Moles/volume]
in
Plasma
|
|
16363-4
|
Ammonia
[Moles/mass]
in
Tissue
|
|
16364-2
|
Amobarbital
[Mass/volume]
in
Gastric
fluid
|
|
16365-9
|
Amoxicillin+Clavulanate
[Mass/volume]
in
Serum
or
Plasma
|
|
16366-7
|
Diethylpropion
[Mass/volume]
in
Serum
or
Plasma
|
|
16367-5
|
Deprecated
Amphetamine/Methamphetamine
[Mass
ratio]
in
Urine
Qualitative
|
|
16369-1
|
Amphetamines
[Presence]
in
Urine
by
Confirmatory
method
|
|
1637-8
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
insulin
IV
|
|
16370-9
|
Amphotericin
B
[Mass/volume]
in
Urine
|
|
16373-3
|
Amyl
ether
[Presence]
in
Blood
|
|
16374-1
|
Amyl
nitrite
[Mass/volume]
in
Serum
or
Plasma
|
|
16378-2
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
16379-0
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
1638-6
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--96
hours
post
5000
U
HCG
IM
|
|
16380-8
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
16381-6
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
16382-4
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
16383-2
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16384-0
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
16385-7
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
16386-5
|
Deprecated
Rifabutin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16387-3
|
Rifabutin+Ethambutol
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16388-1
|
Anticonvulsants
[Identifier]
in
Urine
|
|
16389-9
|
Antidepressants
[Identifier]
in
Serum
or
Plasma
|
|
1639-4
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--pre
5000
U
HCG
IM
|
|
16390-7
|
Antidiuretics
[Identifier]
in
Urine
|
|
16391-5
|
Antimony
[Presence]
in
Urine
|
|
16392-3
|
Nuclear
Ab
[Presence]
in
Serum
by
Rodent
substrate
|
|
16393-1
|
Nuclear
Ab
[Units/volume]
in
Serum
by
Rodent
substrate
|
|
16394-9
|
Nuclear
Ab
[Presence]
in
Body
fluid
by
Immunofluorescence
|
|
16395-6
|
Antipsychotics
[Identifier]
in
Urine
|
|
164-4
|
Cephapirin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1640-2
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
dose
TRH
IV
|
|
16400-4
|
Appearance
of
Seminal
plasma
|
|
16401-2
|
Arginine
[Presence]
in
Urine
|
|
16402-0
|
Aromatic
solvents
[Identifier]
in
Blood
|
|
16403-8
|
Arsenic
[Presence]
in
Serum
or
Plasma
|
|
16404-6
|
Arsenic
[Presence]
in
Urine
|
|
16405-3
|
Arylamidase
[Presence]
in
Urine
|
|
16406-1
|
Arylamidase
[Enzymatic
activity/volume]
in
Urine
|
|
16407-9
|
Asbestos
identified
in
Sputum
by
Light
microscopy
|
|
16408-7
|
Ascorbate
[Mass/volume]
in
Urine
|
|
16409-5
|
Ascorbate
[Mass/volume]
in
Serum
or
Plasma
--post
dose
|
|
1641-0
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
dose
TRH
IV
|
|
16410-3
|
Asparagine
[Presence]
in
Urine
|
|
16411-1
|
Aspartate
[Presence]
in
Urine
|
|
16412-9
|
Aspartate
aminotransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16414-5
|
Aspergillus
amstelodami
Ab
[Units/volume]
in
Serum
|
|
16415-2
|
Aspergillus
flavus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16416-0
|
Aspergillus
terreus
Ab
[Units/volume]
in
Serum
|
|
16417-8
|
Aspergillus
versicolor
Ab
[Units/volume]
in
Serum
|
|
16418-6
|
Azatadine
[Presence]
in
Urine
|
|
16419-4
|
Azathioprine
[Mass/volume]
in
Serum
or
Plasma
|
|
1642-8
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
16420-2
|
Azithromycin
[Mass/volume]
in
Serum
or
Plasma
|
|
16421-0
|
Azithromycin+Ethambutol
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16422-8
|
Azlocillin
[Mass/volume]
in
Urine
|
|
16423-6
|
Aztreonam
[Mass/volume]
in
Urine
|
|
16424-4
|
Deprecated
Sulfasalazine
[Mass/volume]
in
Serum
or
Plasma
|
|
16425-1
|
Babesia
sp
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16426-9
|
Babesia
sp
IgM
Ab
[Titer]
in
Serum
|
|
16427-7
|
Babesia
microti
Ab
[Titer]
in
Serum
|
|
16428-5
|
Bacitracin
[Mass/volume]
in
Serum
or
Plasma
|
|
16429-3
|
Barbiturates
[Presence]
in
Urine
by
Confirmatory
method
|
|
1643-6
|
Thyrotropin
[Mass/volume]
in
Serum
or
Plasma
--pre
dose
TRH
IV
|
|
16430-1
|
Barbiturates
[Units/volume]
in
Urine
|
|
16431-9
|
Barium
[Presence]
in
Urine
|
|
16432-7
|
Barium
[Mass/volume]
in
Blood
|
|
16433-5
|
Basement
membrane
Ab
[Presence]
in
Serum
|
|
16434-3
|
Basement
membrane
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16435-0
|
Deprecated
White
Bean
IgE
Ab
[Units/volume]
in
Serum
|
|
16436-8
|
Deprecated
Bean
string
IgE
Ab
[Units/volume]
in
Serum
|
|
16437-6
|
Bendroflumethiazide
[Units/volume]
in
Urine
|
|
16438-4
|
Benzaldehyde
[Presence]
in
Urine
|
|
16439-2
|
Benzene
[Presence]
in
Blood
|
|
1644-4
|
Triglyceride
[Mass/volume]
in
Serum
or
Plasma
--12
hours
fasting
|
|
16440-0
|
Benzene
ring
IgE
Ab
[Units/volume]
in
Serum
|
|
16441-8
|
Benzene
ring
IgG
Ab
[Units/volume]
in
Serum
|
|
16442-6
|
Benzene
ring
IgM
Ab
[Units/volume]
in
Serum
|
|
16443-4
|
Benzonatate
[Mass/volume]
in
Serum
|
|
16444-2
|
Benzophenone
[Mass/volume]
in
Serum
or
Plasma
|
|
16446-7
|
Benzoylecgonine
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16447-5
|
Cocaine
[Units/volume]
in
Serum
or
Plasma
|
|
16448-3
|
Cocaine
[Units/volume]
in
Urine
|
|
16449-1
|
Benzthiazide
[Mass/volume]
in
Serum
or
Plasma
|
|
1645-1
|
Xylose
[Mass/volume]
in
Blood
--2
hours
post
25
g
xylose
PO
|
|
16450-9
|
Benzylhydrazine
[Mass/volume]
in
Serum
or
Plasma
|
|
16451-7
|
Beryllium
[Presence]
in
Urine
|
|
16452-5
|
Beta
alanine
[Presence]
in
Urine
|
|
16453-3
|
Beta
aminoisobutyrate
[Presence]
in
Urine
|
|
16454-1
|
Beta
galactosidase
[Enzymatic
activity/volume]
in
Blood
|
|
16455-8
|
Beta
hydroxybutyrate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
16456-6
|
Beta
hydroxybutyrate
[Moles/volume]
in
Urine
|
|
16457-4
|
Beta-N-acetylhexosaminidase.A
[Enzymatic
activity/volume]
in
Leukocytes
|
|
16458-2
|
Bethanechol
[Mass/volume]
in
Serum
or
Plasma
|
|
16459-0
|
Bicarbonate
[Moles/volume]
in
Body
fluid
|
|
1646-9
|
Xylose
[Mass/time]
in
5
hour
Urine
--post
dose
PO
|
|
16460-8
|
Bicarbonate
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
16461-6
|
Bicarbonate
[Moles/volume]
in
Red
Blood
Cells
|
|
16462-4
|
Bicarbonate
[Moles/volume]
in
Amniotic
fluid
|
|
16463-2
|
Bile
acid.dihydroxy
[Mass/volume]
in
Serum
|
|
16464-0
|
Bile
acid
[Units/volume]
in
Exhaled
gas
|
|
16465-7
|
Bile
acid
[Mass/volume]
in
Urine
|
|
16466-5
|
Bile
acid.trihydroxy
[Mass/volume]
in
Serum
|
|
16467-3
|
Bismuth
[Presence]
in
Blood
|
|
16468-1
|
Bismuth
[Presence]
in
Urine
|
|
16469-9
|
Bismuth/Creatinine
[Mass
Ratio]
in
Urine
|
|
1647-7
|
Tuberculosis
reaction
wheal
[Diameter]
--3
days
post
25
TU
intradermal
|
|
16470-7
|
Blastomyces
dermatitidis
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
16471-5
|
Blastomyces
dermatitidis
Ab
[Units/volume]
in
Serum
|
|
16472-3
|
Blastomyces
dermatitidis
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16473-1
|
Bordetella
parapertussis
Ab
[Units/volume]
in
Serum
|
|
16474-9
|
Bordetella
pertussis
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16475-6
|
Borrelia
burgdorferi
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
16476-4
|
Borrelia
burgdorferi
Ab
[Presence]
in
Body
fluid
by
Immunoassay
|
|
16477-2
|
Borrelia
burgdorferi
Ab
[Presence]
in
Body
fluid
|
|
16478-0
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
16479-8
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
1648-5
|
Tuberculosis
reaction
wheal
[Diameter]
--3
days
post
5
TU
intradermal
|
|
16480-6
|
Borrelia
burgdorferi
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
16481-4
|
Borrelia
burgdorferi
IgG
Ab
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
16482-2
|
Borrelia
burgdorferi
IgM
Ab
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
16483-0
|
Borrelia
hermsii
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16484-8
|
Boysenberry
IgE
Ab
[Units/volume]
in
Serum
|
|
16485-5
|
Bromodiphenhydramine
[Mass/volume]
in
Urine
|
|
16486-3
|
Brucella
abortus
IgA+IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
16487-1
|
Brucella
abortus
IgG
Ab
[Units/volume]
in
Serum
by
Agglutination
|
|
16488-9
|
Brucella
abortus
IgG
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16489-7
|
Brucella
melitensis
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
1649-3
|
Calcitriol
[Mass/volume]
in
Serum
or
Plasma
|
|
16490-5
|
Brucella
suis
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
16491-3
|
Brush
border
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
16492-1
|
Bufotenine
[Units/volume]
in
Urine
|
|
16493-9
|
Bufotenine
[Units/volume]
in
Serum
or
Plasma
|
|
16494-7
|
Bumetanide
[Units/volume]
in
Urine
|
|
16495-4
|
Buprenorphine
[Units/volume]
in
Serum
or
Plasma
|
|
16496-2
|
Buprenorphine
[Units/volume]
in
Urine
|
|
16497-0
|
Butabarbital
[Mass/volume]
in
Gastric
fluid
|
|
16498-8
|
Butalbital
[Units/volume]
in
Gastric
fluid
|
|
16499-6
|
Butorphanol
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
165-1
|
Cephapirin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1650-1
|
1,4-Alpha
glucan
branching
enzyme
[Enzymatic
activity/volume]
in
Leukocytes
|
|
16500-1
|
Butyrate
(C4)
[Mass/volume]
in
Stool
|
|
16501-9
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16502-7
|
C
peptide
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
16503-5
|
C
reactive
protein
[Mass/volume]
in
Body
fluid
|
|
16504-3
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--1.5
minutes
post
XXX
challenge
|
|
16505-0
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
16506-8
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
16507-6
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--4
hours
post
XXX
challenge
|
|
16508-4
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
XXX
challenge
|
|
16509-2
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
1651-9
|
1-Methylhistidine
[Presence]
in
Serum
or
Plasma
|
|
16510-0
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
16511-8
|
Calcitonin
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
16512-6
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
16513-4
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
16514-2
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
16515-9
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
16516-7
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
16517-5
|
Calcium.ionized
[Moles/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16518-3
|
Calcium
[Mass/time]
in
2
hour
Urine
|
|
16519-1
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
1652-7
|
1-Methylhistidine
[Mass/volume]
in
Serum
or
Plasma
|
|
16520-9
|
Calcium
[Moles/volume]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
16521-7
|
Calcium
[Moles/volume]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
16522-5
|
Calcium
[Moles/volume]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
16523-3
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
--5
minutes
post
XXX
challenge
|
|
16524-1
|
Calcium
[Moles/volume]
in
Serum
or
Plasma
--6
hours
post
XXX
challenge
|
|
16525-8
|
Calcium/Phosphate
[Mass
Ratio]
in
Serum
or
Plasma
|
|
16526-6
|
Calcium/Protein
[Mass
Ratio]
in
Serum
or
Plasma
|
|
16527-4
|
Calcium/Sodium
[Mass
Ratio]
in
Serum
or
Plasma
|
|
16528-2
|
Campylobacter
coli
rRNA
[Units/volume]
in
Serum
by
DNA
probe
|
|
16529-0
|
Campylobacter
jejuni
rRNA
[Units/volume]
in
Serum
by
DNA
probe
|
|
1653-5
|
1-Methylhistidine
[Mass/volume]
in
Urine
|
|
16530-8
|
Campylobacter
jejuni
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16531-6
|
Campylobacter
lari
rRNA
[Units/volume]
in
Serum
by
DNA
probe
|
|
16532-4
|
Campylobacter
lari
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16533-2
|
Helicobacter
pylori
Ab
[Titer]
in
Serum
|
|
16534-0
|
Campylobacter
sp
rRNA
[Presence]
in
Serum
by
DNA
probe
|
|
16535-7
|
Canary
droppings
IgE
Ab
[Units/volume]
in
Serum
|
|
16536-5
|
Canary
serum
proteins
Ab
[Units/volume]
in
Serum
|
|
16537-3
|
Candida
albicans
Ab
[Units/volume]
in
Serum
by
Immune
diffusion
(ID)
|
|
16538-1
|
Candida
sp
IgA
Ab
[Units/volume]
in
Saliva
(oral
fluid)
|
|
16539-9
|
Candida
sp
Ag
[Presence]
in
Serum
|
|
1654-3
|
1-Naphthalene
[Mass/volume]
in
Urine
|
|
16540-7
|
Deprecated
Cannabinoids
[Presence]
in
Serum
or
Plasma
by
Confirm
method
|
|
16542-3
|
Cannabinoids
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16543-1
|
Cannabinoids
[Mass/volume]
in
Unknown
substance
by
Confirmatory
method
|
|
16544-9
|
Canrenone
[Units/volume]
in
Urine
|
|
16545-6
|
Capreomycin
[Mass/volume]
in
Serum
or
Plasma
|
|
16546-4
|
Captopril
[Mass/volume]
in
Serum
or
Plasma
|
|
16547-2
|
Carbamate
pesticides
[Type]
in
Urine
|
|
16548-0
|
Carbamazepine
[Mass/volume]
in
Urine
|
|
16549-8
|
Carbinoxamine
[Presence]
in
Urine
|
|
1655-0
|
Deprecated
11-Deoxy/11-Oxy
steroids
in
Urine
|
|
16550-6
|
Carbohydrates
[Identifier]
in
Urine
|
|
16551-4
|
Carbon
dioxide,
total
[Moles/volume]
in
Capillary
blood
|
|
16553-0
|
Carnitine
[Mass/mass]
in
Tissue
|
|
16555-5
|
Carnitine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16556-3
|
Carnitine
[Mass/volume]
in
Amniotic
fluid
|
|
16557-1
|
Carnosine
[Presence]
in
Urine
|
|
16558-9
|
Catecholamines
[Mass/volume]
in
Plasma
--2
hours
post
XXX
challenge
|
|
16559-7
|
Catecholamines
[Mass/volume]
in
Plasma
--3
hours
post
XXX
challenge
|
|
1656-8
|
11-Deoxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16560-5
|
Catecholamines
[Mass/volume]
in
Plasma
--5th
specimen
post
XXX
challenge
|
|
16561-3
|
Catecholamines
[Mass/volume]
in
Plasma
--6th
specimen
post
XXX
challenge
|
|
16562-1
|
Cathartic
laxatives
[Identifier]
in
Urine
|
|
16563-9
|
Cathepsin
D
in
Serum
or
Plasma
|
|
16564-7
|
Cefaclor
[Mass/volume]
in
Serum
or
Plasma
|
|
16565-4
|
Cefadroxil
[Mass/volume]
in
Serum
or
Plasma
|
|
16566-2
|
Cefazolin
[Mass/volume]
in
Urine
|
|
16567-0
|
Cefixime
[Mass/volume]
in
Serum
or
Plasma
|
|
16568-8
|
Cefuroxime
IgE
Ab
[Units/volume]
in
Serum
|
|
16569-6
|
Ceftriaxone
IgE
Ab
[Mass/volume]
in
Serum
|
|
1657-6
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
|
|
16570-4
|
Centromere
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
16571-2
|
Cephadrine
[Mass/volume]
in
Serum
or
Plasma
|
|
16572-0
|
Cephaloridine
[Mass/volume]
in
Serum
or
Plasma
|
|
16573-8
|
Deprecated
Cerebroside
sulfatase
[Presence]
in
Serum
or
Plasma
|
|
16574-6
|
Deprecated
Cerebroside
sulfatase
[Enzymatic
activity/mass]
in
Tissue
|
|
16575-3
|
Deprecated
Cerebroside
sulfatase
B
in
urine
|
|
16576-1
|
Deprecated
Cerebroside
sulfatase
B
in
amniotic
fluid
|
|
16577-9
|
Deprecated
Cerebroside
sulfatase
B
in
serum
or
plasma
|
|
16578-7
|
Deprecated
Cerebroside
sulfatase
B
in
tissue
|
|
16579-5
|
Deprecated
Cerebroside
sulfatase
B
in
blood
|
|
1658-4
|
11-Hydroxyandrostenedione
[Mass/volume]
in
Serum
or
Plasma
|
|
16580-3
|
Deprecated
Cerebroside
sulfatase
B
in
leukocytes
|
|
16581-1
|
Chlamydophila
pneumoniae
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16582-9
|
Chlamydophila
pneumoniae
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16583-7
|
Chlamydophila
pneumoniae
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16584-5
|
Chlamydophila
pneumoniae
rRNA
[Presence]
in
Sputum
by
DNA
probe
|
|
16585-2
|
Chlamydophila
pneumoniae
rRNA
[Presence]
in
Serum
or
Plasma
by
DNA
probe
|
|
16586-0
|
Chlamydophila
psittaci
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16587-8
|
Chlamydophila
psittaci
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16588-6
|
Chlamydophila
psittaci
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16589-4
|
Chlamydia
sp
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1659-2
|
11-Hydroxyandrosterone
[Mass/volume]
in
Urine
|
|
16590-2
|
Chlamydia
sp
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16591-0
|
Chlamydia
sp
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16592-8
|
Chlamydia
sp
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16593-6
|
Chlamydia
sp
Ag
[Presence]
in
Urine
|
|
16594-4
|
Chlamydia
trachomatis
IgA
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16595-1
|
Chlamydia
trachomatis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16596-9
|
Chlamydia
trachomatis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
16597-7
|
Chlamydia
trachomatis
B
IgG
Ab
[Units/volume]
in
Serum
|
|
16598-5
|
Chlamydia
trachomatis
C
IgG
Ab
[Units/volume]
in
Serum
|
|
16599-3
|
Chlamydia
trachomatis
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
166-9
|
Cephapirin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1660-0
|
11-Hydroxyetiocholanolone
[Mass/volume]
in
Serum
|
|
16600-9
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Genital
specimen
by
DNA
probe
|
|
16601-7
|
Chlamydia
trachomatis
rRNA
[Presence]
in
Urine
by
DNA
probe
|
|
16602-5
|
Deprecated
Chlamydia
trachomatis
rRNA
[Presence]
in
Urine
by
DNA
probe
|
|
16603-3
|
Chloramphenicol
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
16604-1
|
Chloramphenicol
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
16605-8
|
Chlorocycline
[Mass/volume]
in
Urine
|
|
16606-6
|
Chlorine
[Mass/volume]
in
Dialysis
fluid
|
|
16607-4
|
Chlorine
[Mass/volume]
in
Water
|
|
16608-2
|
Chlorpheniramine
[Units/volume]
in
Urine
|
|
16609-0
|
Chlorphentermine
[Units/volume]
in
Blood
|
|
1661-8
|
11-Ketoandrosterone
[Mass/volume]
in
Serum
|
|
16610-8
|
Chlorphentermine
[Units/volume]
in
Urine
|
|
16611-6
|
Chlorpyrifos
[Mass/volume]
in
Urine
|
|
16612-4
|
Chlorthalidone
[Mass/volume]
in
Serum
or
Plasma
|
|
16613-2
|
Cholesterol
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16614-0
|
Cholesterol
crystals
[Presence]
in
Body
fluid
by
Light
microscopy
|
|
16615-7
|
Cholesterol.total/Cholesterol
in
LDL
[Mass
Ratio]
in
Serum
or
Plasma
|
|
16616-5
|
Cholesterol
in
HDL/Cholesterol
in
LDL
[Mass
Ratio]
in
Serum
or
Plasma
|
|
16617-3
|
Choriogonadotropin.intact
[Moles/volume]
in
Semen
|
|
16618-1
|
Cladosporium
herbarum
Ab
[Units/volume]
in
Serum
|
|
16619-9
|
Clarithromycin
[Mass/volume]
in
Serum
or
Plasma
|
|
1662-6
|
11-Ketoetiocholanolone
[Mass/volume]
in
Serum
|
|
16620-7
|
Clarithromycin+Ethambutol
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16621-5
|
Clindamycin
[Mass/volume]
in
Serum
or
Plasma
--peak
|
|
16622-3
|
Clindamycin
[Mass/volume]
in
Serum
or
Plasma
--trough
|
|
16623-1
|
Clofazimine
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16624-9
|
Clomipramine
[Units/volume]
in
Milk
|
|
16625-6
|
Clomipramine
[Mass/volume]
in
Milk
|
|
16626-4
|
Clostridium
tetani
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
16627-2
|
Clostridium
tetani
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
16628-0
|
Cloxacillin
[Mass/volume]
in
Serum
or
Plasma
|
|
16629-8
|
Deprecated
Activated
partial
thrombplastin
time
(aPTT)
in
Blood
from
control
by
Coagulation
assay
|
|
1663-4
|
11-Oxycorticosterone
[Mass/volume]
in
Serum
|
|
16630-6
|
aPTT
in
control
Blood
by
Coagulation
1:1
saline
|
|
16631-4
|
aPTT
in
Blood
by
Coagulation
1:1
saline
|
|
16632-2
|
Cocaethylene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16633-0
|
Cocaine
[Presence]
in
Blood
|
|
16634-8
|
Coccidioides
immitis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16635-5
|
Coccidioides
immitis
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
16636-3
|
Coccidioides
immitis
IgA
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16637-1
|
Coccidioides
immitis
IgE
Ab
[Units/volume]
in
Serum
|
|
16638-9
|
Coccidioides
immitis
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16639-7
|
Coccidioides
immitis
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1664-2
|
17-Hydroxycorticosteroids
[Mass/volume]
in
Amniotic
fluid
|
|
16640-5
|
Coccidioides
reaction
wheal
[Diameter]
|
|
16641-3
|
Cockatiel
droppings
Ab
[Units/volume]
in
Serum
|
|
16642-1
|
Cockatiel
droppings
IgG
Ab
[Units/volume]
in
Serum
|
|
16643-9
|
Cockatoo
droppings
Ab
[Units/volume]
in
Serum
|
|
16644-7
|
Codeine
Free
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16645-4
|
Colistin
[Mass/volume]
in
Serum
or
Plasma
|
|
16647-0
|
Collagen
Ab
[Units/volume]
in
Serum
|
|
16648-8
|
Copper
[Mass/volume]
in
Body
fluid
|
|
16649-6
|
Coproporphyrinogen
oxidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
1665-9
|
17-Hydroxycorticosteroids
[Mass/volume]
in
Plasma
|
|
16650-4
|
Cilantro
IgE
Ab
[Units/volume]
in
Serum
|
|
16651-2
|
Corticosterone
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
16652-0
|
Corticotropin
[Mass/volume]
in
Amniotic
fluid
by
Radioimmunoassay
(RIA)
|
|
16653-8
|
Corticotropin
Canine
[Mass/volume]
in
Plasma
|
|
16654-6
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--1.5
hours
post
XXX
challenge
|
|
16655-3
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--10
minutes
post
XXX
challenge
|
|
16656-1
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--15
minutes
post
XXX
challenge
|
|
16657-9
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--1
hour
post
XXX
challenge
|
|
16658-7
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--1
minute
post
XXX
challenge
|
|
16659-5
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--2.5
hours
post
XXX
challenge
|
|
1666-7
|
17-Hydroxycorticosteroids
[Mass/volume]
in
Urine
|
|
16660-3
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--20
minutes
post
XXX
challenge
|
|
16661-1
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--2
hours
post
XXX
challenge
|
|
16662-9
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--30
minutes
post
XXX
challenge
|
|
16663-7
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--3
hours
post
XXX
challenge
|
|
16664-5
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--45
minutes
post
XXX
challenge
|
|
16665-2
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--5
minutes
post
XXX
challenge
|
|
16666-0
|
Corticotropin
[Mass/volume]
in
Plasma
by
Radioimmunoassay
(RIA)
--9th
specimen
post
XXX
challenge
|
|
16667-8
|
Cortisol
Free
[Mass/time]
in
48
hour
Urine
|
|
16668-6
|
Cortisol
Free
[Mass/time]
in
72
hour
Urine
|
|
16669-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
1667-5
|
17-Hydroxyketosteroids
[Mass/volume]
in
Urine
|
|
16670-2
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
16671-0
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--1
minute
post
XXX
challenge
|
|
16672-8
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
16673-6
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--50
minutes
post
XXX
challenge
|
|
16674-4
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--70
minutes
post
XXX
challenge
|
|
16675-1
|
Cortisol
[Mass/volume]
in
Serum
or
Plasma
--80
minutes
post
XXX
challenge
|
|
16676-9
|
Corynebacterium
diphtheriae
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
16677-7
|
Coxiella
burnetii
IgG
Ab
[Units/volume]
in
Serum
|
|
16678-5
|
Coxiella
burnetii
IgM
Ab
[Units/volume]
in
Serum
|
|
16679-3
|
Coxsackievirus
A
Ab
[Units/volume]
in
Serum
|
|
1668-3
|
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16680-1
|
Coxsackievirus
A
IgG
Ab
[Units/volume]
in
Serum
|
|
16681-9
|
Coxsackievirus
A
IgM
Ab
[Units/volume]
in
Serum
|
|
16682-7
|
Coxsackievirus
A2
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16683-5
|
Coxsackievirus
A4
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
16684-3
|
Coxsackievirus
B
Ab
[Units/volume]
in
Serum
|
|
16685-0
|
Coxsackievirus
B
IgG
Ab
[Units/volume]
in
Serum
by
Neutralization
test
|
|
16686-8
|
Coxsackievirus
B
IgM
Ab
[Units/volume]
in
Serum
by
Neutralization
test
|
|
16687-6
|
Creatine
[Mass/volume]
in
Vitreous
fluid
|
|
16688-4
|
Creatine
kinase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
16689-2
|
Creatinine
[Mass/time]
in
48
hour
Urine
|
|
1669-1
|
Deprecated
17-Hydroxyprogesterone
[Mass/volume]
in
Serum
|
|
16690-0
|
Creatinine
[Mass/time]
in
72
hour
Urine
|
|
16691-8
|
Cresols
[Identifier]
in
Unspecified
specimen
|
|
16692-6
|
Cryptococcus
sp
Ag
[Presence]
in
Body
fluid
|
|
16693-4
|
Cryptococcus
sp
Ag
[Presence]
in
Urine
|
|
16694-2
|
Cumene
[Presence]
in
Blood
|
|
16695-9
|
Cobalamin
(Vitamin
B12)
[Mass/volume]
in
Blood
|
|
16696-7
|
Cobalamin
(Vitamin
B12)
[Mass/volume]
in
Urine
--post
XXX
challenge
|
|
16697-5
|
Cyclohexane
[Presence]
in
Blood
|
|
16698-3
|
Cyclohexanol
[Mass/volume]
in
Blood
|
|
16699-1
|
Cyclohexanol
[Mass/volume]
in
Urine
|
|
167-7
|
Cephapirin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1670-9
|
17-Hydroxyprogesterone
[Mass/volume]
in
Urine
|
|
16700-7
|
Cyclohexanol/Creatinine
[Mass
Ratio]
in
Urine
|
|
16701-5
|
Cyclopropane
[Presence]
in
Blood
|
|
16702-3
|
Cycloserine
[Mass/volume]
in
Urine
|
|
16703-1
|
Cyclosporine
[Mass/volume]
in
Plasma
|
|
16704-9
|
Cyproheptadine
[Mass/volume]
in
Serum
or
Plasma
|
|
16705-6
|
Cystathionine
[Presence]
in
Urine
|
|
16706-4
|
Taenia
solium
larva
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16707-2
|
Taenia
solium
larva
IgM
Ab
[Units/volume]
in
Serum
|
|
16708-0
|
Taenia
solium
larva
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16709-8
|
Cystine
[Units/volume]
in
Urine
|
|
1671-7
|
17-Ketogenic
steroids
[Mass/volume]
in
Blood
|
|
16710-6
|
Cystine
crystals
[Presence]
in
Stone
by
Infrared
spectroscopy
|
|
16711-4
|
Cystine+Homocystine
[Presence]
in
Urine
|
|
16712-2
|
Cytomegalovirus
Ab
[Units/volume]
in
Body
fluid
|
|
16713-0
|
Cytomegalovirus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16714-8
|
Cytomegalovirus
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
16715-5
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16716-3
|
Cytomegalovirus
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
16717-1
|
Cytomegalovirus
Ag
[Presence]
in
Urine
by
Immunoassay
|
|
16718-9
|
Cytomegalovirus
Ag
[Presence]
in
Blood
|
|
16719-7
|
Cytomegalovirus
inclusion
bodies
[Presence]
in
Urine
by
Microscopic
observation
|
|
1672-5
|
Deprecated
17-Ketogenic
steroids
[Mass/volume]
in
Blood
|
|
16720-5
|
Dechlorane
[Presence]
in
Blood
|
|
16721-3
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
16722-1
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--10th
specimen
post
XXX
challenge
|
|
16723-9
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
16724-7
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--3rd
specimen
post
XXX
challenge
|
|
16725-4
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--4th
specimen
post
XXX
challenge
|
|
16726-2
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--5th
specimen
post
XXX
challenge
|
|
16727-0
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--6th
specimen
post
XXX
challenge
|
|
16728-8
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16729-6
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
1673-3
|
17-Ketogenic
steroids
[Mass/time]
in
24
hour
Urine
|
|
16730-4
|
Dehydroepiandrosterone
sulfate
(DHEA-S)
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
16731-2
|
Deprecated
Dehydroepiandrosterone.unconjugated
[Mass/volume]
in
Serum
or
Plasma
|
|
16732-0
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
16733-8
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
16734-6
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
16735-3
|
Dehydroepiandrosterone
(DHEA)
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
16736-1
|
Dengue
virus
1
Ab
[Titer]
in
Serum
|
|
16737-9
|
Dengue
virus
2
Ab
[Titer]
in
Serum
|
|
16738-7
|
Dengue
virus
3
Ab
[Titer]
in
Serum
|
|
16739-5
|
Dengue
virus
4
Ab
[Titer]
in
Serum
|
|
1674-1
|
18-Hydroxycorticosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
16740-3
|
Dengue
virus
Ab
[Presence]
in
Serum
|
|
16741-1
|
American
house
dust
mite
IgG
Ab
[Presence]
in
Blood
|
|
16742-9
|
European
house
dust
mite
IgG
Ab
[Presence]
in
Blood
|
|
16743-7
|
Deprecated
Nordiazepam
[Presence]
in
Serum
or
Plasma
|
|
16744-5
|
Deprecated
Nordiazepam
[Presence]
in
Urine
|
|
16745-2
|
Deprecated
Desmethylmethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
16746-0
|
Nortrimipramine
[Mass/volume]
in
Serum
or
Plasma
|
|
16747-8
|
Dextromoramide
[Presence]
in
Serum
or
Plasma
|
|
16748-6
|
Propoxyphene
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16749-4
|
Propoxyphene
+
Norpropoxyphene
[Units/volume]
in
Urine
|
|
1675-8
|
2,3-Diphosphoglycerate
[Mass/volume]
in
Red
Blood
Cells
|
|
16750-2
|
Dezocine
[Mass/volume]
in
Serum
or
Plasma
|
|
16751-0
|
Dezocine
[Mass/volume]
in
Blood
|
|
16752-8
|
Deprecated
Diacetate
[Presence]
in
Urine
|
|
16753-6
|
Deprecated
Dialtrazene
|
|
16754-4
|
Diamorphine
[Mass/volume]
in
Unknown
substance
|
|
16755-1
|
Diamorphine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16756-9
|
Diamorphine
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16757-7
|
Diazepam+Nordiazepam
[Mass/volume]
in
Serum
or
Plasma
|
|
16758-5
|
Dicamba
[Mass/volume]
in
Serum
or
Plasma
|
|
16759-3
|
Dicamba
[Mass/volume]
in
Urine
|
|
1676-6
|
2,3-Diphosphoglycerate
[Mass/volume]
in
Serum
|
|
16760-1
|
Deprecated
Dicarboxylporphyrin
[Mass/volume]
in
Blood
|
|
16761-9
|
Protoporphyrin
[Mass/volume]
in
Stool
|
|
16762-7
|
Dichlorobenzene
[Mass/volume]
in
Blood
|
|
16763-5
|
Dichlorodiphenyldichloroethylene
[Mass/volume]
in
Urine
|
|
16764-3
|
Dichlorodiphenyldichloroethylene
[Mass/volume]
in
Blood
|
|
16765-0
|
Dichlorodiphenyltrichloroethane
[Mass/volume]
in
Milk
|
|
16766-8
|
Dichloroethane
[Presence]
in
Blood
|
|
16767-6
|
Deprecated
2,4-Dichlorophenoxyacetate
[Mass/volume]
in
Urine
|
|
16768-4
|
Dichlorvos
[Mass/volume]
in
Urine
|
|
16769-2
|
Dicloxacillin
[Mass/volume]
in
Urine
|
|
1677-4
|
Alpha
hydroxybutyrate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16770-0
|
Dicoumarol
[Mass/volume]
in
Urine
|
|
16771-8
|
Dicyclomine
[Mass/volume]
in
Serum
or
Plasma
|
|
16772-6
|
Dieldrin
[Mass/volume]
in
Urine
|
|
16773-4
|
Dieldrin
[Mass/volume]
in
Blood
|
|
16774-2
|
Diethylcarbamazepine
[Mass/volume]
in
Serum
or
Plasma
|
|
16775-9
|
Dihydrocodeine
Free
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16776-7
|
Diltiazem
[Mass/volume]
in
Urine
|
|
16777-5
|
Dimethylacetamide
[Presence]
in
Urine
|
|
16778-3
|
Dinitrophenol
[Presence]
in
Serum
or
Plasma
|
|
16779-1
|
Dinitrophenol
[Mass/volume]
in
Urine
|
|
1678-2
|
20-Hydroxyprogesterone
[Mass/volume]
in
Serum
|
|
16780-9
|
Disopyramide
[Mass/volume]
in
Urine
|
|
16781-7
|
Disulfiram
[Presence]
in
Urine
|
|
16782-5
|
Deprecated
DNA
double
strand
Ab
[Presence]
in
Serum
by
Farr
method
|
|
16784-1
|
Dopamine
[Mass/volume]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
16785-8
|
Dopamine
[Mass/volume]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
16786-6
|
Dopamine
[Mass/volume]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
16787-4
|
Dopamine
[Mass/volume]
in
Urine
--5th
specimen
post
XXX
challenge
|
|
16788-2
|
Dopamine
[Mass/volume]
in
Urine
--6th
specimen
post
XXX
challenge
|
|
16789-0
|
Dopamine
[Mass/volume]
in
Urine
--7th
specimen
post
XXX
challenge
|
|
1679-0
|
24r-Hydroxycalcidiol
[Mass/volume]
in
Serum
or
Plasma
|
|
16790-8
|
Deprecated
Doxepin+Desmethyldoxepin
[Mass/volume]
in
Serum
or
Plasma
|
|
16791-6
|
Doxylamine
[Mass/volume]
in
Serum
or
Plasma
|
|
16792-4
|
Doxylamine
[Mass/volume]
in
Urine
|
|
16793-2
|
Drugs
identified
in
Unknown
substance
by
Screen
method
|
|
16794-0
|
Echinococcus
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
16795-7
|
Echovirus
Ab
[Units/volume]
in
Serum
|
|
16796-5
|
Echovirus
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16797-3
|
Echovirus
1
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16798-1
|
Echovirus
14
Ab
[Units/volume]
in
Serum
|
|
16799-9
|
Deprecated
Echovirus
140
Ab
by
complement
fixation
|
|
168-5
|
Cephradine
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1680-8
|
3-Alpha-Androstanediol
glucuronide
[Mass/volume]
in
Serum
|
|
16800-5
|
Echovirus
19
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16801-3
|
Echovirus
3
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16802-1
|
Echovirus
30
Ab
[Units/volume]
in
Serum
|
|
16803-9
|
Echovirus
4
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16804-7
|
Echovirus
40
Ab
[Units/volume]
in
Serum
|
|
16805-4
|
Echovirus
6
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16806-2
|
Echovirus
6+18+30
Ab
[Units/volume]
in
Serum
|
|
16807-0
|
Echovirus
9
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16808-8
|
Anaplasma
phagocytophilum
IgG
Ab
[Units/volume]
in
Serum
|
|
16809-6
|
Anaplasma
phagocytophilum
IgM
Ab
[Units/volume]
in
Serum
|
|
1681-6
|
Beta
hydroxybutyrate
dehydrogenase
[Enzymatic
activity/volume]
in
Blood
|
|
16811-2
|
Arachidate
(C20:0)
[Mass/volume]
in
Serum
or
Plasma
|
|
16812-0
|
Emetine
[Presence]
in
Serum
or
Plasma
|
|
16813-8
|
Emetine
[Units/volume]
in
Serum
or
Plasma
|
|
16814-6
|
Endomysium
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
16815-3
|
Endomysium
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
16816-1
|
Enoxacin
[Mass/volume]
in
Urine
|
|
16817-9
|
Entamoeba
histolytica
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16818-7
|
Entamoeba
histolytica
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16819-5
|
Entamoeba
histolytica
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1682-4
|
Beta
hydroxybutyrate
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16820-3
|
Entamoeba
histolytica
Ab
[Units/volume]
in
Serum
by
Complement
fixation
|
|
16821-1
|
Epinephrine
[Mass/volume]
in
Plasma
--4
hours
post
XXX
challenge
|
|
16822-9
|
Epithelial
cells
[Presence]
in
Nose
by
Light
microscopy
|
|
16823-7
|
Epstein
Barr
virus
early
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
16824-5
|
Epstein
Barr
virus
nuclear
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16825-2
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Presence]
in
Body
fluid
|
|
16826-0
|
Epstein
Barr
virus
capsid
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16827-8
|
Epstein
Barr
virus
capsid
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16828-6
|
Erythrocytes
[#/volume]
in
Seminal
plasma
by
Manual
count
|
|
16829-4
|
Erythromycin
[Mass/volume]
in
Urine
|
|
1683-2
|
3-Hydroxyisovalerate
[Mass/volume]
in
Urine
|
|
16830-2
|
Erythromycin+Ethambutol
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16832-8
|
Escherichia
coli
enterotoxic
identified
in
Stool
by
Organism
specific
culture
|
|
16833-6
|
Escherichia
coli
K1
Ag
[Presence]
in
Unspecified
specimen
by
Immunoassay
|
|
16834-4
|
Escherichia
coli
K1
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
16835-1
|
Escherichia
coli
shiga-like
identified
in
Stool
by
Organism
specific
culture
|
|
16836-9
|
Escherichia
coli
verotoxic
identified
in
Stool
by
Organism
specific
culture
|
|
16838-5
|
Estriol
(E3)
[Mass/volume]
in
Body
fluid
|
|
1684-0
|
3-Methoxy-4-Hydroxyphenylglycol
[Mass/volume]
in
Urine
|
|
16840-1
|
Ethacrynate
[Mass/volume]
in
Serum
or
Plasma
|
|
16841-9
|
Ethambutol+Rifampin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
16842-7
|
Ethanol
[Mass/volume]
in
Unknown
substance
|
|
16843-5
|
Ethanol
[Mass/volume]
in
Body
fluid
|
|
16844-3
|
Ethinamate
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
16845-0
|
Ethionamide
[Mass/volume]
in
Serum
or
Plasma
|
|
16847-6
|
Ethoheptazine
[Presence]
in
Serum
or
Plasma
|
|
16848-4
|
Ethoheptazine
[Mass/volume]
in
Serum
or
Plasma
|
|
16849-2
|
Ethyl
benzene
[Mass/volume]
in
Urine
|
|
1685-7
|
3-Methylhistidine
[Presence]
in
Serum
or
Plasma
|
|
16850-0
|
Ethylene
oxide
[Mass/volume]
in
Blood
|
|
16851-8
|
Ethylmorphine
[Units/volume]
in
Urine
|
|
16852-6
|
Etodolac
[Mass/volume]
in
Serum
or
Plasma
|
|
16853-4
|
Fat
[Mass]
in
Stool
|
|
16855-9
|
Fat
[Mass/time]
in
48
hour
Stool
|
|
16856-7
|
Fat.microscopic
observation
[Identifier]
in
Synovial
fluid
by
Sudan
IV
stain
|
|
16857-5
|
Fenclorvos
[Presence]
in
Blood
|
|
16858-3
|
Fentanyl
[Mass/volume]
in
Body
fluid
|
|
16859-1
|
Fibrinogen
[Presence]
in
Platelet
poor
plasma
|
|
1686-5
|
3-Methylhistidine
[Mass/volume]
in
Serum
or
Plasma
|
|
16860-9
|
Fibrinopeptide
A
Ag
[Units/volume]
in
Peritoneal
fluid
by
Immunologic
method
|
|
16861-7
|
Fibrinopeptide
A
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16862-5
|
Fibrinopeptide
B
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16863-3
|
Fibrinopeptide
B
beta
(1-14)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16864-1
|
Fibrinopeptide
B
beta
(1-42)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16865-8
|
Fibrinopeptide
B
beta
(15-42)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16866-6
|
Fibrinopeptide
B
beta
(43-47)
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
16867-4
|
Fibronectin
aggregate
IgG
Ab
[Mass/volume]
in
Serum
|
|
16868-2
|
Finch
droppings
IgE
Ab
[Presence]
in
Serum
|
|
16869-0
|
Deprecated
Flurbiprofen
[Mass/volume]
in
Serum
or
Plasma
|
|
1687-3
|
3-Methylhistidine
[Mass/volume]
in
Urine
|
|
16870-8
|
Fluconazole
[Mass/volume]
in
Urine
|
|
16871-6
|
Fluoride
[Units/volume]
in
Bone
|
|
16872-4
|
Fluorocarbons
[Identifier]
in
Serum
or
Plasma
|
|
16873-2
|
Follitropin
[Moles/volume]
in
Serum
or
Plasma
--105
minutes
post
XXX
challenge
|
|
16874-0
|
Formate+Formaldehyde
[Mass/volume]
in
Blood
|
|
16875-7
|
Francisella
tularensis
Ab
[Titer]
in
Serum
|
|
16876-5
|
Francisella
tularensis
IgA
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
16877-3
|
Francisella
tularensis
IgG
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
16878-1
|
Francisella
tularensis
IgM
Ab
[Units/volume]
in
Serum
|
|
16879-9
|
Francisella
tularensis
Ag
[Presence]
in
Serum
by
Immunofluorescence
|
|
1688-1
|
4-Pyridoxate
[Mass/volume]
in
Serum
or
Plasma
|
|
16881-5
|
Gallium
[Mass/volume]
in
Blood
|
|
16882-3
|
Gamma
aminobutyrate
[Presence]
in
Urine
|
|
16883-1
|
Deprecated
Gamma
aminobutyrate
[Mass/volume]
in
Urine
|
|
16884-9
|
Deprecated
Gamma
aminobutyrate
[Presence]
in
Serum
or
Plasma
|
|
16885-6
|
Deprecated
Gamma
aminobutyrate
[Mass/volume]
in
Serum
or
Plasma
|
|
16886-4
|
Deprecated
Gamma
aminobutyrate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16887-2
|
Gamma
aminobutyrate
[Mass/volume]
in
Amniotic
fluid
|
|
16888-0
|
Gamma
chlordane
[Mass/volume]
in
Urine
|
|
1689-9
|
5'-Nucleotidase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
16890-6
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
16891-4
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--11th
specimen
post
XXX
challenge
|
|
16892-2
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
16893-0
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
16894-8
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--25
minutes
post
XXX
challenge
|
|
16895-5
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
16896-3
|
Gastrin
[Mass/volume]
in
Serum
or
Plasma
--5
minutes
post
XXX
challenge
|
|
16898-9
|
Giardia
lamblia
65
Ag
[Presence]
in
Stool
|
|
16899-7
|
Giardia
lamblia
Ag
[Presence]
in
Unspecified
specimen
|
|
169-3
|
Cephradine
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1690-7
|
5'-Nucleotidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
16900-3
|
Gliadin
Ab
[Units/volume]
in
Saliva
(oral
fluid)
|
|
16901-1
|
Gliadin
IgA
Ab
[Presence]
in
Serum
|
|
16902-9
|
Gliadin
IgG
Ab
[Presence]
in
Serum
|
|
16903-7
|
Glucose
[Mass/volume]
in
Vitreous
fluid
|
|
16904-5
|
Glucose
[Presence]
in
Urine
--1st
specimen
post
XXX
challenge
|
|
16905-2
|
Glucose
[Presence]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
16906-0
|
Glucose
[Presence]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
16907-8
|
Glucose
[Presence]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
16908-6
|
Glucose
[Presence]
in
Urine
--5th
specimen
post
XXX
challenge
|
|
16909-4
|
Glucose
[Presence]
in
Urine
--6th
specimen
post
XXX
challenge
|
|
1691-5
|
5,10-Methylenetetrahydrofolate
reductase
[Enzymatic
activity/volume]
in
Serum
|
|
16910-2
|
Glucose
[Presence]
in
Urine
--7th
specimen
post
XXX
challenge
|
|
16911-0
|
Glucose
[Presence]
in
Urine
--8th
specimen
post
XXX
challenge
|
|
16912-8
|
Glucose
[Presence]
in
Urine
--9th
specimen
post
XXX
challenge
|
|
16913-6
|
Fasting
glucose
[Presence]
in
Urine
|
|
16914-4
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--post
XXX
challenge
|
|
16915-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--post
meal
|
|
16916-9
|
Glutamate
[Presence]
in
Urine
|
|
16917-7
|
Glutamine
[Presence]
in
Urine
|
|
16918-5
|
Glutathione
[Mass/volume]
in
Serum
or
Plasma
|
|
16919-3
|
Glycine
[Presence]
in
Urine
|
|
1692-3
|
5-Hydroxyindoleacetate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
16920-1
|
Glycoproteins
[Presence]
in
Serum
or
Plasma
|
|
16921-9
|
St.
Augustine
grass
IgE
Ab
[Units/volume]
in
Serum
|
|
16922-7
|
Wild
rye
grass
IgE
Ab
[Units/volume]
in
Serum
|
|
16923-5
|
Guaifenesin
[Mass/volume]
in
Serum
or
Plasma
|
|
16924-3
|
Haemophilus
influenzae
IgG
Ab
[Units/volume]
in
Serum
|
|
16925-0
|
Haemophilus
influenzae
A
Ag
[Presence]
in
Urine
|
|
16926-8
|
Haemophilus
influenzae
A
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
16927-6
|
Haemophilus
influenzae
B
IgG
Ab
[Units/volume]
in
Serum
|
|
16928-4
|
Hantavirus
puumala
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
16929-2
|
Helicobacter
pylori
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1693-1
|
5-Hydroxyindoleacetate
[Mass/volume]
in
Serum
|
|
16930-0
|
Helminth
IgE
Ab
[Units/volume]
in
Serum
|
|
16931-8
|
Hematocrit/Hemoglobin
[Ratio]
of
Blood
by
Automated
count
|
|
16932-6
|
Hemoglobin
A3/Hemoglobin.total
in
Blood
by
Electrophoresis
|
|
16933-4
|
Hepatitis
B
virus
core
Ab
[Presence]
in
Serum
|
|
16934-2
|
Hepatitis
B
virus
polymerase
DNA
[Presence]
in
Blood
by
Probe
and
target
amplification
method
|
|
16935-9
|
Hepatitis
B
virus
surface
Ab
[Units/volume]
in
Serum
|
|
16936-7
|
Hepatitis
C
virus
IgG
Ab
[Units/volume]
in
Serum
|
|
16937-5
|
Hepatitis
G
virus
RNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
16938-3
|
Heptacarboxylporphyrin
[Mass/volume]
in
Stool
|
|
16939-1
|
Heptachlor
[Mass/volume]
in
Urine
|
|
1694-9
|
5-Hydroxyindoleacetate
[Mass/volume]
in
Urine
|
|
16940-9
|
Heptachlorepoxide
[Mass/volume]
in
Urine
|
|
16941-7
|
Herbicide
[Identifier]
in
Unspecified
specimen
|
|
16942-5
|
Herpes
simplex
virus
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16943-3
|
Herpes
simplex
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16944-1
|
Herpes
simplex
virus
IgM
Ab
[Units/volume]
in
Serum
|
|
16945-8
|
Herpes
simplex
virus
Ag
[Presence]
in
Unspecified
specimen
|
|
16947-4
|
Herpes
simplex
virus
1
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
16948-2
|
Herpes
simplex
virus
1
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16949-0
|
Herpes
simplex
virus
1
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
1695-6
|
5-Hydroxyindoleacetate
[Mass/time]
in
24
hour
Urine
|
|
16950-8
|
Herpes
simplex
virus
1
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
16952-4
|
Herpes
simplex
virus
1
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
16953-2
|
Herpes
simplex
virus
1
DNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
16954-0
|
Herpes
simplex
virus
2
Ab
[Presence]
in
Serum
|
|
16955-7
|
Herpes
simplex
virus
2
IgG
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16956-5
|
Herpes
simplex
virus
2
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
16957-3
|
Herpes
simplex
virus
2
IgG
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
16958-1
|
Herpes
simplex
virus
2
IgG
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
16959-9
|
Herpes
simplex
virus
2
DNA
[Presence]
in
Serum
or
Plasma
by
Probe
and
target
amplification
method
|
|
1696-4
|
5-Methyltetrahydrofolate
homocysteine
methyltransferase
[Enzymatic
activity/volume]
in
Serum
|
|
16960-7
|
Herpes
simplex
virus
2
DNA
[Presence]
in
Cerebral
spinal
fluid
by
Probe
and
target
amplification
method
|
|
16962-3
|
Heterophile
Ab
[Presence]
in
Synovial
fluid
by
Latex
agglutination
|
|
16963-1
|
Hexacarboxylporphyrin
[Mass/volume]
in
Blood
|
|
16964-9
|
Hexacarboxylporphyrin
[Mass/volume]
in
Stool
|
|
16965-6
|
Lindane
[Mass/volume]
in
Blood
|
|
16966-4
|
Hexachloroethane
[Mass/volume]
in
Blood
|
|
16967-2
|
Hexokinase
1
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16968-0
|
Hexokinase
3
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16969-8
|
Histone
H2a+H2b
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
1697-2
|
6-Phosphogluconate
dehydrogenase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
16970-6
|
Histoplasma
capsulatum
Ab
[Presence]
in
Serum
by
Complement
fixation
|
|
16971-4
|
Histoplasma
capsulatum
IgA
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16972-2
|
Histoplasma
capsulatum
IgE
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16973-0
|
Histoplasma
capsulatum
IgM
Ab
[Presence]
in
Serum
by
Immune
diffusion
(ID)
|
|
16974-8
|
HIV
1
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
16975-5
|
HIV
1
IgG
Ab
[Presence]
in
Serum
|
|
16976-3
|
HIV
1
Ag
[Units/volume]
in
Serum
|
|
16977-1
|
HIV
1
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
16978-9
|
HIV
1
p24
Ab
[Units/volume]
in
Serum
|
|
16979-7
|
HIV
1
p24
Ag
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1698-0
|
8-Hydroxyamoxapine
[Mass/volume]
in
Serum
or
Plasma
|
|
16980-5
|
HTLV
II
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16981-3
|
HTLV
I
DNA
[Presence]
in
Unspecified
specimen
by
Probe
and
target
amplification
method
|
|
16982-1
|
HTLV
I+II
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
16983-9
|
Hydralazine
[Presence]
in
Urine
|
|
16984-7
|
Hydrastine
[Presence]
in
Urine
|
|
16985-4
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--1.5
hours
post
dose
glucose
|
|
16986-2
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--1
hour
post
dose
glucose
|
|
16987-0
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--2.5
hours
post
dose
glucose
|
|
16988-8
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--2
hours
post
dose
glucose
|
|
16989-6
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--3.5
hours
post
dose
glucose
|
|
1699-8
|
Alpha-L-iduronidase
[Enzymatic
activity/mass]
in
Tissue
|
|
16990-4
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--3
hours
post
dose
glucose
|
|
16991-2
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--4.5
hours
post
dose
glucose
|
|
16992-0
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--4
hours
post
dose
glucose
|
|
16993-8
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--5.5
hours
post
dose
glucose
|
|
16994-6
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--5
hours
post
dose
glucose
|
|
16995-3
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--6
hours
post
dose
glucose
|
|
16996-1
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--pre
dose
glucose
|
|
16997-9
|
Hydrogen/Expired
gas
[Volume
Fraction]
in
Exhaled
gas
--post
dose
glucose
|
|
16998-7
|
Hydromorphone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
16999-5
|
Hydroquinone
[Mass/volume]
in
Urine
|
|
17-4
|
Amoxicillin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
170-1
|
Cephradine
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1700-4
|
Acetaldehyde
[Mass/volume]
in
Blood
|
|
17000-1
|
Hydroxylysine
[Presence]
in
Urine
|
|
17001-9
|
Hydroxyproline
[Presence]
in
Urine
|
|
17002-7
|
Hydroxytriazolam
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17003-5
|
Serotonin
[Mass/volume]
in
Urine
|
|
17004-3
|
Hypoxanthine
[Mass/volume]
in
Urine
|
|
17005-0
|
IgA
subclass
1
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17006-8
|
IgA
subclass
2
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17007-6
|
IgG
[Presence]
in
Serum
|
|
17008-4
|
IgG/Beta
tubulin
[Mass
Ratio]
in
Serum
|
|
17009-2
|
IgM
[Presence]
in
Serum
|
|
1701-2
|
Acetaldehyde
[Mass/volume]
in
Serum
or
Plasma
|
|
17010-0
|
Imipenem
[Mass/volume]
in
Serum
or
Plasma
|
|
17012-6
|
Influenza
virus
A
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17013-4
|
Influenza
virus
A+B
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17014-2
|
Influenza
virus
B
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17015-9
|
Influenza
virus
B
IgG
Ab
[Units/volume]
in
Serum
|
|
17016-7
|
Influenza
virus
B
IgM
Ab
[Units/volume]
in
Serum
|
|
17017-5
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--10
minutes
post
XXX
challenge
|
|
17018-3
|
Insulin
[Mass/volume]
in
Serum
or
Plasma
--20
minutes
post
XXX
challenge
|
|
17019-1
|
Insulin-like
growth
factor-I
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
1702-0
|
Acetoacetate
[Mass/volume]
in
Urine
|
|
17020-9
|
Intercellular
substance
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17021-7
|
Intercellular
substance
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17022-5
|
Interleukin
1+2
[Units/volume]
in
Serum
or
Plasma
|
|
17023-3
|
Deprecated
Interleukin
7
[Units/volume]
in
Serum
or
Plasma
|
|
17024-1
|
Iodine.inorganic
[Mass/volume]
in
Serum
or
Plasma
|
|
17025-8
|
Iron
[Mass/volume]
in
Water
|
|
17026-6
|
Isocyanate
IgE
Ab
[Units/volume]
in
Serum
|
|
17027-4
|
Isocyanate
IgG
Ab
[Units/volume]
in
Serum
|
|
17028-2
|
Isocyanate
IgM
Ab
[Units/volume]
in
Serum
|
|
17029-0
|
Isoleucine
[Presence]
in
Urine
|
|
1703-8
|
Acetoacetate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17030-8
|
Isopropyl
ether
[Presence]
in
Blood
|
|
17031-6
|
Jo-1
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17032-4
|
Jo-1
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17033-2
|
Ketamine
[Presence]
in
Urine
by
Confirmatory
method
|
|
17034-0
|
Ketoprofen
[Mass/volume]
in
Serum
or
Plasma
|
|
17035-7
|
Ketorolac
[Mass/volume]
in
Serum
or
Plasma
|
|
17036-5
|
La
Crosse
virus
Ab
[Titer]
in
Serum
|
|
17037-3
|
La
Crosse
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
17038-1
|
La
Crosse
virus
IgG
Ab
[Titer]
in
Serum
|
|
17039-9
|
La
Crosse
virus
IgM
Ab
[Titer]
in
Serum
|
|
1704-6
|
Acetoacetate
[Presence]
in
Serum
or
Plasma
|
|
17040-7
|
Labetalol
[Presence]
in
Serum
or
Plasma
|
|
17041-5
|
Lactate
dehydrogenase
[Presence]
in
Urine
|
|
17042-3
|
Lactoglobulin
IgE
Ab
[Units/volume]
in
Serum
|
|
17043-1
|
Lactose
[Mass/volume]
in
Urine
|
|
17044-9
|
Lamellar
bodies
[Presence]
in
Amniotic
fluid
|
|
17045-6
|
Latex
IgE
Ab
[Units/volume]
in
Blood
|
|
17046-4
|
Latex
IgG
Ab
[Units/volume]
in
Serum
|
|
17047-2
|
Latex
Bencard
IgE
Ab
[Units/volume]
in
Serum
|
|
17048-0
|
Latex
glove
extract
IgE
Ab
[Units/volume]
in
Blood
|
|
17049-8
|
Latex
glove
extract
ammoniated
IgE
Ab
[Units/volume]
in
Blood
|
|
1705-3
|
Acetoacetate
[Mass/volume]
in
Serum
or
Plasma
|
|
17050-6
|
Latex
glove
extract
buffered
IgE
Ab
[Units/volume]
in
Blood
|
|
17051-4
|
Laxatives
[Identifier]
in
Urine
|
|
17052-2
|
Lead
[Presence]
in
Blood
|
|
17053-0
|
Legionella
longbeachae
1
IgG
Ab
[Presence]
in
Serum
|
|
17054-8
|
Legionella
longbeachae
1
IgM
Ab
[Presence]
in
Serum
|
|
17055-5
|
Legionella
longbeachae
2
IgG
Ab
[Presence]
in
Serum
|
|
17056-3
|
Legionella
longbeachae
2
IgM
Ab
[Presence]
in
Serum
|
|
17057-1
|
Legionella
pneumophila
Ag
[Presence]
in
Unspecified
specimen
|
|
17058-9
|
Legionella
pneumophila
Ag
[Presence]
in
Urine
by
Latex
agglutination
|
|
17059-7
|
Legionella
pneumophila
Ag
[Presence]
in
Urine
by
Immunofluorescence
|
|
1706-1
|
Acetonitrile
[Mass/volume]
in
Blood
|
|
17060-5
|
Legionella
pneumophila
1
Ab
[Titer]
in
Serum
|
|
17061-3
|
Legionella
pneumophila
1
IgM
Ab
[Units/volume]
in
Serum
|
|
17062-1
|
Legionella
pneumophila
2
Ab
[Titer]
in
Serum
|
|
17063-9
|
Legionella
pneumophila
2
IgM
Ab
[Units/volume]
in
Serum
|
|
17064-7
|
Legionella
pneumophila
3
Ab
[Titer]
in
Serum
|
|
17065-4
|
Legionella
pneumophila
3
IgM
Ab
[Units/volume]
in
Serum
|
|
17066-2
|
Legionella
pneumophila
4
Ab
[Titer]
in
Serum
|
|
17067-0
|
Legionella
pneumophila
4
IgM
Ab
[Units/volume]
in
Serum
|
|
17068-8
|
Legionella
pneumophila
5
Ab
[Titer]
in
Serum
|
|
17069-6
|
Legionella
pneumophila
5
IgM
Ab
[Units/volume]
in
Serum
|
|
1707-9
|
Acetylcholine
[Mass/volume]
in
Serum
|
|
17070-4
|
Legionella
pneumophila
6
Ab
[Titer]
in
Serum
|
|
17071-2
|
Legionella
pneumophila
7
Ab
[Presence]
in
Serum
|
|
17072-0
|
Legionella
pneumophila
8
Ab
[Presence]
in
Serum
|
|
17073-8
|
Legionella
pneumophila
9
Ab
[Presence]
in
Serum
|
|
17074-6
|
Leucine
[Units/volume]
in
Amniotic
fluid
|
|
17075-3
|
Lidocaine
[Mass/volume]
in
Urine
|
|
17076-1
|
Lidocaine
[Mass/volume]
in
Body
fluid
|
|
17077-9
|
Deprecated
Lindane
[Mass/volume]
in
Blood
|
|
17078-7
|
Fatty
acids.esterified
[Mass/volume]
in
Serum
or
Plasma
|
|
17079-5
|
Fatty
acids.long
chain
[Identifier]
in
Serum
or
Plasma
|
|
1708-7
|
Acetylcholinesterase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
17080-3
|
Fatty
acids.very
long
chain
[Identifier]
in
Serum
or
Plasma
|
|
17081-1
|
Deprecated
Triglyceride
[Mass/volume]
in
Serum
or
Plasma
--post
CFst
|
|
17082-9
|
Lipoprotein.alpha
[Mass/volume]
in
Body
fluid
|
|
17083-7
|
Lipoprotein.beta
[Mass/volume]
in
Body
fluid
|
|
17084-5
|
Lipoprotein.pre-beta
[Mass/volume]
in
Body
fluid
|
|
17085-2
|
Lipoproteins
[Presence]
in
Serum
or
Plasma
|
|
17086-0
|
Lithium
[Mass/volume]
in
Body
fluid
|
|
17087-8
|
Loperamide
[Mass/volume]
in
Serum
or
Plasma
|
|
17088-6
|
Lorazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17089-4
|
Lorcainide
[Mass/volume]
in
Serum
or
Plasma
|
|
1709-5
|
Acetylcholinesterase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
17090-2
|
Loxapine+8-Hydroxyloxapine
[Mass/volume]
in
Serum
or
Plasma
|
|
17091-0
|
Lumpfish
roe
IgE
Ab
[Units/volume]
in
Serum
|
|
17092-8
|
Lupus
erythematosus
factor
[Presence]
in
Serum
by
Latex
agglutination
|
|
17094-4
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--105
minutes
post
XXX
challenge
|
|
17095-1
|
Lutropin
[Moles/volume]
in
Serum
or
Plasma
--75
minutes
post
XXX
challenge
|
|
17096-9
|
Kappa
lymphocytes/100
lymphocytes
in
Blood
|
|
17097-7
|
CD10+CD20+
cells/100
cells
in
Blood
|
|
17098-5
|
CD100
cells/100
cells
in
Blood
|
|
17099-3
|
CD102
cells/100
cells
in
Blood
|
|
171-9
|
Cephradine
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1710-3
|
Acetylcholinesterase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17100-9
|
CD103
cells/100
cells
in
Blood
|
|
17101-7
|
CD104
cells/100
cells
in
Blood
|
|
17102-5
|
CD105
cells/100
cells
in
Blood
|
|
17103-3
|
CD106
cells/100
cells
in
Blood
|
|
17104-1
|
CD107a
cells/100
cells
in
Blood
|
|
17105-8
|
CD107b
cells/100
cells
in
Blood
|
|
17106-6
|
CD115
cells/100
cells
in
Blood
|
|
17107-4
|
CD117
cells/100
cells
in
Blood
|
|
17108-2
|
CD118
cells/100
cells
in
Blood
|
|
17109-0
|
CD11a
cells/100
cells
in
Blood
|
|
1711-1
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Blood
|
|
17110-8
|
CD11b
cells/100
cells
in
Blood
|
|
17111-6
|
CD12
cells/100
cells
in
Blood
|
|
17112-4
|
CD120A
cells/100
cells
in
Blood
|
|
17113-2
|
CD120B
cells/100
cells
in
Blood
|
|
17114-0
|
CD122
cells/100
cells
in
Blood
|
|
17115-7
|
CD126
cells/100
cells
in
Blood
|
|
17116-5
|
CD128
cells/100
cells
in
Blood
|
|
17117-3
|
CD15
cells/100
cells
in
Blood
|
|
17118-1
|
CD16B
cells/100
cells
in
Blood
|
|
17119-9
|
CD16-CD34+
cells/100
cells
in
Blood
|
|
1712-9
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Vaginal
fluid
|
|
17120-7
|
CD17
cells/100
cells
in
Blood
|
|
17121-5
|
CD18
cells/100
cells
in
Blood
|
|
17122-3
|
CD19+Kappa+
cells/100
cells
in
Blood
|
|
17123-1
|
CD19+Lambda+
cells/100
cells
in
Blood
|
|
17124-9
|
CD2+CD20+
cells/100
cells
in
Blood
|
|
17125-6
|
CD22+CD19+
cells/100
cells
in
Blood
|
|
17126-4
|
CD24
cells/100
cells
in
Blood
|
|
17127-2
|
CD26
cells/100
cells
in
Blood
|
|
17128-0
|
CD27
cells/100
cells
in
Blood
|
|
17129-8
|
CD28
cells/100
cells
in
Blood
|
|
1713-7
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Semen
|
|
17130-6
|
CD29
cells/100
cells
in
Blood
|
|
17131-4
|
CD3+CD69+
cells/100
cells
in
Blood
|
|
17132-2
|
CD3+IL2R1+
cells/100
cells
in
Blood
|
|
17133-0
|
CD3+CD16+
cells/100
cells
in
Blood
|
|
17135-5
|
CD3+CD56+
cells/100
cells
in
Blood
|
|
17136-3
|
CD3+DR+
cells/100
cells
in
Blood
|
|
17137-1
|
CD30
cells/100
cells
in
Blood
|
|
17138-9
|
CD31
cells/100
cells
in
Blood
|
|
17139-7
|
CD32
cells/100
cells
in
Blood
|
|
1714-5
|
Prostatic
acid
phosphatase
[Enzymatic
activity/volume]
in
Serum
|
|
17140-5
|
CD34+DR+
cells/100
cells
in
Blood
|
|
17141-3
|
CD36
cells/100
cells
in
Blood
|
|
17142-1
|
CD37
cells/100
cells
in
Blood
|
|
17143-9
|
CD39
cells/100
cells
in
Blood
|
|
17144-7
|
CD4+CD69+
cells/100
cells
in
Blood
|
|
17145-4
|
Deprecated
CD4+2H4
cells/100
cells
in
Blood
|
|
17146-2
|
CD4+CD8+
cells/100
cells
in
Blood
|
|
17147-0
|
CD40
cells/100
cells
in
Blood
|
|
17148-8
|
CD41
cells/100
cells
in
Blood
|
|
17149-6
|
CD42a
cells/100
cells
in
Blood
|
|
1715-2
|
Acid
phosphatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17150-4
|
CD42b
cells/100
cells
in
Blood
|
|
17151-2
|
CD42c
cells/100
cells
in
Blood
|
|
17152-0
|
CD42d
cells/100
cells
in
Blood
|
|
17153-8
|
CD4+CD45RA+
cells/CD8
Cells
[#
Ratio]
in
Blood
|
|
17154-6
|
CD43
cells/100
cells
in
Blood
|
|
17155-3
|
CD44
cells/100
cells
in
Blood
|
|
17156-1
|
CD44R
cells/100
cells
in
Blood
|
|
17157-9
|
CD45RA
cells/100
cells
in
Blood
|
|
17158-7
|
CD45RB
cells/100
cells
in
Blood
|
|
17159-5
|
CD45RO
cells/100
cells
in
Blood
|
|
1716-0
|
Acidity.titratable
[Mass/volume]
in
Urine
|
|
17160-3
|
CD46
cells/100
cells
in
Blood
|
|
17161-1
|
CD47
cells/100
cells
in
Blood
|
|
17162-9
|
CD48
cells/100
cells
in
Blood
|
|
17163-7
|
CD49a
cells/100
cells
in
Blood
|
|
17164-5
|
CD49b
cells/100
cells
in
Blood
|
|
17165-2
|
CD49c
cells/100
cells
in
Blood
|
|
17166-0
|
CD49d
cells/100
cells
in
Blood
|
|
17167-8
|
CD49e
cells/100
cells
in
Blood
|
|
17168-6
|
CD49f
cells/100
cells
in
Blood
|
|
17169-4
|
CD5+CD2-
cells/100
cells
in
Blood
|
|
1717-8
|
Acylcarnitine
[Mass/volume]
in
Serum
or
Plasma
|
|
17170-2
|
CD50
cells/100
cells
in
Blood
|
|
17171-0
|
CD51
cells/100
cells
in
Blood
|
|
17172-8
|
CD52
cells/100
cells
in
Blood
|
|
17173-6
|
CD53
cells/100
cells
in
Blood
|
|
17174-4
|
CD54
cells/100
cells
in
Blood
|
|
17175-1
|
CD55
cells/100
cells
in
Blood
|
|
17176-9
|
CD58
cells/100
cells
in
Blood
|
|
17177-7
|
CD59
cells/100
cells
in
Blood
|
|
17178-5
|
CD6
cells/100
cells
in
Blood
|
|
17179-3
|
CD62E
cells/100
cells
in
Blood
|
|
1718-6
|
Acyl
CoA
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
17180-1
|
CD62L
cells/100
cells
in
Blood
|
|
17181-9
|
CD62P
cells/100
cells
in
Blood
|
|
17182-7
|
CD63
cells/100
cells
in
Blood
|
|
17183-5
|
CD64
cells/100
cells
in
Blood
|
|
17184-3
|
CD66a
cells/100
cells
in
Blood
|
|
17185-0
|
CD66b
cells/100
cells
in
Blood
|
|
17186-8
|
CD66c
cells/100
cells
in
Blood
|
|
17187-6
|
CD66d
cells/100
cells
in
Blood
|
|
17188-4
|
CD66e
cells/100
cells
in
Blood
|
|
17189-2
|
CD68
cells/100
cells
in
Blood
|
|
1719-4
|
Adenine
[Mass/volume]
in
Serum
|
|
17190-0
|
CD69
cells/100
cells
in
Blood
|
|
17191-8
|
CD3-CD7+cells/100
cells
in
Blood
|
|
17192-6
|
CD72
cells/100
cells
in
Blood
|
|
17193-4
|
CD73
cells/100
cells
in
Blood
|
|
17194-2
|
CD74
cells/100
cells
in
Blood
|
|
17195-9
|
CD77
cells/100
cells
in
Blood
|
|
17196-7
|
CD79a
cells/100
cells
in
Blood
|
|
17197-5
|
CD79b
cells/100
cells
in
Blood
|
|
17198-3
|
CD8+CD28+
cells/100
cells
in
Blood
|
|
17199-1
|
CD80
cells/100
cells
in
Blood
|
|
172-7
|
Chloramphenicol
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1720-2
|
Adenine
phosphoribosyltransferase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
17200-7
|
CD82
cells/100
cells
in
Blood
|
|
17201-5
|
CD83
cells/100
cells
in
Blood
|
|
17202-3
|
CD85
cells/100
cells
in
Blood
|
|
17203-1
|
CD86
cells/100
cells
in
Blood
|
|
17204-9
|
CD87
cells/100
cells
in
Blood
|
|
17205-6
|
CD88
cells/100
cells
in
Blood
|
|
17206-4
|
CD9
cells/100
cells
in
Blood
|
|
17207-2
|
CD91
cells/100
cells
in
Blood
|
|
17208-0
|
CD93
cells/100
cells
in
Blood
|
|
17209-8
|
CD94
cells/100
cells
in
Blood
|
|
1721-0
|
Adenosine
triphosphate
[Mass/volume]
in
Blood
|
|
17210-6
|
CD95
cells/100
cells
in
Blood
|
|
17211-4
|
CD96
cells/100
cells
in
Blood
|
|
17212-2
|
CD97
cells/100
cells
in
Blood
|
|
17213-0
|
CD98
cells/100
cells
in
Blood
|
|
17214-8
|
CD99
cells/100
cells
in
Blood
|
|
17215-5
|
CV
lymphocytes/100
lymphocytes
in
Blood
|
|
17216-3
|
Cytoplasmic
CD3
cells/100
cells
in
Blood
|
|
17217-1
|
Cytoplasmic
CD79
cells/100
cells
in
Blood
|
|
17218-9
|
Cytoplasmic
Ig
mu
cells/100
cells
in
Blood
|
|
17219-7
|
Cytoplasmic
Ig
cells/100
cells
in
Blood
|
|
1722-8
|
Adenosine
deaminase
[Enzymatic
activity/volume]
in
Blood
|
|
17220-5
|
FMC7
cells/100
cells
in
Blood
|
|
17221-3
|
CD235a
cells/100
cells
in
Blood
|
|
17222-1
|
HLE
lymphocytes/100
lymphocytes
in
Blood
|
|
17223-9
|
Deprecated
CD14
cells/100
cells
in
Blood
|
|
17224-7
|
Lambda
lymphocytes/100
lymphocytes
in
Blood
|
|
17225-4
|
SMIg
lymphocytes/100
lymphocytes
in
Blood
|
|
17226-2
|
SmIg-Cd79
cells/100
cells
in
Blood
|
|
17227-0
|
Lymphocytes/100
leukocytes
in
Synovial
fluid
by
Automated
count
|
|
17228-8
|
Lymphocytic
choriomeningitis
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
17229-6
|
Lymphocytic
choriomeningitis
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1723-6
|
Adenosine
deaminase
binding
protein
[Mass/volume]
in
Urine
|
|
17230-4
|
Lysine
[Presence]
in
Urine
|
|
17231-2
|
Lysosomal
enzymes
[Identifier]
in
Plasma
|
|
17232-0
|
Lysozyme
[Enzymatic
activity/volume]
in
Tear
|
|
17234-6
|
Magnesium.plasma/Magnesium.RBC
[Molar
ratio]
in
Blood
|
|
17235-3
|
Magnesium
[Moles/volume]
in
Leukocytes
|
|
17236-1
|
Magnesium
[Moles/volume]
in
Stool
|
|
17237-9
|
Magnesium
[Moles/mass]
in
Hair
|
|
17238-7
|
Malignin
Ab
[Units/volume]
in
Serum
|
|
1724-4
|
Adenosine
diphosphate
[Mass/volume]
in
Serum
|
|
17241-1
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
17242-9
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--40
minutes
post
XXX
challenge
|
|
17243-7
|
Prolactin
[Mass/volume]
in
Serum
or
Plasma
--pre
XXX
challenge
|
|
17244-5
|
Manganese
[Mass/mass]
in
Hair
|
|
17245-2
|
Deprecated
Meclizine
[Mass/volume]
in
Serum
or
Plasma
|
|
17246-0
|
Mefenamate
[Mass/volume]
in
Serum
or
Plasma
|
|
17247-8
|
Melanin
[Units/volume]
in
Urine
|
|
17248-6
|
Melanin
[Units/volume]
in
Serum
or
Plasma
|
|
17249-4
|
Menthol
[Mass/volume]
in
Blood
|
|
1725-1
|
Adenosine
monophosphate
deaminase
[Enzymatic
activity/volume]
in
Serum
|
|
17250-2
|
Mephobarbital
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17251-0
|
Mepivacaine
[Presence]
in
Serum
or
Plasma
|
|
17252-8
|
Mercaptopurine
[Presence]
in
Serum
or
Plasma
|
|
17253-6
|
Mercury
[Mass/volume]
in
Milk
|
|
17254-4
|
Mercury
[Mass/volume]
in
Food
|
|
17255-1
|
Mercury
[Mass/volume]
in
Dialysis
fluid
|
|
17256-9
|
Mesoridazine
[Mass/volume]
in
Urine
|
|
17257-7
|
Mesothelial
cells
[Presence]
in
Body
fluid
by
Light
microscopy
|
|
17258-5
|
Metandienone
[Mass/volume]
in
Serum
or
Plasma
|
|
17259-3
|
Methadone.long
acting
metabolite
[Mass/volume]
in
Serum
or
Plasma
|
|
1726-9
|
Adenosine
monophosphate.cyclic
[Mass/volume]
in
Serum
or
Plasma
|
|
17260-1
|
Methamphetamine
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17261-9
|
Methapyrilene
[Mass/volume]
in
Urine
|
|
17263-5
|
Methemalbumin
[Presence]
in
Serum
or
Plasma
|
|
17264-3
|
Methionine
[Presence]
in
Urine
|
|
17265-0
|
Methocarbamol
[Units/volume]
in
Serum
or
Plasma
|
|
17266-8
|
Methotrexate
[Mass/volume]
in
Urine
|
|
17267-6
|
Methoxychlor
[Mass/volume]
in
Urine
|
|
17268-4
|
Deprecated
Methsuximide+Normethsuximide
[Mass/volume]
in
Serum
or
Plasma
|
|
17269-2
|
Methyl
isobutyl
ketone
[Mass/volume]
in
Urine
|
|
1727-7
|
Adenosine
monophosphate.cyclic
[Mass/time]
in
24
hour
Urine
|
|
17270-0
|
Methylacrylate
[Mass/volume]
in
Serum
or
Plasma
|
|
17271-8
|
Deprecated
1,1,1-Trichloroethane
[Mass/volume]
in
Serum
or
Plasma
|
|
17272-6
|
Methylenedianiline
[Mass/volume]
in
Blood
|
|
17273-4
|
Methylephedrine
[Units/volume]
in
Urine
|
|
17274-2
|
Methylergonovine
[Mass/volume]
in
Serum
or
Plasma
|
|
17275-9
|
Methylfentanyl
[Mass/volume]
in
Serum
or
Plasma
|
|
17276-7
|
2-Methylpentane
[Mass/volume]
in
Blood
|
|
17277-5
|
Metolazone
[Mass/volume]
in
Serum
or
Plasma
|
|
17278-3
|
Miconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
17279-1
|
Bacteria
identified
in
Pleural
fluid
by
Aerobe
culture
|
|
1728-5
|
Adenosine
monophosphate.cyclic/Creatinine
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17280-9
|
Microscopic
observation
[Identifier]
in
Tissue
by
Malaria
thick
smear
|
|
17281-7
|
Microscopic
observation
[Identifier]
in
Sputum
by
KOH
preparation
|
|
17282-5
|
Minoxidil
[Mass/volume]
in
Serum
or
Plasma
|
|
17283-3
|
Mirtazapine
[Mass/volume]
in
Serum
or
Plasma
|
|
17284-1
|
Mitochondria
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17285-8
|
Mitochondria
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17286-6
|
Monocytes/100
leukocytes
in
Synovial
fluid
by
Manual
count
|
|
17287-4
|
Monocytes/100
leukocytes
in
Urine
by
Manual
count
|
|
17288-2
|
Ganglioside
GM1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17289-0
|
Monosodium
glutamate
(MSG)
IgE
Ab
[Units/volume]
in
Serum
|
|
1729-3
|
Adenosine
triphosphatase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
17290-8
|
Morphine
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17291-6
|
Deprecated
Mulberry
tree
IgE
Ab
[Units/volume]
in
Serum
|
|
17292-4
|
Mumps
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17293-2
|
Mumps
virus
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
17294-0
|
Mushroom
toxins
[Identifier]
in
Urine
|
|
17296-5
|
Mycobacterium
tuberculosis
complex
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17297-3
|
Deprecated
Mycobacterium
tuberculosum
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17298-1
|
Deprecated
Mycobacterium
tuberculosis
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17299-9
|
Mycoplasma
fermentans
Ab
[Presence]
in
Serum
|
|
173-5
|
Chloramphenicol
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1730-1
|
Adenosine
triphosphatase
[Enzymatic
activity/volume]
in
Semen
|
|
17300-5
|
Mycoplasma
hominis
Ab
[Titer]
in
Serum
by
Complement
fixation
|
|
17301-3
|
Mycoplasma
hominis
Ab
[Presence]
in
Serum
|
|
17302-1
|
Mycoplasma
pneumoniae
Ab
[Presence]
in
Serum
|
|
17303-9
|
Mycoplasma
pneumoniae
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17304-7
|
Mycoplasma
pneumoniae
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
17305-4
|
Myelin
IgA
Ab
[Presence]
in
Serum
|
|
17306-2
|
Myelin
IgG
Ab
[Presence]
in
Serum
|
|
17307-0
|
Myelin
IgM
Ab
[Presence]
in
Serum
|
|
17308-8
|
Myelin
associated
glycoprotein
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
1731-9
|
Adenylate
kinase
[Enzymatic
activity/volume]
in
Serum
|
|
17310-4
|
Myelin
associated
glycoprotein
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17311-2
|
Myelin
associated
glycoprotein
IgA
Ab
[Units/volume]
in
Serum
|
|
17312-0
|
Myelin
associated
glycoprotein
IgG
Ab
[Units/volume]
in
Serum
|
|
17313-8
|
Myelin
associated
glycoprotein
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17314-6
|
Myelin
associated
glycoprotein
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
17315-3
|
Myelin
basic
protein
Ab
[Mass/volume]
in
Serum
|
|
17316-1
|
Myeloperoxidase
Ab
[Presence]
in
Serum
|
|
17317-9
|
N-acetylprocainamide
[Mass/volume]
in
Urine
|
|
17318-7
|
Nalbuphine
[Mass/volume]
in
Serum
or
Plasma
|
|
17319-5
|
Nalidixate
[Mass/volume]
in
Serum
or
Plasma
|
|
1732-7
|
Adenylosuccinate
lyase
[Enzymatic
activity/volume]
in
Serum
|
|
17320-3
|
Nefazodone
[Mass/volume]
in
Urine
|
|
17321-1
|
Neisseria
meningitidis
A+Y
Ag
[Presence]
in
Urine
|
|
17322-9
|
Neisseria
meningitidis
Ab
[Presence]
in
Serum
|
|
17323-7
|
Neisseria
meningitidis
Ag
[Presence]
in
Urine
|
|
17324-5
|
Neisseria
meningitidis
Ag
[Units/volume]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
17325-2
|
Neisseria
meningitidis
C+w135
Ag
[Presence]
in
Urine
|
|
17326-0
|
Neisseria
meningitidis
A
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17327-8
|
Neisseria
meningitidis
B
Ab
[Units/volume]
in
Serum
|
|
17328-6
|
Neisseria
meningitidis
B
Ag
[Presence]
in
Urine
by
Latex
agglutination
|
|
17329-4
|
Neisseria
meningitidis
C
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1733-5
|
Adipate
[Mass/volume]
in
Urine
|
|
17330-2
|
Neisseria
meningitidis
Y
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
17331-0
|
Neisseria
meningitidis
polyvalent
Ab
[Units/volume]
in
Serum
|
|
17332-8
|
Neisseria
meningitidis
polyvalent
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
17333-6
|
Neisseria
meningitidis
w135
Ag
[Presence]
in
Serum
or
Plasma
by
Latex
agglutination
|
|
17334-4
|
Neopterin/Creatinine
[Mass
Ratio]
in
Urine
|
|
17335-1
|
Neostigmine
[Mass/volume]
in
Serum
or
Plasma
|
|
17336-9
|
Neuronal
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17337-7
|
Neuronal
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17338-5
|
Neuronal
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17339-3
|
Neuronal
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
1734-3
|
Aldosterone
renal
clearance
in
24
hour
|
|
17340-1
|
Neuronal
IgG
Ab
[Presence]
in
Body
fluid
by
Immunoassay
|
|
17341-9
|
Neuronal
nuclear
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17342-7
|
Neuronal
nuclear
type
2
Ab
[Units/volume]
in
Serum
|
|
17343-5
|
Neuronal
nuclear
type
2
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17344-3
|
Neuronal
nuclear
type
2
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17345-0
|
Deprecated
Neutrophil
Ab
[Units/volume]
in
Serum
|
|
17346-8
|
Neutrophil
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17347-6
|
Neutrophil
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17348-4
|
Neutrophil
IgA
Ab
[Units/volume]
in
Serum
|
|
17349-2
|
Neutrophil
IgG
Ab
[Units/volume]
in
Serum
|
|
1735-0
|
Alanine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17350-0
|
Neutrophil
IgM
Ab
[Units/volume]
in
Serum
|
|
17351-8
|
Neutrophil
cytoplasmic
Ab
[Presence]
in
Serum
|
|
17352-6
|
Neutrophil
cytoplasmic
Ab
[Interpretation]
in
Serum
|
|
17353-4
|
Neutrophil
cytoplasmic
Ab.classic
[Presence]
in
Serum
by
Immunofluorescence
|
|
17354-2
|
Neutrophil
cytoplasmic
IgA
Ab
[Presence]
in
Serum
|
|
17355-9
|
Neutrophil
cytoplasmic
IgG
Ab
[Presence]
in
Serum
|
|
17356-7
|
Neutrophil
cytoplasmic
IgM
Ab
[Presence]
in
Serum
|
|
17357-5
|
Neutrophil
cytoplasmic
Ab.perinuclear
[Presence]
in
Serum
by
Immunofluorescence
|
|
17358-3
|
Neutrophil
Cytoplasmic
Ab
atypical
[Units/volume]
in
Serum
|
|
17359-1
|
Neutrophils
[#/volume]
in
Semen
by
Manual
count
|
|
1736-8
|
Alanine
[Presence]
in
Serum
or
Plasma
|
|
17360-9
|
Heptane
[Mass/volume]
in
Blood
|
|
17361-7
|
Deprecated
Hexane
[Mass/volume]
in
Blood
|
|
17362-5
|
Nicotinamide
[Presence]
in
Urine
|
|
17363-3
|
Nitrazepam
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
17364-1
|
Nitrophenol
[Presence]
in
Urine
|
|
17365-8
|
Nitroprusside
[Mass/volume]
in
Serum
or
Plasma
|
|
17366-6
|
Nizatidine
[Mass/volume]
in
Serum
or
Plasma
|
|
17367-4
|
Nomifensine
[Mass/volume]
in
Serum
or
Plasma
|
|
17368-2
|
Norepinephrine
[Mass/volume]
in
Plasma
--standing
|
|
17369-0
|
Norepinephrine
[Mass/volume]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
1737-6
|
Alanine
[Mass/volume]
in
Serum
or
Plasma
|
|
17370-8
|
Norepinephrine
[Mass/volume]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
17371-6
|
Norepinephrine
[Mass/volume]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
17372-4
|
Norepinephrine
[Mass/volume]
in
Urine
--5th
specimen
post
XXX
challenge
|
|
17373-2
|
Norepinephrine
[Mass/volume]
in
Urine
--6th
specimen
post
XXX
challenge
|
|
17374-0
|
Norepinephrine
[Mass/volume]
in
Urine
--7th
specimen
post
XXX
challenge
|
|
17375-7
|
Norflunitrazepam
[Mass/volume]
in
Blood
|
|
17376-5
|
Norpropoxyphene
[Presence]
in
Urine
by
Confirmatory
method
|
|
17377-3
|
Norpropoxyphene
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17378-1
|
Novobiocin
[Mass/volume]
in
Serum
or
Plasma
|
|
17379-9
|
Propanol
[Mass/volume]
in
Blood
|
|
1738-4
|
Alanine
[Mass/volume]
in
Urine
|
|
17380-7
|
Nuclear
Ab.histone
reactive
[Presence]
in
Serum
|
|
17381-5
|
Uroporphyrin
[Mass/time]
in
24
hour
Stool
|
|
17382-3
|
Octadecanoate
(C18:0)
[Mass/volume]
in
Serum
or
Plasma
|
|
17384-9
|
Opiates
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17385-6
|
Organic
acids
[Units/volume]
in
Urine
|
|
17386-4
|
Organic
acids
[Units/volume]
in
Blood
|
|
17387-2
|
Organic
acids
[Units/volume]
in
Serum
or
Plasma
|
|
17388-0
|
Organochlorine
pesticides
[Type]
in
Urine
|
|
17389-8
|
Ornithine
[Presence]
in
Urine
|
|
1739-2
|
Alanine
[Mass/time]
in
24
hour
Urine
|
|
17390-6
|
Orphenadrine
[Mass/volume]
in
Urine
|
|
17391-4
|
Orthocresol
[Mass/volume]
in
Blood
|
|
17392-2
|
Osmium
[Mass/volume]
in
Urine
|
|
17393-0
|
Ovary
Ab
[Presence]
in
Serum
|
|
17394-8
|
Oxychlordane
[Mass/volume]
in
Urine
|
|
17395-5
|
Oxymorphone
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
17396-3
|
Oxytetracycline
[Mass/volume]
in
Serum
or
Plasma
|
|
17397-1
|
Oxytriphylline
[Mass/volume]
in
Serum
or
Plasma
|
|
17398-9
|
Human
papilloma
virus
11
Ag
[Presence]
in
Unspecified
specimen
|
|
17399-7
|
Human
papilloma
virus
16
Ag
[Presence]
in
Unspecified
specimen
|
|
174-3
|
Chloramphenicol
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1740-0
|
Alanine
aminopeptidase
[Mass/volume]
in
Serum
|
|
17400-3
|
Human
papilloma
virus
16+18
Ag
[Presence]
in
Unspecified
specimen
|
|
17401-1
|
Human
papilloma
virus
18
Ag
[Presence]
in
Unspecified
specimen
|
|
17402-9
|
Human
papilloma
virus
31
Ag
[Presence]
in
Unspecified
specimen
|
|
17403-7
|
Human
papilloma
virus
31+33+35
Ag
[Presence]
in
Unspecified
specimen
|
|
17404-5
|
Human
papilloma
virus
33
Ag
[Presence]
in
Unspecified
specimen
|
|
17405-2
|
Human
papilloma
virus
42
Ag
[Presence]
in
Unspecified
specimen
|
|
17406-0
|
Human
papilloma
virus
43
Ag
[Presence]
in
Unspecified
specimen
|
|
17407-8
|
Human
papilloma
virus
44
Ag
[Presence]
in
Unspecified
specimen
|
|
17408-6
|
Human
papilloma
virus
45
Ag
[Presence]
in
Unspecified
specimen
|
|
17409-4
|
Human
papilloma
virus
5
Ag
[Presence]
in
Unspecified
specimen
|
|
1741-8
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Amniotic
fluid
|
|
17410-2
|
Human
papilloma
virus
51
Ag
[Presence]
in
Unspecified
specimen
|
|
17411-0
|
Human
papilloma
virus
6
Ag
[Presence]
in
Unspecified
specimen
|
|
17412-8
|
Human
papilloma
virus
6+11
Ag
[Presence]
in
Unspecified
specimen
|
|
17413-6
|
Papova
virus
SV
40
Ab
[Units/volume]
in
Serum
|
|
17414-4
|
Parainfluenza
virus
1+2+3
Ag
[Presence]
in
Unspecified
specimen
|
|
17415-1
|
Parainfluenza
virus
A
Ab
[Units/volume]
in
Serum
|
|
17416-9
|
Parakeet
droppings
Ab
[Units/volume]
in
Serum
|
|
17417-7
|
Parakeet
droppings
IgG
Ab
[Units/volume]
in
Serum
|
|
17418-5
|
Parakeet
serum
Ab
[Units/volume]
in
Serum
|
|
17419-3
|
Parathion
[Mass/volume]
in
Urine
|
|
1742-6
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17420-1
|
Parrot
droppings
Ab
[Units/volume]
in
Serum
|
|
17421-9
|
Parrot
serum
Ab
[Units/volume]
in
Serum
|
|
17422-7
|
Parvovirus
B19
IgG+IgM
Ab
[Units/volume]
in
Serum
|
|
17423-5
|
Deprecated
Parvovirus
B19
IgM
Ab
[Presence]
in
Serum
|
|
17424-3
|
1,4-Dichlorobenzene
[Mass/volume]
in
Blood
|
|
17426-8
|
Penicillium
roqueforti
IgE
Ab
[Units/volume]
in
Serum
|
|
17427-6
|
Penicillium
sp
Ab
[Units/volume]
in
Serum
|
|
17428-4
|
Pentacarboxylporphyrins
[Mass/time]
in
24
hour
Stool
|
|
17429-2
|
Pentachlorophenol
[Mass/volume]
in
Blood
|
|
1743-4
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
With
P-5'-P
|
|
17430-0
|
Pentane
[Mass/volume]
in
Blood
|
|
17431-8
|
Pentobarbital
[Mass/volume]
in
Gastric
fluid
|
|
17432-6
|
Tetrachloroethylene
[Mass/volume]
in
Serum
or
Plasma
|
|
17433-4
|
pH
of
Unspecified
specimen
|
|
17434-2
|
Phenazopyridine
[Mass/volume]
in
Serum
or
Plasma
|
|
17435-9
|
Pheniramine
[Mass/volume]
in
Urine
|
|
17436-7
|
Phenobarbital
[Mass/volume]
in
Gastric
fluid
|
|
17437-5
|
Phenolphthalein
[Mass/volume]
in
Urine
|
|
17438-3
|
Phenolphthalein
[Mass/volume]
in
Blood
|
|
17439-1
|
Phenols
[Mass/volume]
in
Blood
|
|
1744-2
|
Alanine
aminotransferase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
by
Without
P-5'-P
|
|
17440-9
|
Phenothiazines
[Units/volume]
in
Serum
or
Plasma
|
|
17441-7
|
Phenothiazines
[Units/volume]
in
Urine
|
|
17442-5
|
Phenylephrine
[Mass/volume]
in
Serum
or
Plasma
|
|
17443-3
|
Phenylpropanolamine
[Mass/volume]
in
Urine
|
|
17444-1
|
Phenytoin
[Mass/volume]
in
Urine
|
|
17445-8
|
Phoma
herbarum
IgG
Ab
[Units/volume]
in
Serum
|
|
17446-6
|
Phoma
sp
IgE
Ab
[Units/volume]
in
Serum
|
|
17447-4
|
Phosphate
[Presence]
in
Stool
|
|
17448-2
|
Phosphatidylethanolamine
IgA
Ab
[Presence]
in
Serum
|
|
17449-0
|
Phosphatidylethanolamine
IgG
Ab
[Presence]
in
Serum
|
|
1745-9
|
Albumin
[Mass/volume]
in
Amniotic
fluid
|
|
17450-8
|
Phosphatidylethanolamine
IgM
Ab
[Presence]
in
Serum
|
|
17451-6
|
Phosphatidylglycerol
IgA
Ab
[Presence]
in
Serum
|
|
17452-4
|
Phosphatidylglycerol
IgG
Ab
[Presence]
in
Serum
|
|
17453-2
|
Phosphatidylglycerol
IgM
Ab
[Presence]
in
Serum
|
|
17454-0
|
Phosphatidylinositol
IgA
Ab
[Presence]
in
Serum
|
|
17455-7
|
Phosphatidylinositol
IgG
Ab
[Presence]
in
Serum
|
|
17456-5
|
Phosphatidylinositol
IgM
Ab
[Presence]
in
Serum
|
|
17457-3
|
Phosphoethanolamine
[Presence]
in
Urine
|
|
17458-1
|
Phosphoethanolamine
[Presence]
in
Serum
or
Plasma
|
|
17459-9
|
Phospholipid
IgA
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1746-7
|
Albumin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17460-7
|
Phosphoserine
[Presence]
in
Urine
|
|
17461-5
|
Phosphoserine
[Presence]
in
Serum
or
Plasma
|
|
17462-3
|
Picloram
[Mass/volume]
in
Urine
|
|
17463-1
|
Pigeon
droppings
Ab
[Units/volume]
in
Serum
|
|
17464-9
|
Pigeon
feather
IgE
Ab
[Presence]
in
Serum
|
|
17465-6
|
Pigeon
serum
IgE
Ab
[Presence]
in
Serum
|
|
17466-4
|
Deprecated
Plasminogen
activator
inhibitor
1
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
17467-2
|
Plasminogen
activator
inhibitor
2
Ag
[Units/volume]
in
Platelet
poor
plasma
by
Immunoassay
|
|
17468-0
|
Plutonium
[Mass/volume]
in
Urine
|
|
17469-8
|
PM-1
Ab
[Units/volume]
in
Serum
|
|
1747-5
|
Albumin
[Mass/volume]
in
Body
fluid
|
|
17470-6
|
PM-1
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17471-4
|
PM-1
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17472-2
|
Polybrominated
biphenyl
[Mass/volume]
in
Serum
or
Plasma
|
|
17473-0
|
Polymyxin
B
[Mass/volume]
in
Serum
or
Plasma
|
|
17474-8
|
Porphobilinogen
[Moles/volume]
in
Serum
or
Plasma
|
|
17475-5
|
Porphyrins
[Units/volume]
in
Urine
|
|
17476-3
|
Porphyrins
[Units/volume]
in
Red
Blood
Cells
|
|
17477-1
|
Porphyrins
[Units/volume]
in
Stool
|
|
17478-9
|
Porphyrins
[Presence]
in
Body
fluid
|
|
17479-7
|
Prazepam
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
1748-3
|
Albumin
[Mass/volume]
in
Pleural
fluid
|
|
17480-5
|
Pregnenolone
[Mass/volume]
in
Urine
|
|
17481-3
|
Probenecid
[Units/volume]
in
Urine
|
|
17482-1
|
Procainamide
[Mass/volume]
in
Urine
|
|
17483-9
|
Progesterone
[Mass/volume]
in
Urine
|
|
17484-7
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
17485-4
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
17486-2
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
17487-0
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
17488-8
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--7th
specimen
post
XXX
challenge
|
|
17489-6
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--8th
specimen
post
XXX
challenge
|
|
1749-1
|
Albumin
[Mass/volume]
in
Peritoneal
fluid
|
|
17490-4
|
Progesterone
[Mass/volume]
in
Serum
or
Plasma
--9th
specimen
post
XXX
challenge
|
|
17491-2
|
Proinsulin
[Mass/volume]
in
Serum
or
Plasma
--baseline
|
|
17492-0
|
Proline
[Presence]
in
Urine
|
|
17493-8
|
Prostaglandin
E
[Mass/volume]
in
Serum
or
Plasma
|
|
17494-6
|
Prostaglandin
F2
alpha
[Mass/volume]
in
Urine
|
|
17495-3
|
Prostaglandins
[Mass/volume]
in
Urine
|
|
17496-1
|
Alpha
1
globulin
[Mass/volume]
in
Body
fluid
by
Electrophoresis
|
|
17497-9
|
Alpha
2
globulin
[Mass/volume]
in
Body
fluid
by
Electrophoresis
|
|
17498-7
|
Beta
globulin
[Mass/volume]
in
Body
fluid
by
Electrophoresis
|
|
17499-5
|
Gamma
globulin
[Mass/volume]
in
Body
fluid
by
Electrophoresis
|
|
175-0
|
Chloramphenicol
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1750-9
|
Albumin
[Mass/volume]
in
Semen
|
|
17501-8
|
Protoporphyrin
[Mass/volume]
in
Serum
or
Plasma
|
|
17502-6
|
Pseudomonas
aeruginosa
Ab
[Units/volume]
in
Serum
|
|
17504-2
|
Psilocybin
[Presence]
in
Urine
|
|
17505-9
|
Psilocybin/Psilocin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17506-7
|
Quinacrine
[Mass/volume]
in
Serum
or
Plasma
|
|
17507-5
|
Quinidine
[Mass/volume]
in
Urine
|
|
17508-3
|
Quinine
[Units/volume]
in
Urine
|
|
17509-1
|
Marsh
Ragweed
IgE
Ab
[Units/volume]
in
Serum
|
|
1751-7
|
Albumin
[Mass/volume]
in
Serum
or
Plasma
|
|
17510-9
|
Raisin
IgE
Ab
[Units/volume]
in
Serum
|
|
17511-7
|
Red
dye
IgE
Ab
[Units/volume]
in
Serum
|
|
17512-5
|
Redfish
IgE
Ab
[Units/volume]
in
Serum
|
|
17513-3
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--5
hours
post
XXX
challenge
|
|
17514-1
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--9th
specimen
post
XXX
challenge
|
|
17515-8
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--baseline
|
|
17516-6
|
Renin
[Enzymatic
activity/volume]
in
Plasma
--supine
|
|
17517-4
|
Respiratory
syncytial
virus
IgG
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
17518-2
|
Respiratory
syncytial
virus
IgG
Ab
[Titer]
in
Serum
|
|
17519-0
|
Respiratory
syncytial
virus
IgM
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1752-5
|
Albumin
[Mass/volume]
in
Synovial
fluid
|
|
17520-8
|
Respiratory
syncytial
virus
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17521-6
|
Reticulin
Ab
[Presence]
in
Serum
|
|
17522-4
|
Reticulin
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
17523-2
|
Reticulin
IgG
Ab
[Titer]
in
Serum
|
|
17524-0
|
Reticulin
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
17525-7
|
Retinoate
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
17526-5
|
Retinyl
esters
[Mass/volume]
in
Serum
or
Plasma
|
|
17527-3
|
Retinol
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
17528-1
|
Retinol
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
dose
|
|
17529-9
|
Retinol
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
dose
|
|
1753-3
|
Albumin
[Presence]
in
Urine
|
|
17530-7
|
Retrovirus
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17531-5
|
Rh
[Type]
in
Amniotic
fluid
|
|
17532-3
|
Rheumatoid
arthritis
nuclear
Ab
[Presence]
in
Serum
|
|
17533-1
|
Rheumatoid
arthritis
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17534-9
|
Rheumatoid
factor
[Units/volume]
in
Body
fluid
by
Immunoassay
|
|
17535-6
|
Ribonucleoprotein
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17536-4
|
Ribonucleoprotein
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17537-2
|
Rickettsia
spotted
fever
group
RNA
[Presence]
in
Serum
by
Probe
and
target
amplification
method
|
|
17538-0
|
Rickettsia
spotted
fever
group
RNA
[Presence]
in
Serum
by
DNA
probe
|
|
17539-8
|
Rickettsia
typhi
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
1754-1
|
Albumin
[Mass/volume]
in
Urine
|
|
17540-6
|
Rickettsia
typhi
IgA
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17541-4
|
Rickettsia
typhi
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17544-8
|
Bartonella
quintana
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17545-5
|
Bartonella
quintana
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17546-3
|
Bartonella
quintana
rRNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17547-1
|
Rotavirus
Ag
[Presence]
in
Stool
|
|
17548-9
|
Rotavirus
RNA
[Presence]
in
Unspecified
specimen
by
DNA
probe
|
|
17549-7
|
Rubella
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1755-8
|
Albumin
[Mass/time]
in
24
hour
Urine
|
|
17550-5
|
Rubella
virus
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
17551-3
|
Rubella
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
17552-1
|
Rubella
virus
IgM
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17553-9
|
Measles
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17554-7
|
Measles
virus
IgA
Ab
[Units/volume]
in
Serum
|
|
17555-4
|
Measles
virus
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17556-2
|
Measles
virus
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17557-0
|
Saccharomonospora
viridis
IgG
Ab
[Units/volume]
in
Serum
|
|
17558-8
|
Saint
Louis
encephalitis
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17559-6
|
Salicylates
[Presence]
in
Blood
|
|
1756-6
|
Albumin
in
CSF/Albumin
in
Serum
or
Plasma
|
|
17560-4
|
Salicylates
[Presence]
in
Gastric
fluid
|
|
17561-2
|
Salmon
roe
IgE
Ab
[Units/volume]
in
Serum
|
|
17562-0
|
Salmonella
sp
Ab
[Presence]
in
Serum
|
|
17563-8
|
Salmonella
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17564-6
|
Salmonella
typhi
O
D
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
17565-3
|
Salmonella
typhi
H
D
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
17566-1
|
Salmonella
typhi
O
Ab
[Presence]
in
Serum
|
|
17567-9
|
Sasapyrine
[Mass/volume]
in
Serum
or
Plasma
|
|
17568-7
|
Sarcosine
[Presence]
in
Urine
|
|
17569-5
|
SCL-70
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
1757-4
|
Albumin
renal
clearance
in
24
hour
|
|
17570-3
|
SCL-70
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17571-1
|
Scopolamine
[Mass/volume]
in
Urine
|
|
17572-9
|
2-Butanol
[Mass/volume]
in
Blood
|
|
17573-7
|
Secobarbital
[Mass/volume]
in
Gastric
fluid
|
|
17574-5
|
Selenium
[Mass/volume]
in
Body
fluid
|
|
17575-2
|
Serine
[Presence]
in
Urine
|
|
17576-0
|
Shigella
sp
identified
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17577-8
|
Ganglioside
GQ1a
IgM
Ab
[Presence]
in
Serum
|
|
17578-6
|
Ganglioside
GQ1b
Ab
[Presence]
in
Serum
|
|
17579-4
|
Ganglioside
GQ1b
IgG
Ab
[Presence]
in
Serum
|
|
1758-2
|
Albumin.glycated
[Mass/volume]
in
Serum
or
Plasma
|
|
17580-2
|
Ganglioside
GQ1b
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
17581-0
|
Ganglioside
GQ1b
IgM
Ab
[Presence]
in
Serum
|
|
17582-8
|
Silver
[Mass/volume]
in
Dialysis
fluid
|
|
17583-6
|
Sjogrens
syndrome-A
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17584-4
|
Sjogrens
syndrome-A
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17585-1
|
Sjogrens
syndrome-A
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17586-9
|
Sjogrens
syndrome-B
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17587-7
|
Sjogrens
syndrome-B
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17588-5
|
Sjogrens
syndrome-B
extractable
nuclear
IgG
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17589-3
|
Smith
extractable
nuclear
Ab
[Titer]
in
Serum
by
Immune
diffusion
(ID)
|
|
1759-0
|
Albumin/Globulin
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17590-1
|
Smith
extractable
nuclear
Ab
[Titer]
in
Serum
by
Immunoassay
|
|
17591-9
|
Smith
extractable
nuclear
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17592-7
|
Smith
extractable
nuclear
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17593-5
|
Smooth
muscle
Ab
[Presence]
in
Sweat
|
|
17594-3
|
Deprecated
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
17595-0
|
Deprecated
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
17597-6
|
Somatotropin
[Mass/volume]
in
Serum
or
Plasma
--52
hours
post
XXX
challenge
|
|
17598-4
|
Specific
gravity
of
Synovial
fluid
|
|
17599-2
|
Volume
of
24
hour
Peritoneal
dialysis
fluid
|
|
176-8
|
Chlortetracycline
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1760-8
|
Alcohol
dehydrogenase
[Enzymatic
activity/volume]
in
Serum
|
|
17600-8
|
Volume
of
6
hour
Urine
|
|
17601-6
|
Volume
of
24
hour
Sputum
|
|
17602-4
|
Volume
of
Seminal
plasma
|
|
17603-2
|
Volume
of
24
hour
Stool
|
|
17604-0
|
Volume
of
24
hour
Sweat
|
|
17605-7
|
Volume
of
24
hour
Unspecified
specimen
|
|
17606-5
|
Volume
of
Stool
|
|
17607-3
|
Volume
of
Cerebral
spinal
fluid
|
|
17608-1
|
Weight
[Mass/time]
of
48
hour
Stool
|
|
17609-9
|
Weight
[Mass/time]
of
72
hour
Stool
|
|
1761-6
|
Aldolase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17610-7
|
Spermatozoa
Motile
[Presence]
in
Semen
--30
minutes
post
collection
|
|
17611-5
|
Stimulants
[Identifier]
in
Serum
or
Plasma
|
|
17612-3
|
Deprecated
Streptococcus
pneumoniae
1
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17613-1
|
Deprecated
Streptococcus
pneumoniae
1
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17614-9
|
Streptococcus
pneumoniae
12
Ab
[Presence]
in
Serum
|
|
17615-6
|
Deprecated
Streptococcus
pneumoniae
12
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17616-4
|
Deprecated
Streptococcus
pneumoniae
12
Ab
[Ratio]
in
Serum
--2nd
specimen/1st
specimen
|
|
17617-2
|
Streptococcus
pneumoniae
14
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
17618-0
|
Streptococcus
pneumoniae
14
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
17619-8
|
Streptococcus
pneumoniae
14
Ab
[Ratio]
in
Serum
by
Immunoassay
--2nd
specimen/1st
specimen
|
|
1762-4
|
Aldosterone
[Mass/volume]
in
Blood
|
|
17620-6
|
Deprecated
Streptococcus
pneumoniae
56
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17621-4
|
Deprecated
Streptococcus
pneumoniae
56
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17622-2
|
Streptocuccus
pneumoniae
18
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17623-0
|
Deprecated
Streptococcus
pneumoniae
19
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17624-8
|
Deprecated
Streptococcus
pneumoniae
23
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17625-5
|
Deprecated
Streptococcus
pneumoniae
23
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17626-3
|
Deprecated
Streptococcus
pneumoniae
3
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17627-1
|
Streptococcus
pneumoniae
3
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
17628-9
|
Deprecated
Streptococcus
pneumoniae
3
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17629-7
|
Streptococcus
pneumoniae
3
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
1763-2
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
|
|
17630-5
|
Streptococcus
pneumoniae
3
Ab
[Ratio]
in
Serum
--2nd
specimen/1st
specimen
|
|
17631-3
|
Deprecated
Streptococcus
pneumoniae
36a+6b
IgG
Ab
[Units/volume]
in
Serum
|
|
17632-1
|
Streptococcus
pneumoniae
4
IgG
Ab
[Units/volume]
in
Serum
|
|
17633-9
|
Deprecated
Streptococcus
pneumoniae
4
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17634-7
|
Deprecated
Streptococcus
pneumoniae
4
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17635-4
|
Streptococcus
pneumoniae
56
IgG
Ab
[Units/volume]
in
Serum
|
|
17636-2
|
Deprecated
Streptococcus
pneumoniae
26
Ab
[Units/volume]
in
Serum
--1st
specimen
|
|
17637-0
|
Deprecated
Streptococcus
pneumoniae
26
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
17638-8
|
Streptococcus
pneumoniae
51
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
17639-6
|
Streptococcus
pneumoniae
51
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
1764-0
|
Aldosterone
[Mass/volume]
in
Urine
|
|
17640-4
|
Streptococcus
pneumoniae
51
Ab
[Ratio]
in
Serum
by
Immunoassay
--2nd
specimen/1st
specimen
|
|
17641-2
|
Streptococcus
pneumoniae
8
Ab
[Presence]
in
Serum
|
|
17642-0
|
Streptococcus
pneumoniae
8
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17643-8
|
Streptococcus
pneumoniae
9
Ab
[Presence]
in
Serum
by
Immunoassay
|
|
17644-6
|
Streptococcus
pneumoniae
9
Ab
[Ratio]
in
Serum
by
Immunoassay
--1st
specimen/2nd
specimen
|
|
17645-3
|
Streptococcus
pneumoniae
9
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
17646-1
|
Streptococcus
pneumoniae
9
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
17647-9
|
Streptococcus
pneumoniae
Ab
[Units/volume]
in
Serum
|
|
17648-7
|
Streptococcus
pneumoniae
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
17649-5
|
Streptococcus
pneumoniae
IgG
Ab
[Ratio]
in
Serum
by
Immunoassay
--1st
specimen/2nd
specimen
|
|
1765-7
|
Aldosterone
[Mass/time]
in
24
hour
Urine
|
|
17650-3
|
Streptococcus
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--1st
specimen
|
|
17651-1
|
Streptococcus
pneumoniae
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
--2nd
specimen
|
|
17652-9
|
Streptococcus
pneumoniae
Ag
[Presence]
in
Unspecified
specimen
by
Latex
agglutination
|
|
17653-7
|
Deprecated
Streptococcus
pneumoniae
group
A
Ag
|
|
17654-5
|
Deprecated
Streptococcus
pneumoniae
group
B
Ab
by
Immunoassay
|
|
17655-2
|
Deprecated
Streptococcus
pneumoniae
group
B
Ag
in
urine
by
immunofluorescence
|
|
17656-0
|
Streptococcus
pyogenes
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17657-8
|
Streptolysin
O
Ab
[Units/volume]
in
Synovial
fluid
|
|
17658-6
|
Strontium/Creatinine
[Mass
Ratio]
in
Urine
|
|
17659-4
|
Strychnine
[Units/volume]
in
Serum
or
Plasma
|
|
1766-5
|
Aldosterone
receptors
[#]
in
Leukocytes
|
|
17660-2
|
Strychnine
[Units/volume]
in
Urine
|
|
17661-0
|
Succinylcholine
[Mass/volume]
in
Serum
or
Plasma
|
|
17662-8
|
Succinylpurines
[Presence]
in
Urine
|
|
17663-6
|
Sulfadiazine
IgE
Ab
[Units/volume]
in
Serum
|
|
17664-4
|
Sulfalazine
IgE
Ab
[Units/volume]
in
Serum
|
|
17665-1
|
Sulfamedraxozole
IgE
Ab
[Units/volume]
in
Serum
|
|
17666-9
|
Sulfate
[Mass/volume]
in
Dialysis
fluid
|
|
17667-7
|
Sulfate.organic/Sulfate.total
in
Urine
|
|
17668-5
|
Sulfatide
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17669-3
|
Sulfatide
IgG
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
1767-3
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--supine
|
|
17670-1
|
Sulfatide
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17671-9
|
Sulfatide
IgM
Ab
[Units/volume]
in
Serum
by
Immunoassay
|
|
17672-7
|
Sulfide
[Mass/volume]
in
Urine
|
|
17673-5
|
Sulfisoxazole
IgE
Ab
[Units/volume]
in
Serum
|
|
17674-3
|
Sulfonamide
[Units/volume]
in
Serum
or
Plasma
|
|
17675-0
|
Sulfonamide
[Units/volume]
in
Urine
|
|
17676-8
|
Sulindac
sulfide
metabolite
[Mass/volume]
in
Serum
or
Plasma
|
|
17677-6
|
Deprecated
Helianthus
annuus
Ab.IgE
|
|
17678-4
|
Taurine
[Presence]
in
Urine
|
|
17679-2
|
Taurine
[Presence]
in
Cerebral
spinal
fluid
|
|
1768-1
|
Aldosterone
[Mass/volume]
in
Serum
or
Plasma
--upright
|
|
17681-8
|
Tellurium
[Presence]
in
Urine
|
|
17682-6
|
Terpineol
[Presence]
in
Blood
|
|
17683-4
|
2-Methyl-2-Propanol
[Mass/volume]
in
Blood
|
|
17685-9
|
Testosterone
Free
[Mass/volume]
in
Dialysis
fluid
|
|
17686-7
|
Testosterone.weakly
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
17687-5
|
Testosterone/Epitestosterone
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17688-3
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--1.5
hours
post
XXX
challenge
|
|
17689-1
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--15
minutes
post
XXX
challenge
|
|
1769-9
|
Fatty
acids.nonesterified
[Mass/volume]
in
Serum
or
Plasma
|
|
17690-9
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--2
hours
post
XXX
challenge
|
|
17691-7
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--30
minutes
post
XXX
challenge
|
|
17692-5
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--45
minutes
post
XXX
challenge
|
|
17693-3
|
Testosterone
[Mass/volume]
in
Serum
or
Plasma
--4
days
post
XXX
challenge
|
|
17694-1
|
Deprecated
Coproporphyrin
[Mass/time]
in
24
hour
Stool
|
|
17695-8
|
Tetrachlorodiphenylethane
[Mass/volume]
in
Blood
|
|
17696-6
|
Tetrachlorodiphenylethane
[Mass/volume]
in
Urine
|
|
17697-4
|
Tetrachloroethane
[Mass/volume]
in
Blood
|
|
17698-2
|
Tetraethyl
lead
[Mass/volume]
in
Blood
|
|
17699-0
|
Thebaine
[Mass/volume]
in
Serum
or
Plasma
|
|
177-6
|
Chlortetracycline
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1770-7
|
Aliphatic
carboxylate,
C14-C26.absorption
[Mass/volume]
in
Serum
or
Plasma
|
|
17700-6
|
Theophylline
[Mass/volume]
in
Urine
|
|
17701-4
|
Thiazides
[Mass/volume]
in
Urine
|
|
17703-0
|
Thorium
[Mass/volume]
in
Urine
|
|
17704-8
|
Threonine
[Presence]
in
Urine
|
|
17705-5
|
Thyroglobulin
IgM
Ab
[Units/volume]
in
Serum
|
|
17706-3
|
Thyroperoxidase
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
17707-1
|
Thyroperoxidase
IgM
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
17708-9
|
Thyroid
stimulating
immunoglobulins
[Presence]
in
Serum
|
|
17709-7
|
Ticlopidine
[Presence]
in
Urine
|
|
1771-5
|
Aliphatic
carboxylate,
C14-C26.esters
[Mass/volume]
in
Serum
or
Plasma
|
|
17710-5
|
Tin/Creatinine
[Mass
Ratio]
in
Urine
|
|
17712-1
|
Toluene
diisocyanate
[Mass/volume]
in
Blood
|
|
17713-9
|
Topiramate
[Mass/volume]
in
Serum
or
Plasma
|
|
17714-7
|
Toxaphene
[Mass/volume]
in
Serum
or
Plasma
|
|
17715-4
|
Toxocara
canis
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunoassay
|
|
17716-2
|
Toxoplasma
gondii
IgE
Ab
[Units/volume]
in
Serum
|
|
17717-0
|
Toxoplasma
gondii
IgG+IgM
Ab
[Presence]
in
Serum
|
|
17718-8
|
Tramadol
[Presence]
in
Urine
by
Confirmatory
method
|
|
17719-6
|
Tramadol
[Mass/volume]
in
Urine
|
|
1772-3
|
Aliphatic
carboxylate,
C14-C26.esters
[Mass/volume]
in
Stool
|
|
17720-4
|
Trans
nonachlor
[Mass/volume]
in
Urine
|
|
17721-2
|
Trans
nonachlor
[Mass/volume]
in
Blood
|
|
17723-8
|
Treponema
pallidum
Ab
[Presence]
in
Serum
by
Immobilization
|
|
17724-6
|
Treponema
pallidum
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17725-3
|
Treponema
pallidum
Ab
[Units/volume]
in
Serum
by
Latex
agglutination
|
|
17726-1
|
Treponema
pallidum
IgG
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
17727-9
|
Treponema
pallidum
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17728-7
|
Treponema
pallidum
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17729-5
|
Treponema
pallidum
IgM
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
1773-1
|
Fatty
acids.very
long
chain
C24:0
(Tetracosanoate)/C22:0
(Docosanoate)
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17730-3
|
Triamterene
[Units/volume]
in
Urine
|
|
17732-9
|
Trichinella
spiralis
Ab
[Presence]
in
Serum
by
Latex
agglutination
|
|
17733-7
|
Trichinella
spiralis
IgA
Ab
[Presence]
in
Serum
|
|
17734-5
|
Trichinella
spiralis
IgG
Ab
[Units/volume]
in
Serum
|
|
17735-2
|
Trichinella
spiralis
IgM
Ab
[Presence]
in
Serum
|
|
17736-0
|
Trichloroacetate
[Mass/volume]
in
Blood
|
|
17737-8
|
Trichloroethane
[Mass/volume]
in
Urine
|
|
17738-6
|
Chloral
hydrate
[Presence]
in
Urine
|
|
17739-4
|
Chloral
hydrate
[Presence]
in
Urine
by
Confirmatory
method
|
|
1774-9
|
Fatty
acids.very
long
chain
C26:0
(Hexacosanoate)/C22:0
(Docosanoate)
[Mass
Ratio]
in
Serum
or
Plasma
|
|
17740-2
|
Trichlorophenoxyacetate
[Presence]
in
Blood
|
|
17741-0
|
Trichlorophenoxyacetate
[Mass/volume]
in
Serum
or
Plasma
|
|
17742-8
|
Trichlorothiazide
[Presence]
in
Urine
|
|
17743-6
|
Triiodothyronine
resin
uptake
(T3RU)
in
Serum
or
Plasma
--1
hour
post
XXX
challenge
|
|
17744-4
|
Trimellitic
anhydride
(TMA)
IgG
Ab
[Units/volume]
in
Serum
|
|
17745-1
|
Trimellitic
anhydride
(TMA)
IgM
Ab
[Units/volume]
in
Serum
|
|
17746-9
|
Trimeprazine
[Presence]
in
Serum
or
Plasma
|
|
17747-7
|
Trimethoprim
[Mass/volume]
in
Urine
|
|
17748-5
|
Trimethylamine
[Presence]
in
Urine
|
|
17749-3
|
Tromethamine
[Mass/volume]
in
Serum
or
Plasma
|
|
1775-6
|
Alkaline
phosphatase
[Mass/volume]
in
Body
fluid
|
|
17750-1
|
Trypsinogen
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17751-9
|
Tryptamine
[Mass/volume]
in
Serum
or
Plasma
|
|
17752-7
|
Tryptophan
[Presence]
in
Urine
|
|
17753-5
|
Tungsten
[Mass/volume]
in
Serum
or
Plasma
|
|
17754-3
|
Tyrosine
[Presence]
in
Blood
|
|
17755-0
|
Urate
[Mass/time]
in
2
hour
Urine
|
|
17756-8
|
Urate
[Mass/time]
in
4
hour
Urine
|
|
17757-6
|
Urea
nitrogen
[Mass/volume]
in
Peritoneal
dialysis
fluid
|
|
17758-4
|
Urea
nitrogen
[Mass/volume]
in
Vitreous
fluid
|
|
17759-2
|
Urea
nitrogen
[Mass/volume]
in
Arterial
blood
--post
dialysis
|
|
1776-4
|
Alkaline
phosphatase
[Mass/volume]
in
Urine
|
|
17760-0
|
Urea
nitrogen
[Mass/volume]
in
Venous
blood
--pre
dialysis
|
|
17761-8
|
Urobilinogen
[Mass/time]
in
48
hour
Stool
|
|
17762-6
|
Valproate
[Mass/volume]
in
Urine
|
|
17763-4
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17764-2
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
17765-9
|
Varicella
zoster
virus
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
by
Immunofluorescence
|
|
17766-7
|
Varicella
zoster
virus
IgM
Ab
[Units/volume]
in
Serum
by
Immunofluorescence
|
|
17767-5
|
Verapamil
[Mass/volume]
in
Urine
|
|
17768-3
|
Vinyl
chloride
[Mass/volume]
in
Blood
|
|
17769-1
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Cerebral
spinal
fluid
|
|
1777-2
|
Alkaline
phosphatase.bone
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17770-9
|
Western
equine
encephalitis
virus
Ab
[Titer]
in
Serum
|
|
17771-7
|
Whitefish
roe
IgE
Ab
[Units/volume]
in
Serum
|
|
17772-5
|
Dimethylbenzene
[Mass/volume]
in
Urine
|
|
17773-3
|
Yeast
[Presence]
in
Stool
by
Light
microscopy
|
|
17774-1
|
Yellow
dye
IgE
Ab
[Units/volume]
in
Serum
|
|
17775-8
|
Yersinia
sp
IgA
Ab
[Units/volume]
in
Serum
|
|
17776-6
|
Yersinia
sp
IgG
Ab
[Units/volume]
in
Serum
|
|
17777-4
|
Yersinia
sp
IgM
Ab
[Units/volume]
in
Serum
|
|
17778-2
|
Zinc
[Mass/volume]
in
Leukocytes
|
|
1778-0
|
Alkaline
phosphatase.intestinal
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17780-8
|
Helicobacter
pylori
Ag
[Presence]
in
Stool
by
Immunoassay
|
|
17781-6
|
21-Hydroxylase
Ab
[Units/volume]
in
Serum
|
|
17782-4
|
Lipoprotein.beta.subparticle
[Entitic
length]
in
Serum
or
Plasma
|
|
17783-2
|
Hemosiderin
[Presence]
in
Urine
by
Light
microscopy
|
|
17784-0
|
Parasites
in
Blood
by
Light
microscopy
|
|
17785-7
|
Radioactive
iodine.thyroid/Radioactive
iodine
dose
[Ratio]
|
|
17786-5
|
Thyrotropin
[Interpretation]
in
Unspecified
specimen--post
dose
TRH
|
|
17787-3
|
Thyroid
gland
NM
Study
report
|
|
17788-1
|
Large
unstained
cells/100
leukocytes
in
Blood
by
Automated
count
|
|
17789-9
|
Large
unstained
cells
[#/volume]
in
Blood
by
Automated
count
|
|
1779-8
|
Alkaline
phosphatase.liver
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17790-7
|
Leukocytes
Left
Shift
[Presence]
in
Blood
by
Automated
count
|
|
17791-5
|
Sjogrens
syndrome-B
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
17792-3
|
Sjogrens
syndrome-A
extractable
nuclear
Ab
[Units/volume]
in
Serum
|
|
17793-1
|
Immunoglobulin
light
chains
[Mass/volume]
in
24
hour
Urine
|
|
17794-9
|
Osmolality
of
Hyperal
solution
|
|
17795-6
|
Potassium
[Moles/volume]
in
Hyperal
solution
|
|
17796-4
|
Sodium
[Moles/volume]
in
Hyperal
solution
|
|
17797-2
|
Thyroid
colloidal
Ab
[Units/volume]
in
Serum
|
|
17798-0
|
Amikacin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17799-8
|
Promyelocytes/100
leukocytes
in
Body
fluid
|
|
178-4
|
Chlortetracycline
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1780-6
|
Alkaline
phosphatase.placental
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17800-4
|
Myelocytes/100
leukocytes
in
Body
fluid
|
|
17801-2
|
Metamyelocytes/100
leukocytes
in
Body
fluid
|
|
17802-0
|
Prolymphocytes/100
leukocytes
in
Body
fluid
|
|
17803-8
|
Plasma
cells/100
leukocytes
in
Body
fluid
|
|
17804-6
|
Promonocytes/100
leukocytes
in
Body
fluid
|
|
17805-3
|
Procainamide
[Mass/volume]
in
Body
fluid
|
|
17806-1
|
N-acetylprocainamide
[Mass/volume]
in
Body
fluid
|
|
17807-9
|
Cyclosporine
[Mass/volume]
in
Body
fluid
|
|
17808-7
|
Tobramycin
[Mass/volume]
in
Urine
|
|
17809-5
|
Hematocrit
[Volume
Fraction]
of
Urine
|
|
1781-4
|
Alkaline
phosphatase.regan
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17810-3
|
Prealbumin/Protein.total
in
Body
fluid
by
Electrophoresis
|
|
17811-1
|
Alpha
1
globulin/Protein.total
by
Electrophoresis
in
Urine
collected
for
unspecified
duration
|
|
17812-9
|
Alpha
1
globulin/Protein.total
in
Body
fluid
by
Electrophoresis
|
|
17813-7
|
Alpha
2
globulin/Protein.total
by
Electrophoresis
in
Urine
collected
for
unspecified
duration
|
|
17814-5
|
Alpha
2
globulin/Protein.total
in
Body
fluid
by
Electrophoresis
|
|
17815-2
|
Beta
globulin/Protein.total
by
Electrophoresis
in
Urine
collected
for
unspecified
duration
|
|
17816-0
|
Beta
globulin/Protein.total
in
Body
fluid
by
Electrophoresis
|
|
17817-8
|
Gamma
globulin/Protein.total
by
Electrophoresis
in
Urine
collected
for
unspecified
duration
|
|
17818-6
|
Gamma
globulin/Protein.total
in
Body
fluid
by
Electrophoresis
|
|
17819-4
|
Albumin/Protein.total
by
Electrophoresis
in
Urine
collected
for
unspecified
duration
|
|
1782-2
|
Alkaline
phosphatase.renal
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17820-2
|
Albumin/Protein.total
in
Body
fluid
by
Electrophoresis
|
|
17821-0
|
Oligoclonal
bands
[Interpretation]
in
Body
fluid
by
Electrophoresis
Narrative
|
|
17822-8
|
CD3+CD4+
(T4
helper)
cells/100
cells
in
Body
fluid
|
|
17823-6
|
CD45
(Lymphs)
cells/100
cells
in
Body
fluid
|
|
17824-4
|
CD3+CD8+
(T8
suppressor
cells)
cells/100
cells
in
Body
fluid
|
|
17825-1
|
CD41a
cells/100
cells
in
Blood
|
|
17826-9
|
CD3
cells/100
cells
in
Body
fluid
|
|
17827-7
|
CD2
cells/100
cells
in
Body
fluid
|
|
17828-5
|
CD16
cells/100
cells
in
Body
fluid
|
|
17829-3
|
CD19
cells/100
cells
in
Body
fluid
|
|
1783-0
|
Alkaline
phosphatase
[Enzymatic
activity/volume]
in
Blood
|
|
17830-1
|
Centromere
Ab
[Units/volume]
in
Body
fluid
|
|
17831-9
|
Deprecated
5-Fluorocytosine
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
17832-7
|
Deprecated
5-Fluorocytosine
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
17833-5
|
Basophils/100
leukocytes
in
Synovial
fluid
|
|
17834-3
|
Eosinophils/100
leukocytes
in
Synovial
fluid
|
|
17835-0
|
Monocytes/100
leukocytes
in
Synovial
fluid
|
|
17836-8
|
Neutrophils/100
leukocytes
in
Synovial
fluid
|
|
17837-6
|
Acid
phosphatase
tartrate
resistant
[Enzymatic
activity/volume]
in
Serum
|
|
17838-4
|
Alkaline
phosphatase.bone
[Mass/volume]
in
Serum
or
Plasma
|
|
17839-2
|
Alpha
fucosidase
[Enzymatic
activity/volume]
in
Blood
|
|
1784-8
|
Alpha
amino
acid
nitrogen
[Mass/volume]
in
Plasma
|
|
17840-0
|
Alpha-L-iduronidase
[Enzymatic
activity/volume]
in
Blood
|
|
17841-8
|
Amylase
[Enzymatic
activity/time]
in
12
hour
Urine
|
|
17842-6
|
Cancer
Ag
27-29
[Units/volume]
in
Serum
or
Plasma
|
|
17843-4
|
Cancer
Ag
72-4
[Units/volume]
in
Serum
or
Plasma
|
|
17844-2
|
Estradiol
(E2).albumin
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
17845-9
|
Lipoprotein.alpha
[Presence]
in
Serum
or
Plasma
|
|
17846-7
|
Lipoprotein.beta
[Presence]
in
Serum
or
Plasma
|
|
17847-5
|
Lipoprotein.pre-beta
[Presence]
in
Serum
or
Plasma
|
|
17848-3
|
Reticulocytes/1000
erythrocytes
in
Blood
by
Manual
|
|
17849-1
|
Reticulocytes/100
erythrocytes
in
Blood
by
Automated
count
|
|
1785-5
|
Alpha
amino
acid
nitrogen
[Mass/time]
in
24
hour
Urine
|
|
17850-9
|
Herpes
simplex
virus
1
IgG
Ab
[Presence]
in
Serum
|
|
17851-7
|
Herpes
simplex
virus
2
IgG
Ab
[Presence]
in
Serum
|
|
17852-5
|
Ureaplasma
urealyticum
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
17853-3
|
Ganglioside
GM1b
IgG
Ab
[Titer]
in
Serum
|
|
17854-1
|
Ganglioside
GM1b
IgM
Ab
[Titer]
in
Serum
|
|
17855-8
|
Hemoglobin
A1c/Hemoglobin.total
in
Blood
by
calculation
|
|
17856-6
|
Hemoglobin
A1c/Hemoglobin.total
in
Blood
by
HPLC
|
|
17857-4
|
Rheumatoid
factor
[Titer]
in
Serum
|
|
17858-2
|
Gamma
glutamyl
transferase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
17859-0
|
Helicobacter
pylori
IgG
Ab
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
1786-3
|
Alpha
aminobutyrate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
17860-8
|
3-Methylhistidine
[Mass/volume]
in
24
hour
Urine
|
|
17861-6
|
Calcium
[Mass/volume]
in
Serum
or
Plasma
|
|
17862-4
|
Calcium
[Mass/volume]
in
Urine
|
|
17863-2
|
Calcium.ionized
[Mass/volume]
in
Serum
or
Plasma
|
|
17864-0
|
Calcium.ionized
[Mass/volume]
in
Serum
or
Plasma
by
Ion-selective
membrane
electrode
(ISE)
|
|
17865-7
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--8
hours
fasting
|
|
17866-5
|
Carnitine/Creatinine
[Ratio]
in
Urine
|
|
17867-3
|
Carnitine
free
(C0)/Creatinine
[Ratio]
in
Urine
|
|
17868-1
|
Acylcarnitine/Creatinine
[Ratio]
in
Urine
|
|
17869-9
|
Orotate/Creatinine
[Molar
ratio]
in
Urine
|
|
1787-1
|
Alpha
aminobutyrate
[Presence]
in
Serum
or
Plasma
|
|
17870-7
|
Orotidine/Creatinine
[Molar
ratio]
in
Urine
|
|
17871-5
|
Hemoglobin
H
[Presence]
in
Blood
by
Heat
denaturation
|
|
17872-3
|
Tetrahydrocannabinol
[Presence]
in
Urine
by
Confirm
method
>25
ng/mL
|
|
17873-1
|
Bacteria
#
2
identified
in
Bone
by
Aerobe
culture
|
|
17874-9
|
Bacteria
#
3
identified
in
Bone
by
Aerobe
culture
|
|
17875-6
|
Bacteria
#
4
identified
in
Bone
by
Aerobe
culture
|
|
17876-4
|
Bacteria
#
5
identified
in
Bone
by
Aerobe
culture
|
|
17877-2
|
Bacteria
#
6
identified
in
Bone
by
Aerobe
culture
|
|
17878-0
|
Bacteria
#
2
identified
in
Bronchial
specimen
by
Aerobe
culture
|
|
17879-8
|
Bacteria
#
3
identified
in
Bronchial
specimen
by
Aerobe
culture
|
|
1788-9
|
Alpha
aminobutyrate
[Mass/volume]
in
Serum
or
Plasma
|
|
17880-6
|
Bacteria
#
4
identified
in
Bronchial
specimen
by
Aerobe
culture
|
|
17881-4
|
Bacteria
#
5
identified
in
Bronchial
specimen
by
Aerobe
culture
|
|
17882-2
|
Bacteria
#
6
identified
in
Bronchial
specimen
by
Aerobe
culture
|
|
17883-0
|
Bacteria
#
2
identified
in
Genital
specimen
by
Aerobe
culture
|
|
17884-8
|
Bacteria
#
3
identified
in
Genital
specimen
by
Aerobe
culture
|
|
17885-5
|
Bacteria
#
4
identified
in
Genital
specimen
by
Aerobe
culture
|
|
17886-3
|
Bacteria
#
5
identified
in
Genital
specimen
by
Aerobe
culture
|
|
17887-1
|
Bacteria
#
6
identified
in
Genital
specimen
by
Aerobe
culture
|
|
17888-9
|
Bacteria
#
2
identified
in
Nose
by
Aerobe
culture
|
|
17889-7
|
Bacteria
#
3
identified
in
Nose
by
Aerobe
culture
|
|
1789-7
|
Deprecated
Alpha
aminobutyrate
[Mass/volume]
in
Serum
|
|
17890-5
|
Bacteria
#
4
identified
in
Nose
by
Aerobe
culture
|
|
17891-3
|
Bacteria
#
5
identified
in
Nose
by
Aerobe
culture
|
|
17892-1
|
Bacteria
#
6
identified
in
Nose
by
Aerobe
culture
|
|
17893-9
|
Bacteria
#
2
identified
in
Sputum
by
Aerobe
culture
|
|
17894-7
|
Bacteria
#
3
identified
in
Sputum
by
Aerobe
culture
|
|
17895-4
|
Bacteria
#
4
identified
in
Sputum
by
Aerobe
culture
|
|
17896-2
|
Bacteria
#
5
identified
in
Sputum
by
Aerobe
culture
|
|
17897-0
|
Bacteria
#
6
identified
in
Sputum
by
Aerobe
culture
|
|
17898-8
|
Bacteria
identified
in
Throat
by
Aerobe
culture
|
|
17899-6
|
Bacteria
#
2
identified
in
Throat
by
Aerobe
culture
|
|
179-2
|
Chlortetracycline
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1790-5
|
Alpha
aminobutyrate
[Mass/volume]
in
Urine
|
|
17900-2
|
Bacteria
#
3
identified
in
Throat
by
Aerobe
culture
|
|
17901-0
|
Bacteria
#
4
identified
in
Throat
by
Aerobe
culture
|
|
17902-8
|
Bacteria
#
5
identified
in
Throat
by
Aerobe
culture
|
|
17903-6
|
Bacteria
#
6
identified
in
Throat
by
Aerobe
culture
|
|
17904-4
|
Bacteria
#
2
identified
in
Tissue
by
Aerobe
culture
|
|
17905-1
|
Bacteria
#
3
identified
in
Tissue
by
Aerobe
culture
|
|
17906-9
|
Bacteria
#
4
identified
in
Tissue
by
Aerobe
culture
|
|
17907-7
|
Bacteria
#
5
identified
in
Tissue
by
Aerobe
culture
|
|
17908-5
|
Bacteria
#
6
identified
in
Tissue
by
Aerobe
culture
|
|
17909-3
|
Bacteria
identified
in
Wound
deep
by
Aerobe
culture
|
|
1791-3
|
Alpha
aminoadipate
[Presence]
in
Plasma
|
|
17910-1
|
Bacteria
#
2
identified
in
Wound
deep
by
Aerobe
culture
|
|
17911-9
|
Bacteria
#
3
identified
in
Wound
deep
by
Aerobe
culture
|
|
17912-7
|
Bacteria
#
4
identified
in
Wound
deep
by
Aerobe
culture
|
|
17913-5
|
Bacteria
#
5
identified
in
Wound
deep
by
Aerobe
culture
|
|
17914-3
|
Bacteria
#
6
identified
in
Wound
deep
by
Aerobe
culture
|
|
17915-0
|
Bacteria
identified
in
Wound
shallow
by
Aerobe
culture
|
|
17916-8
|
Bacteria
#
2
identified
in
Wound
shallow
by
Aerobe
culture
|
|
17917-6
|
Bacteria
#
3
identified
in
Wound
shallow
by
Aerobe
culture
|
|
17918-4
|
Bacteria
#
4
identified
in
Wound
shallow
by
Aerobe
culture
|
|
17919-2
|
Bacteria
#
5
identified
in
Wound
shallow
by
Aerobe
culture
|
|
1792-1
|
Alpha
aminoadipate
[Mass/volume]
in
Plasma
|
|
17920-0
|
Bacteria
#
6
identified
in
Wound
shallow
by
Aerobe
culture
|
|
17921-8
|
Bacteria
#
2
identified
in
Nose
by
Anaerobe
culture
|
|
17922-6
|
Bacteria
#
3
identified
in
Nose
by
Anaerobe
culture
|
|
17923-4
|
Bacteria
#
2
identified
in
Tissue
by
Anaerobe
culture
|
|
17924-2
|
Bacteria
#
3
identified
in
Tissue
by
Anaerobe
culture
|
|
17925-9
|
Bacteria
identified
in
Wound
deep
by
Anaerobe
culture
|
|
17926-7
|
Bacteria
#
2
identified
in
Wound
deep
by
Anaerobe
culture
|
|
17927-5
|
Bacteria
#
3
identified
in
Wound
deep
by
Anaerobe
culture
|
|
17928-3
|
Bacteria
identified
in
Blood
by
Aerobe
culture
|
|
17929-1
|
Bacteria
#
2
identified
in
Blood
by
Aerobe
culture
|
|
1793-9
|
Alpha
aminoadipate
[Mass/volume]
in
Urine
|
|
17930-9
|
Bacteria
#
3
identified
in
Blood
by
Aerobe
culture
|
|
17931-7
|
Bacteria
#
4
identified
in
Blood
by
Aerobe
culture
|
|
17932-5
|
Bacteria
#
5
identified
in
Blood
by
Aerobe
culture
|
|
17933-3
|
Bacteria
#
6
identified
in
Blood
by
Aerobe
culture
|
|
17934-1
|
Bacteria
identified
in
Blood
by
Anaerobe
culture
|
|
17935-8
|
Bacteria
#
2
identified
in
Blood
by
Anaerobe
culture
|
|
17936-6
|
Bacteria
#
3
identified
in
Blood
by
Anaerobe
culture
|
|
17937-4
|
Bacteria
#
2
identified
in
Burn
by
Culture
|
|
17938-2
|
Bacteria
#
3
identified
in
Burn
by
Culture
|
|
17939-0
|
Bacteria
#
4
identified
in
Burn
by
Culture
|
|
1794-7
|
Amylase
[Enzymatic
activity/volume]
in
Duodenal
fluid
|
|
17940-8
|
Bacteria
#
5
identified
in
Burn
by
Culture
|
|
17941-6
|
Bacteria
#
6
identified
in
Burn
by
Culture
|
|
17942-4
|
Bacteria
#
2
identified
in
Line
specimen
by
IV
Line
culture
|
|
17943-2
|
Bacteria
#
3
identified
in
Line
specimen
by
IV
Line
culture
|
|
17944-0
|
Bacteria
#
4
identified
in
Line
specimen
by
IV
Line
culture
|
|
17945-7
|
Bacteria
#
5
identified
in
Line
specimen
by
IV
Line
culture
|
|
17946-5
|
Bacteria
#
6
identified
in
Line
specimen
by
IV
Line
culture
|
|
17947-3
|
Fungus
#
2
identified
in
Unspecified
specimen
by
Culture
|
|
17948-1
|
Fungus
#
3
identified
in
Unspecified
specimen
by
Culture
|
|
17949-9
|
Fungus
#
4
identified
in
Unspecified
specimen
by
Culture
|
|
1795-4
|
Amylase
[Enzymatic
activity/volume]
in
Body
fluid
|
|
17950-7
|
Deprecated
Bacteria
identified
in
Body
fluid
by
Aerobe
culture
|
|
17951-5
|
Bacteria
#
2
identified
in
Body
fluid
by
Aerobe
culture
|
|
17952-3
|
Bacteria
#
3
identified
in
Body
fluid
by
Aerobe
culture
|
|
17953-1
|
Bacteria
#
4
identified
in
Body
fluid
by
Aerobe
culture
|
|
17954-9
|
Bacteria
#
5
identified
in
Body
fluid
by
Aerobe
culture
|
|
17955-6
|
Bacteria
#
6
identified
in
Body
fluid
by
Aerobe
culture
|
|
17956-4
|
Bacteria
identified
in
Body
fluid
by
Anaerobe
culture
|
|
17957-2
|
Bacteria
#
2
identified
in
Body
fluid
by
Anaerobe
culture
|
|
17958-0
|
Bacteria
#
3
identified
in
Body
fluid
by
Anaerobe
culture
|
|
17959-8
|
Bacteria
#
2
identified
in
Peritoneal
fluid
by
Culture
|
|
1796-2
|
Amylase
[Enzymatic
activity/volume]
in
Pleural
fluid
|
|
17960-6
|
Bacteria
#
3
identified
in
Peritoneal
fluid
by
Culture
|
|
17961-4
|
Bacteria
#
4
identified
in
Peritoneal
fluid
by
Culture
|
|
17962-2
|
Bacteria
#
5
identified
in
Peritoneal
fluid
by
Culture
|
|
17963-0
|
Bacteria
#
6
identified
in
Peritoneal
fluid
by
Culture
|
|
17964-8
|
Bacteria
#
2
identified
in
Stool
by
Culture
|
|
17965-5
|
Bacteria
#
3
identified
in
Stool
by
Culture
|
|
17966-3
|
Bacteria
#
4
identified
in
Stool
by
Culture
|
|
17967-1
|
Bacteria
#
5
identified
in
Stool
by
Culture
|
|
17968-9
|
Bacteria
#
6
identified
in
Stool
by
Culture
|
|
17969-7
|
Deprecated
Bacteria
identified
in
Urine
by
Aerobe
culture
|
|
1797-0
|
Amylase
[Enzymatic
activity/volume]
in
Peritoneal
fluid
|
|
17970-5
|
Bacteria
#
2
identified
in
Urine
by
Culture
|
|
17971-3
|
Bacteria
#
3
identified
in
Urine
by
Culture
|
|
17972-1
|
Bacteria
#
4
identified
in
Urine
by
Culture
|
|
17973-9
|
Bacteria
#
5
identified
in
Urine
by
Culture
|
|
17974-7
|
Bacteria
#
6
identified
in
Urine
by
Culture
|
|
17975-4
|
Virus
#
2
identified
in
Unspecified
specimen
by
Culture
|
|
17976-2
|
Virus
#
3
identified
in
Unspecified
specimen
by
Culture
|
|
17977-0
|
Left
atrial
Apical
4
chamber
[Area]
by
US
2D
|
|
17978-8
|
Mitral
valve
Peak
A
wave
by
US.doppler
|
|
17979-6
|
Anterior
mitral
valve
leaflet
A-C
interval
by
US.M-mode
|
|
1798-8
|
Amylase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
17980-4
|
Anterior
mitral
valve
leaflet
A-C
slope
[Velocity]
by
US.M-mode
|
|
17981-2
|
Aortic
valve
Acceleration
by
US.doppler
|
|
17982-0
|
Pulmonic
valve
Acceleration
by
US.doppler
|
|
17983-8
|
Tricuspid
valve
Acceleration
by
US.doppler
|
|
17984-6
|
Aortic
valve
area
method
|
|
17985-3
|
Left
atrial
AP
dimension.left
atrium/AP
dimension.aorta
root
by
US
|
|
17986-1
|
Left
ventricular
Maximum
Apical
2
chamber.diastole
[Volume]
by
US
2D
modified
|
|
17987-9
|
Left
ventricular
Apical
2
chamber.systole.minimum
[Volume]
by
US
2D
modified
|
|
17988-7
|
Right
atrial
Apical
4
chamber
[Area]
by
US
2D
|
|
17989-5
|
Left
ventricular
Maximum
Apical
4
chamber.diastole
[Volume]
by
US
2D
modified
|
|
1799-6
|
Amylase
[Enzymatic
activity/volume]
in
Urine
|
|
17990-3
|
Left
ventricular
Apical
4
chamber.systole.minimum
[Volume]
by
US
2D
modified
|
|
17991-1
|
Left
ventricular
Cardiac
echo
volume
method
|
|
17992-9
|
Aorta
root
Cardiac
output
by
US.doppler
|
|
17993-7
|
Mitral
valve
Cardiac
output
by
US.doppler
|
|
17994-5
|
Pulmonary
artery
Cardiac
output
by
US
|
|
17995-2
|
Aorta
Maximum
coarctation
gradient
[Pressure]
by
US.doppler
|
|
17996-0
|
Aortic
valve
Maximum
cusp
separation
[Length]
by
US
|
|
17997-8
|
Anterior
mitral
valve
leaflet
D-E
excursion
[Length]
by
US.M-mode
|
|
17998-6
|
Aortic
valve
regurgitant
jet
Deceleration
[Time]
by
US.doppler
|
|
17999-4
|
Mitral
valve
Deceleration
[Time]
by
US.doppler
|
|
18-2
|
Amoxicillin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
180-0
|
Cinoxacin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1800-2
|
Amylase
[Enzymatic
activity/time]
in
24
hour
Urine
|
|
18000-0
|
Tricuspid
valve
Deceleration
[Time]
by
US.doppler
|
|
18001-8
|
Mitral
valve
Deceleration.pressure.half
time
by
US.doppler
|
|
18002-6
|
Mitral
valve
Deceleration
slope
[Acceleration]
by
US.doppler
|
|
18003-4
|
Aortic
valve
regurgitant
jet
Deceleration
time
slope
by
US.doppler
|
|
18004-2
|
Atrial
septum
Defect
diameter
by
US
|
|
18005-9
|
Ventricular
septal
Defect
diameter
by
US
|
|
18006-7
|
Inferior
vena
cava
Diameter
by
US
|
|
18007-5
|
Superior
vena
cava
Diameter
by
US
|
|
18008-3
|
Ventricular
septal
Defect.gradient.systole.maximum
[Pressure]
by
US.doppler
|
|
18009-1
|
Ventricular
septal
Defect.gradient.systole.mean
[Pressure]
by
US.doppler
|
|
1801-0
|
Amylase
renal
clearance
in
24
hour
|
|
18010-9
|
Aorta
Diameter
by
US
|
|
18011-7
|
Aorta
arch
and
Neck
Diameter
by
US
|
|
18012-5
|
Ascending
thoracic
aorta
Diameter
by
US
|
|
18013-3
|
Descending
thoracic
aorta
Diameter
by
US
|
|
18014-1
|
Aorta
isthmus
Diameter
by
US
|
|
18015-8
|
Aorta
root
annulo-aortic
junction
Diameter
by
US
|
|
18016-6
|
Aortic
valve
annulus
Diameter
by
US
|
|
18017-4
|
Mitral
valve
annulus
Diameter
by
US
|
|
18018-2
|
Left
ventricular
outflow
tract
Diameter
by
US
|
|
18019-0
|
Left
pulmonary
artery
Diameter
by
US
|
|
1802-8
|
Amylase.P1
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18020-8
|
Main
pulmonary
artery
Diameter
by
US
|
|
18021-6
|
Right
pulmonary
artery
Diameter
by
US
|
|
18022-4
|
Pulmonic
valve
annulus
Diameter
by
US
|
|
18023-2
|
Tricuspid
valve
annulus
Diameter
by
US
|
|
18024-0
|
Left
atrial
Diameter
anterior-posterior
systole
by
US.M-mode
|
|
18025-7
|
Heart
Diameter
anterior-posterior
systole/Aortic
root
diameter
by
US
|
|
18026-5
|
Left
ventricular
End-diastolic
volume
by
US
|
|
18027-3
|
Left
ventricular
End-diastolic
volume
by
US.2D+Calculated
by
single-plane
ellipse
method
|
|
18028-1
|
Left
ventricular
End-diastolic
volume
by
US.2D+Calculated
by
biplane
ellipse
method
|
|
18029-9
|
Left
ventricular
End-diastolic
volume
by
US
2D
modified
|
|
1803-6
|
Amylase.P2
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18030-7
|
Tricuspid
valve
Peak
A
wave
by
US.doppler
|
|
18031-5
|
Tricuspid
valve
Peak
E
wave
by
US.doppler
|
|
18032-3
|
Tricuspid
valve
Pressure
half
time
during
diastole
by
US.doppler
|
|
18033-1
|
Left
ventricular
Diastole-systole
[Volume]
by
US
|
|
18034-9
|
Tricuspid
valve
regurgitant
jet
dP/dT
(1
M/S
to
3
M/S).systole
[Pressure
rate]
by
US.doppler
|
|
18035-6
|
Mitral
valve
regurgitant
jet
dP/dT
(1M/S
to
3
M/S)
[Pressure
rate]
by
US.doppler
continuous
wave
|
|
18036-4
|
Anterior
mitral
valve
leaflet
E
point
to
septal
separation
[Time]
by
US.M-mode
|
|
18037-2
|
Mitral
valve
Peak
E
wave
by
US.doppler
|
|
18038-0
|
Mitral
valve
Peak
E
wave/Peak
A
wave
by
US.doppler
|
|
18039-8
|
Tricuspid
valve
Peak
E
wave/Peak
A
wave
by
US.doppler
|
|
1804-4
|
Amylase.P3
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18040-6
|
Anterior
mitral
valve
leaflet
E-F
slope
[Velocity]
by
US.M-mode
|
|
18041-4
|
Aortic
valve
Ejection
time
by
US.doppler
|
|
18042-2
|
Pulmonic
valve
Ejection
time
by
US.doppler
|
|
18043-0
|
Left
ventricular
Ejection
fraction
by
US
|
|
18044-8
|
Left
ventricular
Ejection
fraction
by
US.2D+Calculated
by
single-plane
ellipse
method
|
|
18045-5
|
Left
ventricular
Ejection
fraction
by
US.2D+Calculated
by
biplane
ellipse
method
|
|
18046-3
|
Left
ventricular
Ejection
fraction
by
US
2D
modified
|
|
18047-1
|
Left
ventricular
Ejection
fraction
by
US
2D
modified
biplane
|
|
18048-9
|
Left
ventricular
Ejection
fraction
by
US
2D
modified
single-plane
|
|
18049-7
|
Left
ventricular
Ejection
fraction
by
US.M-mode+Calculated
by
Teichholz
method
|
|
1805-1
|
Amylase.pancreatic
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18050-5
|
Inferior
vena
cava
Fractional
collapse
by
US
--inspiration
|
|
18051-3
|
Left
ventricular
Fractional
shortening
minor
axis
by
US
|
|
18052-1
|
Right
ventricular
anterior
wall
Fractional
thickening
freewall
by
US
|
|
18053-9
|
Left
ventricular
posterior
wall
Thickening.fractional
change
by
US
|
|
18054-7
|
Interventricular
septum
Fractional
thickness;
fractional
change
by
US
2D
|
|
18055-4
|
Tricuspid
valve
Maximum
gradient
during
diastole
[Pressure]
by
US.doppler
|
|
18056-2
|
Tricuspid
valve
Mean
gradient
during
diastole
[Pressure]
by
US.doppler
|
|
18057-0
|
Mitral
valve
Peak
gradient
[Pressure]
by
US.doppler
|
|
18058-8
|
Pulmonic
valve
Peak
gradient
[Pressure]
by
US.doppler
|
|
18059-6
|
Mitral
valve
Mean
gradient
[Pressure]
by
US.doppler
|
|
1806-9
|
Amylase
S1
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18060-4
|
Pulmonic
valve
Mean
gradient
[Pressure]
by
US.doppler
|
|
18061-2
|
Aortic
valve
Maximum
gradient
during
systole
[Pressure]
by
US.doppler
derived
full
Bernoulli
|
|
18062-0
|
Aortic
valve
Maximum
gradient
during
systole
[Pressure]
by
US.doppler+Calculated
by
simplified
Bernoulli
|
|
18063-8
|
Aortic
valve
Mean
systole
gradient
[Pressure]
by
US.doppler+Calculated
by
simplified
Bernoulli
|
|
18064-6
|
Left
ventricular
outflow
tract
Maximum
gradient
during
systole
[Pressure]
by
US.doppler
|
|
18065-3
|
Tricuspid
valve
regurgitant
jet
Maximum
gradient
during
systole
[Pressure]
by
US.doppler
|
|
18066-1
|
Aortic
valve
Mean
systole
gradient
[Pressure]
by
US.doppler
derived
full
Bernoulli
|
|
18067-9
|
Cardiac
echo
imaging
device
Image
quality
by
US
|
|
18068-7
|
Left
ventricular
Pre
ejection
time
by
US
|
|
18069-5
|
Right
atrial
Intrachamber
mean
systole
pressure
by
Estimated
from
jugular
venous
distention
|
|
1807-7
|
Amylase
S2
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18070-3
|
Right
atrial
Intrachamber
mean
systole
pressure
by
US
|
|
18071-1
|
Left
ventricular
Isovolumic
relaxation
time
by
US.doppler
|
|
18072-9
|
Left
ventricular
Major
axis
apical
2
chamber
diastole
[Length]
by
US
2D
|
|
18073-7
|
Left
ventricular
Major
axis
apical
2
chamber
systole
[Length]
by
US
2D
|
|
18074-5
|
Left
ventricular
Major
axis
apical
4
chamber
diastole
[Length]
by
US
2D
|
|
18075-2
|
Left
ventricular
Major
axis
apical
4
chamber
systole
[Length]
by
US
2D
|
|
18076-0
|
Left
ventricular
Major
axis
apical
systole
[Length]
by
US
2D
|
|
18077-8
|
Left
ventricular
Major
axis
apical
diastole
[Length]
by
US
2D
|
|
18078-6
|
Right
ventricular
Major
axis
diastole
maximum
[Length]
by
US
2D
|
|
18079-4
|
Right
ventricular
Minimum
major
axis
during
systole
[Length]
by
US
2D
|
|
1808-5
|
Amylase
S3
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18080-2
|
Right
ventricular
outflow
tract
Peak
systolic
flow
by
US.doppler
|
|
18081-0
|
Left
ventricular
Minor
axis
at
end
diastole.apical
4
chamber
[Length]
by
US
2D
|
|
18082-8
|
Left
ventricular
Minor
axis
at
end
systole.apical
4
chamber
[Length]
by
US.M-mode
|
|
18083-6
|
Left
ventricular
Internal
diameter
minor
axis
diastole
by
US
2D
|
|
18084-4
|
Right
ventricular
Minor
axis
at
end
diastole
[Length]
by
US
2D
|
|
18085-1
|
Left
ventricular
Internal
diameter
minor
axis
systole
by
US
2D
|
|
18086-9
|
Right
ventricular
Minor
axis
at
end
systole
[Length]
by
US
2D
|
|
18087-7
|
Left
ventricular
Myocardial
mass
by
US
|
|
18088-5
|
Left
ventricular
Myocardial
mass
by
US.M-mode
|
|
18089-3
|
Aortic
valve
Orifice
[Area]
by
US
|
|
1809-3
|
Amylase.salivary
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18090-1
|
Aortic
valve
Orifice
[Area]
by
US.continuity
|
|
18091-9
|
Aortic
valve
Orifice
[Area]
by
US.continuity.VTI+Area
|
|
18092-7
|
Aortic
valve
Orifice
[Area]
by
US.continuity.VTI+Diameter
|
|
18093-5
|
Aortic
valve
Orifice
[Area]
by
US.continuity.Vmax+Area
|
|
18094-3
|
Aortic
valve
Orifice
[Area]
by
US.continuity.Vmax+Diameter
|
|
18095-0
|
Main
pulmonary
artery
Crossection
[Area]
by
US
|
|
18096-8
|
Pulmonic
valve
Orifice
[Area]
by
US.continuity
|
|
18097-6
|
Mitral
valve
Minimum
orifice
[Area]
by
US.doppler
pressure
half
time
|
|
18098-4
|
Mitral
valve
Minimum
orifice
minor
axis
[Area]
by
US
2D
|
|
18099-2
|
Left
ventricular
Apical
plane
2
chamber
diastole
[Area]
by
US
2D
|
|
181-8
|
Cinoxacin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1810-1
|
Amylase/Creatinine
[Mass
Ratio]
in
Serum
or
Plasma
|
|
18100-8
|
Left
ventricular
Apical
plane
2
chamber
systole
[Area]
by
US
2D
|
|
18101-6
|
Left
ventricular
Apical
plane
4
chamber
diastole
[Area]
by
US
2D
|
|
18102-4
|
Left
ventricular
Apical
plane
4
chamber
systole
[Area]
by
US
2D
|
|
18103-2
|
Left
ventricular
outflow
tract
Planimetry
parasternal
short
axis
[Area]
by
US
2D
|
|
18104-0
|
Aortic
valve
Pressure
half
time
by
US.doppler
|
|
18105-7
|
Aortic
valve
regurgitant
jet
Pressure
half
time
by
US.doppler
|
|
18106-5
|
Cardiac
Echo
Study
Procedure
|
|
18107-3
|
Cardiac
echo
study
Procedure
stress
method
|
|
18108-1
|
Aortic
valve
Prosthetic
valve
type
by
US
|
|
18109-9
|
Mitral
valve
Prosthetic
valve
type
by
US
|
|
1811-9
|
Amylase/Creatinine
renal
clearance
[Ratio]
in
24
hour
Urine
and
Serum
or
Plasma
|
|
18110-7
|
Pulmonic
valve
Prosthetic
valve
type
by
US
|
|
18111-5
|
Tricuspid
valve
Prosthetic
valve
type
by
US
|
|
18112-3
|
Aortic
valve
Regurgitation
degree
by
US.doppler
|
|
18113-1
|
Mitral
valve
Regurgitation
degree
by
US.doppler
|
|
18114-9
|
Pulmonic
valve
Regurgitation
degree
by
US.doppler
|
|
18115-6
|
Tricuspid
valve
Regurgitation
degree
by
US.doppler
|
|
18116-4
|
Left
ventricular
Segmental
wall
appearance
by
US
|
|
18117-2
|
Left
ventricular
Segmental
wall
motion
by
US
score
|
|
18118-0
|
Left
ventricular
Segmental
wall
motion
Narrative
by
US
|
|
18119-8
|
Left
ventricular
apical
anterior
Segmental
wall
motion
by
US
|
|
1812-7
|
Alpha
fucosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18120-6
|
Left
ventricular
apical
septum
Segmental
wall
motion
by
US
|
|
18121-4
|
Left
ventricular
basal
anterior
Segmental
wall
motion
by
US
|
|
18122-2
|
Left
ventricular
basal
anterior
septum
Segmental
wall
motion
by
US
|
|
18123-0
|
Left
ventricular
basal
inferior
Segmental
wall
motion
by
US
|
|
18124-8
|
Left
ventricular
basal
lateral
Segmental
wall
motion
by
US
|
|
18125-5
|
Left
ventricular
basal
posterior
Segmental
wall
motion
by
US
|
|
18126-3
|
Left
ventricular
basal
septum
Segmental
wall
motion
by
US
|
|
18127-1
|
Left
ventricular
inferior
apical
Segmental
wall
motion
by
US
|
|
18128-9
|
Left
ventricular
lateral
apical
Segmental
wall
motion
by
US
|
|
18129-7
|
Left
ventricular
mid
anterior
Segmental
wall
motion
by
US
|
|
1813-5
|
Alpha
galactosidase
A
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18130-5
|
Left
ventricular
mid
anterior
septum
Segmental
wall
motion
by
US
|
|
18131-3
|
Left
ventricular
mid
inferior
Segmental
wall
motion
by
US
|
|
18132-1
|
Left
ventricular
mid
lateral
Segmental
wall
motion
by
US
|
|
18133-9
|
Left
ventricular
mid
posterior
Segmental
wall
motion
by
US
|
|
18134-7
|
Left
ventricular
mid
septum
Segmental
wall
motion
by
US
|
|
18135-4
|
Left
ventricular
Minor
axis.mitral
level.diastole
[Area]
by
US
2D
|
|
18136-2
|
Left
ventricular
Minor
axis.mitral
level.systole
[Area]
by
US
2D
|
|
18137-0
|
Left
ventricular
Minor
axis.papillary
level.diastole
[Area]
by
US
2D
|
|
18138-8
|
Left
ventricular
Minor
axis.papillary
level.systole
[Area]
by
US
2D
|
|
18139-6
|
Stress
study
Stage
by
US
|
|
1814-3
|
Acid
alpha
glucosidase
[Enzymatic
activity/volume]
in
Semen
|
|
18140-4
|
Central
cardiovascular
Study
observation
by
US
|
|
18141-2
|
Central
cardiovascular
Study
observation
Narrative
by
US
|
|
18142-0
|
Heart
chambers
Study
observation
by
US
|
|
18143-8
|
Heart
chambers
Study
observation
Narrative
by
US
|
|
18144-6
|
Heart
valves
Study
observation
Narrative
by
US
|
|
18145-3
|
Heart
valves
Study
observation
by
US
|
|
18146-1
|
Central
cardiovascular
Overall
Study
observation
Narrative
by
US
|
|
18147-9
|
Central
cardiovascular
Overall
Study
observation
by
US
|
|
18148-7
|
Left
ventricular
End-systolic
volume
by
US
|
|
18149-5
|
Left
ventricular
End-systolic
volume
by
US.2D+Calculated
by
single-plane
ellipse
method
|
|
1815-0
|
Acid
alpha
glucosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18150-3
|
Left
ventricular
End-systolic
volume
by
US.2D+Calculated
by
biplane
ellipse
method
|
|
18151-1
|
Left
ventricular
End-systolic
volume
by
US
2D
modified
|
|
18152-9
|
Left
ventricular
posterior
wall
Thickness
during
diastole
by
US
|
|
18153-7
|
Right
ventricular
anterior
wall
Thickness
during
diastole
by
US
|
|
18154-5
|
Interventricular
septum
Thickness
during
diastole
by
US
|
|
18155-2
|
Left
ventricular
Thickness
septal
wall/Thickness
posterior
wall
by
US
|
|
18156-0
|
Left
ventricular
posterior
wall
Thickness
during
systole
by
US
|
|
18157-8
|
Right
ventricular
anterior
wall
Thickness
during
systole
by
US
|
|
18158-6
|
Interventricular
septum
Thickness
during
systole
by
US
|
|
18159-4
|
Cardiac
Echo
Study
Transducer
site
|
|
1816-8
|
Acid
alpha
glucosidase
[Enzymatic
activity/volume]
in
Leukocytes
|
|
18160-2
|
Cardiac
echo
imaging
device
Class
|
|
18161-0
|
Tricuspid
valve
Maximum
blood
flow
by
US.doppler
|
|
18162-8
|
Pulmonic
valve
Maximum
blood
flow
by
US.doppler
|
|
18163-6
|
Aorta
root
Peak
systolic
flow
by
US.doppler
|
|
18164-4
|
Left
ventricular
outflow
tract
Peak
systolic
flow
by
US.doppler
|
|
18165-1
|
Pulmonic
valve
regurgitant
jet
Peak
diastole
flow
by
US.doppler
|
|
18166-9
|
Tricuspid
valve
regurgitant
jet
Peak
systolic
flow
by
US.doppler
|
|
18167-7
|
Aorta
root
Mean
systolic
flow
by
US.doppler
|
|
18168-5
|
Aorta
root
Blood
velocity-time
integral
by
US.doppler
|
|
18169-3
|
Aortic
valve
Blood
velocity-time
integral
by
US.doppler
|
|
1817-6
|
Alpha
ketoglutarate
[Mass/volume]
in
Serum
or
Plasma
|
|
18170-1
|
Left
ventricular
outflow
tract
Blood
velocity-time
integral
by
US.doppler
|
|
18171-9
|
Right
ventricular
outflow
tract
Blood
velocity-time
integral
by
US.doppler
|
|
18172-7
|
Mitral
valve
Blood
velocity-time
integral
by
US.doppler
|
|
18173-5
|
Pulmonary
artery
Blood
velocity-time
integral
by
US.doppler
|
|
18174-3
|
Pulmonic
valve
Blood
velocity-time
integral
by
US.doppler
|
|
18175-0
|
Tricuspid
valve
Velocity-time
integral
during
diastole
by
US.doppler
|
|
18176-8
|
Cardiac
echo
imaging
device
Vendor
model
number
|
|
18177-6
|
Cardiac
echo
imaging
device
Vendor
serial
number
|
|
18178-4
|
Left
ventricular
Wall
motion
index
by
US
|
|
18179-2
|
Left
ventricular
Wall
segment
[Identifier]
by
US
|
|
1818-4
|
Alpha
mannosidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18180-0
|
Deprecated
Albumin
|
|
18182-6
|
Osmolality
of
Serum
or
Plasma
by
calculation
|
|
18183-4
|
Melatonin
[Mass/time]
in
24
hour
Urine
|
|
18184-2
|
Erythrocyte
sedimentation
rate
by
2H
Westergren
method
|
|
18185-9
|
Gestational
age
|
|
18186-7
|
Calcium
[Mass/time]
in
12
hour
Urine
|
|
18187-5
|
Lorazepam
[Presence]
in
Urine
|
|
18188-3
|
Acebutolol
[Mass/volume]
in
Unspecified
specimen
|
|
18189-1
|
Acetone
[Mass/time]
in
24
hour
Urine
|
|
1819-2
|
Alpha
mannosidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18190-9
|
Acid
phosphatase
tartrate
resistant
[Presence]
in
Unspecified
specimen
|
|
18191-7
|
Amino
acids
[Identifier]
in
24
hour
Urine
|
|
18192-5
|
Bacteria
[Presence]
in
Nose
by
Light
microscopy
|
|
18194-1
|
Barium
[Mass/time]
in
24
hour
Urine
|
|
18195-8
|
Acid
beta
glucosidase
[Presence]
in
Tissue
|
|
18196-6
|
Beta-N-acetylhexosaminidase.A
[Presence]
in
Tissue
|
|
18197-4
|
Blastomyces
dermatitidis
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18198-2
|
Blastomyces
dermatitidis
IgE
Ab
[Presence]
in
Serum
|
|
18199-0
|
Blastomyces
dermatitidis
IgG
Ab
[Presence]
in
Serum
|
|
182-6
|
Cinoxacin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1820-0
|
Alpha
melanocyte
stimulating
hormone
[Mass/volume]
in
Serum
or
Plasma
|
|
18200-6
|
Blastomyces
dermatitidis
IgM
Ab
[Presence]
in
Serum
|
|
18201-4
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
18202-2
|
Borrelia
burgdorferi
IgA
Ab
[Presence]
in
Cerebral
spinal
fluid
by
Immunoblot
(IB)
|
|
18203-0
|
Borrelia
burgdorferi
IgG+IgM
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
18204-8
|
Caffeine
renal
clearance
in
24
hour
|
|
18205-5
|
Carbon
disulfide
[Presence]
in
Urine
|
|
18206-3
|
Catecholamines
[Mass/volume]
in
Plasma
--7th
specimen
post
XXX
challenge
|
|
18208-9
|
Cocaine
[Mass/volume]
in
Unspecified
specimen
|
|
18209-7
|
Coenzyme
Q10
[Units/volume]
in
Serum
or
Plasma
|
|
1821-8
|
Alpha
naphthylesterase
[Enzymatic
activity/volume]
in
Serum
|
|
18210-5
|
Complement
C1
esterase
inhibitor
bound
IgG
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18211-3
|
Complement
C1
esterase
inhibitor
bound
IgM
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18212-1
|
Complement
C1
esterase
inhibitor
free
IgG
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18213-9
|
Complement
C1
esterase
inhibitor
free
IgM
Ab
[Mass/volume]
in
Serum
or
Plasma
|
|
18214-7
|
Delta
5-Pregnanetriol
[Mass/volume]
in
Urine
|
|
18215-4
|
Delta
alanine
[Mass/volume]
in
Urine
|
|
18216-2
|
Dezocine
[Presence]
in
Urine
by
Confirmatory
method
|
|
18217-0
|
Epidermis
IgA
Ab
[Presence]
in
Tissue
|
|
18218-8
|
Epidermis
IgM
Ab
[Presence]
in
Tissue
|
|
18219-6
|
Epinephrine
[Mass/volume]
in
Urine
--2nd
specimen
post
XXX
challenge
|
|
1822-6
|
Alpha
thymosin
[Mass/volume]
in
Serum
|
|
18220-4
|
Epinephrine
[Mass/volume]
in
Urine
--3rd
specimen
post
XXX
challenge
|
|
18221-2
|
Epinephrine
[Mass/volume]
in
Urine
--4th
specimen
post
XXX
challenge
|
|
18222-0
|
Epinephrine
[Mass/volume]
in
Urine
--5th
specimen
post
XXX
challenge
|
|
18223-8
|
Epinephrine
[Mass/volume]
in
Urine
--6th
specimen
post
XXX
challenge
|
|
18224-6
|
Epinephrine
[Mass/volume]
in
Urine
--7th
specimen
post
XXX
challenge
|
|
18225-3
|
Erythrocyte
shape
[Morphology]
in
Blood
|
|
18226-1
|
Erythrocyte
size
[Morphology]
in
Blood
|
|
18227-9
|
Glucose
[Mass/time]
in
6
hour
Urine
|
|
18228-7
|
Glucose-6-Phosphate
dehydrogenase
[Presence]
in
Tissue
|
|
18229-5
|
Heparan
sulfate
[Presence]
in
Serum
or
Plasma
|
|
1823-4
|
Alpha
tocopherol
[Mass/volume]
in
Serum
or
Plasma
|
|
18230-3
|
Histone
H2a+H2b
Ab
[Units/volume]
in
Serum
|
|
18231-1
|
Histone
H2a+H2b
Ab
[Presence]
in
Serum
by
Immunofluorescence
|
|
18232-9
|
Hydrocorticosterone
[Presence]
in
Urine
|
|
18233-7
|
Influenza
virus
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18234-5
|
Insulin
[Presence]
in
Unknown
substance
|
|
18235-2
|
Ketone
solvents
[Identifier]
in
Blood
|
|
18236-0
|
Lead
[Presence]
in
Tissue
|
|
18237-8
|
Legionella
pneumophila
atypical
IgM
Ab
[Presence]
in
Serum
|
|
18238-6
|
Lithium
[Mass/mass]
in
Tissue
|
|
18239-4
|
Lupus
erythematosus
factor
[Mass/volume]
in
Blood
by
Latex
agglutination
|
|
1824-2
|
Alpha-1-Antichymotrypsin
[Mass/volume]
in
Serum
|
|
18240-2
|
1,3-Dichlorobenzene
[Mass/volume]
in
Blood
|
|
18241-0
|
Cefoxitin
IgE
Ab
[Units/volume]
in
Serum
|
|
18242-8
|
Methyprylon
[Mass/time]
in
24
hour
Urine
|
|
18243-6
|
Mycoplasma
pneumoniae
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18244-4
|
Niacin
[Mass/volume]
in
Serum
or
Plasma
|
|
18245-1
|
Nickel
[Mass/volume]
in
Unspecified
specimen
|
|
18246-9
|
Nitrogen
[Mass/volume]
in
Stool
|
|
18247-7
|
Nitrogen
[Mass/volume]
in
Dialysis
fluid
|
|
18248-5
|
Nordiazepam
[Mass/volume]
in
Stool
|
|
18249-3
|
Para
aminobenzoate
[Mass/volume]
in
Serum
or
Plasma
|
|
1825-9
|
Alpha
1
antitrypsin
[Mass/volume]
in
Serum
or
Plasma
|
|
18250-1
|
Pentacarboxylporphyrins
[Mass/volume]
in
Blood
|
|
18251-9
|
Polychlorinated
biphenyl
(PCB)
[Presence]
in
Tissue
|
|
18252-7
|
Prednisone
[Mass/time]
in
24
hour
Urine
|
|
18253-5
|
Serotonin
[Mass/time]
in
24
hour
Urine
|
|
18254-3
|
Silicate
[Mass/volume]
in
Body
fluid
|
|
18255-0
|
Sulfonylurea
[Mass/volume]
in
Serum
or
Plasma
|
|
18256-8
|
Sulfonylurea
[Mass/volume]
in
Urine
|
|
18257-6
|
Coproporphyrin
[Mass/volume]
in
Blood
|
|
18258-4
|
Trimethoprim
IgE
Ab
[Units/volume]
in
Serum
|
|
18259-2
|
Vasoactive
intestinal
peptide
[Mass/time]
in
24
hour
Urine
|
|
1826-7
|
Alpha
1
antitrypsin
MM
[Mass/volume]
in
Serum
or
Plasma
|
|
18260-0
|
Zinc
[Presence]
in
Tissue
|
|
18261-8
|
Cholesterol
in
LDL
[Mass/volume]
in
Serum
or
Plasma
ultracentrifugate
|
|
18262-6
|
Cholesterol
in
LDL
[Mass/volume]
in
Serum
or
Plasma
by
Direct
assay
|
|
18263-4
|
Cholesterol
in
HDL
[Mass/volume]
in
Serum
or
Plasma
ultracentrifugate
|
|
18264-2
|
Deprecated
Direct
bilirubin
[Mass/volume]
in
Serum
or
Plasma
|
|
18265-9
|
Acetaminophen
[Presence]
in
Body
fluid
|
|
18266-7
|
CD3+CD4+
(T4
helper)
cells/CD3+CD8+
(T8
suppressor
cells)
cells
[#
Ratio]
in
Body
fluid
|
|
18267-5
|
CD16+CD56+
cells/100
cells
in
Blood
|
|
18268-3
|
CD16+CD56+
cells/100
cells
in
Body
fluid
|
|
18269-1
|
Immune
complex
[Units/volume]
in
Body
fluid
|
|
1827-5
|
Alpha
1
antitrypsin
MS
[Mass/volume]
in
Serum
or
Plasma
|
|
18270-9
|
Carbamazepine
10,11-Epoxide
[Moles/volume]
in
Serum
or
Plasma
|
|
18271-7
|
Alpha
1
antitrypsin
fecal
clearance
in
24
hour
|
|
18272-5
|
RNA
Ab
[Units/volume]
in
Serum
|
|
18273-3
|
Blood
group
antibody
screen
[Presence]
in
Serum
or
Plasma
from
Blood
product
unit
|
|
18274-1
|
Blood
group
antibody
screen
[Presence]
in
Serum
or
Plasma
from
donor
|
|
18275-8
|
Blood
group
antigens
present
[Identifier]
on
Red
Blood
Cells
from
donor
|
|
18276-6
|
Blood
group
antigens
absent
[Identifier]
on
Red
Blood
Cells
from
donor
|
|
18277-4
|
Hemoglobin
F
[Presence]
in
Gastric
fluid
by
Apt-Downey
method
|
|
18278-2
|
Hemoglobin
F
[Presence]
in
Meconium
by
Apt-Downey
method
|
|
18279-0
|
Deprecated
Hemoglobin
F
[Presence]
in
Stool
by
Apt-Downey
method
|
|
1828-3
|
Alpha
1
antitrypsin
MZ
[Mass/volume]
in
Serum
or
Plasma
|
|
18280-8
|
Background
stain
[Presence]
in
Blood
by
Light
microscopy
|
|
18281-6
|
Calcium
[Moles/volume]
corrected
for
total
protein
in
Serum
or
Plasma
|
|
18282-4
|
Cannabinoids
[Presence]
in
Urine
by
Screen
method
|
|
18283-2
|
CD11
cells/100
cells
in
Blood
|
|
18284-0
|
CD198
cells/100
cells
in
Blood
|
|
18285-7
|
CDA
cells/100
cells
in
Blood
|
|
18286-5
|
Donath
Landsteiner
Ab
[Presence]
in
Blood
|
|
18287-3
|
Donath
Landsteiner
Ab
[Presence]
in
control
Serum
and
RBC
|
|
18288-1
|
Donath
Landsteiner
Ab
[Titer]
in
control
Serum
and
RBC
|
|
18289-9
|
Erythrocytes
[Morphology]
in
Cerebral
spinal
fluid
by
Light
microscopy
|
|
1829-1
|
Alpha
1
antitrypsin
SS
[Mass/volume]
in
Serum
or
Plasma
|
|
18290-7
|
Erythrocytes
[Morphology]
in
Synovial
fluid
by
Light
microscopy
|
|
18291-5
|
Hemoglobin
F/Hemoglobin.total
in
Blood
from
newborn
|
|
18292-3
|
Deprecated
Hemoglobin.fetal/Hemoglobin.total^post
amniocentesis
|
|
18293-1
|
Deprecated
Hemoglobin.fetal/Hemoglobin.total^post
partum
|
|
18294-9
|
Deprecated
Hemoglobin.fetal/Hemoglobin.total^pre
amniocentesis
|
|
18295-6
|
Deprecated
Hemoglobin.fetal/Hemoglobin.total^pre
partum
|
|
18296-4
|
Glucose
[Interpretation]
in
Serum
or
Plasma--post
dose
glucose
|
|
18297-2
|
Acid
hemolysis
[Mass/volume]
of
Red
Blood
Cells
|
|
18298-0
|
High
titer
low
avidity
Ab
[Presence]
in
Serum
or
Plasma
|
|
18299-8
|
IgA
[Presence]
in
Serum
by
Immunofixation
|
|
183-4
|
Cinoxacin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1830-9
|
Alpha
1
antitrypsin
SZ
[Mass/volume]
in
Serum
or
Plasma
|
|
18300-4
|
IgA
[Presence]
in
Urine
by
Immunofixation
|
|
18301-2
|
IgG
[Presence]
in
Serum
by
Immunofixation
|
|
18302-0
|
IgG
[Presence]
in
Urine
by
Immunofixation
|
|
18303-8
|
IgM
[Presence]
in
Serum
by
Immunofixation
|
|
18304-6
|
IgM
[Presence]
in
Urine
by
Immunofixation
|
|
18305-3
|
Amoeba
identified
in
Aspirate
by
Iron
hematoxylin
stain
|
|
18306-1
|
Hydatid
cyst
identified
in
Aspirate
by
Iron
hematoxylin
stain
|
|
18307-9
|
Ova
and
parasites
identified
in
Stool
by
Iron
hematoxylin
stain
|
|
18308-7
|
Pneumocystis
sp
identified
in
Lung
tissue
by
Immunohistochemical
|
|
18309-5
|
Nucleated
erythrocytes/100
leukocytes
[Ratio]
in
Blood
by
Manual
count
|
|
1831-7
|
Alpha
1
antitrypsin
ZZ
[Mass/volume]
in
Serum
or
Plasma
|
|
18310-3
|
Deprecated
Hemoglobin.other/Hemoglobin.total
[interpretation]
in
Blood
|
|
18311-1
|
Pelger
Huet
cells
[Presence]
in
Blood
by
Light
microscopy
|
|
18312-9
|
Platelet
satellitism
[Presence]
in
Blood
by
Light
microscopy
|
|
18313-7
|
Coagulation
of
Semen
by
Visual
observation
|
|
18314-5
|
Morphology
[Interpretation]
in
Blood
Narrative
|
|
18319-4
|
Neutrophils.vacuolated
[Presence]
in
Blood
by
Light
microscopy
|
|
1832-5
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Amniotic
fluid
|
|
18320-2
|
Globulin
[Mass/volume]
in
Urine
by
calculation
|
|
18321-0
|
Benzidine
[Mass/volume]
in
Serum
or
Plasma
|
|
18322-8
|
Norketamine
[Mass/volume]
in
Urine
|
|
18323-6
|
Smith
extractable
nuclear
IgG
Ab
[Units/volume]
in
Serum
|
|
18324-4
|
Cockatiel
serum
IgE
Ab
[Units/volume]
in
Serum
|
|
18325-1
|
Oxymorphone
[Presence]
in
Urine
by
Confirmatory
method
|
|
18326-9
|
Microscopic
observation
[Identifier]
in
Cervix
by
Other
stain
|
|
18327-7
|
Microscopic
observation
[Identifier]
in
Duodenal
fluid
by
Other
stain
|
|
18328-5
|
Microscopic
observation
[Identifier]
in
Body
fluid
by
Other
stain
|
|
18329-3
|
Neutrophil
cytoplasmic
IgA
Ab
[Units/volume]
in
Serum
|
|
1833-3
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18330-1
|
Neutrophil
cytoplasmic
IgG
Ab
[Units/volume]
in
Serum
|
|
18331-9
|
Neutrophil
cytoplasmic
IgM
Ab
[Units/volume]
in
Serum
|
|
18332-7
|
Thyroperoxidase
IgG
Ab
[Units/volume]
in
Serum
or
Plasma
|
|
18333-5
|
Echovirus
7
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18334-3
|
Naltrexone
[Presence]
in
Urine
by
Confirmatory
method
|
|
18335-0
|
Antihistamines
[Presence]
in
Urine
by
Confirmatory
method
|
|
18336-8
|
Methyl
tert-butyl
ether
[Mass/volume]
in
Blood
|
|
18337-6
|
Hydroxyitraconazole
[Mass/volume]
in
Serum
or
Plasma
|
|
18338-4
|
Nortramadol
[Mass/volume]
in
Urine
|
|
18339-2
|
Nortramadol
[Presence]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
1834-1
|
Alpha-1-Fetoprotein
[Mass/volume]
in
Serum
or
Plasma
|
|
18340-0
|
Nortramadol
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
18341-8
|
Propylene
glycol
[Mass/volume]
in
Urine
|
|
18342-6
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--3
hours
post
XXX
challenge
|
|
18343-4
|
6-Monoacetylmorphine
(6-MAM)
[Presence]
in
Serum
or
Plasma
by
Screen
method
|
|
18344-2
|
Beta-N-acetylhexosaminidase
[Enzymatic
activity/volume]
in
Platelets
|
|
18345-9
|
Protein
S
Ag/Coagulation
factor
VII
Ag
Ag
[Mass
Ratio]
in
Platelet
poor
plasma
by
Coagulation
assay
|
|
18346-7
|
Deprecated
Streptococcus
pneumoniae
56
IgG
Ab
[Units/volume]
in
Serum
|
|
18347-5
|
Streptococcus
pneumoniae
12
Ab
[Units/volume]
in
Serum
--2nd
specimen
|
|
18348-3
|
Toxoplasma
gondii
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18349-1
|
CD8+CD25+
cells
[#/volume]
in
Blood
|
|
1835-8
|
Alpha-2-Macroglobulin
[Mass/volume]
in
Serum
or
Plasma
|
|
18350-9
|
CD8+CD57+
cells
[#/volume]
in
Blood
|
|
18351-7
|
11-Deoxycortisol
[Mass/volume]
in
Serum
or
Plasma
--2nd
specimen
post
XXX
challenge
|
|
18352-5
|
Volume
of
4
hour
Urine
|
|
18353-3
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--6
hours
post
50
g
lactose
PO
|
|
18354-1
|
Glucose
[Mass/volume]
in
Serum
or
Plasma
--12
hours
post
50
g
lactose
PO
|
|
18355-8
|
Methylenedioxyamphetamine
[Mass/volume]
in
Urine
|
|
18356-6
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Serum
or
Plasma
|
|
18357-4
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Blood
|
|
18358-2
|
Methylenedioxymethamphetamine
[Mass/volume]
in
Urine
by
Confirmatory
method
|
|
18359-0
|
Methylenedioxyamphetamine
[Mass/volume]
in
Blood
|
|
1836-6
|
Alpha-2-Retinol
binding
protein
[Mass/volume]
in
Serum
or
Plasma
|
|
18360-8
|
8-Hydroxyamoxapine
[Mass/volume]
in
Urine
|
|
18361-6
|
Adenosine
monophosphate.cyclic/Creatinine
[Mass
Ratio]
in
Urine
|
|
18362-4
|
Alpha-2-Retinol
binding
protein
[Mass/time]
in
24
hour
Urine
|
|
18363-2
|
Carnitine
free
(C0)
[Units/mass]
in
Tissue
|
|
18364-0
|
Chondroitin
sulfate
[Mass/volume]
in
Serum
|
|
18365-7
|
Cortisol
Free
[Mass/volume]
in
Saliva
(oral
fluid)
|
|
18366-5
|
Cytochrome
C
oxidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18367-3
|
Iodine
Free
[Mass/volume]
in
Serum
or
Plasma
|
|
18368-1
|
Magnesium
[Moles/time]
in
2
hour
Urine
|
|
18369-9
|
Magnesium
[Moles/time]
in
4
hour
Urine
|
|
1837-4
|
Alpha-N-acetylglucosaminidase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
18370-7
|
Nitrite
[Mass/volume]
in
Blood
|
|
18371-5
|
Methyl
parathion
[Mass/volume]
in
Urine
|
|
18372-3
|
Potassium
[Moles/time]
in
6
hour
Urine
|
|
18373-1
|
Protein
[Mass/time]
in
6
hour
Urine
|
|
18374-9
|
Riboflavin
[Mass/volume]
in
24
hour
Urine
|
|
18375-6
|
Deprecated
Serotonin
[Mass/volume]
in
Urine
|
|
18376-4
|
Sodium
[Moles/time]
in
6
hour
Urine
|
|
18377-2
|
Sodium
[Moles/time]
in
12
hour
Urine
|
|
18378-0
|
Transcortin
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18379-8
|
Urate
[Mass/time]
in
6
hour
Urine
|
|
1838-2
|
Alpha-N-acetylglucosaminidase
[Enzymatic
activity/mass]
in
Tissue
|
|
18380-6
|
Uroporphyrinogen
decarboxylase
[Entitic
Catalytic
Activity]
in
Red
Blood
Cells
|
|
18381-4
|
Uroporphyrinogen
decarboxylase
[Enzymatic
activity/volume]
in
Blood
|
|
18382-2
|
Dry
weight
[Mass/time]
of
24
hour
Stool
|
|
18383-0
|
Alfentanil
[Presence]
in
Urine
|
|
18384-8
|
Butabarbital
[Mass/volume]
in
Serum
or
Plasma
by
Confirmatory
method
|
|
18385-5
|
Butalbital
[Presence]
in
Urine
by
Confirmatory
method
|
|
18386-3
|
Chlorothiazide
[Presence]
in
Serum
or
Plasma
|
|
18387-1
|
Diamorphine
[Mass/volume]
in
Serum
or
Plasma
|
|
18388-9
|
Diazepam
[Presence]
in
Urine
by
Confirmatory
method
|
|
18389-7
|
Methaqualone
[Presence]
in
Urine
by
Confirmatory
method
|
|
1839-0
|
Ammonia
[Moles/volume]
in
Blood
|
|
18390-5
|
Opiates
[Presence]
in
Urine
by
Confirmatory
method
|
|
18391-3
|
Paraldehyde
[Mass/volume]
in
Urine
|
|
18392-1
|
Phencyclidine
[Presence]
in
Urine
by
Confirmatory
method
|
|
18393-9
|
Quinidine+Quinine
[Presence]
in
Urine
|
|
18394-7
|
HLA-A24(9)
[Presence]
|
|
18395-4
|
Aspergillus
niger
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18396-2
|
HIV
1
p24
Ag
[Presence]
in
Serum
or
Plasma
by
Immunoassay
|
|
18397-0
|
Polio
virus
1
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
18398-8
|
Polio
virus
2
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
18399-6
|
Polio
virus
3
Ab
[Titer]
in
Cerebral
spinal
fluid
by
Complement
fixation
|
|
184-2
|
Ciprofloxacin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1840-8
|
Ammonia
[Moles/volume]
in
Cerebral
spinal
fluid
|
|
18400-2
|
Spermatozoa
IgA
Ab
[Units/volume]
in
Cervical
mucus
|
|
18401-0
|
Spermatozoa
IgG
Ab
[Units/volume]
in
Cervical
mucus
|
|
18402-8
|
Spermatozoa
IgA
Ab
[Units/volume]
in
Semen
|
|
18403-6
|
Spermatozoa
IgG
Ab
[Units/volume]
in
Semen
|
|
18404-4
|
Spermatozoa
IgM
Ab
[Units/volume]
in
Semen
|
|
18405-1
|
Arsenate
[Mass/volume]
in
Urine
|
|
18406-9
|
Arsenic
trioxide
[Mass/volume]
in
Urine
|
|
18407-7
|
Leukocytes
in
12
hour
Urine
sediment
by
Light
microscopy
|
|
18408-5
|
CD3+HLA-DR+
cells/100
cells
in
Blood
|
|
18409-3
|
Curvularia
lunata
IgG
Ab
[Units/volume]
in
Serum
|
|
1841-6
|
Ammonia
[Moles/volume]
in
Serum
|
|
18410-1
|
Epicoccum
purpurascens
IgG
Ab
[Units/volume]
in
Serum
|
|
18411-9
|
Rhizopus
nigricans
IgG
Ab
[Units/volume]
in
Serum
|
|
18412-7
|
Stemphylium
botryosum
IgG
Ab
[Units/volume]
in
Serum
|
|
18413-5
|
HLA-DR16
[Presence]
|
|
18414-3
|
Psilocin
[Presence]
in
Urine
|
|
18415-0
|
Psilocin
[Mass/volume]
in
Urine
|
|
18416-8
|
Aspergillus
nidulans
IgG
Ab
[Units/volume]
in
Serum
|
|
18417-6
|
Black
Bean
IgG
Ab
[Units/volume]
in
Serum
|
|
18418-4
|
Casein
IgA
Ab
[Units/volume]
in
Serum
|
|
18419-2
|
Cephalosporine
mold
IgG
Ab
[Units/volume]
in
Serum
|
|
1842-4
|
Ammonia
[Moles/volume]
in
Urine
|
|
18420-0
|
Chaetomium
globosum
IgG
Ab
[Units/volume]
in
Serum
|
|
18421-8
|
Fusarium
oxysporum
IgG
Ab
[Units/volume]
in
Serum
|
|
18422-6
|
Microcytes
[Presence]
in
Urine
by
Light
microscopy
|
|
18423-4
|
Phthalic
anhydride
IgG
Ab
[Units/volume]
in
Serum
|
|
18424-2
|
Phthalic
anhydride
IgM
Ab
[Units/volume]
in
Serum
|
|
18425-9
|
Zucchini
IgG
Ab
[Units/volume]
in
Serum
|
|
18426-7
|
Aspergillus
sp
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18427-5
|
Epstein
Barr
virus
early
Ab
[Presence]
in
Body
fluid
|
|
18428-3
|
Epstein
Barr
virus
nuclear
IgG
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18429-1
|
Rickettsia
rickettsii
IgG
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
1843-2
|
Ammonia
nitrogen
[Mass/time]
in
24
hour
Urine
|
|
18430-9
|
Rickettsia
rickettsii
IgM
Ab
[Units/volume]
in
Cerebral
spinal
fluid
|
|
18431-7
|
Amphetamines
[Presence]
in
Stool
by
Screen
method
|
|
18432-5
|
Tetrahydrocannabinol
[Presence]
in
Stool
by
Screen
method
|
|
18433-3
|
Deprecated
1,3-Dichlorobenzene
[Mass/volume]
in
Blood
|
|
18434-1
|
1,2-Dichlorobenzene
[Mass/volume]
in
Blood
|
|
18435-8
|
Sufentanil
[Presence]
in
Urine
|
|
18436-6
|
Acetylcarnitine
(C2)
[Mass/volume]
in
Serum
or
Plasma
|
|
18437-4
|
Acrylylcarnitine
(C3:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18438-2
|
Propionylcarnitine
(C3)
[Mass/volume]
in
Serum
or
Plasma
|
|
18439-0
|
Butyrylcarnitine
(C4)
[Mass/volume]
in
Serum
or
Plasma
|
|
1844-0
|
Ammonium
ion
[Moles/volume]
in
Arterial
blood
|
|
18440-8
|
Crotonylcarnitine
(C4:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18441-6
|
Isovalerylcarnitine
(C5)
[Mass/volume]
in
Serum
or
Plasma
|
|
18442-4
|
3-Hydroxybutyrylcarnitine
(C4-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
18443-2
|
Hexanoylcarnitine
(C6)
[Mass/volume]
in
Serum
or
Plasma
|
|
18444-0
|
3-Hydroxyisovalerylcarnitine
(C5-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
18445-7
|
Benzoylcarnitine
(BzCn)
[Mass/volume]
in
Serum
or
Plasma
|
|
18446-5
|
Methylmalonylcarnitine
(C4-DC)
[Mass/volume]
in
Serum
or
Plasma
|
|
18447-3
|
Octenoylcarnitine
(C8:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18448-1
|
Octanoylcarnitine
(C8)
[Mass/volume]
in
Serum
or
Plasma
|
|
18449-9
|
Glutarylcarnitine
(C5-DC)
[Mass/volume]
in
Serum
or
Plasma
|
|
1845-7
|
Ammonium
ion
[Moles/volume]
in
Plasma
|
|
18450-7
|
Adipoylcarnitine
(C6-DC)
[Mass/volume]
in
Serum
or
Plasma
|
|
18451-5
|
cis-4-Decenoylcarnitine
(Cis
4
C10:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18452-3
|
Decanoylcarnitine
(C10)
[Mass/volume]
in
Serum
or
Plasma
|
|
18453-1
|
Suberylcarnitine
(C8-DC)
[Mass/volume]
in
Serum
or
Plasma
|
|
18454-9
|
Dodecenoylcarnitine
(C12:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18455-6
|
Dodecanoylcarnitine
(C12)
[Mass/volume]
in
Serum
or
Plasma
|
|
18456-4
|
Tetradecadienoylcarnitine
(C14:2)
[Mass/volume]
in
Serum
or
Plasma
|
|
18457-2
|
Tetradecenoylcarnitine
(C14:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18458-0
|
3-Hydroxytetradecadienoylcarnitine
(C14:2-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
18459-8
|
3-Hydroxytetradecenoylcarnitine
(C14:1-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
1846-5
|
Amylo-alpha-1,6-glucosidase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
18460-6
|
Palmitoylcarnitine
(C16)
[Mass/volume]
in
Serum
or
Plasma
|
|
18461-4
|
3-Hydroxypalmitoylcarnitine
(C16-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
18462-2
|
Linoleoylcarnitine
(C18:2)
[Mass/volume]
in
Serum
or
Plasma
|
|
18463-0
|
Oleoylcarnitine
(C18:1)
[Mass/volume]
in
Serum
or
Plasma
|
|
18464-8
|
3-Hydroxylinoleoylcarnitine
(C18:2-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
18465-5
|
3-Hydroxyoleoylcarnitine
(C18:1-OH)
[Mass/volume]
in
Serum
or
Plasma
|
|
18466-3
|
Dicarboxyoleylcarnitine
(C18:1-DC)
[Mass/volume]
in
Serum
or
Plasma
|
|
18467-1
|
Venlafaxine
[Mass/volume]
in
Urine
|
|
18468-9
|
Aspergillus
fumigatus
Ab
[Presence]
in
Cerebral
spinal
fluid
|
|
18469-7
|
Methyclothiazide
[Mass/volume]
in
Serum
or
Plasma
|
|
1847-3
|
Amyloid
associated
protein
[Mass/volume]
in
Serum
|
|
18470-5
|
Norclomipramine
[Mass/volume]
in
Urine
|
|
18471-3
|
Metoclopramide
[Mass/volume]
in
Urine
|
|
18472-1
|
Organophosphate
pesticides
[Identifier]
in
Urine
|
|
18473-9
|
Hydromorphone
[Presence]
in
Urine
by
Confirmatory
method
|
|
18474-7
|
HER2
Ag
[Presence]
in
Tissue
by
Immune
stain
|
|
18475-4
|
Phenylalanine/Creatinine
[Molar
ratio]
in
Urine
|
|
18476-2
|
Uroporphyrinogen
decarboxylase
[Presence]
in
Red
Blood
Cells
|
|
18477-0
|
Lithium
[Moles/time]
in
24
hour
Urine
|
|
18478-8
|
Human
papilloma
virus
16+18
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
18479-6
|
Human
papilloma
virus
31+35+51
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
1848-1
|
Androstanolone
[Mass/volume]
in
Serum
or
Plasma
|
|
18480-4
|
Human
papilloma
virus
6+11
DNA
[Presence]
in
Tissue
by
DNA
probe
|
|
18481-2
|
Streptococcus
pyogenes
Ag
[Presence]
in
Throat
|
|
18482-0
|
Yeast
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
18483-8
|
Yeast
[Presence]
in
Genital
specimen
by
Organism
specific
culture
|
|
18484-6
|
Ku
Ab
[Presence]
in
Serum
|
|
18485-3
|
Mi-2
Ab
[Presence]
in
Serum
|
|
18486-1
|
Methylenediamine
[Presence]
in
Urine
|
|
18487-9
|
Broad
casts
[#/area]
in
Urine
sediment
by
Microscopy
low
power
field
|
|
18488-7
|
Calcium
[Mass/volume]
in
24
hour
Urine
|
|
18489-5
|
Valproate.protein
bound
[Mass/volume]
in
Serum
or
Plasma
|
|
1849-9
|
Androstanolone
[Mass/volume]
in
Semen
|
|
18490-3
|
Chlamydia
trachomatis
G+F+K
IgA
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
18491-1
|
Chlamydia
trachomatis
G+F+K
IgG
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
18492-9
|
Chlamydia
trachomatis
G+F+K
IgM
Ab
[Titer]
in
Serum
by
Immunofluorescence
|
|
18493-7
|
Ova
and
parasites
identified
in
Stool
by
Concentration--3rd
specimen
|
|
18494-5
|
Ova
and
parasites
identified
in
Stool
by
Concentration--2nd
specimen
|
|
18495-2
|
Ova
and
parasites
identified
in
Stool
by
Trichrome
stain--3rd
specimen
|
|
18496-0
|
Ova
and
parasites
identified
in
Stool
by
Trichrome
stain--2nd
specimen
|
|
18497-8
|
Microscopic
observation
[Identifier]
in
Thyroid
fine
needle
aspirate
by
Cyto
stain
|
|
18498-6
|
Microscopic
observation
[Identifier]
in
Breast
fine
needle
aspirate
by
Cyto
stain
|
|
18499-4
|
Microscopic
observation
[Identifier]
in
Nipple
discharge
by
Cyto
stain
|
|
185-9
|
Ciprofloxacin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1850-7
|
Androstanediol
[Mass/volume]
in
Urine
|
|
18500-9
|
Microscopic
observation
[Identifier]
in
Cervix
by
Cyto
stain.thin
prep
|
|
18501-7
|
Microscopic
observation
[Identifier]
in
Buccal
smear
by
Cyto
stain
|
|
18502-5
|
Microscopic
observation
[Identifier]
in
Deep
tissue
fine
needle
aspirate
by
Cyto
stain
|
|
18503-3
|
Microscopic
observation
[Identifier]
in
Superficial
tissue
fine
needle
aspirate
by
Cyto
stain
|
|
18504-1
|
PP
interval
mean
|
|
18505-8
|
R-R
interval
(Mean
value
during
study)
by
EKG
|
|
18506-6
|
P
wave
axis
horizontal
plane
Reference
beat
|
|
18507-4
|
QRS
axis.horizontal
plane
Reference
beat
|
|
18508-2
|
R
wave
axis.horizontal
plane
|
|
18509-0
|
T
wave
axis.horizontal
plane
Reference
beat
|
|
1851-5
|
Androstenedione
[Mass/volume]
in
Amniotic
fluid
|
|
18510-8
|
ST
segment
axis.horizontal
plane
|
|
18511-6
|
P
wave
onset
[Time]
Reference
beat
|
|
18512-4
|
P
wave
offset
[Time]
Reference
beat
|
|
18513-2
|
QRS
onset
[Time]
Reference
beat
|
|
18514-0
|
QRS
offset
[Time]
Reference
beat
|
|
18515-7
|
T
wave
offset
[Time]
Reference
beat
|
|
18516-5
|
P
wave
axis
frontal
plane
Reference
beat
|
|
18517-3
|
QRS
axis.frontal
plane
Reference
beat
|
|
18518-1
|
T
wave
axis.frontal
plane
Reference
beat
|
|
18519-9
|
Reference
beat
|
|
1852-3
|
Androstenedione
[Mass/volume]
in
Capillary
blood
|
|
18520-7
|
P-R
Interval
Lead
AVF
|
|
18521-5
|
P-R
Interval
Lead
AVL
|
|
18522-3
|
P-R
Interval
Lead
AVR
|
|
18523-1
|
P-R
Interval
Lead
I
|
|
18524-9
|
P-R
Interval
Lead
II
|
|
18525-6
|
P-R
Interval
Lead
III
|
|
18526-4
|
P-R
Interval
Lead
V1
|
|
18527-2
|
P-R
Interval
Lead
V2
|
|
18528-0
|
P-R
Interval
Lead
V3
|
|
18529-8
|
P-R
Interval
Lead
V4
|
|
1853-1
|
Androstenedione
[Mass/volume]
in
Semen
|
|
18530-6
|
P-R
Interval
Lead
V5
|
|
18531-4
|
P-R
Interval
Lead
V6
|
|
18532-2
|
Q-T
interval
Lead
AVF
|
|
18533-0
|
Q-T
interval
Lead
AVL
|
|
18534-8
|
Q-T
interval
Lead
AVR
|
|
18535-5
|
Q-T
interval
Lead
I
|
|
18536-3
|
Q-T
interval
Lead
II
|
|
18537-1
|
Q-T
interval
Lead
III
|
|
18538-9
|
Q-T
interval
Lead
V1
|
|
18539-7
|
Q-T
interval
Lead
V2
|
|
1854-9
|
Androstenedione
[Mass/volume]
in
Serum
or
Plasma
|
|
18540-5
|
Q-T
interval
Lead
V3
|
|
18541-3
|
Q-T
interval
Lead
V4
|
|
18542-1
|
Q-T
interval
Lead
V5
|
|
18543-9
|
Q-T
interval
Lead
V6
|
|
18544-7
|
ST
amplitude.J
point+20
ms
Lead
AVF
|
|
18545-4
|
ST
amplitude.J
point+20
ms
Lead
AVL
|
|
18546-2
|
ST
amplitude.J
point+20
ms
Lead
AVR
|
|
18547-0
|
ST
amplitude.J
point+20
ms
Lead
I
|
|
18548-8
|
ST
amplitude.J
point+20
ms
Lead
II
|
|
18549-6
|
ST
amplitude.J
point+20
ms
Lead
III
|
|
1855-6
|
Androstenedione
[Mass/volume]
in
Urine
|
|
18550-4
|
ST
amplitude.J
point+20
ms
Lead
V1
|
|
18551-2
|
ST
amplitude.J
point+20
ms
Lead
V2
|
|
18552-0
|
ST
amplitude.J
point+20
ms
Lead
V3
|
|
18553-8
|
ST
amplitude.J
point+20
ms
Lead
V4
|
|
18554-6
|
ST
amplitude.J
point+20
ms
Lead
V5
|
|
18555-3
|
ST
amplitude.J
point+20
ms
Lead
V6
|
|
18556-1
|
ST
amplitude.J
point+60
ms
Lead
AVF
|
|
18557-9
|
ST
amplitude.J
point+60
ms
Lead
AVL
|
|
18558-7
|
ST
amplitude.J
point+60
ms
Lead
AVR
|
|
18559-5
|
ST
amplitude.J
point+60
ms
Lead
I
|
|
1856-4
|
Androsterone
[Mass/volume]
in
Serum
or
Plasma
|
|
18560-3
|
ST
amplitude.J
point+60
ms
Lead
II
|
|
18561-1
|
ST
amplitude.J
point+60
ms
Lead
III
|
|
18562-9
|
ST
amplitude.J
point+60
ms
Lead
V1
|
|
18563-7
|
ST
amplitude.J
point+60
ms
Lead
V2
|
|
18564-5
|
ST
amplitude.J
point+60
ms
Lead
V3
|
|
18565-2
|
ST
amplitude.J
point+60
ms
Lead
V4
|
|
18566-0
|
ST
amplitude.J
point+60
ms
Lead
V5
|
|
18567-8
|
ST
amplitude.J
point+60
ms
Lead
V6
|
|
18568-6
|
ST
amplitude.J
point+80
ms
Lead
AVF
|
|
18569-4
|
ST
amplitude.J
point+80
ms
Lead
AVL
|
|
1857-2
|
Angiotensin
converting
enzyme
[Enzymatic
activity/volume]
in
Blood
|
|
18570-2
|
ST
amplitude.J
point+80
ms
Lead
AVR
|
|
18571-0
|
ST
amplitude.J
point+80
ms
Lead
I
|
|
18572-8
|
ST
amplitude.J
point+80
ms
Lead
II
|
|
18573-6
|
ST
amplitude.J
point+80
ms
Lead
III
|
|
18574-4
|
ST
amplitude.J
point+80
ms
Lead
V1
|
|
18575-1
|
ST
amplitude.J
point+80
ms
Lead
V2
|
|
18576-9
|
ST
amplitude.J
point+80
ms
Lead
V3
|
|
18577-7
|
ST
amplitude.J
point+80
ms
Lead
V4
|
|
18578-5
|
ST
amplitude.J
point+80
ms
Lead
V5
|
|
18579-3
|
ST
amplitude.J
point+80
ms
Lead
V6
|
|
1858-0
|
Angiotensin
I
[Mass/volume]
in
Plasma
|
|
18580-1
|
Ambulance
transport,
Origination
site
|
|
18581-9
|
Ambulance
transport,
Origination
site
Address
|
|
18582-7
|
Ambulance
transport,
Destination
site
Name
|
|
18583-5
|
Ambulance
transport,
Destination
site
Address
|
|
18584-3
|
Body
weight
at
ambulance
transport
Set
|
|
18588-4
|
Ambulance
transport,
Purpose
of
stretcher
(narrative)
|
|
18589-2
|
Ambulance
transport,
Admitted
at
destination
facility
|
|
1859-8
|
Angiotensin
II
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18591-8
|
Confined
to
bed
before
ambulance
transport
|
|
18592-6
|
Confined
to
bed
after
ambulance
transport
|
|
18593-4
|
Ambulance
transport,
Discharged
from
origin
institution
|
|
18594-2
|
Psychiatric
service
attachment
|
|
18598-3
|
Control
number
identification.claims
attachment
|
|
186-7
|
Ciprofloxacin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1860-6
|
Angiotensin
II
[Mass/volume]
in
Plasma
|
|
18600-7
|
Primary
practitioner
identifier
|
|
18601-5
|
Primary
practitioner
profession
|
|
18602-3
|
ED
practitioner
identifier
|
|
18605-6
|
Medication
current
Set
|
|
18606-4
|
Current
medication,
Name
and
Identifier
|
|
18607-2
|
Current
medication
Dose
|
|
18608-0
|
Current
medication,
Timing
+
Quantity
|
|
18609-8
|
Current
medication,
Route
|
|
1861-4
|
Angiotensinogen
[Mass/volume]
in
Plasma
|
|
18610-6
|
Medication
administered
Set
|
|
18611-4
|
Administered
medication,
Name
and
Identifier
|
|
18612-2
|
Administered
medication,
Route
|
|
18614-8
|
Administered
medication,
Timing
|
|
18615-5
|
Medication
administered
Dose
|
|
18616-3
|
Administered
medication,
Strength
|
|
18617-1
|
Medication
discharge
Set
|
|
18618-9
|
Discharge
medication,
Name
and
Identifier
|
|
18619-7
|
Discharge
medication
Dose
|
|
1862-2
|
Aniline
[Mass/volume]
in
Serum
or
Plasma
|
|
18620-5
|
Discharge
medication,
Timing
+
Quantity
|
|
18621-3
|
Discharge
medication,
Route
|
|
18622-1
|
Discharge
medication,
Amount
dispensed
|
|
18623-9
|
Discharge
medication,
Refills
|
|
18624-7
|
ED
problem
(narrative)
|
|
18626-2
|
Psychiatric
rehabilitation
treatment
plan,
New/revised
|
|
18627-0
|
Psychiatric
rehabilitation
treatment
plan,
Date
onset
or
exacerbation
of
primary
diagnosis
|
|
18628-8
|
Deprecated
Psychiatric
rehabilitation
treatment
plan,
start
date
|
|
18629-6
|
Deprecated
Clinical
discipline
-
Psychiatric
rehabilitation
treatment
plan
|
|
1863-0
|
Anion
gap
4
in
Serum
or
Plasma
|
|
18630-4
|
Primary
diagnosis
|
|
18631-2
|
Psychiatric
rehabilitation
treatment
plan,
Diagnosis
addressed
by
plan
Set
|
|
18632-0
|
Psychiatric
rehabilitation
treatment
plan,
Author
of
treatment
plan
Set
|
|
18633-8
|
Psychiatric
rehabilitation
treatment
plan,
Author
name
|
|
18634-6
|
Psychiatric
rehabilitation
treatment
plan,
Author
profession
Identifier
|
|
18635-3
|
Psychiatric
rehabilitation
treatment
plan,
Signature
date
Date
and
time
|
|
18637-9
|
Psychiatric
rehabilitation
treatment
plan,
Visit
frequency
TQ2
|
|
18638-7
|
Psychiatric
rehabilitation
treatment
plan,
Visit
duration
Time
|
|
18639-5
|
Psychiatric
rehabilitation
treatment
plan,
Date
range
(from/through)
described
by
plan
Set
|
|
1864-8
|
Anserine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18640-3
|
Psychiatric
rehabilitation
treatment
plan,
Start
date
|
|
18641-1
|
Psychiatric
rehabilitation
treatment
plan,
End
date
|
|
18642-9
|
Psychiatric
rehabilitation
treatment
plan,
Date
range
(from/through)
Set
|
|
18643-7
|
Psychiatric
rehabilitation
treatment
plan,
Start
date
of
hospitalization
leading
to
treatment
|
|
18644-5
|
Psychiatric
rehabilitation
treatment
plan,
End
date
of
hospitalization
leading
to
treatment
|
|
18645-2
|
Psychiatric
rehabilitation
treatment
plan,
Continuation
status
|
|
18646-0
|
Psychiatric
rehabilitation
treatment
plan,
Date
attending
MD
referred
patient
for
Date
|
|
18647-8
|
Psychiatric
rehabilitation
treatment
plan,
Date
attending
MD
signed
Date
and
time
|
|
18648-6
|
Psychiatric
rehabilitation
treatment
plan,
Date
rehabilitation
professional
signed
Date
and
time
|
|
18649-4
|
Psychiatric
rehabilitation
treatment
plan,
Signature
of
responsible
attending
physician
on
file
|
|
1865-5
|
Anserine
[Presence]
in
Serum
or
Plasma
|
|
18650-2
|
Psychiatric
rehabilitation
treatment
plan,
Signature
of
responsible
rehabilitation
professional
on
file
|
|
18651-0
|
Psychiatric
rehabilitation
treatment
plan,
Medication
administered
Set
|
|
18652-8
|
Psychiatric
rehabilitation
treatment
plan,
Prognosis
for
rehabilitation
|
|
18653-6
|
Psychiatric
rehabilitation
treatment
plan,
Estimated
date
of
completion
Date
|
|
18654-4
|
Psychiatric
rehabilitation
treatment
plan,
Date
of
last
plan
of
treatment
certification
|
|
18655-1
|
Psychiatric
rehabilitation
treatment
plan,
Past
medical
history
and
Level
of
function
(narrative)
|
|
18656-9
|
Psychiatric
rehabilitation
treatment
plan
Initial
evaluation
note
(narrative)
|
|
18657-7
|
Psychiatric
rehabilitation
treatment
plan,
Plan
of
treatment
(narrative)
|
|
18658-5
|
Psychiatric
rehabilitation
treatment
plan
Progress
note
and
attainment
of
goals
(narrative)
|
|
18659-3
|
Psychiatric
rehabilitation
treatment
plan,
Reason
to
continue
(narrative)
|
|
1866-3
|
Anserine
[Mass/volume]
in
Serum
or
Plasma
|
|
18660-1
|
Psychiatric
rehabilitation
treatment
plan,
Justification
(narrative)
|
|
18661-9
|
Psychiatric
rehabilitation
treatment
plan,
Psychiatric
symptoms
(narrative)
|
|
18662-7
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
Chief
complaint+Reason
for
referral+Reason
for
relapse
if
known
(narrative)
|
|
18663-5
|
Alcohol-substance
abuse,
rehabilitation
plan,
History
of
present
alcohol/substance
abuse
(narrative)
|
|
18664-3
|
Rehabilitation
treatment
plan,
Follow-up
approach
Set
|
|
18665-0
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
Agency
that
will
follow
up
Identifier
|
|
18666-8
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
Person
that
will
follow
up
after
Identifier
|
|
18667-6
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
Methodology
for
follow
up
(narrative)
Text
|
|
18668-4
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
Frequency
of
assessments
for
follow
up
#
|
|
18669-2
|
Rehabilitation
treatment
plan,
Level
of
patient
participation
Text
|
|
1867-1
|
Anserine
[Mass/volume]
in
Urine
|
|
18670-0
|
Rehabilitation
treatment
plan,
Date
of
next
planned
rehabilitation
treatment
Set
|
|
18671-8
|
Psychiatric
rehabilitation
treatment
plan,
Next
plan
of
treatment
(narrative)
Text
|
|
18672-6
|
Alcohol
or
substance
abuse
symptoms
with
physiological
dependence
indicator
|
|
18673-4
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
rehabilitation
problem
remission
status
|
|
18674-2
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
longest
period
of
sobriety
for
abused
substance
(composite)
|
|
18675-9
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
abused
substance
|
|
18676-7
|
Alcohol-substance
abuse
rehabilitation
treatment
plan,
longest
period
of
sobriety
|
|
18677-5
|
Service
claims
attachment
|
|
18679-1
|
ED
claims
attachment
(composite)
|
|
1868-9
|
Antithrombin
Ag
[Mass/volume]
in
Platelet
poor
plasma
by
Immunologic
method
|
|
18682-5
|
Ambulance
claims
attachment
|
|
18684-1
|
First
Blood
pressure
Set
|
|
18685-8
|
First
Blood
pressure
special
circumstances
|
|
18686-6
|
First
Respiration
rate
Set
|
|
18687-4
|
First
Respiration
rate
special
circumstances
|
|
18688-2
|
First
Body
temperature
Set
|
|
18689-0
|
First
Body
temperature
special
circumstances
|
|
1869-7
|
Apolipoprotein
A-I
[Mass/volume]
in
Serum
or
Plasma
|
|
18690-8
|
First
Body
weight
Set
|
|
18692-4
|
First
Body
weight
special
circumstances
|
|
18693-2
|
ED
consultant
practitioner
Set
|
|
18694-0
|
ED
consultant
practitioner
name
|
|
18695-7
|
ED
clinical
finding
type
|
|
18696-5
|
ED
clinical
finding
(narrative)
|
|
18697-3
|
ED
clinical
finding
data
source
|
|
18698-1
|
ED
clinical
finding
(composite)
|
|
18699-9
|
ED
practitioner
Set
|
|
187-5
|
Ciprofloxacin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1870-5
|
Apolipoprotein
A-II
[Mass/volume]
in
Serum
or
Plasma
|
|
18700-5
|
ED
practitioner
name
|
|
18701-3
|
ED
practitioner
profession
|
|
18702-1
|
ED
practitioner
role
|
|
18703-9
|
ED
diagnostic
procedure
results
Set
|
|
18704-7
|
ED
referring
practitioner
Set
|
|
18705-4
|
ED
referring
practitioner
name
|
|
18706-2
|
ED
referring
practitioner
identifier
|
|
18707-0
|
ED
referring
practitioner
profession
|
|
18708-8
|
First
Heart
rate
Set
|
|
18709-6
|
First
Heart
rate
special
circumstances
|
|
1871-3
|
Apolipoprotein
B-100
[Mass/volume]
in
Serum
or
Plasma
|
|
18710-4
|
Primary
practitioner
Set
|
|
18711-2
|
Primary
practitioner
name
|
|
18716-1
|
Allergy
studies
(set)
|
|
18717-9
|
Blood
bank
studies
(set)
|
|
18718-7
|
Cell
marker
studies
(set)
|
|
18719-5
|
Chemistry
studies
(set)
|
|
1872-1
|
Apolipoprotein
B-150
[Mass/volume]
in
Serum
or
Plasma
|
|
18720-3
|
Coagulation
studies
(set)
|
|
18721-1
|
Therapeutic
drug
monitoring
studies
(set)
|
|
18722-9
|
Fertility
studies
(set)
|
|
18723-7
|
Hematology
studies
(set)
|
|
18724-5
|
HLA
studies
(set)
|
|
18725-2
|
Microbiology
studies
(set)
|
|
18726-0
|
Radiology
studies
(set)
|
|
18727-8
|
Serology
studies
(set)
|
|
18728-6
|
Toxicology
studies
(set)
|
|
18729-4
|
Urinalysis
studies
(set)
|
|
1873-9
|
Apolipoprotein
B-48
[Mass/volume]
in
Serum
or
Plasma
|
|
18730-2
|
Psychiatric
rehabilitation
treatment
plan,
Author
ID
Identifier
|
|
18733-6
|
Physician
attending
Progress
note
|
|
18734-4
|
Occupational
therapy
Initial
evaluation
note
|
|
18735-1
|
Physical
therapy
Initial
evaluation
note
|
|
18736-9
|
Physician
Initial
evaluation
note
|
|
18737-7
|
Podiatry
Initial
evaluation
note
|
|
18738-5
|
Psychology
Initial
evaluation
note
|
|
18739-3
|
Social
work
Initial
evaluation
note
|
|
1874-7
|
Apolipoprotein
B/Apolipoprotein
A-I
[Mass
Ratio]
in
Serum
or
Plasma
|
|
18740-1
|
Speech-language
pathology
Initial
evaluation
note
|
|
18741-9
|
Deprecated
Attending
physician
progress
note
|
|
18742-7
|
Arthroscopy
study
|
|
18743-5
|
Autopsy
report
|
|
18744-3
|
Bronchoscopy
study
|
|
18745-0
|
Cardiac
catheterization
study
|
|
18746-8
|
Colonoscopy
Study
|
|
18747-6
|
Deprecated
CT
Unspecified
system
Study
|
|
18748-4
|
Diagnostic
imaging
study
|
|
18749-2
|
Electromyogram
study
|
|
1875-4
|
Apolipoprotein
C-I
[Mass/volume]
in
Serum
or
Plasma
|
|
18750-0
|
Electrophysiology
study
|
|
18751-8
|
Endoscopy
study
|
|
18752-6
|
Exercise
stress
test
study
|
|
18753-4
|
Flexible
sigmoidoscopy
study
|
|
18754-2
|
Holter
monitor
study
|
|
18755-9
|
Deprecated
MRI
Unspecified
site
study
|
|
18756-7
|
MR
Spine
study
|
|
18757-5
|
Deprecated
Nuclear
medicine
study
|
|
18758-3
|
Deprecated
PET
scan
Unspecified
system
Study
|
|
18759-1
|
Spirometry
study
|
|
1876-2
|
Apolipoprotein
C-II
[Mass/volume]
in
Serum
or
Plasma
|
|
18760-9
|
Deprecated
US
Unspecified
system
Study
|
|
18761-7
|
Provider-unspecified
Transfer
summary
|
|
18762-5
|
Deprecated
Chiropractor
Progress
note
|
|
18763-3
|
Physician
consulting
Initial
evaluation
note
|
|
18764-1
|
Deprecated
Nurse
practitioner
Progress
note
|
|
18765-8
|
Deprecated
Podiatry
visit
note
|
|
18766-6
|
Deprecated
Psychology
visit
note
|
|
18767-4
|
Blood
gas
studies
(set)
|
|
18768-2
|
Cell
counts+Differential
studies
(set)
|
|
18769-0
|
Microbial
susceptibility
tests
Set
|
|
1877-0
|
Apolipoprotein
C-III
[Mass/volume]
in
Serum
or
Plasma
|
|
18770-8
|
Dictating
practitioner
name
|
|
18771-6
|
Provider
signing
name
|
|
18772-4
|
Surgeon.resident
name
|
|
18773-2
|
Surgeon.staff
name
|
|
18774-0
|
Staff
practitioner
name
|
|
18775-7
|
Staff
practitioner
identifier
|
|
18776-5
|
Plan
of
care
|
|
18777-3
|
Psychiatric
rehabilitation
treatment
plan,
Primary
diagnosis
(narrative)
|
|
18779-9
|
Radiology
Comparison
study
-
date
and
time
|
|
1878-8
|
Apolipoprotein
A-III
[Mass/volume]
in
Serum
or
Plasma
|
|
18780-7
|
Ordering
practitioner
identifier
|
|
18781-5
|
Ordering
practitioner
name
|
|
18782-3
|
Radiology
Study
observation
(narrative)
|
|
18783-1
|
Radiology
Study
recommendation
(narrative)
|
|
18785-6
|
Radiology
Reason
for
study
(narrative)
|
|
18789-8
|
Include
all
data
of
the
selected
type
within
the
date
window
associated
with
the
service
|
|
1879-6
|
Apolipoprotein
E2
[Mass/volume]
in
Serum
or
Plasma
|
|
18790-6
|
Include
all
data
of
the
selected
type
on
or
before
the
date
of
service
|
|
18791-4
|
Include
all
data
of
the
selected
type
within
or
aligned
to
an
encounter
by
the
same
service
or
encounter
|
|
18792-2
|
Include
all
data
of
the
selected
type
on
or
after
the
date
of
service
|
|
18793-0
|
Use
no
fixed
time
limit
on
data
(any
of
the
selected
type
are
relevant
no
matter
when
obtained)
|
|
18794-8
|
Send
all
items
of
the
specified
type
within
the
time
window
|
|
18795-5
|
Send
all
items
of
the
specified
type
within
the
time
window
relevant
to
the
service
|
|
18796-3
|
Send
all
abnormals
within
the
time
window
|
|
18797-1
|
Send
the
first
abnormals
within
the
time
window
|
|
18798-9
|
Send
the
last
abnormals
within
the
time
window
|
|
18799-7
|
Send
the
first
(i.e.,
oldest)
result
for
each
kind
of
observation
in
the
time
window
|
|
188-3
|
Clarithromycin
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
1880-4
|
Beta
2
glycoprotein
1
[Mass/volume]
in
Serum
or
Plasma
|
|
18800-3
|
Send
the
worst
abnormal
result
for
each
kind
of
observation
in
the
time
window
|
|
18802-9
|
Send
the
last
(most
recent)
within
the
time
window
|
|
18803-7
|
Include
all
data
of
the
selected
type
that
represents
observations
made
30
days
or
fewer
before
the
starting
date
of
service
|
|
18804-5
|
Include
all
data
of
the
selected
type
that
represents
observations
made
3
months
or
fewer
before
the
starting
date
of
service
|
|
18805-2
|
Include
all
data
of
the
selected
type
that
represents
observations
made
six
months
or
fewer
before
the
starting
date
of
service
|
|
18806-0
|
Include
all
data
of
the
selected
type
that
represents
observations
made
nine
months
or
fewer
before
the
starting
date
of
service
|
|
18807-8
|
Include
all
data
of
the
selected
type
that
represents
observations
made
one
year
or
less
before
the
starting
date
of
service
|
|
1881-2
|
Apolipoprotein
LPA
[Mass/volume]
in
Serum
or
Plasma
|
|
18810-2
|
EKG
Study
observation
overall
(narrative)
|
|
18812-8
|
Ambulance
transport,
Ordering
practitioner
Identifier
|
|
18813-6
|
Ambulance
transport,
Ordering
practitioner
name
|
|
18814-4
|
Ambulance
transport,
Reason
for
scheduled
trip
|
|
18815-1
|
Ambulance
transport,
Reason
for
scheduled
trip
additional
service
information
(narrative)
|
|
18816-9
|
Medication
name
+
identifier
|
|
18817-7
|
Medication
dose
|
|
18818-5
|
Medication
timing
+
Quantity
|
|
18819-3
|
Psychiatric
rehabilitation
treatment
plan,
Medication
route
Identifier
|
|
1882-0
|
Apolipoprotein
LPQ
[Mass/volume]
in
Serum
or
Plasma
|
|
18820-1
|
Psychiatric
rehabilitation
treatment
plan,
Primary
diagnosis
Identifier
|
|
18821-9
|
Diagnosis
addressed
by
plan
|
|
18822-7
|
Diagnosis
addressed
by
plan
(narrative)
|
|
18823-5
|
Alcohol
and/or
substance
abuse
service
attachment
|
|
18824-3
|
Cardiac
service
attachment
|
|
18825-0
|
Medical
social
services
attachment
|
|
18826-8
|
Occupational
therapy
service
attachment
|
|
1883-8
|
Apolipoprotein
A
[Mass/volume]
in
Serum
or
Plasma
|
|
18833-4
|
First
Body
weight
|
|
18834-2
|
Radiology
Comparison
study
(narrative)
|
|
18835-9
|
Aortic
valve
area
method
Narrative
|
|
18836-7
|
Cardiac
stress
study
Procedure
|
|
18837-5
|
Left
ventricle
Segmental
wall
appearance
by
US
Narrative
|
|
18838-3
|
Cardiac
echo
study
Transducer
site
Narrative
|
|
18839-1
|
Cardiac
echo
imaging
device
Class
Narrative
|
|
1884-6
|
Apolipoprotein
B
[Mass/volume]
in
Serum
or
Plasma
|
|
18840-9
|
Left
ventricular
Wall
motion
index
by
US
Narrative
|
|
18841-7
|
Hospital
consultations
Document
|
|
18842-5
|
Discharge
summary
|
|
18843-3
|
EKG
Comparison
study
(narrative)
|
|
18844-1
|
EKG
impression
Narrative
|
|
18845-8
|
Reference
beat
type
(narrative)
by
EKG
|
|
18846-6
|
Examination
level
ultrasound
(narrative)
|
|
18847-4
|
Narrative
Fetal
position
palpation
|
|
18848-2
|
Narrative
Fetal
position
US
|
|
18849-0
|
Narrative
Fetal
presentation
palpation
|
|
1885-3
|
Apolipoprotein
C
[Mass/volume]
in
Serum
or
Plasma
|
|
18850-8
|
Narrative
Fetal
presentation
US
|
|
18851-6
|
Fetal
Placenta
Grade
US
(narrative)
|
|
18852-4
|
Deprecated
Operative
note
-
surgical
drains
(narrative)
|
|
18855-7
|
5-Fluorocytosine
[Susceptibility]
|
|
18857-3
|
Almecillin
[Susceptibility]
|
|
18859-9
|
Amdinocillin
[Susceptibility]
|
|
1886-1
|
Apolipoprotein
E
[Mass/volume]
in
Serum
or
Plasma
|
|
18860-7
|
Amikacin
[Susceptibility]
|
|
18861-5
|
Amoxicillin
[Susceptibility]
|
|
18862-3
|
Amoxicillin+Clavulanate
[Susceptibility]
|
|
18863-1
|
Amphotericin
B
[Susceptibility]
|
|
18864-9
|
Ampicillin
[Susceptibility]
|
|
18865-6
|
Ampicillin+Sulbactam
[Susceptibility]
|
|
18866-4
|
Azithromycin
[Susceptibility]
|
|
18867-2
|
Azlocillin
[Susceptibility]
|
|
18868-0
|
Aztreonam
[Susceptibility]
|
|
18869-8
|
Bacampicillin
[Susceptibility]
|
|
1887-9
|
Appearance
of
Amniotic
fluid
|
|
18870-6
|
Bacitracin
[Susceptibility]
|
|
18871-4
|
Butirosin
[Susceptibility]
|
|
18872-2
|
Capreomycin
[Susceptibility]
|
|
18873-0
|
Carbenicillin
[Susceptibility]
|
|
18874-8
|
Cefaclor
[Susceptibility]
|
|
18875-5
|
Cefadroxil
[Susceptibility]
|
|
18876-3
|
Cefamandole
[Susceptibility]
|
|
18877-1
|
Cefatrizine
[Susceptibility]
|
|
18878-9
|
Cefazolin
[Susceptibility]
|
|
18879-7
|
Cefepime
[Susceptibility]
|
|
1888-7
|
Aquacobalamin
[Mass/volume]
in
Serum
or
Plasma
|
|
18880-5
|
Cefixime
[Susceptibility]
|
|
18881-3
|
Cefmetazole
[Susceptibility]
|
|
18882-1
|
Cefodizime
[Susceptibility]
|
|
18883-9
|
Cefonicid
[Susceptibility]
|
|
18884-7
|
Cefoperazone
[Susceptibility]
|
|
18885-4
|
Ceforanide
[Susceptibility]
|
|
18886-2
|
Cefotaxime
[Susceptibility]
|
|
18887-0
|
Cefotetan
[Susceptibility]
|
|
18888-8
|
Cefoxitin
[Susceptibility]
|
|
18889-6
|
Cefpirome
[Susceptibility]
|
|
1889-5
|
Arachidonate
(C20:4w6)
[Mass/volume]
in
Serum
or
Plasma
|
|
18890-4
|
Cefpodoxime
[Susceptibility]
|
|
18891-2
|
Cefprozil
[Susceptibility]
|
|
18892-0
|
Cefsulodin
[Susceptibility]
|
|
18893-8
|
Ceftazidime
[Susceptibility]
|
|
18894-6
|
Ceftizoxime
[Susceptibility]
|
|
18895-3
|
Ceftriaxone
[Susceptibility]
|
|
18896-1
|
Cefuroxime
Parenteral
[Susceptibility]
|
|
18897-9
|
Cephalexin
[Susceptibility]
|
|
18898-7
|
Cephaloglycin
[Susceptibility]
|
|
18899-5
|
Cephaloridine
[Susceptibility]
|
|
189-1
|
Clarithromycin
[Susceptibility]
by
Minimum
inhibitory
concentration
(MIC)
|
|
1890-3
|
Arginase
[Enzymatic
activity/volume]
in
Red
Blood
Cells
|
|
18900-1
|
Cephalothin
[Susceptibility]
|
|
18901-9
|
Cephapirin
[Susceptibility]
|
|
18902-7
|
Cephradine
[Susceptibility]
|
|
18903-5
|
Chloramphenicol
[Susceptibility]
|
|
18904-3
|
Chlortetracycline
[Susceptibility]
|
|
18905-0
|
Cinoxacin
[Susceptibility]
|
|
18906-8
|
Ciprofloxacin
[Susceptibility]
|
|
18907-6
|
Clarithromycin
[Susceptibility]
|
|
18908-4
|
Clindamycin
[Susceptibility]
|
|
18909-2
|
Clotrimazole
[Susceptibility]
|
|
1891-1
|
Arginine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
18910-0
|
Cloxacillin
[Susceptibility]
|
|
18911-8
|
Colistimethate
|
|
18912-6
|
Colistin
[Susceptibility]
|
|
18913-4
|
Cyclacillin
[Susceptibility]
|
|
18914-2
|
Cycloserine
[Susceptibility]
|
|
18915-9
|
Demeclocycline
[Susceptibility]
|
|
18916-7
|
Dicloxacillin
[Susceptibility]
|
|
18917-5
|
Doxycycline
[Susceptibility]
|
|
18918-3
|
Enoxacin
[Susceptibility]
|
|
18919-1
|
Erythromycin
[Susceptibility]
|
|
1892-9
|
Arginine
[Presence]
in
Serum
or
Plasma
|
|
18920-9
|
Erythromycin+Sulfisoxazole
[Susceptibility]
|
|
18921-7
|
Ethambutol
[Susceptibility]
|
|
18922-5
|
Ethionamide
[Susceptibility]
|
|
18923-3
|
Floxacillin
[Susceptibility]
|
|
18924-1
|
Fluconazole
[Susceptibility]
|
|
18925-8
|
Deprecated
5-Fluorocytosine
[Susceptibility]
|
|
18926-6
|
Framycetin
[Susceptibility]
|
|
18927-4
|
Fusidate
[Susceptibility]
|
|
18928-2
|
Gentamicin
[Susceptibility]
|
|
18929-0
|
Gentamicin.high
potency
[Susceptibility]
|
|
1893-7
|
Arginine
[Mass/volume]
in
Serum
or
Plasma
|
|
18930-8
|
Gramicidin
D
[Susceptibility]
|
|
18931-6
|
Hetacillin
[Susceptibility]
|
|
18932-4
|
Imipenem
[Susceptibility]
|
|
18933-2
|
Deprecated
Imipenem+Cilastatin
[Susceptibility]
|
|
18934-0
|
Isoniazid
[Susceptibility]
|
|
18935-7
|
Kanamycin
[Susceptibility]
|
|
18936-5
|
Kanamycin.high
potency
[Susceptibility]
|
|
18937-3
|
Ketoconazole
[Susceptibility]
|
|
18938-1
|
Lincomycin
[Susceptibility]
|
|
18939-9
|
Lomefloxacin
[Susceptibility]
|
|
1894-5
|
Arginine
[Mass/volume]
in
Urine
|
|
18940-7
|
Loracarbef
[Susceptibility]
|
|
18941-5
|
Lymecycline
[Susceptibility]
|
|
18942-3
|
Meclocycline
[Susceptibility]
|
|
18943-1
|
Meropenem
[Susceptibility]
|
|
18944-9
|
Methacycline
[Susceptibility]
|
|
18945-6
|
Methicillin
[Susceptibility]
|
|
18946-4
|
Metronidazole
[Susceptibility]
|
|
18947-2
|
Mezlocillin
[Susceptibility]
|
|
18948-0
|
Minocycline
[Susceptibility]
|
|
18949-8
|
Miocamycin
[Susceptibility]
|
|
1895-2
|
Arginine
[Mass/time]
in
24
hour
Urine
|
|
18950-6
|
Moxalactam
[Susceptibility]
|
|
18951-4
|
Nafcillin
[Susceptibility]
|
|
18952-2
|
Nalidixate
[Susceptibility]
|
|
18953-0
|
Neomycin
[Susceptibility]
|
|
18954-8
|
Netilmicin
[Susceptibility]
|
|
18955-5
|
Nitrofurantoin
[Susceptibility]
|
|
18956-3
|
Norfloxacin
[Susceptibility]
|
|
18957-1
|
Novobiocin
[Susceptibility]
|
|
18958-9
|
Nystatin
[Susceptibility]
|
|
18959-7
|
Ofloxacin
[Susceptibility]
|
|
1896-0
|
Argininosuccinate
[Mass/volume]
in
Serum
or
Plasma
|
|
18960-5
|
Oleandomycin
[Susceptibility]
|
|
18961-3
|
Oxacillin
[Susceptibility]
|
|
18962-1
|
Oxytetracycline
[Susceptibility]
|
|
18963-9
|
Pefloxacin
[Susceptibility]
|
|
18964-7
|
Penicillin
[Susceptibility]
|
|
18965-4
|
Penicillin
G
[Susceptibility]
|
|
18966-2
|
Penicillin
V
[Susceptibility]
|
|
18967-0
|
Phenethicillin
[Susceptibility]
|
|
18968-8
|
Pipemidate
[Susceptibility]
|
|
18969-6
|
Piperacillin
[Susceptibility]
|
|
1897-8
|
Argininosuccinate
[Mass/volume]
in
Urine
|
|
18970-4
|
Piperacillin+Tazobactam
[Susceptibility]
|
|
18971-2
|
Pivampicillin
[Susceptibility]
|
|
18972-0
|
Polymyxin
B
[Susceptibility]
|
|
18973-8
|
Pyrazinamide
[Susceptibility]
|
|
18974-6
|
Rifampin
[Susceptibility]
|
|
18975-3
|
Ristocetin
[Susceptibility]
|
|
18976-1
|
Rolitetracycline
[Susceptibility]
|
|
18977-9
|
Rosoxacin
[Susceptibility]
|
|
18978-7
|
Roxithromycin
[Susceptibility]
|
|
18979-5
|
Sisomicin
[Susceptibility]
|
|
1898-6
|
Argininosuccinate
lyase
[Enzymatic
activity/volume]
in
Serum
|
|
18980-3
|
Spectinomycin
[Susceptibility]
|
|
18981-1
|
Spiramycin
[Susceptibility]
|
|
18982-9
|
Streptomycin
[Susceptibility]
|
|
18983-7
|
Streptomycin.high
potency
[Susceptibility]
|
|
18984-5
|
Sulfadiazine
[Susceptibility]
|
|
18985-2
|
Sulfamethoxazole
[Susceptibility]
|
|
18986-0
|
Sulfisoxazole
[Susceptibility]
|
|
18987-8
|
Sulfonamide
[Susceptibility]
|
|
18988-6
|
Talampicillin
[Susceptibility]
|
|
18989-4
|
Teicoplanin
[Susceptibility]
|
|
1899-4
|
Argininosuccinate
synthase
[Enzymatic
activity/mass]
in
Tissue
|
|
18990-2
|
Temafloxacin
[Susceptibility]
|
|
18991-0
|
Temocillin
[Susceptibility]
|
|
18992-8
|
Terbinafine
[Susceptibility]
|
|
18993-6
|
Tetracycline
[Susceptibility]
|
|
18994-4
|
Ticarcillin
[Susceptibility]
|
|
18995-1
|
Ticarcillin+Clavulanate
[Susceptibility]
|
|
18996-9
|
Tobramycin
[Susceptibility]
|
|
18997-7
|
Trimethoprim
[Susceptibility]
|
|
18998-5
|
Trimethoprim+Sulfamethoxazole
[Susceptibility]
|
|
18999-3
|
Troleandomycin
[Susceptibility]
|
|
19-0
|
Amoxicillin+Clavulanate
[Susceptibility]
by
Minimum
lethal
concentration
(MLC)
|
|
190-9
|
Clarithromycin
[Susceptibility]
by
Disk
diffusion
(KB)
|
|
1900-0
|
Arylamidase
[Enzymatic
activity/volume]
in
Serum
|
|
19000-9
|
Vancomycin
[Susceptibility]
|
|
19001-7
|
Viomycin
[Susceptibility]
|
|
19002-5
|
Physical
therapy
service
attachment
|
|
19003-3
|
Respiratory
therapy
service
attachment
|
|
19004-1
|
Skilled
nursing
service
attachment
|
|
19005-8
|
Radiology
Imaging
study
[Impression]
(narrative)
|
|
19006-6
|
Cardiac
echo
imaging
device
Image
quality
Narrative
by
US
|
|
19007-4
|
Psychiatric
rehabilitation
treatment
plan,
Primary
diagnosis
Set
|
|
19008-2
|
Transducer
site
Narrative
|
|
19009-0
|
Medication
current
(narrative)
|
|
1901-8
|
Arylsulfatase
[Enzymatic
activity/volume]
in
Serum
or
Plasma
|
|
19010-8
|
Medication
discharge
(narrative)
|
|
19011-6
|
Medication
administered
(narrative)
|
|
19012-4
|
Discharge
medication,
Substitution
instruction
|
|
19013-2
|
Medications
current
report
request
|
|
19014-0
|
Medications
discharge
report
request
|
|
19015-7
|
Medications
administered
report
request
|
|
19016-5
|
X12
277,
all
requests
for
information
that
are
included
in
this
transaction
are
stated
for
individual
services
|
|
1902-6
|
Ascorbate
[Mass/volume]
in
Blood
|
|
19021-5
|
Palpitation
Cervix
Study
observation
(narrative)
|
|
19022-3
|
Neisseria
meningitidis
C+w135
Ag
[Presence]
in
Cerebral
spinal
fluid
|
|
19023-1
|
Granulocytes/100
leukocytes
in
Blood
by
Automated
count
|
|
1903-4
|
Ascorbate
[Mass/volume]
in
Serum
or
Plasma
|
|
1904-2
|
Ascorbate
[Presence]
in
Urine
|
|
19044-7
|
Fish
Feed
IgE
Ab
RAST
class
[Presence]
in
Serum
|
|
19045-4
|
Salmon
IgG
Ab
RAST
class
[Presence]
in
Serum
|
|
19046-2
|
Deprecated
Bovine
serum
albumin
(BSA)
IgE
Ab
RAST
class
in
Serum
|
|
19047-0
|
Tuna
IgG
Ab
RAST
class
[Presence]
in
Serum
|
|
19048-8
|
Nucleated
erythrocytes/100
leukocytes
[Ratio]
in
Blood
|
|
19049-6
|
Metanephrine
[Mass/time]
in
24
hour
Urine
|
|
1905-9
|
Ascorbate
[Mass/time]
in
24
hour
Urine
|
|
19050-4
|
Metanephrines
[Mass/volume]
in
24
hour
Urine
|
|
19051-2
|
Saquinavir
[Mass/volume]
in
Serum
or
Plasma
|
|
19052-0
|
Borrelia
burgdorferi
DNA
[Presence]
in
Urine
by
Probe
with
amplification
|
|
19053-8
|
Brucella
sp
Ab
[Titer]
in
Serum
by
Agglutination
|
|
19054-6
|
Mycoplasma
pneumoniae
[Presence]
in
Unspecified
specimen
by
Organism
specific
culture
|
|
19055-3
|
Carboxy
tetrahydrocannabinol/Creatinine
[Mass
Ratio]
in
Urine
|
|
19056-1
|
Mercury
[Presence]
in
Urine
|
|
19057-9
|
ABO
and
Rh
group
[Type]
in
Blood
from
newborn
|
|
19058-7
|
Allergens
identified
in
Serum
|
|
19059-5
|
Amphetamines
cutoff
[Mass/volume]
in
Urine
|
|
1906-7
|
Asparagine
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
19060-3
|
Deprecated
Blood
group
antibodies
identified
in
Serum
or
Plasma
|
|
19064-5
|
Benzodiazepines
cutoff
[Mass/volume]
in
Urine
|
|
19065-2
|
Benzoylecgonine
cutoff
[Mass/volume]
in
Urine
|
|
19066-0
|
Blood
bank
comment
|
|
1907-5
|
Asparagine
[Presence]
in
Serum
or
Plasma
|
|
19071-0
|
Blood
removed
from
patient
[Volume]
|
|
19072-8
|
Calcium.ionized
[Moles/volume]
adjusted
to
pH
7.4
in
Serum
or
Plasma
|
|
19073-6
|
Cannabinoids
cutoff
[Mass/volume]
in
Urine
|
|
19074-4
|
Carnitine
esters
[Moles/volume]
in
Serum
or
Plasma
|
|
19075-1
|
Cells
Counted
Total
[#]
in
Cerebral
spinal
fluid
|
|
19076-9
|
Cells
Counted
Total
[#]
in
Unspecified
specimen
|
|
19077-7
|
Cells
identified
in
Body
fluid
|
|
19078-5
|
CD23
cells/100
cells
in
Unspecified
specimen
|
|
19079-3
|
CD43
cells/100
cells
in
Unspecified
specimen
|
|
1908-3
|
Asparagine
[Mass/volume]
in
Serum
or
Plasma
|
|
19080-1
|
Choriogonadotropin
[Units/volume]
in
Serum
or
Plasma
|
|
19085-0
|
Deprecated
Collection
duration
of
Urine
-
time
unspecified
|
|
19086-8
|
Collection
of
urine
specimen
end
date
|
|
19087-6
|
Collection
of
urine
specimen
end
time
|
|
19088-4
|
Collection
of
urine
specimen
start
date
|
|
19089-2
|
Collection
of
urine
specimen
start
time
|
|
1909-1
|
Asparagine
[Mass/volume]
in
Urine
|
|
19090-0
|
Colony
count
[#/volume]
in
Urine
|
|
19091-8
|
Colony
count
[#]
in
Urine
by
Visual
count
|
|
19092-6
|
Cotinine
cutoff
[Mass/volume]
in
Urine
|
|
19096-7
|
Electrolytes
-
single
valence
[Interpretation]
in
24
hour
Urine
Narrative
|
|
19098-3
|
Erythrocytes
[Presence]
in
Amniotic
fluid
|
|
19099-1
|
Events
counted
[#]
in
Unspecified
specimen
|
|
191-7
|
Clarithromycin
[Susceptibility]
by
Serum
bactericidal
titer
|
|
1910-9
|
Asparagine
[Mass/time]
in
24
hour
Urine
|
|
19101-5
|
Fungus
colony
count
[#/volume]
in
Unspecified
specimen
by
Culture
|
|
19102-3
|
Genetic
screen
in
Unspecified
specimen
by
Molecular
genetics
method
Narrative
|
|
19104-9
|
Glucose
[Interpretation]
in
Serum
or
Plasma--1
hour
post
dose
glucose
|
|
19105-6
|
Glucose
[Interpretation]
in
Serum
or
Plasma--3
hours
post
dose
glucose
|
|
19106-4
|
Herpes
simplex
virus
IgG
Ab
[Presence]
in
Serum
|
|
19107-2
|
Histoplasma
capsulatum
Ag
[Units/volume]
in
Serum
by
Radioimmunoassay
(RIA)
|
|
19108-0
|
Histoplasma
capsulatum
Ag
[Presence]
in
Serum
|
|
19109-8
|
Histoplasma
capsulatum
Ag
[Presence]
in
Unspecified
specimen
|
|
1911-7
|
Aspartate
[Mass/volume]
in
Cerebral
spinal
fluid
|
|
19110-6
|
HIV
1
gp41+gp43
Ab
[Presence]
in
Serum
by
Immunoblot
(IB)
|
|
19111-4
|
Mother's
hospital
number
|
|
19113-0
|
IgE
[Units/volume]
in
Serum
or
Plasma
|
|
19114-8
|
Lamellar
bodies
[#/volume]
in
Amniotic
fluid
|
|
1912-5
|
Aspartate
[Presence]
in
Serum
or
Plasma
|
|
19122-1
|
CD42
cells/100
cells
in
Blood
|
|
19123-9
|
Magnesium
[Mass/volume]
in
Serum
or
Plasma
|
|
19124-7
|
Magnesium
[Mass/volume]
in
Urine
|
|
19125-4
|
Meconium
[Presence]
in
Amniotic
fluid
|
|
19126-2
|
Bacteria
identified
in
Bone
marrow
by
Aerobe
culture
|
|
19127-0
|
Bacteria
identified
in
Sputum
by
Acute
Respiratoy
Distress
(ARDS)
culture
|
|
19128-8
|
Bacteria
identified
in
Catheter
tip
by
Culture
|
|
19129-6
|
Microscopic
observation
[Identifier]
in
Tissue
by
Biopsy
culture
|
|
1913-3
|
Aspartate
[Mass/volume]
in
Serum
or
Plasma
|
|
19132-0
|
Mother's
name
|
|
19133-8
|
Neisseria
meningitidis
A+C+w135+Y
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
19134-6
|
Neisseria
meningitidis
B+Escherichia
coli
K1
Ag
[Presence]
in
Cerebral
spinal
fluid
by
Latex
agglutination
|
|
19137-9
|
Neuronal
nuclear
Ab
[Units/volume]
in
Serum
by
Immunoblot
(IB)
|
|
19138-7
|
Opiates
cutoff
[Mass/volume]
in
Urine
|
|
19139-5
|
Pathologist
name
|
|
1914-1
|
Aspartate
[Mass/volume]
in
Urine
|
|
19140-3
|
Phospholipid
Ab
[Presence]
in
Serum
|
|
19141-1
|
Propoxyphene
[Presence]
in
Urine
|
|
19144-5
|
Reason
for
drug
test
[Interpretation]
|
|
19145-2
|
Reference
lab
test
name
|
|
19146-0
|
Reference
lab
test
results
|
|
19147-8
|
Reference
lab
test
reference
range
|
|
19148-6
|
RhoGam
candidate
(yes/no)
|
|
19149-4
|
Rifabutin
[Susceptibility]
|
|
1915-8
|
Aspartate
[Mass/time]
in
24
hour
Urine
|
|
19150-2
|
Specimen
creatinine
acceptable
[Presence]
in
Urine
|
|
19151-0
|
Specimen
drawn
[Date
and
time]
of
Serum
or
Plasma
|
|
19152-8
|
Specimen
specific
gravity
acceptable
[Presence]
in
Urine
|
|
19153-6
|
Volume
in
Urine
collected
for
unspecified
duration
|
|
19156-9
|
Susceptibility
method
-
Unspecified
specimen
|
|
19157-7
|
Tube
number
of
Cerebral
spinal
fluid
|
Terminology
.
Page
versions:
R5
R4B
R4
R3
R2
|
Propose
a
change